Telltales

Hunt, Mike, and Jason go more than half healthcare this week: Moderna’s Merck-partnered mRNA cancer vaccine cleared phase 3 in melanoma and the stock doubled. Plus Hormuz at a standstill, $7 trillion of federal spending with only one line left to cut, and xAI putting agents on the shelf.The Cashflow MemoKey Takeaways* Hormuz traffic has gone from 15-20 ships a day to effectively zero and Hunt sees an indefinite stalemate, so with WTI at 82 last Thursday against a 2027 strip at 73, the backwardated 2027 price is the number to underwrite because it is the number operators use for their own capital decisions.* Gas printed under $3 front-month while the 2027 strip holds near $3.40, and with the Permian supplying two-thirds of US supply growth, new Gulf Coast pipelines narrowing Waha to roughly 50 cents under Henry Hub, and LNG feedgas above 18 Bcf/d this year, the 108.5 and 110.5 Bcf/d supply estimates for ’26 and ’27 both look too low.* On Exhibit A’s $7 trillion of FY26 federal spending, healthcare is the only line with real money in it (Medicaid alone is $600 billion, half federally funded), because defense is heading to $1.1-1.2 trillion and interest is locked at a 3.5% average rate with the 10-year at 4.6% - and Jason put Medicare improper payments near 6% with fraud between 3% and north of 10%.* Moderna doubled on a Merck-partnered phase 3 melanoma readout (Keytruda alone versus Keytruda plus a personalized 34-antigen mRNA vaccine) that met all endpoints on a press release with no data attached, validating a decade of platform work rather than a single drug.* The capital-allocation scoreboard flipped: BioNTech was the safer steward and still holds roughly $15 billion of COVID cash to Moderna’s $3 billion as of the March balance sheet, but the hare reached the cancer readout first, and Montana’s read is that the trial proves the technology rather than the drug, which is what makes Moderna’s nine other cancer studies matter.* xAI shipped off-the-shelf Grok agents that cut agent build time from months to about a day, 64% of OpenAI’s tokens are now consumed agentically rather than through human prompts, and that demand curve widens the compute gap further just as Nvidia backstops the physical shell of an OpenAI data center in Ohio and the governors of Pennsylvania, New York, and Texas impose one-year delays or audits on new projects.Show Notes[00:00:30] Exhibit C: Iran, Hormuz, and the Stalemate Traffic through the strait has fallen from 15-20 ships a day to near zero on projectile risk. Hunt sees no path to resolution and argues the 2027 strip at 73, not spot at 82, is the price that should drive investment decisions.[00:04:03] Exhibit B: Natural Gas and the Permian Problem Front-month gas under $3 against a 2027 strip near $3.40. New pipelines have pulled Waha to roughly 50 cents under Henry Hub, and rising associated gas means the published supply estimates are almost certainly too low.[00:05:51] Exhibit A: $7 Trillion and One Place to Cut Long rates are rising worldwide on deficits, not just in the US. Hunt walks the spending columns and finds healthcare is the only category with real savings available, with Medicaid at $600 billion the specific target.[00:10:58] Moderna vs. BioNTech: Page 15 The two mRNA COVID winners diverged on capital allocation - BioNTech kept roughly $15 billion, Moderna ran cash down to $3 billion. Then Moderna announced results and doubled.[00:12:44] The Phase 3 Melanoma Readout Jason lays out the Merck joint development study: stage 3 and 4 melanoma patients, surgical resection, then Keytruda alone versus Keytruda plus an mRNA cancer vaccine. All endpoints met, though no data was released with the press release.[00:13:51] How the Cancer Vaccine Actually Works Montana explains antigen identification via genetic sequencing, the 34 most prominent antigens per tumor, lipid encapsulation, and priming the immune system to catch recurrence before it becomes a tumor.[00:17:48] Nine More Cancers: Does the Platform Travel? Mike asks how investors should handicap the same approach across Moderna’s nine other studies. Montana’s answer: this proves the technology, not a drug - the question is whether the antigen flags stay identifiable.[00:20:07] MRD Testing and the Sequencing Layer Minimal residual disease testing as a monitoring tool, reading cell-free tumor DNA from a blood draw to guide treatment protocols before an end-of-treatment scan.[00:22:06] xAI Ships Agents Off the Shelf Grok agents cut build time from the months Mike and Jason spent to about a day. Jason’s read: AI is just software, and the endpoint is a personal assistant that ships on every phone.[00:25:25] The Token Gap Widens Agentic consumption is now 64% of OpenAI’s tokens versus human prompts. If an agent ships native on every handset, demand steps up again against compute that already cannot serve it.[00:27:43] Nvidia Backstops a Data Center Shell Nvidia is guaranteeing the building, not just the GPUs, on an Ohio site with OpenAI as end customer. Ben Thompson frames it as discounting by taking risk instead of cutting price.[00:28:48] Governors Hit Pause One-year delays in Pennsylvania and New York, an audit requirement in Texas, and a public-sentiment problem that Jensen Huang himself is flagging as a constraint on where the chips can go.Get the Cash Flow Memo at telltales.us and subscribe for a new episode every Wednesday.Cashtags$BNTX $MRK $MRNA $NVDA $PFE This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →The AI Buildout Just Became a Credit TradeBroadcom put up the best AI guidance in the semiconductor industry and lost five percent for it. Nobody who read the release thinks that was a demand problem. The buildout has passed the point where equity markets fund it, and what prices the chip names from here is whether somebody else’s lender says yes.Start with the number that did the damage. Bank of America’s Tom Curcuruto put the financing requirement sitting behind the chip buildout at three-hundred-seventy billion dollars, and downgraded on XPU credit risk¹². Not on units. Not on the guide. Fifty-six billion of 2026 AI revenue, up a hundred and eighty percent³, was never in dispute. The bank asked who writes the checks and did not like the answer.Three-hundred-seventy billion dollars.That is the analytical move worth taking seriously, because it re-prices the whole complex. An order book is a claim on somebody else’s balance sheet. When the buyer is Alphabet, the claim is money good and the conversation stays boring. Alphabet’s own filings show AI purchase commitments going from three-hundred-thirty-two billion at the end of the first quarter to eight-hundred-eleven billion by the end of the second⁴, with capex guided to one-ninety-five to two-oh-five billion and free cash flow explicitly taken negative to fund it⁵. Alphabet can carry that. The question was never Alphabet. The question is the tier underneath: the neoclouds, the sovereign projects, the model labs whose GPU orders are contracted against capital they have not raised yet.The last time the equipment cycle outran its customers’ ability to pay, the vendors solved it themselves. Lucent and Nortel financed the competitive carriers buying their gear, booked the revenue, and carried the receivable. When the carriers could not refinance in 2001, the write-downs landed on the vendors’ own income statements. Ugly, and useful, because you could see it coming in the filings. The receivable line moved first.This cycle solved the same problem in a way that removes exactly that tell. The credit is not on the vendor’s books. It is syndicated out to private capital, which is what Nvidia’s five-hundred-billion-dollar third-party financing platform with Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR is actually for⁶. Hunt, Jason and Mike took that apart on Wednesday’s show from the supply side. Read it from the credit side and it is the more interesting object: the vendor arranging the loan without holding the loan. Revenue converts to cash on delivery, and the duration risk sits with somebody whose marks nobody publishes quarterly. There is no receivable line to watch, because there is no receivable.Which is why Intel is the honest data point of the week. A company that needed twenty billion dollars to fund AI capacity went and sold common stock at ninety-five a share to get it⁷, upsized from fifteen. That is what it looks like when the credit window is not the cheapest window available to you. The cashflow read is in Marcus’s column below, short version, the memo has the whole complex priced as though the funding is settled. Page one of the Cash Flow Memo has Alphabet at roughly fifty-six billion of trailing free cash flow against a hundred and thirty-two billion of trailing capex⁸⁹. The buildout is already being paid for out of somebody’s balance sheet. The only live question is whose, and at what spread.What changes the read. The disclosure that matters on Broadcom’s next print is customer concentration, not the AI revenue guide. If the ten-K names the XPU customers and they are all investment grade, the BofA cut ages badly. If the concentration line stays vague, the three-hundred-seventy billion is not a modeling assumption, it is a gap. Nvidia reports Wednesday the twenty-sixth¹⁰, and the tell there is the same one: financed demand versus funded demand, and whether management will separate them out loud. Watch private credit spreads on data-center paper alongside the print. Those two things now move the semis together, and the thesis breaks the first quarter they diverge.Wall Street’s consensus on the AI financing question: the demand is real, so the money will be there. The demand was real in 1999 too. It was the money that stopped.The Tape — W2633Universe of 94 cashflow-memo names, snap dates 2026-08-07 → 2026-08-14. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamMicron is the one line on this table where two multiples describe two different companies. Forward P/E of 6.5 says the market has already called the top of the memory cycle. EV/FCF of 40.7 says the cash from this cycle has not arrived yet. Both can be true for another quarter or two, and NTM revenue growth of 92.8% is the only thing reconciling them. Consensus reads the 6.5 as cheap. It is not cheap, it is a peak-earnings multiple behaving the way peak-earnings multiples behave, and the composite here is carried by the growth leg, not the cash leg. The test on the next print is whether free cash flow converges toward earnings or the gap holds open on capex. I read it as roughly 60/40 that it closes.Telltales Yield — Bottom 10This Week’s ReportersSector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps90 of 92 ranked-eligible names ranked. 2 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-08-14.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoWho’s Paying For ItThe AI buildout outgrew its own cash flow, and this week the invoices got itemized.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 14 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2634.Chapter markers* Time | Segment* 0:00 | Cold open — the buildout outran the cash flow* 0:45 | Theme — who’s paying for it: Alphabet, Broadcom, Intel* 4:45 | Deep dive — Apple: Cook hands over the margin* 8:45 | Rapid fire — PayPal, Eli Lilly, Snowflake, Microsoft* 11:45 | Close — Consensus Watch and the forward week* 12:40 | Closing disclaimerFull transcriptCold openAva: The AI buildout has officially outrun free cash flow. This week three companies showed you how they intend to cover the gap. Alphabet is covering it with commitments. Broadcom is covering it with somebody else’s credit. Intel covered it by printing $20 billion of new stock in a single week. And the largest company in the memo, which is not building any of it, is paying for it anyway, out of gross margin, in the same week it changed CEOs. Somebody always pays. This week the invoices got itemized.Ava: Telltales Weekend Update. I’m Ava Cabot, with Marcus Graham at the cashflow desk.Theme — who’s paying for itAva: Alphabet on page 1, Broadcom on page 2, Intel on page 3. Three pages of the Cash Flow Memo, one problem. Start with Alphabet, because Alphabet stopped being a cash-generative company this quarter and told you so in writing. AI purchase commitments went from $332.4 billion at the end of the first quarter to $811 billion by the end of the second[^news-googl-commitments-20260814]. In one quarter. Capital expenditure guidance for the full year moved to $195-205 billion, and Alphabet said plainly that this takes free cash flow negative[^news-googl-capex-20260814]. And in the same week the world found out that Berkshire Hathaway spent the quarter buying it, lifting its stake 83% to nearly 106 million shares, about $37.8 billion, now a top-three Berkshire holding[^news-googl-berkshire-20260814][^news-googl-berkshire-stake-20260814]. Marcus, what does Buffett see that the free cash flow line doesn’t?Marcus: Alphabet stopped being a cash machine on purpose, and that’s a defensible thing to do once. The memo has capex running about $132 billion trailing twelve months[^memo-googl-capex-20260814] against roughly $56 billion of trailing free cash flow[^memo-googl-fcf-20260814]. Then they guided capex to $195-205 billion for the year[^news-googl-capex-20260814]. When you spend at that rate free cash flow goes negative, and that’s the cost of the build, not a flag. Which means the multiple isn’t the right frame on this name right now. What actually prices Alphabet is whether that commitment book converts into revenue that clears the depreciation it just bought. I’d hold that read until the December quarter shows an operating margin with the new asset base in it.Ava: There is one more line in Alphabet’s filings worth sitting with. More than 70% of net income last quarter came from investments in other companies, largely Elon Musk’s SpaceX[^news-googl-spacex-income-20260814]. Alphabet disclosed a 7.2% stake in SpaceX Class A stock — 551.2 million shares across Alphabet, XXVI Holdings and Google[^news-googl-spacex-stake-20260814]. The search company’s earnings quality this quarter is a rocket company. Now Broadcom, which had the opposite kind of week: the numbers were excellent and the stock fell anyway. AI revenue guidance for 2026 of $56 billion, up 180%. Quarterly revenue of $22.2 billion, up 48%. EPS of $2.44 against $2.40 consensus[^news-avgo-ai-guidance-20260814]. AI semiconductor revenue alone hit $10.8 billion in the quarter, up 143%[^news-avgo-ai-guidance-20260814]. The stock finished down nearly 5%[^news-avgo-drop-20260814].Marcus: Broadcom’s problem isn’t demand. It’s who funds the customer. Bank of America didn’t cut the revenue line, it cut the credit — analyst Tom Curcuruto put the financing requirement behind that chip buildout at $370 billion[^news-avgo-financing-20260814], and downgraded on XPU credit risk[^news-avgo-bofa-cut-20260814]. The memo has Broadcom at about 54x trailing free cash flow[^memo-avgo-evfcf-20260814] on $36 billion of trailing FCF[^memo-avgo-fcf-20260814]. That is a price that assumes every one of those customers can pay for what they ordered. The disclosure I’d watch next print is customer concentration, not the revenue guide.Ava: The order book is only as good as the balance sheet on the other end of it. Which brings us to Intel, which did not wait for anybody else’s balance sheet. Intel announced a $15 billion common stock offering and then upsized it to $20 billion, at $95 a share, to fund AI capacity[^news-intc-offering-20260811]. Marcus — what does that raise tell you about Intel’s own cash flow?Marcus: That management doesn’t think it has any. $20 billion of equity[^news-intc-offering-20260811] against about $4 billion of trailing free cash flow[^memo-intc-fcf-20260814] and $12 billion of trailing capex[^memo-intc-capex-20260814]. Everything this company generates in a year, raised in a week and sold to strangers, and it still doesn’t cover the spend. At that free cash flow level the multiple is noise, so don’t use it. What decides this is whether the foundry customers behind the raise are contracted or hoped for, and Intel hasn’t told you which.Deep dive — AppleAva: Apple is the other name on page 1, and Apple is the one company in this conversation that could write the check for all of it and has decided not to. Tim Cook steps down as chief executive on September 1. John Ternus takes the job. Cook becomes Executive Chairman[^news-aapl-ceo-transition-20260814]. Twenty-five years, and the handoff lands in the middle of a quarter that split cleanly down the middle: revenue of $109.4 billion, up 16%, EPS up 29% — and the stock down 5%[^news-aapl-q3-earnings-20260814].Marcus: Apple is funding the AI era by declining to participate in it, and the cash flow statement has never looked better for it. The memo has Apple at about 32x trailing free cash flow[^memo-aapl-evfcf-20260814], a 3.1% free cash flow yield[^memo-aapl-fcfyield-20260814], on $137 billion of trailing free cash flow[^memo-aapl-fcf-20260814]. That is a business getting better at turning revenue into cash while the story around it gets worse. The quarter is fine. The guide is where the argument is.Ava: And the guide is where it went wrong. Apple told the Street to expect 9% to 11% revenue growth in the September quarter, against consensus above 12%[^news-aapl-q4-guidance-20260814]. Gross margin is guided to slip to 47%-48%, from roughly 50% in June[^news-aapl-margin-guidance-20260814]. Jefferies had already cut the stock to a sell-equivalent rating four days earlier, taking its target to $263.66 from $285.56, on supply-chain checks indicating the all-glass iPhone has been cancelled[^news-aapl-jefferies-target-20260810][^news-aapl-jefferies-downgrade-20260810].Marcus: Here is the comparison the headlines missed. Apple spent about $10 billion on capital expenditure over the last twelve months[^memo-aapl-capex-20260814] and $82 billion buying back its own stock[^memo-aapl-buyback-20260814]. Alphabet, same page of the memo, same end market, spent $132 billion on capex over the same window[^memo-googl-capex-20260814]. One of them is buying capacity. The other is buying scarcity in its own shares. Both are coherent strategies and we find out which one was right somewhere around the end of the decade.Ava: Two philosophies, one page. Marcus, on the margin guide specifically — cost or mix?Marcus: I’d weight it as cost. 47%-48% against roughly 50% in June[^news-aapl-margin-guidance-20260814] is a guided step down, not a modeled one. Call it 70/30 that this is component cost and it persists into next year, rather than a one-product build expense that washes out. The December print is the test.Ava: So the new chief executive’s first job is finding the margin his predecessor just gave away.Marcus: And that’s the real succession risk, which is timing rather than strategy. Ternus is a hardware engineer inheriting a company whose next four quarters get decided by component prices and a single launch, with the market already paying about 33x forward earnings for the handoff[^memo-aapl-fwdpe-20260814]. Apple’s trailing revenue is $467 billion[^memo-aapl-revenue-20260814], so the margin step they just guided is somewhere around $9 billion a year of gross profit that has to come from somewhere else. I’d wait for the December print for real evidence, not the keynote.Ava: Which is September 9, when Apple is expected to show the iPhone 18 Pro, the Pro Max, and an all-new foldable[^news-aapl-september-event-20260814]. Eight days after Ternus takes the chair. Cook spent his final weeks as CEO opening a manufacturing plant in Houston alongside Commerce Secretary Howard Lutnick[^news-aapl-houston-plant-20260814]. A supply-chain executive closing out a supply-chain career, handing the company to another supply-chain executive, at the exact moment the binding constraint stopped being supply and started being what supply costs.Rapid fireAva: Rapid fire. Somebody finally put a price on PayPal. Stripe and the private-equity firm Advent International are in talks to buy it at $60.50 a share[^news-pypl-acquisition-talks-20260814]. The stock closed 1.9% above the bid[^news-pypl-bid-premium-20260814], which is the market’s way of saying the first number is not the last number. Going in, the memo had PayPal at 7.5x trailing free cash flow[^memo-pypl-evfcf-20260814] at a 13.4% free cash flow yield[^memo-pypl-fcfyield-20260814], on nearly $7 billion of trailing free cash flow[^memo-pypl-fcf-20260814]. And in the same week PayPal said it will cut roughly 20% of its workforce, about 4,800 people, over the next few years[^news-pypl-layoffs-20260814], while raising full-year adjusted EPS guidance to about $5.38[^news-pypl-guidance-raise-20260814]. A 13% yield and a 20% headcount cut is what a company looks like once it has quietly agreed the growth story is over and the cash is the story.Ava: Eli Lilly put up a quarter that makes the rest of large-cap healthcare look sedentary. Second-quarter revenue of $22.97 billion, up 47.7%, beating consensus by 11.4%, with adjusted EPS of $8.38 against $6.58 expected[^news-lly-earnings-20260814]. Full-year EPS guidance went up nearly $3 at the midpoint, to $35.50-36.50[^news-lly-eps-guidance-20260813]. The oral GLP-1, Foundayo, took its first European approval in the UK[^news-lly-foundayo-approval-20260812], with weekly prescriptions at a new high of 29,388[^news-lly-foundayo-prescriptions-20260814]. And Lilly sued six companies over black-market sales of retatrutide, the obesity drug it has not launched yet[^news-lly-retatrutide-suits-20260812]. Suing counterfeiters of a product you cannot buy is its own kind of demand data. Lilly also agreed to acquire three vaccine biotechs — Curevo, LimmaTech and Vaccine Company — for up to $3.8 billion[^news-lly-vaccine-acquisition-20260814]. That is a company spending obesity money on vaccines, which is what you do when you have more cash than pipeline. The memo has Lilly at 55x trailing free cash flow[^memo-lly-evfcf-20260814] on $21 billion of trailing FCF[^memo-lly-fcf-20260814].Ava: And Snowflake is being priced as though the AI-agent story is already settled. Oppenheimer took its target to $400 from $295, citing consumption trends and adoption of the company’s coding agent[^news-snow-oppenheimer-20260813]. Snowflake raised full-year guidance to about $7.65 billion[^news-snow-fy-guidance-20260813], on quarterly revenue of $1.39 billion, up 33%[^news-snow-q1-earnings-20260814]. The memo has Snowflake at 95x trailing free cash flow[^memo-snow-evfcf-20260814] on about $1.2 billion of trailing FCF[^memo-snow-fcf-20260814]. 95x. At that multiple the guidance is not a data point, it is the whole investment case.Ava: And Microsoft told you what the buildout costs in a single line item. Net losses on its OpenAI investment reduced Microsoft’s net income by $3.1 billion and diluted EPS by $0.41 — that is Microsoft’s own investor-relations disclosure, not somebody’s estimate[^news-msft-openai-loss-20260810]. JPMorgan raised its price target to $625 from $550 in the same week, on 24x projected fiscal 2028 EPS[^news-msft-jpm-target-20260814]. The memo has Microsoft at 53x trailing free cash flow[^memo-msft-evfcf-20260814], on $70 billion of trailing FCF[^memo-msft-fcf-20260814] against $116 billion of trailing capital expenditure[^memo-msft-capex-20260814]. Microsoft is the only name in the memo paying for this buildout twice: once through its own capex, and once through its partner’s income statement.Ava: Forward calendar. Home Depot Tuesday[^earn-hd]. Lowe’s and Target Wednesday[^earn-low][^earn-tgt]. Walmart and Deere Thursday[^earn-wmt][^earn-de]. The entire American consumer inside three days. And then the print that settles the argument in this whole show — NVDA, Wednesday the 26th[^earn-nvda]. We will take that one the weekend before it lands.CloseAva: That’s the show. Wall Street’s consensus on the AI trade this week: the demand is real, so the financing will sort itself out. Broadcom lost 5% finding out those are two separate questions.Ava: The buildout has outrun free cash flow, and every name we covered this week is a different answer to who pays. Alphabet pays out of its own cash flow until there isn’t any. Broadcom is asking its customers’ lenders. Intel asked the equity market and got $20 billion. Microsoft is paying twice and disclosing both. And Apple, which isn’t building any of it, is still handing its new CEO two points of gross margin.Ava: On Wednesday’s episode 2633, Hunt, Jason, and Mike took apart Nvidia’s $500 billion third-party financing platform[^ep-e2633] — the supply side of the exact question this show just spent 13 minutes on. Hunt, Jason, and Mike are back Wednesday on episode 2634.Ava: Download the memo at telltales.us. 20 pages, every week. And send us feedback through the Substack. Every note gets seen.Ava: The show is produced entirely with AI tools, and both voices you’re hearing are AI-generated.Closing disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you. The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* Apple Inc. (2026, August 14). Apple CEO Tim Cook confirms John Ternus as new CEO on September 1. MacRumors. https://www.macrumors.com/2026/08/14/apple-ceo-tim-cook-reflects-on-legacy-apple/* Barchart. (2026, August 14). Oppenheimer just gave Snowflake stock a big vote of confidence. Barchart. https://www.barchart.com/story/news/3857783/oppenheimer-just-gave-snowflake-stock-a-big-vote-of-confidence* BigGo Finance. (2026, August 14). Hyperscaler purchase commitments surge past $1.5 trillion, led by Alphabet. BigGo Finance. https://finance.biggo.com/news/e321e44d-121e-4d0e-8c2d-47ad70fcff25* BigGo Finance. (2026, August 14). JPMorgan lifts Microsoft price target to $625 on AI infrastructure and Copilot profit potential. BigGo Finance. https://finance.biggo.com/news/f76980e4-671d-45a0-8b53-aa2d96cc789e* Breaking The News. (2026, August 14). Broadcom down nearly 5% amid BofA cut, exploit reports. Breaking The News. https://breakingthenews.net/Article/Broadcom-down-nearly-5-amid-BofA-cut-exploit-reports/66924839* CNBC. (2026, August 10). Apple is a sell, glass iPhone debut may be canceled, Jefferies says. CNBC. https://www.cnbc.com/2026/08/10/apple-is-a-sell-glass-iphone-debut-may-be-canceled-jefferies-says-.html* CNBC. (2026, August 10). Don’t let a Wall Street analyst’s downgrade of Apple scare you out of the stock. CNBC. https://www.cnbc.com/2026/08/10/dont-let-a-wall-street-analysts-downgrade-of-apple-scare-you-out-of-the-stock.html* CNBC. (2026, August 11). Intel upsizes stock offering to $20 billion at $95 per share as AI demand accelerates. CNBC. https://www.cnbc.com/2026/08/10/intel-intc-stock-offering-ai.html* CNBC. (2026, August 12). Eli Lilly’s weight loss pill Foundayo gets UK approval. CNBC. https://www.cnbc.com/2026/08/11/eli-lilly-weight-loss-pill-foundayo-gets-uk-approval-plus-oil-holds-back-stocks.html* CNBC. (2026, August 12). Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide. CNBC. https://www.cnbc.com/2026/08/12/lilly-lawsuits-obesity-drug-retatrutide.html* CNBC. (2026, August 14). Apple’s Tim Cook joined by Howard Lutnick in opening Houston manufacturing plant. CNBC. https://www.cnbc.com/2026/08/13/apples-tim-cook-and-howard-lutnick-open-houston-manufacturing-plant.html* CNBC. (2026, August 14). Berkshire Hathaway boosts Alphabet to a top three holding, ups Delta and housing bets. CNBC. https://www.cnbc.com/2026/08/14/berkshire-hathaway-boosts-alphabet-to-a-top-three-holding-ups-delta-and-housing-bets.html* eciks.org. (2026, August 14). Broadcom guides $56B AI revenue for 2026, up 180% from prior year. eciks.org. https://eciks.org/21181-broadcom-avgo-ai-revenue-guidance-2026* Fierce Pharma. (2026, August 14). The oral GLP-1 tracker: Novo’s Wegovy pill vs Lilly’s Foundayo. Fierce Pharma. https://www.fiercepharma.com/pharma/oral-glp-1-tracker-launch-trajectories-lilly-foundayo-novo-wegovy-pill* Forbes. (2026, August 14). iPhone 18 Pro event tipped as Apple shifts key release schedule date. Forbes. https://www.forbes.com/sites/davidphelan/2026/08/14/iphone-18-pro-event-tipped-as-apple-shifts-key-release-schedule-date/* MarketScreener/Reuters. (2026, August 14). Alphabet becomes Berkshire Hathaway’s third-largest investment. MarketScreener. https://www.marketscreener.com/news/alphabet-becomes-berkshire-hathaway-s-third-largest-investment-ce7859dfdb8ef224* Microsoft Corporation. (2026, August 10). FY26 Q1 — Performance [Investor relations disclosure]. Microsoft Investor Relations. https://www.microsoft.com/en-us/investor/earnings/fy-2026-q1/performance* MM&M Online. (2026, August 14). Rx Rundown: KKR, Eli Lilly, Procter & Gamble and more. MM&M Online. https://www.mmm-online.com/news/rx-rundown-kkr-eli-lilly-procter-gamble-and-more/* Panda Forecast. (2026, August 14). GOOG Stocktwits, news and mentions. Panda Forecast. https://pandaforecast.com/company-news/?ticker=goog* Space Exploration Technologies Corp. (2026, August 14). Schedule 13G — passive investment disclosure (Alphabet, XXVI Holdings, Google; 7.2% of SpaceX Class A) [SEC filing]. Stock Titan. https://www.stocktitan.net/sec-filings/SPCX/schedule-13g-space-exploration-technologies-corp-passive-investment-d-8e184da44355.html* TechCrunch. (2026, August 14). Talks to sell PayPal to Stripe and Advent are heating up. TechCrunch. https://techcrunch.com/2026/08/14/talks-to-sell-paypal-to-stripe-and-advent-are-heating-up/* The New York Times. (2026, August 14). Amazon and Alphabet’s profits reveal circular nature of A.I. boom. The New York Times. https://www.nytimes.com/2026/08/14/business/ai-tech-profits.html* Ts2.tech. (2026, August 14). PayPal stock closes 1.9% above $60.50 bid as talks continue. Ts2.tech. https://ts2.tech/en/paypal-stock-closes-1-9-above-60-50-bid-as-talks-continue/* Watcher Guru. (2026, August 14). Should you buy Apple stock after its 5% post-earnings drop? Watcher Guru. https://watcher.guru/news/should-you-buy-apple-stock-after-its-5-post-earnings-drop* Yahoo Finance. (2026, August 13). Eli Lilly (LLY) Q2 2026 earnings call transcript. Yahoo Finance. https://finance.yahoo.com/healthcare/articles/eli-lilly-lly-q2-2026-032008362.html* Yahoo Finance. (2026, August 13). Oppenheimer revamps Snowflake stock target for 2026. Yahoo Finance. https://ca.finance.yahoo.com/news/oppenheimer-revamps-snowflake-stock-target-200242396.html* Yahoo Finance. (2026, August 14). 5 revealing analyst questions from Eli Lilly’s Q2 earnings call. Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/5-revealing-analyst-questions-eli-054900384.html* Yahoo Finance. (2026, August 14). Apple dropped by 5% after earnings. Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/apple-dropped-5-earnings-history-105000023.html* Yahoo Finance. (2026, August 14). Broadcom plunges 5% as its AI boom faces a $370 billion financing question. Yahoo Finance. https://finance.yahoo.com/technology/ai/articles/broadcom-plunges-5-ai-boom-170842189.html* Yahoo Finance. (2026, August 14). Tech layoffs 2026: Tracking all of the job losses across TikTok, Microsoft, Meta, Oracle, Samsung, Zillow and others. Yahoo Finance. https://tech.yahoo.com/general/article/tech-layoffs-2026-tracking-all-of-the-job-losses-across-tiktok-microsoft-meta-oracle-samsung-zillow-and-others-144545528.html* ZoomInfo. (2026, August 13). Snowflake — Overview, news & similar companies. ZoomInfo. https://www.zoominfo.com/c/snowflake-computing/367752085Internal dataInternal data is provided on a best efforts basis.Earnings slateForward earnings dates are sourced from the W2633 earnings slate, pulled 2026-08-14. See 04. Publishing/shows/weekend-update/W2633/dryrun/earnings_slate.md.* HD — Home Depot, 2026-08-18 (Tuesday). Consensus EPS $4.73, consensus revenue $47.3B.* LOW — Lowe’s, 2026-08-19 (Wednesday). Consensus EPS $4.23, consensus revenue $26.2B.* TGT — Target, 2026-08-19 (Wednesday). Consensus EPS $2.25, consensus revenue $26.1B.* WMT — Walmart, 2026-08-20 (Thursday). Consensus EPS $0.74, consensus revenue $186.7B.* DE — Deere & Company, 2026-08-20 (Thursday). Consensus EPS $4.71, consensus revenue $10.8B.* NVDA — Nvidia, 2026-08-26 (Wednesday). Consensus EPS $2.08, consensus revenue $91.9B. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt, Jason, and Mike walk the Cash Flow Memo through $90 oil that will not change oil-patch spending, a compute market sold out through 2028, and a healthcare desk that still found time for Eliquis.The Cashflow MemoKey Takeaways* Hunt’s $70-$90 oil range still holds at the top - crude is ~$90 and he does not see it running much higher - but Iran’s infeasible demands (US bases out, Hormuz cargo tolls, reparations, sanctions off) keep him closer to 90 than 80 for 6-12 months; ~20 ships/day still move (Iraqi crude allowed, Saudis can go Red Sea), producers still underwrite $70-75 so activity does not spike, and $90 oil maps to roughly $4.00-$4.20 US gasoline.* Industrial read-through is Caterpillar: data-center turbines plus reshoring and data-center construction more than offset lagging housing, and Hunt says tariffs, $90 oil, and the political noise are not changing what they hold or add; Mike wants more macro time on these calls now that Warsh is detoxifying Fed guidance.* Compute demand is still exponential: Jassy says AWS AI is sold out through 2026-27 and most of 2028, $200B of CapEx this year still will not close it, and recursive learning models by year-end are another multiple of inference per user - Hunt prefers Amazon, Google, and Microsoft as the compute owners and cannot make up his mind on Meta.* Supply cannot catch that demand in ’27-’28: New York’s >200 MW hold, Virginia saturation, and the Texas governor’s ERCOT audit all push off-grid; combined cycle is 3-4 years out, simple turbines (GE, Cat, Siemens) are sold out, SpaceX Memphis (~$30B, 2 GW, 1-1.5 year payout to Anthropic and Google, 4-5 GW ambition by end-’27) is the exception; Hunt would avoid CoreWeave even after it extended 2020 A100s through 2029 at a 25% price hike.* Chip and memory bottlenecks sit behind the power constraint - TSMC wafers plus packaging, Intel closer on packaging than lithography, memory prices hitting Apple - and Tesla/SpaceX’s Terafab is a first-principles end-run around ASML (particle-accelerator EUV vs tin-droplet lasers) that Huawei is already pursuing; healthcare: FDA closes the GRAS food-ingredient loophole, the childhood vaccine schedule goes 17 to 11 diseases (Japan’s MMR split was reversed after completion collapsed), Thermo Fisher is seeing early-stage equipment rebound, and the AZN-BMY rumor died even as Eliquis (one-third of BMY sales, largest Medicare Part D line) faces a 2028 patent cliff that Jason puts at ~$10B of Part D savings.Show Notes[00:00] Intro & Cash Flow Memo Download the memo at telltales.us; 30 minutes on energy, technology, and healthcare cash flows.[00:27] Iran, Hormuz, and $90 Oil Iran’s demands are not negotiable, so Hunt keeps oil closer to $90 than $80 for 6–12 months. About 20 ships a day still move; Iraqi crude is allowed through, and Saudi barrels can go Red Sea.[04:20] $70 Decisions and Caterpillar Producers still underwrite $70–75, so activity does not spike. Caterpillar is the industrial read-through: data-center turbines and reshoring more than offset weak housing.[07:47] AWS Sold Out Through 2028 Jassy says AWS AI demand is sold out through this year, next year, and most of 2028. $200B of CapEx will not close it, and recursive models by year-end add another multiple of inference per user.[10:37] The Grid Says Build Your Own Power New York’s hold, Virginia saturation, and the Texas governor’s ERCOT audit all push data centers off-grid. Combined cycle is years out; simple turbines are sold out. SpaceX Memphis (~$30B, 2 GW) is the exception.[14:45] A 2020 Chip Gets a 25% Hike CoreWeave extended Nvidia A100 rentals through 2029 at a 25% price increase. Hunt would still avoid the stock and own Amazon, Google, and Microsoft instead.[16:31] TSMC, Memory, and the Terafab TSMC wafers and packaging, plus a memory squeeze that hits Apple, sit behind the power constraint. Tesla and SpaceX are planning a Terafab that replaces ASML’s tin-droplet EUV with a particle accelerator.[22:15] Why It Won’t Run on Your Phone Frontier models need a rack of GPUs and have to run 24/7 even when the phone is offline. On-device AI will route requests, not replace the cloud.[24:11] Huawei and the China Supply Threat Locked out of the latest ASML tools, China is already on particle accelerators and e-beam. If the rest of the world stays chip-constrained, Huawei has a willing market.[26:12] Healthcare: FDA, Vaccines, and the Eliquis Cliff FDA closes the GRAS loophole; the childhood schedule goes 17→11 diseases. Thermo Fisher is seeing early-stage equipment rebound. The AZN–BMY rumor died; Eliquis is one-third of BMY and the largest Medicare Part D line, with a 2028 patent cliff Jason puts at ~$10B of savings.Subscribe for the weekly Cash Flow Memo walkthrough, download the memo at telltales.us, and join us next Wednesday.Cashtags$AAPL $AMZN $ASML $BMY $CAT $CRWV $GOOGL $INTC $META $MSFT $NVDA $SEI $TSLA $TSM This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →A note from the desk: this week’s update is landing a few days late. We hit a technical problem over the weekend that took our production pipeline down. Everything below is as of Friday’s close, August 7. We’re back on the normal cadence next week. ## The Public Market Just Quoted a Price on a Drug Pipeline. The Price Was Zero.Eighteen billion dollars of biotech changed hands inside seventy-two hours this week, and not one dollar of it was priced by the tape. That is the part worth sitting with. Not the premiums, not the CEO change, not the guidance cut. The fact that when a listed market and a private buyer looked at the same molecules on the same Monday, they came back with numbers that do not live in the same decade.The cleanest evidence is an instrument almost nobody will look at. Curium is paying a hundred-two-fifty a share in cash for Lantheus at closing, plus up to twelve dollars a share in contingent value rights tied to clinical milestones, with the deal closing in the first half of 2027.¹ Lantheus finished the week around a hundred and one.² Read that as the market does: the cash is money-good, and the twelve dollars of clinical optionality is worth approximately nothing.Approximately nothing.That is not a Lantheus fact. It is a quoted, tradeable, sector-wide statement about what the public market will pay for radiopharmaceutical milestones it has not yet seen work, and the answer is that it will not pay. Every discounted-cash-flow argument about pipeline value in this space now has a live market print arguing against it, and the print says zero.Meanwhile the buyers on the other side of that refusal are underwriting the exact same molecules at a discount rate the tape will not touch. Vertex beat the quarter, raised the year to roughly thirteen billion, and wrote a ten-billion-dollar cash check for Crinetics at eighty-five a share in the same week.³⁴⁵ It can do that because a franchise throwing off close to four billion of trailing free cash flow, marked in the Cash Flow Memo around thirty times, funds a decade-long option without going near the debt line.⁶⁷ Curium is private capital reaching the same conclusion through a different funding stack. Both transacted above where the listed market had the asset marked. The cashflow read is in Marcus’s column below; short version, Lantheus screens like a cash machine and now trades like a legal document.And then BioNTech, which is the one that ratifies all of it. Seven times trailing free cash flow, a fourteen percent yield, a market that has effectively stopped underwriting a future at all.⁸⁹ Management’s answer was not to argue. It halved the revenue guide, replaced the co-founder in the CEO seat, said it would close manufacturing sites affecting up to eighteen hundred and sixty jobs, and authorized a billion-dollar buyback.¹⁰¹¹¹² That is a management team agreeing, in cash, with the tape’s refusal to fund its own pipeline.Here is the second-order effect nobody put a number on this week. Every one of these transactions moves the option value of a drug pipeline off a public balance sheet and onto a private or strategic one, at the precise moment the public market has declared that optionality worthless. Public shareholders get the cash and forfeit the decade. That is not a premium — it is a settlement. Crinetics holders get eighty-five dollars today; Vertex gets whatever those molecules are in 2034. Lantheus holders get a hundred-two-fifty and a lottery ticket the market has already voided. The premium is the consolation prize for handing over the part that compounds.What changes the read. Watch the contingent value right itself. It is a listed instrument that will trade between now and the close in the first half of 2027, and it is the only continuous public quote on radiopharmaceutical milestone risk anyone will get. If it develops a real bid, the public market is re-underwriting clinical optionality and this discount closes. If it sits at nothing through the close, the price-setting has moved permanently off the tape, and the next listed rare-disease or radiopharma name to go strategic or private goes at a premium the screens never marked. The other test is BioNTech’s oncology data, which is the only thing that separates a rational retreat at seven times from a market that got it wrong.Wall Street’s consensus on biotech M&A: a premium is a win for shareholders. Ten billion in cash and a contingent value right nobody will bid for suggests the premium is what you get paid to stop owning the decade.The Tape — W2632Universe of 94 cashflow-memo names, snap dates 2026-07-31 → 2026-08-07. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamLantheus ranks in the table above on cash flows that stopped setting its price this week. The composite reads it as a balanced cash generator, 8.2% FCF yield, top-five in the universe, and none of that is what clears the stock now. It is a legal document trading against $102.50 of cash at closing plus up to $12 a share in contingent value rights, and the tape is marking that $12 at approximately nothing. That is not laziness. Radiopharmaceutical milestones are clinical, not commercial, and the public market has never priced that risk well in either direction. The test between now and the first-half-2027 close is whether the CVR develops a real bid. A bid means someone is re-underwriting milestones the seller could not prove standing on its own.Telltales Yield — Bottom 10This Week’s ReportersSector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps85 of 92 ranked-eligible names ranked. 7 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-08-07.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoWeekend Update - W2632Why a Q2 beat bought nothing this week, and $18 billion of biotech changed handsThe Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the companies in the Cash Flow Memo. About 14 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2633.Chapter markers* Time | Segment* 0:00 | Cold open — a good quarter bought nothing* 0:45 | Theme — the quarter is a receipt (AMD, CVS, Celsius)* 4:45 | Deep dive — page 15: Vertex, Lantheus, BioNTech* 8:45 | Rapid fire — ConocoPhillips, Harrow, and the forward calendar* 11:45 | Close, Consensus Watch, and the Wednesday tease* 12:40 | Closing disclaimerFull transcriptCold openAva: A good quarter bought you nothing this week. The companies that beat got sold. The one that missed got an activist who wants the CEO’s job. And the biggest checks anyone wrote were for assets that don’t pay off until the 2030s — $18 billion of biotech changed hands inside 72 hours[^news-vrtx-crinetics-20260804][^news-lnth-curium-20260803]. Nobody was paying for the quarter. They were paying for the next five years. So today: two beats that got punished, one miss that turned into a proxy fight, and three companies on the same page of the memo making three incompatible bets on the same decade.Ava: Telltales Weekend Update. I’m Ava Cabot, with Marcus Graham at the cashflow desk.Theme — the quarter is a receiptAva: AMD delivered about as clean a print as semis produced this quarter, and the market took 7% out of the stock for it. Revenue $11.5 billion, up 52% year-over-year. Gross margin 54%. Net income $2.3 billion, EPS $1.30[^news-amd-q2-20260805]. Then the Q3 guide landed at $13.0 billion at the midpoint, above consensus[^news-amd-q3guide-20260805]. Beat, beat, and beat. Down 7%[^news-amd-stockdrop-20260805]. Marcus — what did they actually get punished for?Marcus: Not the quarter. The price of admission. The memo had AMD at 88x trailing free cash flow going into this print, Q1 10-Q confirmed[^memo-amd-evfcf-20260807], on $8.7 billion of trailing free cash flow[^memo-amd-fcf-20260807]. We re-anchor when the Q2 10-Q files. At 88x you are not buying a beat, you are buying years of uninterrupted acceleration — and Jean Hu just told you the data center step-up is second-half weighted[^news-amd-datacenter-20260805]. Second-half weighted means the proof shows up after the multiple already has to hold. That’s the part that got sold.Ava: And in the same week they went shopping. AMD agreed to buy Taalas, a Canadian startup, to add another category of AI silicon for the data center[^news-amd-taalas-20260806]. Marcus, is that a company that thinks it’s ahead?Marcus: It’s a company hedging its own roadmap, which is the correct thing to do and an uncomfortable thing to watch. Going into this print the memo had AMD running $1.2 billion of capex trailing twelve[^memo-amd-capex-20260807] against under $1 billion of buybacks[^memo-amd-buyback-20260807], Q1 10-Q confirmed — and that was before Taalas. Lisa Su spent the week praising Elon Musk after SpaceX committed to Nvidia exclusively[^news-amd-musk-20260805]. Buying a second accelerator architecture says management does not believe one roadmap wins this market outright. That is honest, and it is the opposite of what a multiple in the high 80s is underwriting. The test is whether the Taalas silicon shows up in a customer deployment before that multiple has to be defended again.Ava: Gracious in public, hedging in the checkbook. CVS beat the quarter, raised the year, then said one thing about 2027 and gave it all back. Adjusted EPS guidance up to $7.90–$8.10, from $7.30–$7.50[^news-cvs-q2guide-20260805]. $2 billion of costs already out the door, stores closed, leadership reshuffled[^news-cvs-costs-20260805]. And then a preliminary look at 2027 profit that disappointed, plus a warning about the pharmacy benefit business next year. Shares fell[^news-cvs-2027-20260805]. Marcus — twelve months of execution against one sentence about a year that hasn’t started.Marcus: On this balance sheet, the sentence should win. The memo had CVS at 16x trailing free cash flow going in, Q1 10-Q confirmed[^memo-cvs-evfcf-20260807], carrying 7.5 turns of debt to free cash flow[^memo-cvs-debtfcf-20260807]. That leverage is what makes a 2027 comment expensive — a levered turnaround gets paid for the trajectory, not for the print. What would change my view is the pharmacy benefit line holding through next year’s renewal cycle. If it doesn’t, the deleveraging slides a year to the right, and the multiple is the thing doing the waiting.Ava: And then Celsius, where a missed quarter turned into a job application. Q2 revenue $817.9 million against consensus of $870 million[^news-celh-revenue-20260806]. GAAP EPS down to $0.14 from $0.33 a year ago[^news-celh-eps-20260805]. The core Celsius brand shrank about 12%[^news-celh-brand-20260806]; Alani Nu retail sales grew 56%[^news-celh-alani-20260806]. So the growth is real. It’s just not the name on the can, and it’s not the name on the building. Adjusted EPS came in at $0.36, so the operating business is not broken[^news-celh-adjeps-20260805] — what’s broken is the story that Celsius, the brand, is the growth engine. Then Friday. Russ Savage, the man who founded Rockstar Energy, disclosed a 4.7% stake, more than 12 million shares, and said the board should replace CEO John Fieldly[^news-celh-savage-20260807]. With himself. Nobody buys 12 million shares of a company to relitigate last quarter. He’s buying the next five years of a portfolio he thinks is being run by the wrong person — and he built a competitor in this exact category before he bought a share of this one[^news-celh-savage-20260807].Deep dive — page 15: Vertex, Lantheus, BioNTechAva: Page 15 of the Cash Flow Memo is pharma and biotech, and this week three names on that one page made three completely different bets on the same decade. Vertex is buying. Lantheus is being bought. BioNTech is shrinking.Ava: Vertex beat, with Q2 revenue of $3.33 billion, up 12%[^news-vrtx-q2rev-20260803], raised full-year guidance to $13.1–$13.2 billion[^news-vrtx-guidance-20260804], and agreed to pay $10 billion in cash for Crinetics at $85 a share[^news-vrtx-crinetics-20260804]. Lantheus agreed to sell itself to Curium for up to $8 billion — $102.50 a share in cash at closing, plus up to $12 a share in contingent value rights, closing in the first half of 2027[^news-lnth-curium-20260803]. And BioNTech cut full-year revenue guidance from €2.5–€3.1 billion down to €1.6–€1.9 billion[^news-bntx-guidance-20260804], named Guido Oelkers to replace co-founder Ugur Sahin as CEO[^news-bntx-ceo-20260803], and said it will close manufacturing sites affecting up to 1,860 jobs while authorizing a $1 billion buyback[^news-bntx-layoffs-20260805]. Marcus — three answers to the same question. Which one is the market getting wrong?Marcus: Lantheus, and the spread tells you where. The stock closed the week around $101[^memo-lnth-price-20260807] against $102.50 of cash at closing[^news-lnth-curium-20260803]. That’s a market saying the deal closes, and pricing the $12 of contingent value rights at approximately nothing. In radiopharmaceuticals the milestones are clinical, not commercial. A CVR with no bid is the market’s statement about what the buyer thinks it’s getting, and what the seller could never prove standing on its own.Ava: Free option, no bid. And Vertex is standing on the other side of that trade.Marcus: Vertex is paying cash for a pipeline it can’t sell for years, and it can afford to. The memo had Vertex at 30x trailing free cash flow going into the print, Q1 10-Q confirmed[^memo-vrtx-evfcf-20260807], on $3.7 billion of trailing free cash flow[^memo-vrtx-fcf-20260807]. $10 billion out the door against that clears without touching the debt line. We re-anchor when the Q2 10-Q files. What I’d watch is whether the raised guide survives the integration year, because a company that raises the year and writes the biggest check in its history in the same week is telling you the core franchise is funding the option, not the other way around.Marcus: BioNTech is the one nobody wants to look at, and it’s the most honest of the three. Going into this print the memo had them at 7x trailing free cash flow[^memo-bntx-evfcf-20260807] at a 14% yield[^memo-bntx-fcfyield-20260807], Q1 10-Q confirmed, and those are euros, translated in the memo at today’s rate. That is a market that has stopped underwriting a future at all. Halving the guide, closing plants, and authorizing a buyback is management agreeing with that price. I’d weight it as a rational retreat rather than a value trap — but the two look identical until the oncology pipeline delivers data.Ava: So what does page 15 actually say this week?Marcus: That the discount rate on a biotech pipeline is being set by somebody other than the public market. Vertex at 30x trailing free cash flow and BioNTech at 7x sit on that same page[^memo-vrtx-evfcf-20260807][^memo-bntx-evfcf-20260807], applied to the same underlying activity — finding molecules that work. Curium is private capital, Vertex is a strategic, and both transacted above where the tape had the asset marked. When the price-setters on a page are a private buyer and a strategic buyer, the listed multiple stops being the opinion that matters. What would flip that is the Lantheus CVR trading with a real bid before the close.Ava: Same page, same week, same disease franchises. One company spent $10 billion buying a decade. One took $102.50 a share to hand its decade to somebody else. One said out loud that it doesn’t have one to sell. Three managements priced their own optionality in public inside 72 hours. The earnings reactions were the small part.Rapid fireAva: Rapid fire. ConocoPhillips posted its best profit since 2022 and used the same press cycle to change CEOs[^news-cop-profit-20260806]. Q2 earnings of $3.23 a share[^news-cop-q2eps-20260806]. Ryan Lance is out after 14 years into a transitional executive chair role; CFO Andy O’Brien becomes president and CEO September 1, with Konnie Haynes-Welsh moving up to CFO[^news-cop-succession-20260806]. Going into the print, the memo had Conoco at 9x trailing free cash flow[^memo-cop-evfcf-20260807] at a 10.8% yield[^memo-cop-fcfyield-20260807], on $18.5 billion of trailing free cash flow[^memo-cop-fcf-20260807]. That trailing twelve carried $4.0 billion of dividends and $4.5 billion of buybacks[^memo-cop-dividend-20260807][^memo-cop-buyback-20260807]. Handing a franchise returning that much capital to the finance seat at the top of the cycle is a choice. The thing to watch is whether the return pace survives the handoff, because a new CEO who came up through the CFO’s chair has every incentive to build a war chest in his first year.Ava: Harrow bought a product four days before it has to explain itself. Definitive agreement for the global rights to Tyrvaya from Viatris — $30 million up front, up to $70 million more in milestones tied to net sales[^news-hrow-tyrvaya-20260806]. Tyrvaya is the only FDA-approved nasal spray for dry eye disease[^news-hrow-tyrvaya-fda-20260806]. On page 20 of the memo, Harrow sits at 46x trailing free cash flow[^memo-hrow-evfcf-20260807] with 8 turns of debt to free cash flow[^memo-hrow-debtfcf-20260807], Q1 10-Q confirmed. And Harrow reports Monday, consensus at a $0.23 loss on $70.4 million of revenue[^earn-hrow]. A levered specialty pharma company buying a commercial asset the week of its own print is either conviction or timing. Monday says which.Ava: Also on page 20. Uber grew gross bookings 22%[^news-uber-bookings-20260804] and non-GAAP operating income 40%[^news-uber-opinc-20260804], then guided Q3 light and dropped 5%[^news-uber-guidance-20260805] — the same week it committed more than $10 billion to a robotaxi aggregator strategy[^news-uber-robotaxi-20260806]. And Airbnb beat and raised full-year revenue guidance to at least mid-teens growth[^news-abnb-guidance-20260807], with the stock up 15%[^news-abnb-surge-20260807] on a World Cup travel surge[^news-abnb-worldcup-20260807]. Brian Chesky says the company will spend a lot more on AI this year because inference came in cheaper than he budgeted for[^news-abnb-ceoai-20260807]. Which is a CEO announcing his own forecast was wrong, in the happiest available way.Ava: Two more. Palantir grew US commercial revenue 149% to $764 million[^news-pltr-commercial-20260804], total revenue 93%[^news-pltr-total-20260804], raised the year to 82% growth[^news-pltr-fyguide-20260804], and put up 29% in a single session[^news-pltr-surge-20260804]. The memo had it at 102x trailing free cash flow before any of that, Q1 10-Q confirmed[^memo-pltr-evfcf-20260807]. 102x. Alex Karp’s line on the call was that his customers have, quote, declined to become vassal states of the language labs[^news-pltr-karp-20260804]. Nobody has ever sold sovereignty harder, and at 102x, nobody has ever needed to. And Disney beat on fiscal Q3[^news-dis-q3-20260805], sold its 50% stake in A+E Global Media to Hearst for $1.2 billion[^news-dis-ae-20260805], and signed a global short-form content deal with TikTok[^news-dis-tiktok-20260806] — three storylines, one week. Disney is selling the cable asset and renting the attention.Ava: Forward calendar. Harrow Monday[^earn-hrow]. Venture Global Tuesday[^earn-vg]. Then the consumer block the week after — Home Depot Tuesday[^earn-hd], Lowe’s and Target Wednesday[^earn-low][^earn-tgt], Walmart and Deere Thursday[^earn-wmt][^earn-de]. Five names, three days, and the whole picture on household spending.CloseAva: That’s the show. A good quarter bought nothing this week. Wall Street’s consensus on earnings season: a beat gets bought. AMD beat on revenue, profit, and the guide and lost 7%. CVS beat and raised and gave it back on one sentence about 2027. Consensus is still grading last quarter’s tape.Ava: What actually got paid for this week was the 2030s — $10 billion for Crinetics, up to $8 billion for Lantheus, $100 million for a single nasal spray. The prints were the receipts.Ava: On Wednesday’s episode 2632, Hunt, Jason, and Mike took Harrow through the AI-in-healthcare segment and landed on it as a commercialization business, one where AI isn’t the deciding factor[^ep-e2632]. Four days later Harrow went out and bought something to commercialize. Hunt, Jason, and Mike are back Wednesday on episode 2633.Ava: Download the memo at telltales.us. Twenty pages, every week. And send us feedback through the Substack. Every note gets seen.Ava: The show is produced entirely with AI tools, and both voices you’re hearing are AI-generated.Closing disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you. The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* Advanced Micro Devices. (2026, August 5). AMD reports second quarter 2026 financial results [Press release]. https://ir.amd.com/news-events/press-releases/detail/1295/amd-reports-second-quarter-2026-financial-results* Associated Press. (2026, August 7). New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine. AP News. https://apnews.com/article/flu-vaccine-moderna-mrna-fda-mflusiva-59d991a6bf70c26e2f0c210cc8ca87f1* Automotive World. (2026, August 6). Uber pledges $10bn to robotaxis, Waymo still important. Automotive World. https://www.automotiveworld.com/news/uber-pledges-10bn-to-robotaxis-waymo-still-important/* Axios. (2026, August 5). Disney selling A+E stake, announces partnership with TikTok. Axios. https://www.axios.com/2026/08/05/disney-ea-hearst-cable-tv* BioNTech. (2026, August 3). BioNTech announces appointment of Guido Oelkers to management board as Chief Executive Officer [Press release]. https://www.biontech.com/int/en/home/mediaroom/news/press-releases/2026/08/BioNTech-Announces-Appointment-of-Guido-Oelkers-to-Management-Board-as-Chief-Executive-Officer.html* BioNTech. (2026, August 4). BioNTech announces second quarter 2026 financial results and corporate update [Press release]. https://investors.biontech.de/news-releases/news-release-details/biontech-announces-second-quarter-2026-financial-results-and* Bloomberg. (2026, August 5). CVS Health falls after warning on 2027 outlook, Caremark challenges. Bloomberg. https://www.bloomberg.com/news/articles/2026-08-05/cvs-raises-outlook-as-medical-cost-improvement-drives-profits* Bloomberg. (2026, August 6). Advanced Micro Devices to buy startup Taalas for new AI chips. Bloomberg. https://www.bloomberg.com/news/articles/2026-08-06/advanced-micro-devices-to-buy-startup-taalas-for-new-ai-chips* Celsius Holdings, Inc. (2026, August 5). Celsius Holdings reports second quarter 2026 financial results [Press release]. https://ir.celsiusholdingsinc.com/news/news-details/2026/Celsius-Holdings-Reports-Second-Quarter-2026-Financial-Results/default.aspx* CNBC. (2026, August 4). Palantir (PLTR) earnings Q2 2026. CNBC. https://www.cnbc.com/2026/08/03/palantir-pltr-earnings-q2-2026.html* CNBC. (2026, August 4). Palantir stock skyrockets 29%, narrowly missing its best day ever after otherworldly results. CNBC. https://www.cnbc.com/2026/08/04/palantir-2q-earnings-ai-sovereign-tools.html* CNBC. (2026, August 5). AMD earnings report Q2 2026. CNBC. https://www.cnbc.com/2026/08/04/amd-earnings-report-q2-2026.html* CNBC. (2026, August 5). CVS Health (CVS) earnings Q2 2026. CNBC. https://www.cnbc.com/2026/08/05/cvs-health-cvs-earnings-q2-2026.html* CNBC. (2026, August 5). Disney (DIS) earnings Q3 2026. CNBC. https://www.cnbc.com/2026/08/05/disney-dis-earnings-q3-2026.html* CNBC. (2026, August 5). Lisa Su brushes off Musk’s Nvidia commitment as AMD stock sinks after earnings. CNBC. https://www.cnbc.com/2026/08/05/amd-stock-today-earnings-q2.html* CNBC. (2026, August 5). Uber stock sinks 5% after weak guidance despite revenue growth. CNBC. https://www.cnbc.com/2026/08/05/uber-stock-q2-2026-earnings.html* CNBC. (2026, August 6). Airbnb raises its outlook as growth accelerates and AI speeds product development [Video]. CNBC. https://www.cnbc.com/video/2026/08/06/airbnb-raises-its-outlook-as-growth-accelerates-and-ai-speeds-product-development.html* CNBC. (2026, August 6). ConocoPhillips CEO Ryan Lance departs as oil producer posts best profit since 2022. CNBC. https://www.cnbc.com/2026/08/06/conocophillips-ceo-ryan-lance-departs-as-oil-producer-posts-best-profit-since-2022.html* CNBC. (2026, August 7). Chesky says Airbnb will spend a lot more on AI as earnings beat and stock surges 15%. CNBC. https://www.cnbc.com/2026/08/07/chesky-airbnb-ai-earnings.html* CNBC. (2026, August 7). Rockstar Energy founder builds Celsius stake, wants to take over as CEO. CNBC. https://www.cnbc.com/2026/08/07/rockstar-energy-founder-celsius-stake-ceo.html* ConocoPhillips. (2026, August 6). ConocoPhillips announces planned leadership succession: Andy O’Brien named president and CEO, Ryan Lance to assume transitional executive chair role, Konnie Haynes-Welsh appointed CFO [Press release]. https://www.conocophillips.com/news-media/story/conocophillips-announces-planned-leadership-succession-andy-obrien-named-president-and-ceo-ryan-lance-to-assume-transitional-executive-chair-role-konnie-haynes-welsh-appointed-cfo/* ConocoPhillips. (2026, August 6). ConocoPhillips announces second-quarter 2026 results and quarterly dividend [Press release]. https://www.conocophillips.com/news-media/story/conocophillips-announces-second-quarter-2026-results-and-quarterly-dividend/* CVS Health. (2026, August 5). CVS Health Corporation reports strong second quarter 2026 results and raises full-year 2026 guidance [Press release]. https://www.cvshealth.com/news/company-news/cvs-health-corporation-reports-strong-second-quarter-2026-results-and-raises-full-year-2026-guidance.html* Globe Newswire. (2026, August 6). Harrow acquires global rights to TYRVAYA, the first and only FDA-approved nasal spray for dry eye disease [Press release]. https://www.globenewswire.com/news-release/2026/08/06/3340081/0/en/harrow-acquires-global-rights-to-tyrvaya-the-first-and-only-fda-approved-nasal-spray-for-dry-eye-disease.html* Invezz. (2026, August 7). Airbnb stock jumps 11% as World Cup travel sparks a surprise growth burst. Invezz. https://invezz.com/news/2026/08/07/airbnb-stock-jumps-11-as-world-cup-travel-sparks-a-surprise-growth-burst/* Lantheus Holdings. (2026, August 3). Curium announces definitive agreement to merge with Lantheus [Press release]. https://investor.lantheus.com/news-releases/news-release-details/curium-announces-definitive-agreement-merge-lantheus* Ophthalmology Times. (2026, August 7). Harrow acquires global rights to Tyrvaya. Ophthalmology Times. https://www.ophthalmologytimes.com/view/harrow-acquires-global-rights-to-tyrvaya* Palantir Technologies. (2026, August 4). Q2 2026 press release [Exhibit 99.1]. U.S. Securities and Exchange Commission EDGAR. https://www.sec.gov/Archives/edgar/data/1321655/000132165526000039/a2026q2ex991pressrelease.htm* Reuters. (2026, August 3). Palantir lifts annual revenue forecast on steady demand. Reuters. https://reuters.com/technology/palantir-raises-annual-revenue-forecast-strong-demand-us-government-commercial-2026-08-03* Reuters. (2026, August 5). BioNTech SE company page: manufacturing site closures and $1.0 billion buyback authorization. Reuters. https://www.reuters.com/company/biontech-se/* StockAnalysis. (2026, August 6). Celsius Holdings (CELH) stock price & overview. StockAnalysis. https://stockanalysis.com/stocks/celh/* StockTitan. (2026, August 4). Crinetics (Nasdaq: CRNX) agrees to $85 cash-per-share sale to Vertex [8-K material event]. StockTitan. https://www.stocktitan.net/sec-filings/CRNX/8-k-crinetics-pharmaceuticals-inc-reports-material-event-3bad8e8db9de.html* The Walt Disney Company. (2026, August 6). The Walt Disney Company and TikTok announce a first-of-its-kind global short-form content-sharing deal [Press release]. https://thewaltdisneycompany.com/news/tiktok-content-sharing-deal/* TradingKey. (2026, August 5). AMD beat on revenue, profit, and guidance — So why did the stock drop 7%? TradingKey. https://www.tradingkey.com/analysis/stocks/us-stocks/262074451-amd-q2-2026-earnings-double-beat-stock-falls-tradingkey* Uber Technologies. (2026, August 4). Uber announces results for second quarter 2026 [Press release]. https://investor.uber.com/news-events/news/press-release-details/2026/Uber-Announces-Results-for-Second-Quarter-2026/default.aspx* Vertex Pharmaceuticals. (2026, August 3). Vertex reports second quarter 2026 financial results [Press release]. https://news.vrtx.com/news-releases/news-release-details/vertex-reports-second-quarter-2026-financial-results* Yahoo Finance. (2026, August 4). Vertex Pharmaceuticals Inc (VRTX) (Q2 2026) earnings call highlights: Revenue surges 12%. Yahoo Finance. https://finance.yahoo.com/healthcare/articles/vertex-pharmaceuticals-inc-vrtx-q2-050826035.html* Yahoo Finance. (2026, August 6). Celsius Q2 earnings call highlights. Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/celsius-q2-earnings-call-highlights-130400635.html* Yahoo Finance UK. (2026, August 6). Celsius Holdings Inc (CELH) (Q2 2026) earnings call highlights: Portfolio growth drives 11%. Yahoo Finance UK. https://uk.finance.yahoo.com/news/celsius-holdings-inc-celh-q2-190423226.htmlNote: reference 2 (AP News) is retained from the dryrun source pool and is not cited in the shipped script. All other entries map to at least one footnote in the canonical.Internal dataInternal data is provided on a best efforts basis.Earnings slateForward earnings dates are sourced from the W2632 earnings slate, pulled 2026-08-07. See 04. Publishing/shows/weekend-update/W2632/dryrun/earnings_slate.md.* DE - Deere & Company, 2026-08-20 (Thursday), consensus EPS 4.71, consensus revenue $10.8B* HD - Home Depot, 2026-08-18 (Tuesday), consensus EPS 4.73, consensus revenue $47.3B* HROW - Harrow Inc, 2026-08-10 (Monday), consensus EPS -0.23, consensus revenue $70.4M* LOW - Lowe’s, 2026-08-19 (Wednesday), consensus EPS 4.25, consensus revenue $26.2B* TGT - Target, 2026-08-19 (Wednesday), consensus EPS 2.30, consensus revenue $26.1B* VG - Venture Global, 2026-08-11 (Tuesday), consensus EPS 0.48, consensus revenue $4.7B* WMT - Walmart, 2026-08-20 (Thursday), consensus EPS 0.74, consensus revenue $186.8B This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt, Mike, and Jason walk the Cash Flow Memo through an oil tape driven by Hormuz headlines, a power grid that has started saying no to data centers, and the valuation question underneath the Tesla-SpaceX merger.The Cashflow MemoKey Takeaways* Oil is trading the Hormuz headline, not the fundamentals: Saudi Aramco earned $33B in Q2 because price more than offset shipped volume, and its CEO says ~2 mmbbl/d of Saudi supply covers customers with or without the Strait open. Hunt’s pattern holds (roughly $90 on missile strikes, high-$70s to $80 when calm, ~$20 of backwardation to the 12-month strip at ~$70-72), and he reads the market as pricing this better than the commentators do.* Natural gas is holding $3.50 on LNG alone (13 Bcf/d in 2024, 16 in 2025, 18+ this year, 20 next) with gas-for-power flat since 2025; the swing factor is data centers forcing on-site turbines, which would restore ~1.5 Bcf/d/yr of power demand and firm gas toward $4. Supply growth is 10 of the last 15 Bcf/d from Permian associated gas, so incremental supply keys off the oil price, not the gas price.* Siting, not chips, is now the binding constraint on the buildout: New York has a one-year hold, Virginia is saturated (Google will not propose more), and the Texas governor just ordered audits (effectively ~12 months) of 900 GW of proposals against ~90 GW of installed state capacity. Combined cycle cannot be built fast enough and turbines are sold out, so on-site generation is the only path.* SpaceX is the episode’s central valuation debate: hosts expect Tesla merged into SpaceX on a trailing-45-day price basis after the China operations are spun out, and treat the equity as a data center business that buys land-free siting. Jason underwrites just south of $90 (~8 GW next year at ~$35B/GW, 20 GW target, 15% IRR), Hunt anchors $50 at roughly half the current price, and Mike flags lockup expiries and launch or regulatory stumbles as the cheaper entry. Launch economics gate the space leg: $1,000/kg makes a gigawatt cost $31B to loft, $150/kg makes it $4.7B, and Starship has flown four times.* Healthcare AI expands capability rather than cutting cost, with one exception. Lilly’s Isomorphic Labs partnership is about a year old with nothing to show yet, and scientists at Lilly, Regeneron, and Pfizer will assault IT budgets for tokens rather than save money. UnitedHealth is the real cost-out: $1.5B of IT spend, one-third to make Optum Insight AI-first and two-thirds to insurance systems, with a pre-auth pilot cutting missing-information denials 68% and appeals nearly 90%. Energy IT departments (Exxon, midstream, EOG) get genuine savings, and the token spend routes through Amazon, Microsoft, and Google because no one gets fired for running a Chinese open-weight model on a hyperscaler.Show Notes[00:00] Intro & Cash Flow Memo Download the memo at telltales.us; 30 minutes on energy, technology, and healthcare cash flows.[00:27] Iran, Hormuz, and $90 Oil Saudi Aramco earned $33B in Q2 as price offset lost volume, and management says ~2 mmbbl/d covers customers either way. Oil runs to roughly $90 on strikes and back to the high-$70s when things calm, with ~$20 of backwardation to the 12-month strip.[03:19] Exhibit B: Gas, LNG, and Permian Supply Gas holds $3.50 on LNG growth from 13 Bcf/d in 2024 to 20 next year, while gas-for-power has been flat since 2025. Ten of the last 15 Bcf/d of supply growth is Permian associated gas, so supply follows the oil price.[05:01] The Grid Says No: New York, Texas, Virginia New York’s one-year hold, Virginia’s saturation, and the Texas governor’s audit letter against 900 GW of proposals versus ~90 GW of state capacity. Combined cycle is too slow and turbines are sold out, so on-site generation wins.[10:40] Tesla into SpaceX: What Is It Worth The hosts expect a trailing-45-day merger after a China spin-out, then split on price: Jason just south of $90 on 8 GW next year at ~$35B/GW and a 15% IRR, Hunt at $50, Mike waiting on lockups and launch risk. Launch cost decides the space leg at $31B versus $4.7B per gigawatt.[18:18] AI in Healthcare: Harrow, Lilly, UnitedHealth Harrow is a commercialization business where AI is not decisive. Lilly’s Isomorphic Labs tie-up is a year old with no results yet. UnitedHealth is spending $1.5B, with a pre-auth pilot cutting missing-information denials 68% and appeals nearly 90%.[22:53] Token Budgets at Pfizer and Regeneron Scientists will consume the IT budget rather than shrink it. Expect more candidates and fewer late failures, not cost savings.[24:20] Energy IT: Exxon, Midstream, EOG Upstream and midstream have run machine learning for years and get real cost savings here. EOG’s decade-old well-file system is the template.[26:12] Open Weights and Why the Hyperscalers Win Open-weight models cut token cost, but IT departments would rather buy from Amazon, Microsoft, and Google than defend a Chinese model to their board. That routes the savings through the hyperscalers.[28:06] Apple’s Siri Problem Apple still has no AI-enabled phone and a software team behind the eight ball. Ecosystem lock-in buys time; it does not buy stagnation.Subscribe for the weekly Cash Flow Memo walkthrough, download the memo at telltales.us, and join us next Wednesday.Cashtags$AAPL $AMZN $EOG $GOOGL $HROW $ILMN $KMI $LLY $MSFT $PFE $REGN $SPCX $TSLA $UNH $XOM This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →Microsoft Bought Twenty Years of Power. The Market Graded the Buyer.The AI build spent this week being graded on the buyer’s income statement. The most consequential thing that happened to it was signed by a seller. Chevron agreed to supply Microsoft with two-point-six-seven gigawatts of behind-the-meter power at a West Texas data center, for twenty years, disclosed inside Chevron’s own second-quarter release.¹ Twenty years. In a week the market spent deciding whether Microsoft’s spending was disciplined and Meta’s was reckless, one of them committed to a two-decade fixed obligation that lands on neither company’s capex line.Start with what a behind-the-meter contract actually is, because the phrase is doing real work. The power never touches the public grid. It is generated on site and delivered straight into the data center, which means Microsoft is not waiting in an interconnection queue and is not buying at a utility tariff that moves. It is buying a fixed claim on generation through 2046. That is not capital expenditure. It does not show up in the capex line the entire market spent the week staring at, it does not depress free cash flow in the quarter it is signed, and it does not appear on any screen sorting hyperscalers by how fast the revenue is catching the build.Which is the same maneuver, in a different costume, as the fourteen-billion-dollar data center venture Meta struck with BlackRock three days earlier.² Both companies are moving the build off their own cash flow statement. One did it with a joint venture and one did it with an offtake contract, and both were signed by companies whose stocks the market was busy re-rating on precisely the cash flow statements the deals are designed to bypass. The show asked who got paid this week. The answer neither company put in a headline is that the counterparties did.Now look at where those counterparties sit on this week’s Tape. Energy carries the lowest expected forward revenue growth of the ten sectors on the board, barely above zero, and the second-worst median composite score in the universe. The screens price the sector as structurally ex-growth. The screens are reading a strip. The strip does not know that the marginal buyer of new American electricity is now a company with a compute deadline and a balance sheet that makes twenty-year commitments look cheap.Be precise about the size, because the size is not the argument. Chevron earned twelve-point-one billion dollars in the quarter, six dollars and eleven cents a share, up nearly four hundred percent year over year.³ Against that, one power contract is a rounding error, and it will be one for years. What is not a rounding error is the precedent: a supermajor just booked two decades of investment-grade contracted demand for a product the market values at spot. The rest of Chevron stays exactly what it was, priced off the same cyclical molecules, and CEO Eimear Bonner told Bloomberg she expects fuel-making margins to stay high for as long as energy markets remain, quote, under stress.⁴ Under stress. That is a CEO describing the best margin environment she has, in the vocabulary of a hostage.The cashflow read is in Marcus’s column below; short version, the highest-ranked name on this week’s board is an oil and gas producer, and the Cash Flow Memo ranked it before the deal that changes it.What changes the read is whether this contract is a species or a specimen. The forward calendar tests it immediately. Occidental reports Wednesday, ConocoPhillips and Cheniere on Thursday.⁵ Cheniere is the cleanest tell, because long-dated contracted offtake against a spot-priced sector is the entire LNG business model and the market has never paid it for the duration. The test on those calls is whether any management team names a data center or hyperscaler counterparty, or whether power demand stays in the abstract-tailwind register it has occupied for two years. Thesis breaks if the Chevron deal stays a one-off through the fourth quarter. One contract is an anecdote. Four is a repricing.Wall Street’s consensus on energy: a terminal-decline sector, correctly priced for no growth. The largest incremental buyer of American electricity just signed up through 2046.The Tape — W2631Universe of 94 cashflow-memo names, snap dates 2026-07-26 → 2026-07-31. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamThe top of this week’s board is ranking a balance sheet that no longer applies. Magnolia takes the number one composite at 13.0x EV/FCF and a 7.7% FCF yield, both computed off the Q1 10-Q, before the company agreed to buy WildFire Energy for $4.06B and priced a stock offering to help fund it. So the row is accurate and it is stale — a producer that pays for an acquisition partly in equity moves its share count, its debt, and its per-share cash flow in the same week the screen ranked it. Consensus is treating the offering as the news; the offering is the financing. The test is the August 5 print: whether management sizes the combined capex program for 2027, or defers it to the close.Telltales Yield — Bottom 10This Week’s ReportersSector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps89 of 92 ranked-eligible names ranked. 3 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-07-31.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoWho’s Getting PaidMicrosoft got paid for spending. Meta got billed for it. Same week, same build.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 14 minutes. No filler.Download the memo at telltales.us. Mike, Jason, and Hunt are back Wednesday on episode E2632.Chapter markers* Time | Segment* 0:00 | Opening disclaimer* 0:15 | Cold open — cash flow did the grading* 0:45 | Theme — who’s getting paid: Microsoft, Meta, Apple* 4:45 | Deep dive — page fifteen: Vertex and Lantheus* 8:45 | Rapid fire — ASML, Intel, Chevron, and the forward week* 11:45 | Close — Consensus Watch* 12:45 | Closing disclaimerFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note before we start: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.Ava: This was the week the AI build stopped being a guide and started being a cash flow statement. Three of the largest companies on earth reported inside 72 hours, and the market handed out three completely different grades for what looks, from the outside, like the same behavior. On Wednesday’s show, episode 2631, Hunt, Jason, and Mike spent their time on open weights versus closed labs, and where the value goes once model economics commoditize[^ep-e2631]. This week the market answered a much narrower version of that question, with money. Cash flow did the grading.Theme — Who’s getting paidAva: Microsoft just got a standing ovation for spending money. Azure crossed $100 billion of revenue in a single fiscal year for the first time[^news-msft-azure-20260730]. Fourth-quarter earnings, $4.74 adjusted, up 23%[^news-msft-q4eps-20260729]. The stock jumped 15% on it[^news-msft-stock-20260730]. And buried underneath the applause: Microsoft Cloud gross margin fell to 68%, and the company’s own explanation was the cost of scaling AI infrastructure and the growing usage of AI features[^news-msft-cloud-margin-20260724]. So the build is already in the margin line. On page 1 of the memo, Apple and Microsoft printed inside two days of each other, and only one of them got that reception. Marcus — who actually got paid this week?Marcus: Microsoft got paid on the income statement and billed on the cash flow statement, and the market only graded the first one. Going into this print the memo had them at about 38x trailing free cash flow[^memo-msft-evfcf-20260331], on roughly $76 billion of trailing free cash flow that was down about 21% year over year[^memo-msft-fcf-20260331]. That’s Q3 10-Q confirmed; we re-anchor when the 10-K files. Azure crossing that line is real money. So is the cash disappearing into the build. What I’d watch on the next print is whether the revenue line starts catching the capex line, or whether we’re still calling this a growth story two years from now.Ava: Meta spent the same kind of money and got the opposite grade. Revenue over $60 billion, up 28%[^news-meta-rev-20260730]. Second-quarter free cash flow down 91%[^news-meta-fcf-20260731]. The stock fell 8%, extending a record losing streak[^news-meta-stock-20260731]. And on the call, Mark Zuckerberg said Meta is, quote, getting a lot of offers for compute at a significant premium over what the company paid[^news-meta-compute-20260731]. Free cash flow down 91%, and the pitch is that people would like to rent his GPUs. There was also a $2.4 billion charge for legal proceedings[^news-meta-legal-20260730], and a $14 billion data center venture with BlackRock[^news-meta-blackrock-20260728]. Marcus, what did that $14 billion buy?Marcus: It bought the ability to keep building without the whole bill landing on Meta’s own cash flow statement. That is what a joint venture is for. Going into this print the memo had Meta at about 30x trailing free cash flow[^memo-meta-evfcf-20260331], on about $50 billion of trailing free cash flow that was still growing 22%[^memo-meta-fcf-20260331]. Q1 10-Q confirmed; we re-anchor when the Q2 10-Q files. So the trailing picture going in was fine. The quarter is what broke. And the move in the stock says the market has decided the quarter is the new trend rather than the exception. I’d weight that as more likely right than wrong, but it is one quarter, and I’d hold that view loosely until the next one confirms it.Ava: Which brings us to the control group. Apple didn’t build anything, and got marked down anyway. The June-quarter print beat, with net sales around $109 billion and iPhone sales up 22% year over year[^news-aapl-q3-20260731]. It was Tim Cook’s last earnings call as CEO, with the stock at a record[^news-aapl-cookcall-20260729]. He hands the job to John Ternus on September 1 and becomes executive chairman[^news-aapl-ceo-20260729]. And then Apple guided the September quarter to 9–11% revenue growth, below where the Street was, and blamed supply constraints[^news-aapl-guide-20260731]. Goldman Sachs cut its price target to $360 on the guide[^news-aapl-ptcut-20260731]. Morgan Stanley also moved to $360, working off calendar 2027 earnings of $10.30 a share[^news-aapl-mspt-20260731]. Two houses, two different models, the same number. Marcus, this one’s for you.Marcus: Apple is the counterexample that makes the rest of the week legible. Going into this print the memo had Apple at about 37x trailing free cash flow[^memo-aapl-evfcf-20260328], on trailing capex of roughly $11 billion[^memo-aapl-capex-20260328], which is a fraction of hyperscaler scale, with free cash flow growing 28%[^memo-aapl-fcf-20260328]. FQ2 10-Q confirmed; we re-anchor when the FQ3 10-Q files. So here is the week in one line. The market paid for the build where the revenue already showed up, billed it where it hasn’t, and then marked Apple down for something else entirely. Parts it can’t get. That’s a supply problem, not a valuation problem, and supply problems resolve on a different clock.Ava: Three companies, one build, three verdicts.Deep dive — Page fifteenAva: Two pharmaceutical deals landed this week, both on page 15 of the memo, and they are the same argument as the hyperscalers — just at a deal table instead of an earnings call. One company had the cash flow to write the biggest check in its history. The other one has cash flow good enough that somebody wants to buy it, and not enough scale to make that go away.Ava: Vertex agreed to acquire Crinetics Pharmaceuticals for $10 billion in cash, $85 a share — the largest acquisition Vertex has ever made[^news-vrtx-crinetics-20260728]. It also signed a collaboration with AbCellera on next-generation T-cell engagers, $28 million up front[^news-vrtx-abcellera-20260729]. And Vertex reports Monday[^earn-vrtx]. Meanwhile, Curium is in advanced talks to acquire Lantheus for about $7 billion, a deal that could be announced within days[^news-lnth-curium-20260727]. And two days after that report landed, B. Riley raised its price target on Lantheus, to $129 from $97[^news-lnth-briley-20260729]. Marcus — which side of that table would you rather be on?Marcus: Lantheus is the more interesting one, because the sell side responded to a takeover report by marking the company up. That does not usually happen when the bid is generous. The memo has Lantheus at about 17x trailing free cash flow[^memo-lnth-evfcf-20260331], at roughly a 6% free cash flow yield[^memo-lnth-fcfyield-20260331], with effectively no net debt[^memo-lnth-debt-20260331]. Q1 10-Q confirmed. A debt-free radiopharmaceutical business throwing off that kind of yield is not a distressed seller. What I’d watch over the next two weeks is whether the board treats that number as a floor or a ceiling, and whether a second name shows up before anything gets signed.Ava: An offer the analysts think is too low. Imagine that.Marcus: Vertex is on the other side of that trade because its cash flow bought it the option to be. The memo has Vertex at about 30x trailing free cash flow[^memo-vrtx-evfcf-20260331], on about $3.7 billion of trailing free cash flow, up roughly 66% year over year[^memo-vrtx-fcf-20260331]. Q1 10-Q confirmed. That is what lets you write an all-cash check of that size without asking anyone’s permission. The honest caveat is that writing the check is the easy part. This is the largest deal Vertex has ever done[^news-vrtx-crinetics-20260728], which means the integration is unproven, and in the meantime the existing franchise is funding all of it. Monday’s print won’t tell you anything about the acquisition. It’ll tell you whether the base business is still carrying the load.Ava: And look at what Vertex is assembling on top of the acquisition. That AbCellera collaboration is aimed at multispecific T-cell engagers for autoimmune disease and other conditions[^news-vrtx-abcellera-20260729]. So inside one week: a $10 billion company purchase and a $28 million science partnership. Very different price tags, same instinct. Lantheus, on the other side of the table, is a radiopharmaceutical business[^news-lnth-curium-20260727] — targeted drugs, narrow patient populations, and specialty sales forces that are expensive to build and hard to replace once you have one.Marcus: Which is why the buy-versus-build math has gone so lopsided. Building a specialty commercial organization takes years you do not get back, so a company with real free cash flow buys one instead, and the price of that shortcut gets set by whoever else has cash that week. Vertex had it. Curium apparently has it. Lantheus is the one being priced. Same mechanism we just watched in the hyperscalers. The currency is a sales force instead of a data center.Marcus: Same page, same week, and what decided which side of the table each one sat on was how much cash each business throws off. What I’d watch from here is that Lantheus number. If $7 billion moves, it tells you the cash flow was worth more than the bid assumed.Ava: Two companies, one page of the memo. The cash flow statement wrote the outcome for both.Rapid fireAva: Rapid fire. Three names, then the forward week.Ava: The most important company in the AI build had one of its worst weeks of the year, and it didn’t report anything. A Shanghai-based, state-backed Chinese company has begun mass producing deep-ultraviolet immersion lithography equipment — the machines ASML has effectively had to itself — reportedly after absorbing staff from a Huawei-backed startup[^news-asml-china-20260729]. The shares slid to their lowest level since early June[^news-asml-stock-20260728]. Bank of America says investors are overreacting to the China threat[^news-asml-bofa-20260728]. Maybe. ASML also posted €5.6 billion of net bookings in mid-2026, on strong demand for its High-NA EUV systems[^news-asml-bookings-20260730]. So the order book is fine and the moat is the open question. Those are different problems, on very different timelines.Ava: Intel, also on page 3, posted its fastest revenue growth in 15 years and announced 24,000 job cuts inside the same ten days. Second-quarter revenue up 25% to $16.1 billion, the strongest growth since Q3 2011[^news-intc-q2-20260723]. The forward guide topped estimates on data center strength[^news-intc-guide-20260723]. Intel also committed to mass production of its 14A node in 2028[^news-intc-14a-20260724]. And CEO Justin Hotard is cutting 24,000 jobs as part of a restructuring[^news-intc-layoffs-20260728]. Growth and a restructuring in the same breath usually means the growth isn’t coming from where the headcount is.Ava: And the AI build showed up in an oil major’s earnings. Chevron reported second-quarter earnings of $12.1 billion, $6.11 a share diluted, up 384% from a year ago[^news-cvx-q2-20260731]. Chevron also signed a 20-year power purchase agreement with Microsoft, supplying 2.67 gigawatts of behind-the-meter power to a West Texas data center[^news-cvx-msft-20260731]. Twenty years. Behind the meter. That is a hyperscaler deciding it would rather buy the gas than wait on the grid. And CEO Eimear Bonner said she expects fuel-making margins to stay high for as long as energy markets remain, quote, under stress[^news-cvx-margins-20260731]. Chevron also confirmed the Caspian Pipeline Consortium is flowing again with ships loading this week[^news-cvx-caspian-20260731], and signed preliminary agreements to advance discussions on Iraq’s West Qurna 2 and Nassiriya fields[^news-cvx-iraq-20260731]. A quadrupled quarter, a 20-year utility contract, and two new frontiers, all in one press cycle.Ava: The forward week is heavy. Palantir and Vertex report Monday[^earn-pltr]. AMD, Caterpillar, Pfizer, Spotify, and TransDigm on Tuesday[^earn-amd]. Wednesday brings Disney, Eli Lilly, Uber, Occidental, and Magnolia[^earn-dis] — which just agreed to buy WildFire Energy for about $4 billion[^news-mgy-wildfire-20260730] and priced a $1.1 billion stock offering the same week[^news-mgy-offering-20260730]. And Thursday: ConocoPhillips, Cheniere, Airbnb, and Lantheus, which may or may not still be an independent company by the time it reports[^earn-lnth].CloseAva: That’s the show. Wall Street’s consensus on the AI trade this week: Microsoft’s spending is disciplined and Meta’s is reckless. Same build, same bill. The only real difference is that one of them can already show you the invoice it sent. Cash flow did the grading this week. Microsoft got paid for the spending, Meta got billed for it, Apple got marked down for parts it couldn’t get — and over on page 15, the company with the cash flow wrote the check while the company with less of it got an offer. Next week the forward calendar does the talking. Download the Cash Flow Memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2632. I’m Ava Cabot. Have a good weekend.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* AppleInsider. (2026, July 31). Goldman Sachs drops Apple price target, sees growth in 2027. AppleInsider. https://appleinsider.com/articles/26/07/31/unimpressed-goldman-sachs-trims-aapl-target-by-10-after-earnings-call* AppleInsider. (2026, July 31). Services slowdown pushes Apple’s price target down to $360. AppleInsider. https://appleinsider.com/articles/26/07/31/services-slowdown-pushes-morgan-stanleys-aapl-target-down-to-360* AppleMagazine. (2026, July 29). Apple CEO transition gets a public preview. AppleMagazine. https://applemagazine.com/apple-ceo-transition-tim-cook-john-ternus/* Bloomberg. (2026, July 23). Intel earnings: (INTC) forecast tops estimates, fueled by data center growth. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-23/intel-forecast-shatters-estimates-fueled-by-data-center-growth* Bloomberg. (2026, July 27). ASML shares drop after report of China producing DUV chipmaking tools. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-27/asml-slides-after-report-of-china-beginning-duv-tool-production* Bloomberg. (2026, July 27). Curium is said to near about $7 billion acquisition of Lantheus. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-27/curium-is-said-to-near-about-7-billion-acquisition-of-lantheus* Bloomberg. (2026, July 31). Chevron says big fuel margins to persist amid energy stress. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-31/chevron-says-big-fuel-margins-to-persist-amid-energy-stress* BioPharma Dive. (2026, July 29). AbCellera, Vertex partner on next-gen T-cell engagers. BioPharma Dive. https://www.biopharmadive.com/news/abcellera-vertex-partnership-next-gen-t-cell-engagers/826471/* Chevron Corporation. (2026, July 31). Chevron reports second quarter 2026 results [Press release]. https://chevroncorp.gcs-web.com/news-releases/news-release-details/chevron-reports-second-quarter-2026-results* CNBC. (2026, July 24). Intel (INTC) earnings report Q2 2026. CNBC. https://www.cnbc.com/2026/07/23/intel-intc-earnings-report-q2-2026.html* CNBC. (2026, July 28). ASML Holding NV — Stock price, quote and news. CNBC. https://www.cnbc.com/quotes/ASML* CNBC. (2026, July 28). Meta partners with BlackRock: Here’s what you need to know [Video]. CNBC. https://www.cnbc.com/video/2026/07/28/meta-partners-with-blackrock.html* CNBC. (2026, July 29). Tim Cook’s last earnings call comes at momentous time for Apple with stock at record. CNBC. https://www.cnbc.com/2026/07/29/tim-cooks-last-earnings-call-comes-at-momentous-time-for-apple-.html* CNBC. (2026, July 30). Apple (AAPL) Q3 2026 earnings report: Live updates. CNBC. https://www.cnbc.com/2026/07/30/apple-earnings-live-updates.html* CNBC. (2026, July 31). Alphabet, Amazon and Microsoft added nearly $1.5 trillion in combined value this week. CNBC. https://www.cnbc.com/2026/07/31/apple-aapl-amazon-amzn-stock-today.html* CNBC. (2026, July 31). Meta sinks 8%, continuing record losing streak, while Microsoft jumps 15% as AI trade splits. CNBC. https://www.cnbc.com/2026/07/30/microsoft-msft-meta-stock-today-earnings.html* Fortune. (2026, July 31). Meta earnings reveal cash flow drops 91% — while Zuckerberg writes op-eds about superintelligence. Fortune. https://fortune.com/2026/07/30/zuckerberg-superintelligence-meta-cash-flow-drop/* Intellizence. (2026, July 28). Companies that announced major layoffs and hiring freezes. Intellizence. https://intellizence.com/insights/layoff-downsizing/major-companies-that-announced-mass-layoffs/* Investing.com. (2026, July 28). Vertex to acquire Crinetics Pharmaceuticals in $10 billion all-cash merger. Investing.com. https://www.investing.com/news/analyst-ratings/ubs-downgrades-crinetics-stock-rating-on-vertex-acquisition-93CH-4815601* Investing.com. (2026, July 31). Chevron says Caspian Pipeline Consortium is flowing, ships loading. Investing.com. https://www.investing.com/news/stock-market-news/chevron-says-caspian-pipeline-consortium-is-flowing-ships-loading-93CH-4829114* Latham & Watkins. (2026, July 30). Latham advises financing sources in connection with US$4.06 billion acquisition of WildFire Energy by Magnolia Oil & Gas. Latham & Watkins. https://www.lw.com/en/news/2026/07/latham-advises-financing-sources-in-connection-with-acquisition-of-wildfire-energy-by-magnolia* Latham & Watkins. (2026, July 30). Latham advises on US$1.1 billion public offering of common stock by Magnolia Oil & Gas. Latham & Watkins. https://www.lw.com/en/news/2026/07/latham-advises-on-public-offering-of-common-stock-by-magnolia-oil-gas* MarketScreener. (2026, July 29). B. Riley raises price target on Lantheus Holdings to $129 from $97, keeps Buy rating. MarketScreener. https://www.marketscreener.com/news/b-riley-raises-price-target-on-lantheus-holdings-to-129-from-97-keeps-buy-rating-ce7f51d3d98ffe22* Microsoft Corporation. (2026, July 24). FY26 Q1 — Performance. Microsoft Investor Relations. https://www.microsoft.com/en-us/investor/earnings/fy-2026-q1/performance* Microsoft Corporation. (2026, July 29). Microsoft fiscal year 2026 fourth quarter earnings conference call. Microsoft Investor Relations. https://www.microsoft.com/en-us/investor/events/fy-2026/earnings-fy-2026-q4* Seoul Economic Daily. (2026, July 29). ASML shares tumble 7% on report of Chinese DUV lithography development. Seoul Economic Daily. https://en.sedaily.com/international/2026/07/29/impregnable-asml-rocked-as-china-lithography-report-wipes* The New York Times. (2026, July 30). Microsoft increases spending on A.I. as profit jumps 31%. The New York Times. https://www.nytimes.com/2026/07/29/technology/microsoft-quarterly-earnings-report.html* Tom’s Hardware. (2026, July 24). Intel commits to 14A mass production in 2028 as its sales rise 25% year-over-year. Tom’s Hardware. https://www.tomshardware.com/pc-components/cpus/intel-commits-to-14a-mass-production-in-2028-as-its-sales-rise-25-percent-year-over-year* Unbox Future. (2026, July 30). Inside the 2026 semiconductor surge: Why Lam Research, Micron & AMD rallied on AI chip CapEx. Unbox Future. https://www.unboxfuture.com/2026/07/inside-2026-semiconductor-surge-why-lam.html* Upstream. (2026, July 31). Chevron sees significant potential in Iraq after latest agreements. Upstream. https://www.upstreamonline.com/field-development/chevron-sees-significant-potential-in-iraq-after-latest-agreements/2-1-2023717* Variety. (2026, July 30). Meta takes $2.4 billion charge for legal proceedings in Q2, revenue booms 28% to over $60 billion. Variety. https://variety.com/2026/digital/news/meta-q2-2026-earnings-results-legal-proceedings-charge-1236823577/Internal dataInternal data is provided on a best efforts basis.Earnings slateForward earnings dates and consensus figures are drawn from the episode’s earnings slate, pulled 2026-07-31. See 04. Publishing/shows/weekend-update/W2631/dryrun/earnings_slate.md.* Palantir, Vertex Pharmaceuticals — 2026-08-03 (Monday)* Advanced Micro Devices, Caterpillar, Pfizer, Spotify, TransDigm — 2026-08-04 (Tuesday)* Disney, Eli Lilly, Uber, Occidental Petroleum, Magnolia Oil & Gas — 2026-08-05 (Wednesday)* Airbnb, Cheniere Energy, ConocoPhillips, Lantheus — 2026-08-06 (Thursday) This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt, Mike, and Jason walk the Cash Flow Memo for value in a still-expensive market — with Iran re-heating the oil tape, open-weights politics reshaping who captures AI rents, and a full-page scan of who benefits from cheaper tokens.The Cashflow MemoKey Takeaways* Iran–US flare-up leaves Hunt more uncertain than any week since February, but base case stays oil in the $80–90 band (not $120–150); US pullback looks like the only workable option versus ground troops or deeper infrastructure strikes.* Open-weights models favor hyperscalers (Amazon, Alphabet, Microsoft, Meta, SpaceX) that already sunk CapEx in chips and avoid model-margin rent; Anthropic/OpenAI lobbying for restricted access is the opposite trade.* Apple’s low CapEx and cash buy optionality, but Siri still needs a real model (open weights or Gemini) and the stock is hardware-defended; hosts note NVIDIA GPU purchases for Gemini after long Nvidia–Apple bad blood.* Value hunt across the memo: most businesses get AI as a sustaining productivity boost; Uber is the standout disruption risk (Tesla/Waymo autonomy); oil E&P trade early-teens EV/FCF vs a normal 8–10x; midstream 6–8% yields with ~3–4% dividend growth are bond-like (~11%) vs the 15% double-in-five hurdle.* Next week teed up: AI impact on healthcare (page 19 skipped) plus where value sits in Tesla and SpaceX after large drawdowns; Starlink V3 and robotaxi-as-base-station ideas pressure cable/wireless ROIC.Show Notes[00:00] Intro & Cash Flow Memo Download the memo at telltales.us; 30 minutes on energy, technology, and healthcare cash flows.[00:00:20] Exhibits A–C: Iran, Gas, Deficit Iran–US ceasefire frays; Hunt sees pullback as the only workable path and keeps oil in an $80–90 investment band with more uncertainty than since February. Permian oil growth is pressuring 2027 gas futures under ~$3.50. Deficit path still points at healthcare as the only real spending lever.[00:06:17] Open Weights vs Closed Labs Hyperscalers align against restricting open-weight models (no model margin to pay); Anthropic/OpenAI lobbied for gatekeeping. Apple’s low CapEx looks fine on hardware cash, but Siri still needs a model — and NVIDIA GPUs for Gemini show the hardware path.[00:11:25] Memo Hunt: Compute Beneficiaries Uber/DoorDash/Airbnb/Five Below — most get sustaining AI productivity; Uber faces autonomy disruption from Tesla and Waymo. Industrials (copper, lithium, fertilizer) and logistics IT departments stand to gain; copper in racks may stay relevant longer as optical interconnects lag.[00:16:43] Financials, Energy & Retail Multiples Banks as capital-light cash generators once regulatory risk is met; oil E&P early-teens EV/FCF vs normal 8–10x after the war bid; midstream yields as bond substitutes short of a 15% hurdle. Costco’s scale-economies-shared model at ~50× FCF; Walmart Labs already deep in AI merchandising; PayPal framed as a change-management opportunity.[00:26:33] Cable, Wireless & Next Week Charter/Comcast trade like telcos as Starlink V3 and space-based capacity raise competition; Elon’s robotaxi-as-base-station idea. Coming attractions: AI in healthcare, plus Tesla and SpaceX valuation levels after drawdowns.Subscribe for the weekly Cash Flow Memo walkthrough — download the memo at telltales.us and join us next Wednesday.Cashtags$AAPL $ABNB $ALB $AM $AMZN $CELH $CHTR $CMCSA $COP $COST $CVX $DASH $DE $EQT $ET $FAST $FDX $FIVE $GNRC $GOOGL $GS $HD $IINN $JPM $KMX $LEN $LNG $LOW $META $MS $MSFT $NEE $NKE $NVDA $PYPL $T $TGT $TMUS $TSLA $SPCX $UBER $UPS $VZ $WMT $XOM This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →GE Vernova Is Already Selling 2031. The Scarcity Was Manufactured Twenty Years Ago.Every company in this week’s news was selling capacity it still has to build. GE Vernova was selling a place in line. It shipped three gigawatts of turbines in the second quarter and booked twenty gigawatts of orders and slot reservations against them.¹ Six or seven claims on the factory for every machine that walked out of it. That is a queue, and Vernova now sets the price of standing in it.Start with what a slot reservation actually is, because the phrase does a great deal of work inside that backlog number. It is not an order for a turbine. It is a paid claim on a window of factory time, booked years before the machine gets built, before the plant is permitted, before the interconnection queue clears. The customer buys optionality on Vernova’s throughput; Vernova sells scarcity forward. Reservations are running four to five years out, per Utility Dive’s account of Tuesday’s call. Bookings for 2031 delivery are being taken right now, and Scott Strazik expects to be more than halfway contracted for that year by December.²Which is why the cash showed up early, and why the way it showed up matters more than the amount. Vernova raised its full-year free cash flow guidance to between eleven and a half and twelve and a half billion dollars, up from six and a half to seven and a half.³ It raised the revenue guide by about a billion. A five-billion-dollar cash raise on a one-billion-dollar revenue raise is not operating leverage, and the company says so plainly: the quarter’s free cash flow rose primarily due to higher positive benefits from working capital.⁴ Translation, in the least mysterious sense: a sold-out factory collects customer money long before it collects revenue. In the Cash Flow Memo, Vernova’s line went from thirty-eight times trailing free cash flow in March to twenty-one in June without the share price doing the work.⁵ The denominator moved.Now the part that decides whether this is a good business or just a good year. Vernova can charge for a place in line because roughly three companies on earth can forge heavy-duty iron at this scale, and the reason there are three is 2002. The 1998-to-2001 merchant power boom pulled forward a decade of gas turbine orders; when gas prices climbed, the orders vanished, the factories emptied, and the downturn consolidated global manufacturing capability into the three suppliers that survived it, per Bloomberg’s reporting on the current bottleneck.⁶ All three remember. Tony Brough, whose firm advises the OEMs, put it flatly last summer: they are expanding, but each of them have been through boom times before so they are taking a measured and careful approach to capacity additions.⁷ That sentence is the investment case. The discipline is not a strategy anyone chose. It is scar tissue, and it converts a cyclical equipment order into a priced option on time.The other half of the asset is the installed base. Of the hundred seventy-six billion dollars of performance obligations on the June balance sheet, roughly half is services rather than equipment.⁸ That is an annuity on machines already spinning, indifferent to whether the next gigawatt gets financed. The cashflow read is in Marcus’s column below; short version, a free cash flow yield can be manufactured, and this week one of the memo’s cheapest-looking names manufactured its own.What changes the read is Vernova. Strazik committed on Wednesday to twenty gigawatts of annual output in the third quarter, twenty-four gigawatts in 2028, and actions to produce 30 GW in 2030.⁹ That is a company being paid to dismantle the exact scarcity that prices its own backlog, run by people who lived through the last time the industry tried it. The tell is not the backlog number, which will keep climbing; management guided to at least a hundred twenty-five gigawatts under contract by year end. The tell is 2032. Strazik described healthy discussions with customers about 2032 bookings and then said he needs more time before we can articulate the timing of contracting in ’32.¹⁰ Healthy discussions, no dates. BNP Paribas read that as possible peak momentum in the gas story, and the jury on the thirty-gigawatt expansion as still out.¹¹ Wind is the standing offset: equipment orders fell forty percent year over year, against a four-hundred-million-dollar segment EBITDA loss carried for the year.¹²Wall Street’s consensus on GE Vernova: a backlog story, and the backlog is the number to track. The backlog is sold out either way. What prices this company is how quickly it decides to stop being scarce.The Tape — W2630Universe of 94 cashflow-memo names, snap dates 2026-07-25 → 2026-07-26. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamSalesforce screens as a cash machine on this table, and the balance sheet under that yield changed character in a single quarter. Per the fiscal Q1 10-Q filed in May, Salesforce raised roughly $24.7B of debt and retired a comparable amount of stock, more than doubling debt/FCF to 2.8x. The 9.7% FCF yield in the row above is a yield on a levered equity stub now, and screens ranking it against unlevered software peers are pricing different risk. I read the recap as management agreeing with the screens, which counts for something. The test on the September 2 print is whether operating cash flow grows into the new interest load, and whether the repurchase pace holds with the debt on the books.Telltales Yield — Bottom 10This Week’s ReportersSector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps90 of 92 ranked-eligible names ranked. 2 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-07-26.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoSigned, Not PaidAI capacity got contracted through 2030, and the only company collecting cash this week was selling turbines.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 99 companies in the Cash Flow Memo. About 14 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2631.Chapter markers* Time | Segment* 0:00 | Open* 0:45 | Theme — Who actually collects* 4:45 | Deep dive — Page 3: AMD and Intel* 8:45 | Rapid-fire — the week’s signatures* 11:45 | Close + Consensus WatchFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.OpenAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.Ava: This was the week the AI build got signed, not paid. In five days: Samsung committed to a chip supply agreement with Broadcom worth more than $200 billion[^news-avgo-samsung-20260725]. Apple committed to years of US-made custom silicon with the same company[^news-avgo-apple-20260723]. AMD wrote an equity check to a customer so that customer could buy AMD’s racks[^news-amd-anthropic-20260722]. And Oracle got its credit rating cut for spending[^news-orcl-sp-20260720]. Almost none of that turns into cash this year. On Wednesday’s show, episode 2630, Hunt, Jason, and Mike walked all 20 pages of the Cash Flow Memo and came at this from the other direction — as the models commoditize, the value moves to the infrastructure[^ep-e2630]. This week the infrastructure sent out its invoices. We’re going to look at who can actually collect.Theme — Who actually collectsAva: Broadcom spent this week getting paid by both sides of a fight it isn’t in. Samsung signed a memorandum of understanding worth more than $200 billion — high-bandwidth memory, leading-edge foundry, advanced packaging, running through 2030[^news-avgo-samsung-20260725]. Two days earlier, Apple committed to a multiyear program with Broadcom to design and produce custom silicon and wireless connectivity for US-made chips, per Apple’s own newsroom[^news-avgo-apple-20260723]. Same week. Opposite ends of the supply chain. Marcus — who’s paying for that plumbing?Marcus: Broadcom doesn’t have to pick a winner in the GPU war. It bills the participants. The memo has it at 52x trailing free cash flow, fiscal Q2 10-Q confirmed[^memo-avgo-evfcf-20260503], on about $36 billion of trailing-twelve free cash flow, up roughly 53% from the prior twelve months[^memo-avgo-fcf-20260503]. That multiple isn’t cheap and it isn’t pretending to be. What it’s asking is that the 2030 end of those contracts is real. The test on the next print is whether the AI semiconductor line keeps compounding once the memory allocation is locked in.Ava: And here’s the part that doesn’t show up in the headline. When AMD launched its Helios rack this week — we’ll come back to that — SemiAnalysis found each rack needs 12 Broadcom Tomahawk switches, and that roughly 85% of the scale-up links inside it run through Broadcom retimers, 500-plus of them per rack[^news-avgo-tomahawk-20260725]. Broadcom is the only merchant supplier with silicon fast enough to do that job. Marcus, what does that do to the Broadcom case?Marcus: It means Broadcom gets paid on an AMD share gain and on an AMD share loss. That’s a different kind of asset than a chip company. The risk isn’t demand, it’s concentration — the International Trade Commission opened an investigation this week into Samsung memory products and several customers including Broadcom, on a patent complaint from Netlist[^news-avgo-netlist-20260721]. When your position depends on being the only supplier who can do the thing, patent risk is the thing that ends it. Not the order book.Ava: And then there’s the company that already collected. GE Vernova generated $5.1 billion of free cash flow in the second quarter alone — more than the whole of 2025, per the company’s release[^news-gev-fcf-20260722]. Orders grew 88% organically. Gas power equipment backlog plus slot reservations went from 100 gigawatts to 116, and management now expects at least 125 by year end[^news-gev-orders-20260722]. Total performance obligations are $176.3 billion as of June 30 — and almost exactly half of that is services, not equipment[^news-gev-rpo-20260722]. And per Talnexis hiring data, Vernova opened 284 new roles in the last seven days against about 2,200 open, top five hiring velocity across everything Talnexis tracks[^tlnx-gev-hiring-20260726]. That’s a backlog turning into payroll.Marcus: Everybody else this week announced. Vernova collected. The memo has it at 21x trailing free cash flow, Q2 10-Q, filed Wednesday[^memo-gev-evfcf-20260630], on $12.4 billion of trailing-twelve free cash flow[^memo-gev-fcf-20260630]. Net debt against that is about a third of a turn[^memo-gev-debtfcf-20260630]. Broadcom’s multiple is priced off cash that’s contracted. This one is priced off cash that already cleared the bank.Marcus: The services half of that backlog is the part I’d underline. Equipment backlog is a promise to build something. A services backlog on installed turbines is an annuity on machines already spinning, and it’s the half that doesn’t care whether the next gigawatt gets financed. What would change the take is wind — management is still carrying an EBITDA loss in that segment for the year, and Vineyard Wind sued in April to stop them exiting a supply agreement[^news-gev-wind-20260722]. Vernova is also lining up grid contracts in Venezuela, which is its own category of risk[^news-gev-venezuela-20260722].Marcus: The gap between those two multiples is most of the week in one number. 52x is priced off a contract book that starts converting toward the end of the decade. 21x is priced off cash in the bank. I’d weight the contract-timing risk higher than the market is right now, and I’d watch the 2027 order book on both names.Deep dive — Page 3: AMD and IntelAva: Two American chip companies had the best week either of them has had in years, and neither one of them got paid for it. Page 3 of the memo, same seven days, completely different reasons the cash isn’t there.Ava: Advanced Micro Devices is putting up to $5 billion into Anthropic[^news-amd-anthropic-20260722], and Anthropic is deploying up to 2 gigawatts of AMD’s MI450 GPUs inside AMD’s Helios racks[^news-amd-mi450-20260722]. Helios entered full production this week[^news-amd-helios-production-20260724], with Microsoft named as a new customer[^news-amd-helios-20260720] and Cerebras signed as a technical partner[^news-amd-cerebras-20260723]. Intel, on the same page, printed $16.1 billion of second-quarter revenue, up 25% year over year — the strongest growth rate since 2011, and its seventh consecutive quarter beating guidance[^news-intc-revenue-20260723][^news-intc-seven-20260724]. It landed Fortinet as the first named external customer of its foundry[^news-intc-fortinet-20260721]. And it lost $11 billion in the quarter on layoff and restructuring charges[^news-intc-loss-20260723]. Marcus — which one of those is the market getting wrong?Marcus: AMD just financed its own order book. An equity check into a customer who then buys the racks isn’t a sale, it’s a vendor loan with a purchase order stapled to it. The memo has AMD at 97x trailing free cash flow, Q1 10-Q confirmed[^memo-amd-evfcf-20260328], on $8.7 billion of trailing-twelve free cash flow — a 1% yield[^memo-amd-fcf-20260328]. That’s the price on a company whose largest new deployment is partly funded off its own balance sheet. What I’d watch is whether Helios revenue shows up in the August 4 filing or stays in the press releases[^earn-amd].Ava: A vendor loan with a purchase order stapled to it. Noted.Ava: There’s a counterweight, and it landed the same week. SemiAnalysis reported that AMD’s MI455X is the first data-center silicon on 2nm, ahead of everything it competes with — and in the same note, that AMD’s software gating massively regressed, with 90% parity against CUDA slipping from this summer out to October[^news-amd-semianalysis-20260725].Marcus: That’s the whole AMD question in one sentence, and it isn’t a hardware question. AMD has been ahead on paper before. The reason the 97x multiple is a stretch isn’t the silicon, it’s that a customer can’t run the silicon until the software clears parity, and that date has now moved. Anthropic’s commitment doesn’t accelerate a compiler. I’d weight the odds of Helios revenue landing on the original schedule at about 50/50, and October is the date that settles it.Marcus: Intel’s problem was never the revenue line. Going into this print the memo had no multiple to quote at all — trailing free cash flow was negative $2 billion at the Q1 10-Q[^memo-intc-fcf-20260328], against $13 billion of trailing capex[^memo-intc-capex-20260328]. That’s a company paying for a fab network out of an income statement that can’t carry it yet. The revenue quarter is real, and it doesn’t touch the denominator. Fortinet matters more than the revenue beat does, because external foundry volume is the only thing that eventually makes that capex line rational.Ava: So the beat isn’t the story. The customer is.Ava: And Intel is now looking for help carrying it. The company committed this week to 14A mass production in 2028[^news-intc-14a-20260724], and separately it’s seeking operating partners for the delayed Ohio fab — with SK Hynix exploring a role running the site rather than buying it[^news-intc-ohio-20260722].Marcus: Both of these are the same trade with different collateral. AMD is spending equity to buy demand it can’t fully serve yet. Intel is spending capex to buy capacity nobody has ordered yet. The one with the customer is carrying 97x. The one with the capacity is carrying negative free cash flow and looking for a partner to help run the building. Neither one converts on this quarter’s numbers, and I’d revisit both on August 4 when AMD reports[^earn-amd].Ava: Two names, one page, both spending someone else’s money to be in the same business. Neither has been paid yet. Which is the week.Rapid-fire — the week’s signaturesAva: Tesla asked to be valued as an industrial AI company in the same quarter its car economics went sideways. Deliveries hit 480,126 vehicles, a quarterly record[^news-tsla-deliveries-20260722]. Revenue was $28.24 billion, up about 26% and ahead of consensus[^news-tsla-revenue-20260722]. Then adjusted earnings per share came in at $0.33 against $0.51 expected, with operating profit down 57% as regulatory credits collapsed[^news-tsla-eps-20260722]. On the second-quarter call, Elon Musk said, quote, this is a massive capex year, end quote, and spent his time on robotics, silicon, and energy rather than on cars[^people-musk-capex-20260722]. Tesla also disclosed it bought an unnamed AI hardware company for $1.95 billion in stock during the quarter[^news-tsla-acquisition-20260724]. On the regulatory side the week split both ways: NHTSA denied a petition seeking a formal defect investigation into the emergency door release on about 180,000 vehicles[^news-tsla-nhtsa-20260724], while the separate probe into Full Self-Driving claims in low-visibility conditions is now at the engineering-analysis stage[^news-tsla-fsd-20260722].Ava: Celsius beat earnings and set a 52-week low on the same day. Page 16 of the memo, and there are two reasons for that. On the print, $0.41 against $0.29 expected[^news-celh-eps-20260723]. The stock still touched $27.45[^news-celh-low-20260723]. Reason one: core Celsius brand net sales grew 6%, a sharp deceleration from prior growth[^news-celh-core-20260720]. Reason two: England published plans to restrict high-caffeine energy drink sales to under-16s, pending a Parliamentary vote[^news-celh-england-20260724]. Bernstein upgraded into the low with a $44 target[^news-celh-bernstein-20260723]. Six other brokers cut their targets and kept their Buy ratings[^news-celh-brokers-20260724]. Starbucks and Chipotle both report Wednesday off the same page[^earn-sbux][^earn-cmg].Ava: Oracle had the week that answers the question Hunt, Jason, and Mike asked on episode 2629 — cheap, or value trap. The Pentagon awarded Oracle a 10-year software consolidation contract worth up to $7 billion[^news-orcl-pentagon-20260724]. In the same seven days, S&P cut Oracle’s credit rating over the data-center capex[^news-orcl-sp-20260720], and Oracle sued Wisconsin regulators over a $7 billion collateral demand tied to a single data center near Madison[^news-orcl-wisconsin-20260722]. Trailing-twelve free cash flow at Oracle is negative $19 billion, against $56 billion of trailing capex[^memo-orcl-fcf-20260531][^memo-orcl-capex-20260531]. Both of those sentences are true at the same time. A 10-year government contract is exactly the kind of revenue that supports a credit rating. It arrived the same week a ratings agency decided the spending in front of it mattered more.Ava: Forward week, and it’s the heaviest of the quarter. Page 1 of the memo prints almost all at once — Microsoft and Meta Wednesday, Apple and Amazon Thursday[^earn-msft][^earn-meta][^earn-aapl][^earn-amzn]. Visa, PayPal and UPS Tuesday[^earn-v][^earn-pypl][^earn-ups]. Palantir Monday the 3rd[^earn-pltr]. And AMD Tuesday the 4th, which is when the Helios question gets its first real answer[^earn-amd].Close + Consensus WatchAva: That’s the show. Wall Street’s consensus on this week’s announcements: demand is now confirmed through 2030. Confirmed demand and collected cash are separated by about four years of capex, and exactly one company in the memo shortened that gap this week. Everything else you heard was a signature. Broadcom signed contracts that convert late in the decade. AMD signed a customer it can’t fully serve until its software catches up. Intel signed one foundry customer and went looking for a partner to help run the building. Vernova banked $5.1 billion in 90 days[^news-gev-fcf-20260722]. Hiring data this week from Talnexis — talnexis.com. Download the Cash Flow Memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2631. The AI build got signed this week. Watch who gets paid.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* Advanced Micro Devices. (2026, July 22). AMD and Anthropic announce strategic partnership to deploy up to 2 gigawatts of AMD Instinct MI450 Series GPUs [Press release]. https://ir.amd.com/news-events/press-releases/detail/1292/amd-and-anthropic-announce-strategic-partnership-to-deploy-up-to-2-gigawatts-of-amd-instinct-mi450-series-gpus* Apple Inc. (2026, July 23). Apple to increase spend with Broadcom to produce billions more U.S. chips [Press release]. https://www.apple.com/newsroom/2026/07/apple-to-increase-spend-with-broadcom-to-produce-billions-more-us-chips/* Bloomberg. (2026, July 22). GE Vernova is preparing to serve Venezuela’s grid this year. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-22/ge-vernova-is-preparing-to-serve-venezuela-s-grid-this-year* Bloomberg. (2026, July 25). Samsung inks $200 billion chip supply with Broadcom. Bloomberg. https://www.bloomberg.com/news/articles/2026-07-25/samsung-inks-200-billion-chip-supply-with-broadcom* Business Insider. (2026, July 22). Elon Musk’s posts about making an espresso in FSD are being scrutinized in a Tesla investigation. Business Insider. https://www.businessinsider.com/elon-musk-post-making-an-espresso-fsd-scrutinized-by-regulators-2026-7* CNBC. (2026, July 20). AMD launches Helios, its first rack AI system to rival Nvidia, adding Microsoft as newest buyer. CNBC. https://www.cnbc.com/2026/07/20/amd-helios-microsoft-ai-nvidia.html* CNBC. (2026, July 21). Intel’s foundry lands first named customer under CEO Lip-Bu Tan, as Fortinet signs on for security chips. CNBC. https://www.cnbc.com/2026/07/21/intel-foundry-lands-fortinet-as-first-customer-for-security-chips.html* CNBC. (2026, July 22). AMD to invest up to $5 billion in Anthropic as part of computing power deal. CNBC. https://www.cnbc.com/2026/07/22/amd-anthropic-ai-chip-investment.html* CNBC. (2026, July 22). Tesla (TSLA) Q2 2026 earnings report. CNBC. https://www.cnbc.com/2026/07/22/tesla-tsla-q2-2026-earnings-report.html* CNBC. (2026, July 23). Cerebras stock gains on AMD partnership. CNBC. https://www.cnbc.com/2026/07/23/cerebras-stock-gains-on-amd-partnership.html* CNBC. (2026, July 24). Oracle signs 10-year software contract with Pentagon worth up to $7 billion. CNBC. https://www.cnbc.com/2026/07/23/oracle-wins-10-year-pentagon-software-contract-worth-up-7-billion.html* Drive Tesla Canada. (2026, July 24). Tesla AI hardware acquisition officially completed in $1.95 billion deal. Drive Tesla Canada. https://driveteslacanada.ca/news/tesla-ai-hardware-acquisition-complete/* GE Vernova. (2026, July 22). GE Vernova reports second quarter 2026 financial results and raises 2026 financial guidance [Press release]. https://www.gevernova.com/news/press-releases/ge-vernova-reports-second-quarter-2026-financial-results-raises-2026-financial* GE Vernova Inc. (2026, July 22). Form 10-Q for the quarterly period ended June 30, 2026 [Quarterly report]. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/1996810/000199681026000147/gev-20260630.htm* IndMoney. (2026, July 24). Intel Q2 2026 earnings: Beat, $11B loss, INTC stock reaction. IndMoney. https://www.indmoney.com/blog/us-stocks/intel-q2-earnings-results-intc-stock-reaction* Intel Corporation. (2026, July 23). Intel reports second-quarter 2026 financial results [Press release]. https://www.intc.com/news-events/press-releases/detail/1776/intel-reports-second-quarter-2026-financial-results* Investing.com. (2026, July 23). Celsius Holdings stock hits 52-week low at $27.45. Investing.com. https://www.investing.com/news/company-news/celsius-holdings-stock-hits-52week-low-at-2745-93CH-4809509* Memeburn. (2026, July 22). Oracle’s data center plans hit a problem money can’t solve. Memeburn. https://memeburn.com/oracles-data-center-plans-hit-a-problem-money-cant-solve/* Musk, E. R. (2026, July 22). Tesla Q2 2026 financial results and Q&A webcast [Earnings call]. Tesla, Inc. https://www.youtube.com/watch?v=9H5y9Uag8AA* Reuters. (2026, July 24). US agency rejects petition seeking Tesla door-release defect probe. Reuters. https://reuters.com/legal/litigation/us-auto-safety-regulator-denies-petition-seeking-tesla-door-release-defect-probe-2026-07-24* Semafor. (2026, July 22). Exclusive: Intel seeks operating partners for Ohio chip fab. Semafor. https://www.semafor.com/article/07/22/2026/intel-seeks-operating-partners-for-ohio-chip-fab* SemiAnalysis. (2026, July 25). Can AMD break the CUDA moat? AMD advancing. SemiAnalysis. https://newsletter.semianalysis.com/p/can-amd-break-the-cuda-moat-amd-advancing* Talnexis. (2026, July 26). Hiring intelligence: 7-day role velocity across 135 tracked companies. Talnexis. https://www.talnexis.com/* Teslarati. (2026, July 22). Tesla (TSLA) Q2 2026 earnings results: Miss on EPS, beat on revenue. Teslarati. https://www.teslarati.com/tesla-tsla-q2-2026-earnings-results/* The New York Times. (2026, July 23). Intel benefits from a new shift in A.I. spending. The New York Times. https://www.nytimes.com/2026/07/23/technology/intel-quarterly-results.html* The Stock Observer. (2026, July 23). Celsius (NASDAQ:CELH) sets new 1-year low – What’s next? The Stock Observer. https://www.thestockobserver.com/2026/07/23/celsius-nasdaqcelh-sets-new-1-year-low-whats-next.html* TIKR. (2026, July 24). Celsius fell to a 2026 low as England moved to restrict energy drinks and six brokers cut targets. TIKR. https://www.tikr.com/blog/celsius-fell-to-a-2026-low-as-england-moved-to-restrict-energy-drinks-and-six-brokers-cut-targets* Tom’s Hardware. (2026, July 24). Intel commits to 14A mass production in 2028 as its sales rise 25% year-over-year. Tom’s Hardware. https://www.tomshardware.com/pc-components/cpus/intel-commits-to-14a-mass-production-in-2028-as-its-sales-rise-25-percent-year-over-year* Trefis. (2026, July 20). History has an opinion on this CELH price level. Trefis. https://www.trefis.com/stock/celh/articles-v3/607934/history-has-an-opinion-on-this-celh-price-level/2026-07-20* Utility Dive. (2026, July 23). GE Vernova gas turbine backlog climbs to 116 GW. Utility Dive. https://www.utilitydive.com/news/ge-vernova-gas-turbine-backlog-climbs-to-116-gw/826039/* Wisconsin Public Radio. (2026, July 20). Oracle’s credit rating cut amid data center legal battle with Wisconsin regulators. WPR. https://www.wpr.org/news/oracles-credit-rating-cut-data-center-legal-battle-wisconsin-regulators* Yahoo Finance. (2026, July 21). Is Broadcom (AVGO) still undervalued as Netlist patent claims test sentiment? Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/broadcom-avgo-still-undervalued-netlist-061112166.html* Yahoo Finance. (2026, July 24). AMD stock gains overnight: Analysts laud chipmaker’s server leadership after strong Helios, customer updates. Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/amd-stock-gains-overnight-analysts-laud-chipmakers-server-leadership-after-strong-helios-customer-updates-053622107.htmlInternal dataInternal data is provided on a best efforts basis. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt, Jason, and Mike walk the full 20-page Cash Flow Memo, from a shut shipping channel in the Strait of Hormuz to a tiny ophthalmology compounder, hunting for value in an elevated market.The Cashflow MemoKey Takeaways* Energy desk: the Strait of Hormuz South Channel is effectively closed after Greek tanker owners pulled out following drone and missile strikes (two crew deaths), pushing Brent into the 90s and WTI into the low 80s; the deep backwardation says the market expects an Iran accommodation within days, and Hunt agrees one is likely by the weekend.* Counterintuitive gas call: despite the data-center power narrative, gas-for-power demand is flat (down in ’25, barely up in ’26), so the ’27 gas strip sits near $3.40; LNG demand is robust, but capacity value is accruing to independent power producers (Constellation, Vistra, NRG), none of which are in the memo.* Fiscal tripwire: defense is asking for ~$1.5T and the total deficit needs to hold near $1.5T or lower to avoid a capital-markets event (a failed Treasury auction) through ’26 and ’27; with interest at ~$1.15T and Social Security off-limits, Medicare and Medicaid (~$1.8T combined) are the only real lever.* AI value migration: with open-source models (Kimi K3 and others) reaching rough parity, model economics commoditize and value accrues to infrastructure, which is why Amazon and Alphabet are the preferred AI-infra owners; on semis, TSMC’s ~$265B Arizona commitment (we don’t want to leave any food on the table) cements leading-edge pricing power, and the standing risk is under-capacity inviting an industry-funded replacement rather than pricing pressure.* Healthcare value hunt: Jason prefers BioNTech over Moderna (more disciplined COVID-era spend, longer research runway) and Regeneron over Lilly (repriced for a post-blockbuster future, pipeline at a discount while Lilly rides the weight-loss hype); the team owns Vertex and Harrow, the latter compounding an ophthalmology sales-force edge by co-branding a topical anesthetic alongside EYLEA biosimilars.Show Notes[00:27] Exhibits B & C: Oil, Hormuz, and Backwardation The South Channel is effectively closed after Greek owners abandon it under drone and missile fire, lifting Brent into the 90s and WTI into the low 80s. The deep backwardation signals the market expects an Iran accommodation within days.[04:44] Exhibit B: Why Natural Gas Is Stuck Gas-for-power demand is flat despite the data-center narrative, pinning the ’27 strip near $3.40. LNG demand is robust, but the seven-day capacity value is accruing to independent power producers outside the memo.[07:00] Exhibit A: The Deficit and the $1.5T Line Defense is asking for roughly $1.5T, and the total deficit must hold near that level to avoid a failed Treasury auction through ’26 and ’27. With interest at ~$1.15T and Social Security untouchable, Medicare and Medicaid are the only real lever.[08:54] Page 1: AI Infrastructure, Amazon and Alphabet As open-source models reach parity, model economics commoditize and value shifts to compute. Amazon leads infrastructure-as-a-service, with Alphabet closing the gap on Azure.[11:42] Chinese Open-Source Models and Security Jason (ex-security) argues a model is just a list of weights, so a Chinese model can run safely in a US data center under the right terms of service. The Fable 5 data-capture change and the Hugging Face hack frame the regulatory-capture debate.[15:39] Page 3: Nvidia and TSMC TSMC’s ~$265B Arizona buildout and don’t leave food on the table line put Intel and Samsung on notice. TSMC sets the leading-edge pace and commands a wafer premium; Nvidia still isn’t a big multiple.[19:07] Pages 4-6: Media and Telecom Netflix keeps losing ground while Meta stays interesting. Telecom is destructive competition, T-Mobile carries the least debt and the highest multiple, and Starlink is a real threat.[22:01] Pages 7-8: Payments and Retail Visa and MasterCard remain great businesses facing a software-style challenge; PayPal and Circle both earn on idle float. Lowe’s and Home Depot are a duopoly, Costco and Walmart look expensive.[24:00] Page 13: Financials Hunt likes all five names. Interactive Brokers has the widest moat on the lowest cost base, and Moody’s is indispensable given the refinancing wall, though both trade rich.[26:00] Page 14: Industrials Caterpillar at roughly 40x free cash flow rides the power-equipment and reshoring wave versus Deere near 20x, but swapping isn’t smart. TransDigm and Fastenal round out the compounders.[28:00] Pages 15-19: Pharma BioNTech is the more disciplined cancer-vaccine bet over Moderna, and the team owns Vertex despite disliking big pharma’s treadmill. Regeneron is the value pick over an expensive, hype-driven Lilly.[31:33] Page 20: Harrow’s Ophthalmology Playbook Harrow is early in commercializing a cluster of eye drugs, leveraging one sales force to co-brand a topical anesthetic with EYLEA biosimilars. Sub-blockbuster drugs are hard to market, which is exactly Harrow’s edge.[33:52] Close: Software Next Week Next week is another full 20-page walk with a focus on software as an opportunity. Get the memo at telltales.us and join us in seven days.Cashtags$AAPL $ALC $AMZN $BNTX $CAT $CHTR $CMCSA $COST $DE $DISH $FAST $GNRC $GOOGL $GS $HD $HROW $IBKR $INTC $JPM $KMX $LLY $LOW $META $MRNA $MS $MSFT $NFLX $NVDA $PFE $PLTR $PYPL $REGN $SPOT $TDG $TGT $TMUS $TSLA $TSM $UNH $V $VRTX $VZ $WMT This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →Wall Street Called PayPal Dead Money for Two Years. This Week, Private Capital Sent a Term Sheet.Two markets looked at the same cash flows this week and reached opposite verdicts. The public market has spent two years pricing PayPal, Comcast, and half the telecom block as value traps — cheap for a reason, and the reason is they’re dying. Then Stripe and the private-equity firm Advent put fifty-three billion dollars on the table for PayPal at a twenty-eight percent premium, and PayPal’s own board came back and said the number was too low.¹² Only one of those two verdicts arrives with committed financing attached.The tell isn’t the premium. It’s what the premium is buying.Start with the balance sheet, because that’s where the buyer started. PayPal carries almost no debt and throws off something close to a sixteen percent free cash flow yield.³ To a public shareholder, that yield is a warning — the market’s way of saying the branded-checkout business is in slow decline and the multiple should stay buried. To a private buyer, the exact same yield is fuel. A clean balance sheet generating that much cash finances its own buyout: you borrow against the cash flow, cover the interest several times over, and fix the growth story out of the public eye on a five-to-seven-year clock instead of a ninety-day one. The public market marks PayPal to next quarter’s narrative. Advent underwrites it to the end of the decade.You could watch the plumbing for that trade get built in real time. Stripe and Advent lined up roughly fifty billion dollars in committed financing from JPMorgan and Morgan Stanley before the bid was even public, per Bloomberg.⁴ And in the same week, KKR started marketing bonds in Germany backed by PayPal’s buy-now-pay-later loans — the first securitization of its kind in Europe.⁵ That’s a second, entirely separate pool of lenders deciding PayPal’s receivables are money-good. When the assets underneath a company finance this easily, the buyout stops being speculative. The debt to do the deal is already there to be borrowed.Here’s the part the show didn’t have room for: this is not really a PayPal story. It’s a repricing of the entire boring half of the Cash Flow Memo. The same math that turns PayPal into a buyout candidate is sitting on page six under the telecom block — Comcast at a fifteen percent yield, Verizon at seven, every one of them a low-growth cash machine the public market has left for dead.⁶⁷ This is the take-private-of-the-cash-cow playbook, the one that ran hot in 2006 and 2007 — except this cycle the fuel isn’t syndicated bank loans and high yield, it’s private credit: direct-lending funds and asset-backed securitizations that did not exist at anything like this scale a decade ago. A financing system that large doesn’t just make one deal possible. It makes the list of takeable public cash machines far longer than the public market has priced in.The cashflow read is in Marcus’s column below; short version, the highest-yielding name in the whole memo is a telecom stock the tape is treating as a warning, not a gift.What changes the read is a term sheet, not a re-rating — and that’s the whole point. The catalyst for the cheap half of the memo was never going to be the public market waking up and paying more. It’s a buyer showing up and taking the company off the market entirely. On PayPal, the test isn’t the headline bid; it’s whether a second bidder appears before earnings on the twenty-eighth — a bank or a card network deciding it can’t let Stripe own these rails — because that’s what turns a negotiation into an auction.⁸ On telecom, the whole block reports Thursday and Friday next week, and the prints will tell the private buyers how fast the broadband base is actually eroding, which is the one number that decides whether these are melting ice cubes or the next names to get a term sheet.⁹Wall Street’s consensus on the cheap half of the memo: value traps, cheap for a reason, and the reason is terminal decline. Private capital spent this week agreeing about the cash and disagreeing about the ending. The trap, it turns out, has bidders — and they brought their own financing.The Tape — W2629Universe of 94 cashflow-memo names, snap dates 2026-07-10 → 2026-07-17. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamComcast is the highest-yielding cash machine in the memo, and the tape is treating that yield as a warning, not a gift. Going into Thursday’s print, the memo has Comcast at 6.5x EV/FCF and a 15.3% trailing FCF yield — a multiple that only pencils if the broadband base is melting. But consensus has next-twelve-month revenue down just 1.3%, so the whole read reduces to erosion speed: a base that leaks two or three points a year more than covers you here; one that loses faster to Starlink does not. I read the multiple as a bet on the pace of decline, not the fact of it. The test Thursday is broadband net adds and churn, not headline EPS — the same number the private buyers circling the cheap half of the memo are watching.Telltales Yield — Bottom 10This Week’s ReportersSector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps91 of 91 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-07-17.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoThe Trap Has BiddersWhile the market prices telecom and payments cash machines for the graveyard, the buyers keep writing billion-dollar checks.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 14 minutes. No filler. Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2630.Chapter markers* Time | Segment* 0:00 | Open* 0:45 | Theme — Telecom’s Squeeze* 4:45 | Deep dive — PayPal* 8:45 | Rapid-fire — the week’s checkbooks* 11:45 | Close + Consensus WatchFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note before we start: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.Ava: Here’s the whole week in one sentence. The public market spent five days pricing its own cash machines for the graveyard — single-digit multiples, double-digit yields, telecom and payments left for dead. And the buyers spent the exact same five days writing billion-dollar checks for those companies. Both of those things happened. They can’t both be right. On Wednesday’s show — episode 2629 — Hunt, Jason, and Mike went value-hunting and found it hiding in plain sight on page 1, in the hyperscalers everyone already owns.[^ep-e2629] This weekend we go to the other end of the memo: to the names the market gave up on, and the people who just tried to buy them.Theme — Telecom’s SqueezeAva: Start with the group nobody wants to own. On page 6 of the Cash Flow Memo this week — the entire telecom block: AT&T, Verizon, T-Mobile, Charter, Comcast.[^memo-page6-20260717] And the squeeze on that page is running in two directions at once. From the outside, it’s satellites — Bernstein cut Comcast’s price target to $28 this week, naming SpaceX’s Starlink as a real threat to the cable broadband business.[^cmcsa-bernstein-pt-20260714] Which is the tell, because in the same breath Comcast was quietly still building — wiring up another 1,500 homes in rural Florida, most of them never served before.[^cmcsa-xfinity-expansion-20260713] Marcus — the market’s already pricing these like they’re melting. Is it right?Marcus: On the cheap ones, I read it as a bet, not a mistake. Comcast’s at 6.5x free cash flow, a 15% yield[^memo-cmcsa-evfcf-20260331][^memo-cmcsa-yield-20260331] — that’s a decline multiple, not a value multiple. So the page comes down to one question: is the decline terminal, or just slow. If the broadband base erodes only 2 or 3% a year, that yield more than covers you. If Starlink takes real share, it doesn’t. The memo can’t settle it — the prints start this week, and they’ll tell us more than the multiple does.Ava: And the money is not sitting still while it waits. Verizon spent the week shrinking on purpose — selling 274 company-owned stores to six operators and cutting 500 corporate jobs, taking its store count down to 1,000 next month.[^vz-stores-layoffs-20260716] Marcus, Verizon carries the fattest dividend on the page and the heaviest balance sheet behind it.Marcus: Verizon’s the balance-sheet name. 13x free cash flow, a 7% yield, but 7x debt to free cash flow[^memo-vz-evfcf-20260331][^memo-vz-yield-20260331][^memo-vz-debtfcf-20260331] — near the top of the memo on leverage. At that payout and that debt load, selling stores and cutting jobs is just how they keep the dividend covered while the top line barely moves. It’s defense, not investment. I’d hold that read until the print Friday.Ava: And then there’s the one going the other way entirely. T-Mobile didn’t shrink the business — it squeezed the customer. This week it force-migrated roughly 8 million people off their old plans onto pricier ones, broke a pile of free-line promotions doing it, and now has until the end of the month to answer the FCC on price-lock complaints.[^tmus-migration-20260713][^tmus-fcc-20260714] Marcus, T-Mobile’s the odd one out on this page.Marcus: T-Mobile’s the odd one, and it’s priced that way. 16x free cash flow, more than double the cable names, and unlike them its free cash flow is still growing — it bought back $12 billion of its own stock last year.[^memo-tmus-evfcf-20260331][^memo-tmus-buyback-20260331] So the page sorts cleanly: Comcast and Verizon are cheap because nobody believes the growth, and T-Mobile’s expensive because people do. That 8 million-customer migration is what funding the growth looks like from the inside, and whether it holds is a regulatory question now, with the FCC answer due this month.Ava: One sector, both ends of the squeeze. And every name on that page reports inside the next week, so we will know a lot more by Friday.Deep dive — PayPalAva: Which brings us to the collision at the center of the whole week. PayPal is the cheapest cash machine in the entire memo — and this week somebody tried to buy it, and the board said the price was too low. Wednesday, Stripe and the private-equity firm Advent put a joint offer on the table: $53 billion, $60.50 a share, a 28% premium.[^pypl-stripe-advent-bid-20260715] The stock jumped 16% on the news.[^pypl-stock-surge-20260715] And then, two days later — today — PayPal’s board came back and called the offer inadequate, said it undervalues the company, citing execution and regulatory risk.[^pypl-board-inadequate-20260717] A 28% premium. And the answer was no. Marcus — is the board delusional, or is it doing the math the market won’t?Marcus: It’s doing the math the market won’t. Going into this, the memo had PayPal at about 6x free cash flow, a 16% yield[^memo-pypl-evfcf-20260331][^memo-pypl-yield-20260331] — the price you pay for a business you think is dying, and PayPal isn’t dying, it’s just boring. And here’s the part the market kept ignoring: last year PayPal bought back more of its own stock than it generated in free cash flow.[^memo-pypl-buyback-20260331] Management’s been telling you it’s cheap with the checkbook for two years. This week a buyer agreed. The board’s read is just that the first bid came in low.Ava: So the smart-money buyer and the company both think it’s underpriced. It was the public market that had it wrong the whole time.Marcus: That’s the trade, and you can see why a private buyer wants it. PayPal carries almost no debt — under 2x free cash flow.[^memo-pypl-debtfcf-20260331] A clean balance sheet throwing off a 16% yield is easy to finance: a buyer like Advent borrows against that cash flow, covers the interest several times over, and fixes the growth story out of the public eye. Stripe and Advent already lined up roughly $50 billion in committed financing from JPMorgan and Morgan Stanley.[^pypl-financing-20260715] So funding isn’t the constraint here.Ava: And you could see the plumbing for that trade getting built in real time this week, couldn’t you?Marcus: You could. Same week as the bid, KKR started marketing bonds backed by PayPal’s buy-now-pay-later loans in Germany — the first securitization of its kind in Europe.[^pypl-kkr-bnpl-20260715] That’s a second set of lenders deciding PayPal’s receivables are money-good. When the assets underneath a company finance that easily, the buyout math gets a lot less speculative — the debt to do the deal is already there to be borrowed.Ava: The lenders showed up before the bidders did. Tells you something.Marcus: It tells you the cash is real, and that the debate now is about price, not about whether the business is worth owning.Ava: So where does this go from here?Marcus: I’d weight it. A board calling a 28% premium inadequate is usually the opening move in a negotiation, not the end of one — so the base case, call it 60%, is a raised bid, something with a 7 in front of it. Maybe 25% of the time it falls apart on financing or regulatory risk and PayPal drifts back to its boring multiple. The rest is a real bidding war, if a bank or a card network decides it can’t let Stripe own these rails. What I’d watch isn’t the headline price — it’s whether a second bidder shows up, because that’s what would turn this from a negotiation into an auction.Ava: An auction for the company Wall Street spent two years calling dead money. And they report earnings the 28th,[^earn-pypl] right into the middle of all of it.Rapid-fire — the week’s checkbooksAva: Which is the theme of the whole rest of the week, because PayPal was not the only check written. A few big ones, and then the forward calendar to close.Ava: One. The biggest check of the week wasn’t in tech at all. NextEra and Dominion filed to merge — a $67 billion all-stock deal that would create the largest regulated electric utility in the country, around 10 million customer accounts across Florida, Virginia, and the Carolinas.[^nee-dominion-merger-20260715] To buy the regulators’ blessing, they’re dangling $2.25 billion in bill credits for customers in Virginia and the Carolinas — the toll you pay to combine two utilities this big.[^nee-dominion-merger-20260715] Here’s the cashflow footnote, though: NextEra already carries about 16x debt to free cash flow — one of the most levered names in the entire memo.[^memo-nee-debtfcf-20260331] And its answer to that was to go get bigger. Powering the AI build costs real money, and somebody has to borrow to do it. This one closes in 2027, if the regulators sign off.Ava: Two. The checkbooks were out in pharma, too. Eli Lilly agreed to pay up to $3.8 billion for a company called AtaiBeckley, to get a Phase 3 nasal spray for depression that hasn’t responded to anything else — a psychedelic-derived drug, bought as pipeline insurance.[^lly-ataibeckley-acquisition-20260716] That’s the pattern of the whole week: if you can’t grow it, buy it.Ava: Three. Now the counter-programming, because while all that cheap cash flow changed hands, the market was busy paying any price for the winners. Apple, page 1 of the memo, reclaimed the title of world’s most valuable company this week — $4.88 trillion, edging back past Nvidia.[^aapl-nvda-20260717] HSBC upgraded it to a Buy the same day and pushed its price target from $260 up to $366 on the AI story.[^aapl-hsbc-20260717] Apple trades around 35x free cash flow.[^memo-aapl-evfcf-20260328] Nobody is calling that a value trap.Ava: Four. Also on page 1 — Tesla. Best quarter in the company’s history: 480,000 vehicles delivered in the second quarter, up 25%.[^tsla-q2-vehicles-20260715] And it reports Wednesday. Now hold that delivery number up against the memo: Tesla trades at nearly 200x free cash flow — the single most expensive name in the whole universe.[^memo-tsla-evfcf-20260331] Same memo, same week: 200x for Tesla, 6x for PayPal. That spread — right there — is what this entire show is about.Ava: And five, the forward calendar, because next week is a wall of earnings. Tuesday, Interactive Brokers.[^earn-ibkr] Wednesday is the big one — Alphabet, ServiceNow, and AT&T all report.[^earn-googl][^earn-now][^earn-t] Then the telecom block we opened with closes out the week: Comcast and T-Mobile on Thursday, Verizon and Charter on Friday.[^earn-cmcsa][^earn-tmus][^earn-vz] We’ll have the prints for you next Saturday.CloseAva: That’s the show. Here’s the one sentence to take with you: this week the public market priced its cash machines for the graveyard, and the private buyers showed up with checks. Telecom at 6 times, PayPal at 6 times — and a $53 billion bid the board still called too cheap. Somebody is wrong, and we find out who over the next few quarters. Wall Street’s consensus on the old cash machines — telecom, payments, the unglamorous half of the memo — is that they’re value traps: cheap for a reason, and the reason is they’re dying. Then somebody put $53 billion on one of them. Turns out the trap has bidders. So keep one eye on the boring half of the memo this coming week — the telecom prints, the PayPal board, whoever’s next with a checkbook. That’s where the argument gets settled. Everything we covered comes straight out of the Cash Flow Memo — download it at telltales.us. Hunt, Jason, and Mike are back Wednesday, on episode 2630. I’m Ava Cabot. Thanks for listening.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* Apple tops Nvidia as world’s largest company amid tech rotation. (2026, July 17). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-17/apple-tops-nvidia-as-world-s-largest-company-amid-tech-rotation* Apple upgraded to Buy by HSBC on agentic AI, hardware pipeline. (2026, July 17). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-17/apple-upgraded-to-buy-by-hsbc-on-agentic-ai-hardware-pipeline* Eli Lilly and Company. (2026, July 16). Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions [Press release]. PR Newswire. https://www.prnewswire.com/news-releases/lilly-to-acquire-ataibeckley-to-advance-therapies-for-treatment-resistant-depression-and-other-mental-health-conditions-302827468.html* FCC demands answers from T-Mobile for violating customer commitments. (2026, July 14). PhoneArena. https://www.phonearena.com/news/t-mobile-plan-migration_id181869* KKR markets debt backed by PayPal’s buy now, pay later loans. (2026, July 15). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-15/kkr-markets-debt-backed-by-paypal-s-buy-now-pay-later-loans* NextEra Energy. (2026, July 15). NextEra Energy and Dominion Energy file to combine, building a stronger company to meet growing power demand across four of America’s fastest-growing states [Press release]. NextEra Energy Newsroom. https://newsroom.nexteraenergy.com/2026-07-15-NextEra-Energy-and-Dominion-Energy-file-to-combine,-building-a-stronger-company-to-meet-growing-power-demand-across-four-of-Americas-fastest-growing-states-while-keeping-energy-affordable-and-reliable* PayPal board sees Stripe-Advent offer as inadequate, sources say. (2026, July 17). Reuters via Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/exclusive-paypal-board-sees-stripe-222532613.html* PayPal stock soars on report of buyout proposal from Stripe, Advent. (2026, July 15). Yahoo Finance. https://finance.yahoo.com/markets/stocks/article/paypal-stock-soars-on-report-of-buyout-proposal-from-stripe-advent-131101969.html* PayPal works with Goldman, Evercore as Stripe, Advent make $50B-plus offer. (2026, July 15). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-15/stripe-advent-offer-to-buy-paypal-for-53-billion-reuters-says* SpaceX’s Starlink threat causes Bernstein to cut Verizon, AT&T, Comcast PTs. (2026, July 14). Invezz. https://invezz.com/news/2026/07/14/spacex-s-starlink-threat-causes-bernstein-to-cut-verizon-att-comcast-pts/* Stripe, Advent make $53 billion takeover offer for PayPal, sending stock soaring. (2026, July 15). CNBC. https://www.cnbc.com/2026/07/15/stripe-advent-offer-to-buy-paypal-for-more-than-53-billion-reuters.html* T-Mobile customers, your bill could increase today. (2026, July 13). Droid Life. https://www.droid-life.com/2026/07/13/t-mobile-customers-your-bill-could-increase-today/* Tesla (TSLA) scores the best 2nd quarter ever, energy business spikes, announces Q2 2026 earnings call schedule. (2026, July 15). Tesla Oracle. https://www.teslaoracle.com/2026/07/15/tesla-tsla-scores-the-best-2nd-quarter-ever-energy-business-spikes-announces-q2-2026-earnings-call-schedule/* Verizon cuts store workers in reorganization strategy. (2026, July 16). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-16/verizon-cuts-store-workers-in-reorganization-strategy* Xfinity and Comcast Business high-speed internet now available to more than 1,500 homes and businesses in Flagler Estates. (2026, July 13). Business Wire. https://www.businesswire.com/news/home/20260713993329/en/Xfinity-and-Comcast-Business-High-Speed-Internet-Now-Available-to-More-Than-1500-Homes-and-Businesses-in-Flagler-EstatesInternal dataInternal data is provided on a best efforts basis. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hormuz risk pushes Hunt’s oil call toward $80 (not $90–100), the team hunts for value on a high market — and lands on hyperscaler infrastructure over AI models — while healthcare delivers the first MRD-guided cancer approval and a live UNH margin-recovery setup.The Cashflow MemoKey Takeaways* Hunt on Hormuz: a multi-week/month US–Iran stalemate keeps crude closer to $80 than $65 (not $90–100); producers still budget off the 2027 strip, so higher spot just widens backwardation rather than spurring rig activity.* Value on page one of the memo: Amazon, Microsoft (~20x earnings), and Google/Alphabet (~30x) look reasonable once hyperscaler CapEx is treated as optional and data-center replacement cost is priced as a real asset; Jason argues models are commoditizing and the durable value is token infrastructure (Amazon Trainium + hosting overlooked).* Oracle near a 52-week low after the OpenAI capacity commitment and ~$110B net debt looks more value trap than bargain; IBM’s mainframe weakness this week is a signal that legacy IT budgets are being redirected to AI, and the hosts float that canceled OpenAI deals could be equity-accretive if capacity re-contracts on the open market.* Memory inflation (gigawatt DC cost maybe doubled) is the live constraint on Nvidia: if hyperscaler CapEx does not re-rate another 30–40%, chip budgets get crowded out even if token demand stays strong; TSMC’s $60B CapEx year still screens cheap net of Taiwan political risk.* Healthcare: first FDA approval of a cancer treatment gated on an MRD (molecular residual disease) blood test (Roche/Genentech, bladder) validates the MRD-supplier thesis; UNH expected to show margin bounce on high-20s/low-30s premium hikes; BioNTech preferred over Moderna on cash discipline; Vertex’s non-opioid pain drug is inflecting as PBM formulary frictions ease; Harrow’s Q1 CVS co-pay buy-down error (negative revenue on formulary patients) is the near-term watch item.Show Notes[00:00:00] Intro & Welcome Mike opens Telltales; grab this week’s Cash Flow Memo at telltales.us.[00:00:26] Exhibits A–C: Deficit, Hormuz & Oil Structure Hunt frames a multi-week Hormuz stalemate as closer-to-$80 crude with wider backwardation, producers still deciding off the 2027 strip; Exhibit A deficit runs roughly flat YoY through May, and any eventual sovereign-credit discipline will hit healthcare first.[00:04:34] Where Is the Value? Hyperscalers on Page One Mike and Jason make the case for Amazon, Microsoft (~20x), and Google (~30x) as infrastructure bets: CapEx is optional, replacement cost of installed data centers is high, and OpenAI lease stress only reinforces that tokens-and-capacity — not the model layer — is where value accrues. Amazon’s Trainium and hosting playbook get special attention.[00:08:24] Oracle: Cheap or Value Trap? Near a 52-week low with ~$110B net debt and heavy OpenAI-linked CapEx, Oracle draws a Charter-style leverage caution; IBM’s mainframe weakness is read as AI budget cannibalization of legacy software, and the hosts float that canceled OpenAI deals could re-rate capacity more cleanly.[00:11:07] Nvidia, TSMC, Micron & the Memory Tax Nvidia and TSMC still screen as cheap on the memo; Jason’s live risk is memory cost doubling the price of a gigawatt of data center, crowding chip orders if hyperscaler CapEx doesn’t re-rate another 30–40%.[00:12:34] Meta, Netflix & Content Share Meta’s cash-flow machine is hard to own without trusting Zuck’s CapEx (well above maintenance for the ad AI flywheel); Netflix at ~$73 looks like a value trap as market-share fears and content mix (Paramount improving) pressure the stock after walking away from Warner.[00:15:43] Healthcare: MRD Approval, UNH Margins, Lilly & Cash-Rich Biotechs First FDA approval of a treatment administered off an MRD molecular test (Roche/Genentech, bladder cancer) validates the residual-disease thesis; UNH expected to print a margin bounce on high-20s/low-30s premium hikes; Lilly stays expensive for a reason; BioNTech preferred to Moderna on post-COVID cash discipline.[00:21:29] Vertex Pipeline & Harrow/CVS Fix Vertex: kidney PDUFA path, non-opioid pain drug prescription data inflecting as PBM formulary issues ease, and a type-1 diabetes stem-cell program advancing; Harrow’s Q1 CVS co-pay buy-down created negative revenue on formulary patients — corrected, but Q2 commentary is the tell.[00:24:54] Next Week & Close Hunt tees up page-20-and-back value hunting for next week; World Cup final Sunday in New Jersey; back in seven days.Get the full Cash Flow Memo with updated financials on ~80 companies at telltales.us — new episodes every week.Cashtags$AMZN $BNTX $BRK.B $BWA $CHTR $CVS $GOOGL $HROW $HYNX $IROC $JPM $KO $LLY $META $MRNA $MSFT $MU $NFLX $NVDA $ORCL $PFE $PZG $TSM $UBER $UNH $VRTXThis post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →Micron and Intel Poured the Same Concrete This Week. The Market Paid One and Punished the Other.Micron and Intel spent the same seven days making the same bet: tens of billions of dollars, poured into American fabs, on the promise that the chips coming out the other end will pay for the concrete. The market paid one and punished the other. Micron raised its U.S. commitment to a quarter-trillion dollars and poured first concrete in Clay, New York a full quarter ahead of schedule, and the stock treated it as vindication.¹² Intel spent the week watching its process-node timeline slip toward 2027 and its oldest rival pass it in the one number that was supposed to be safe. Same reshoring headline. Opposite verdict.The tell isn’t who’s spending. Both are spending. The tell is whose cash already showed up.Page three of the Cash Flow Memo put both names side by side this week, and the cash flow statements underneath them could not look less alike. Micron’s free cash flow grew almost nine hundred percent year over year, to roughly twenty-six billion dollars trailing, and the stock rose with it — about forty times trailing free cash flow, which is not a stock getting more expensive so much as a company whose cash generation finally caught its own multiple from behind.³ The two-hundred-fifty-billion-dollar pledge and the early concrete are Micron telling you, per Bloomberg, that it reads this as a supercycle and not a spike.⁴ That’s the bull case, and the cash flow statement is genuinely backing it.Here’s the part the show didn’t have room for. Memory is the most violently cyclical business in semiconductors, and a cash-flow explosion of this size has, in every prior cycle, been the sound a top makes — peak DRAM pricing, printed straight to the cash flow line, right before it reverts. The entire bull thesis is that this time is structurally different: HBM demand from the AI buildout, long-dated contracts, three suppliers finally acting disciplined instead of flooding the market. Grant all of it, and you still owe yourself the honest shape of it. The contracted, AI-tied book is a slice; the merchant DRAM that fills out the rest still rides the spot cycle, and the swing factor that decides which way the whole thing breaks isn’t Micron at all. It’s whether Samsung and SK Hynix hold supply discipline or reach for share. A nine-hundred-percent cash number tells you the cycle is at its best. It does not tell you the cycle is over.Intel is the same lesson photographed from the other side. There’s no honest multiple to put on it — free cash flow is negative, capex ran about thirteen billion trailing, and none of that spending has turned into a profitable 18A yield yet.⁵ The number that actually moved this week wasn’t a valuation ratio; it was five point eight billion to five point one billion, AMD reported over Intel in data-center revenue, a line that had never crossed before.⁶ Intel is spending upstream of execution it cannot yet prove. Micron is spending downstream of demand it can already bank. The market isn’t anti-capex or pro-capex this week. It’s pricing the timing of the payoff — and it sorted the two names accordingly.The cashflow read is in Marcus’s column below; short version, the best yield-and-growth combination on the entire tape this week isn’t even a chip name. It’s the copper going into the buildings both of these companies are racing to fill.What changes the read is a calendar, not an opinion. Taiwan Semi reports Thursday, and it’s the real test of whether Micron’s supercycle extends across the chip complex or stays a memory-only story; ASML reports Wednesday, the upstream tell on whether the orders behind all this concrete are still coming.⁷⁸ On Micron itself, the test on the next print is whether DRAM pricing holds — the thesis breaks the day spot rolls over and the contracted slice can’t carry the merchant book. On Intel, the test isn’t an earnings beat at all. It’s whether 18A yields profitably on the 2027 timeline this week’s reporting just laid out. Mark both.Wall Street’s consensus on the chip complex: memory and logic are one semiconductor trade. Micron and Intel just spent a week proving they’re two — one compounding, one pricing in a turnaround a year later than it hoped. The harder question is the one the cash explosion buries: whether Micron’s nine hundred percent is a new plateau, or the same old memory peak wearing an AI badge.The Tape — W2628Universe of 94 cashflow-memo names, snap dates 2026-07-03 → 2026-07-10. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamThe best-balanced name on the tape this week isn’t a chip stock or a software stock — it’s a copper miner. Freeport-McMoRan tops the composite at a 6.7% FCF yield against 20.4% NTM revenue growth, at 14.9x EV/FCF. That pairing — cash-cow yield bolted to growth-stock top line — is the AI power buildout showing up one layer beneath the silicon. Every data center Micron and Intel are racing to feed needs copper by the ton, and the tape is starting to pay the picks-and-shovels before the second-order names catch a bid. Consensus still files Freeport under cyclical commodity, which is the read that misses when a secular demand leg gets bolted onto a cyclical business. The test is the Q2 print later this month: whether realized copper pricing confirms the growth the tape is already paying for.Telltales Yield — Bottom 10This Week’s ReportersSector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps91 of 91 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-07-10.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoW2628 — Micron’s Cash Flow Explosion, Intel’s Data-Center Loss, and Satellites Coming for CableMicron’s cash flow explosion, Intel’s data-center loss, and satellites coming for cable.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the companies in the Cash Flow Memo. About 14 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2629.Chapter markers* Time | Segment* 0:00 | Opening disclaimer* 0:15 | Cold open — throughline + prior-Wed callback* 0:50 | Theme — Satellites Come for Cable (Comcast, Charter, T-Mobile)* 5:00 | Deep dive — Micron vs. Intel* 9:15 | Rapid-fire (NextEra Energy, Apple, Broadcom)* 11:45 | Close — Consensus Watch + forward week* 12:15 | Closing disclaimerFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.Ava: Micron just proved what it looks like to win the right side of a technology cycle. Intel proved what it looks like to lose one. Same week, same memo page, completely different cash flow statements — one company’s free cash flow is up almost 900%, the other’s is negative. And it wasn’t just semiconductors — Comcast, Charter, and T-Mobile all got hit with the same question from Wall Street this week: what happens to your subscriber base when a satellite can do what your cable line does? Two banks think it’s a real problem. One thinks it’s overblown. We’ll get into who’s actually right, per the numbers.Ava: On Wednesday, Hunt, Jason, and Mike ran their mid-year predictions scorecard — grading calls on pharma M&A, the AI buildout, and Tesla’s Robotaxi race against Waymo, closing out the full review without needing a second week[^ep-e2628]. This weekend, two different incumbent stories: who’s getting outflanked, and who’s spending like they know it.Theme — Satellites Come for CableAva: On page 6 of the Cash Flow Memo this week — Comcast, Charter, and T-Mobile all got the same verdict delivered from three different directions. The threat has a name now: Starlink. It’s been a hypothetical for two years. This week, for the first time, the sell side started putting actual subscriber-loss numbers on it instead of just gesturing at the risk — and the three companies are responding to that same threat in three completely different ways.Ava: Comcast is dealing with it by spending on two fronts at once. Comcast-owned Sky agreed to buy ITV’s media and entertainment business for up to £1.6 billion — roughly $2.1 billion — with a £200 million earn-out riding on future ad performance[^cmcsa-sky-itv-acquisition-20260706]. Closer to home, Comcast also hit a construction milestone this week, wiring 15,700 new homes and businesses in New Jersey for Xfinity[^cmcsa-phillipsburg-expansion-20260707] — the fiber build going one direction while Wall Street models the satellite bleed going the other. And that’s the real story: Morgan Stanley cut its Comcast price target to $30 from $33 this week, now modeling Starlink at 16 million U.S. broadband subscribers by 2030, costing Comcast and Charter combined 400,000–500,000 broadband subscribers a year[^cmcsa-morgan-stanley-target-20260707]. Marcus — is 6.5 times too cheap, or exactly right?Marcus: Comcast is the cheapest stock in the entire memo, and the market’s telling you exactly why it’s willing to leave it there. 6.5 times trailing free cash flow, on a 15% yield[^memo-cmcsa-evfcf-20260331]. Free cash flow was already down about 21% year over year going into this[^memo-cmcsa-growth-20260331]. That’s not a value stock. That’s a stock priced for a shrinking subscriber base — and this week Morgan Stanley just told you how much more shrinking they expect. The test is whether the ITV content actually slows the bleed, or whether Morgan Stanley’s subscriber-loss estimate turns out to be the optimistic one.Ava: Charter’s getting hit even harder — and it’s not just one bank. Barclays slashed its price target from $200 to $130 this week[^chtr-barclays-target-20260708], and Wells Fargo cut theirs too, citing the same deteriorating broadband trend[^chtr-wells-fargo-target-20260707]. Charter also confirmed it’s shutting down a Network Operations Center team this week[^chtr-noc-closure-20260709] — cost-cutting on the ground while two banks cut targets on paper. The one piece of good news: a California regulator recommended approval of Charter’s $34.5 billion acquisition of Cox Communications, clearing a real hurdle toward closing[^chtr-cpuc-recommendation-20260709]. Marcus, the cashflow take.Marcus: Charter’s the one carrying real balance-sheet risk in this story. 12.5 times trailing free cash flow, but the number that actually matters is leverage — debt to free cash flow at 10.5 times[^memo-chtr-evfcf-20260331][^memo-chtr-debtfcf-20260331]. Free cash flow’s already down 12% year over year[^memo-chtr-growth-20260331]. That kind of price target cut from Barclays in one note isn’t analyst noise — that’s a bank telling you the subscriber math and the leverage math are now the same problem. Watch the leverage ratio, not the multiple. That’s what breaks first if Cox doesn’t close clean or the bleed accelerates.Ava: And then there’s T-Mobile — the one name in this trio Wall Street can’t agree on. Bank of America upgraded T-Mobile to Buy this week, $220 price target, arguing the market is straight-up overreacting to satellite fears[^tmus-bofa-upgrade-20260706]. Two days later, Wells Fargo initiated coverage at Equal Weight, $170 target, citing Starlink as a real threat to postpaid growth[^tmus-wf-initiation-20260708]. It wasn’t a clean week operationally either — a network outage on July 7 hit more than 2,000 users[^tmus-outage-20260707]. And in the middle of that split analyst decision, T-Mobile also lost a 28-year veteran — Chief Business and Product Officer Mike Katz stepped down, staying on only as an advisor through December[^tmus-katz-exit-20260707]. Marcus — who’s actually right here?Marcus: T-Mobile’s the only one of these three actually growing into its number. Just under 16 times trailing free cash flow, and free cash flow’s up 6% year over year — not down, up[^memo-tmus-evfcf-20260331][^memo-tmus-growth-20260331]. Management’s still buying back stock, $12 billion trailing twelve months[^memo-tmus-buyback-20260331]. That’s not a balance sheet bracing for a satellite hit. Bank of America and Wells Fargo disagree because the numbers genuinely don’t show the damage yet at T-Mobile — the disagreement is really about which cable and wireless name gets hit first, and right now T-Mobile’s cash flow statement is voting with BofA.Ava: Verizon’s in the same boat, for what it’s worth — Wells Fargo started coverage there this week too, same Starlink logic, same Equal Weight[^vz-wells-fargo-equal-weight-20260708]. Three telecom names, one satellite story, and completely different balance sheets underneath it. Same page of the memo, three different answers to the same question.Deep dive — Micron vs. IntelAva: The deep dive this week is page 3 of the memo — Micron and Intel. Same industry, same seven days, opposite direction entirely. Both companies make chips. Both are spending tens of billions on U.S. manufacturing. And this week, one of them got paid for it and the other got punished for it. One company just told the market it’s betting a quarter-trillion dollars on a supercycle that isn’t slowing down. The other just watched its oldest rival pass it in the one number that was supposed to be safe.Ava: Micron raised its U.S. manufacturing commitment to $250 billion through 2035 — $50 billion more than the number it announced earlier this year — and poured first concrete at its new fab in Clay, New York, more than a full quarter ahead of schedule[^mu-investment-expansion-20260709][^mu-nyc-fab-concrete-20260709]. It also put another $3 billion into the domestic supply chain this week, including financing to GlobalWafers for a Texas wafer facility[^mu-supply-chain-20260709]. Intel had a rougher week — and it actually started on a high note. Intel stock got an early lift Monday when the Broadcom-Apple chip deal triggered a broader semiconductor rally, up 5% on the read-through[^intc-broadcom-apple-20260706]. That lift didn’t last. Reports surfaced that its 18A and 18A-P manufacturing nodes won’t hit profitable yields until late 2026 at the earliest — more likely 2027[^intc-stock-decline-20260708]. The stock dropped nearly 10% on July 7, another almost 8% on July 8 — a 21% decline in seven trading days[^intc-stock-decline-20260708]. And in the same window, AMD reported more first-quarter data-center revenue than Intel for the first time ever — $5.8 billion to Intel’s $5.1 billion[^intc-amd-datacenterdominance-20260708]. Marcus, start with Micron.Marcus: Micron just re-priced itself without anyone noticing, because the earnings caught up to the multiple instead of the multiple getting cut. The memo has Micron at about 41 times trailing free cash flow now, on $26 billion of trailing FCF — up about 879% from a year ago[^memo-mu-evfcf-20260528][^memo-mu-growth-20260528]. That’s not a stock getting more expensive. That’s a company whose cash generation exploded faster than the stock price did. The pledge increase and the ahead-of-schedule fab are Micron telling you it believes this isn’t a one-quarter DRAM spike. Watch whether pricing holds through the next print — that’s the whole bet.Ava: Now the other side of that page.Marcus: Intel didn’t lose the data-center chip war on a spreadsheet — it lost it on a delayed process node. Capex ran about $13 billion trailing twelve months[^memo-intc-capex-20260328], and none of that spending has translated into a profitable 18A yield yet, which is why free cash flow is negative and there’s no honest multiple to put on this stock right now. The number that actually matters isn’t a valuation ratio — it’s $5.8 billion versus $5.1 billion, AMD over Intel in data-center revenue, a line that has never crossed before[^intc-amd-datacenterdominance-20260708]. The test isn’t the next earnings beat. It’s whether 18A actually yields profitably on the 2027 timeline this report just laid out.Marcus: Same memo page, same week. One company’s balance sheet just got permission to spend more. The other’s still waiting on a process node that isn’t yielding yet.Ava: Micron’s betting on being early. Intel’s betting on catching up. Mark the next print for both.Rapid-fireAva: Rapid-fire. Two more stories this week, no deep analytical beat — just the signal, quick.Ava: NextEra Energy filed the paperwork on the biggest utility merger of the year. The SEC S-4 went in on July 9 — roughly $67 billion, NextEra absorbing Dominion Energy, each Dominion share converting into NextEra stock plus a cash payment, targeting close in the second half of 2027[^nee-dominion-s4-20260709]. Here’s the tension: the Cash Flow Memo already had NextEra’s free cash flow down 65% year over year before any of this[^memo-nee-growth-20260331]. They’re announcing the sector’s largest deal in years off a balance sheet that’s already stretched. NextEra reports its own second-quarter numbers on July 24[^nee-earnings-date-20260710] — that’s the print to watch for how this financing actually gets structured.Ava: Apple and Broadcom extended their chip partnership through 2031 — $30 billion, more than 15 billion U.S.-made chips, including a $1.5 billion facility expansion in Fort Collins, Colorado[^aapl-avgo-chipdeal-20260708]. Apple’s already sitting at about 35 times trailing free cash flow[^memo-aapl-evfcf-20260328] — this is a company paying up for supply-chain certainty, not hunting for a cheap deal. Same week, the EU’s top court rejected Apple’s appeal and upheld its gatekeeper designation under the Digital Markets Act, for both iOS and the App Store[^aapl-eu-antitrust-20260708]. Broadcom, on the other side of the chip deal, got downgraded to Hold by Erste Group — their read is a 35-times forward multiple against Nvidia’s 22, even with the strong margins[^avgo-downgrade-20260707]. One company paying for certainty, one company getting told its certainty is already priced in. Apple’s own Q3 print lands July 30, off guidance of 14–17% revenue growth on iPhone 17 demand[^aapl-q3-call-20260709] — that’s the number that tells you whether paying for certainty was worth it.CloseAva: That’s the show. Wall Street’s consensus on cable and wireless: satellites are coming for all three names the same way. Two banks agree on Comcast and Charter — but Bank of America just broke ranks on T-Mobile, and this week T-Mobile’s own cash flow statement backed them up. Consensus isn’t as unanimous as the headlines make it sound. And on chips: consensus likes to treat memory and logic as the same semiconductor story. Micron and Intel just spent a week proving they’re not — one’s compounding, the other’s now pricing in a 2027 turnaround instead of a 2026 one.Ava: Forward week: earnings season builds fast. JPMorgan and Goldman Sachs both report Tuesday[^earn-jpm][^earn-gs] — the first real read on how the banks are pricing credit risk into the back half of the year. ASML drops Wednesday, and Morgan Stanley reports the same day[^earn-asml][^earn-ms]. Thursday is stacked — Taiwan Semi, Netflix, and UnitedHealth, all in one session[^earn-tsm][^earn-nflx][^earn-unh]. Taiwan Semi in particular is the real test of whether Micron’s supercycle story extends to the rest of the chip complex, or stays a memory-only story. Hunt, Jason, and Mike are back Wednesday on episode E2629. Download the Cash Flow Memo at telltales.us.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* AMD Tops Intel in Q1 Data Center Revenue on AI Demand. (2026, July 8). WinBuzzer. https://winbuzzer.com/2026/05/08/analysis-amd-overtakes-intel-in-data-center-revenu-xcxwbn/* Apple Inc. (2026, July 8). Apple to increase spend with Broadcom to produce billions more U.S. chips [Press release]. Apple Newsroom. https://www.apple.com/newsroom/2026/07/apple-to-increase-spend-with-broadcom-to-produce-billions-more-us-chips/* Apple loses major antitrust appeal in Europe, remains a gatekeeper. (2026, July 8). 9to5Mac. https://9to5mac.com/2026/07/08/apple-loses-major-antitrust-appeal-in-europe-remains-a-gatekeeper/* Apple schedules Q3 2026 earnings conference call for July 30th. (2026, July 9). MacDailyNews. https://macdailynews.com/2026/07/09/apple-schedules-q3-2026-earnings-conference-call-for-july-30th/* Barclays Adjusts Price Target on Charter Communications to $130 From $200. (2026, July 8). MarketScreener. https://www.marketscreener.com/news/barclays-adjusts-price-target-on-charter-communications-to-130-from-200-ce7f5ed9d88ef222* Broadcom Expands Work for Apple Supplying Products through 2031. (2026, July 6). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-06/broadcom-expands-work-for-apple-supplying-products-through-2031* Charter Communications to discontinue Network Operations Center team at Town & Country office. (2026, July 9). First Alert 4. https://www.firstalert4.com/2026/07/09/warn-notice-released-charter-town-country/* Comcast Corporation. (2026, July 7). Comcast Reaches Construction Milestone in Greater Phillipsburg Expansion, Bringing Xfinity and Comcast Business Services to More New Jersey Communities [Press release]. Business Wire. https://www.businesswire.com/news/home/20260707307752/en/Comcast-Reaches-Construction-Milestone-in-Greater-Phillipsburg-Expansion-Bringing-Xfinity-and-Comcast-Business-Services-to-More-New-Jersey-Communities* CPUC Judge Proposes Approving Charter-Cox Merger. (2026, July 9). Broadband Breakfast. https://broadbandbreakfast.com/cpuc-judge-proposes-approving-charter-cox-merger/* Erste Group Moves Broadcom (AVGO) to Hold. (2026, July 7). Yahoo Finance. https://finance.yahoo.com/news/erste-group-moves-broadcom-avgo-164525932.html* ITV agrees sale of media and entertainment business to Sky for up to £1.6bn. (2026, July 6). ITV News. https://www.itv.com/news/2026-07-06/itv-agrees-sale-of-media-and-entertainment-business-to-sky-for-up-to-16bn* Micron Boosts US Spending to $250 Billion to Feed Memory Boom. (2026, July 9). Bloomberg. https://www.bloomberg.com/news/articles/2026-07-09/micron-boosts-us-spending-to-250-billion-amid-memory-demand* Micron Technology, Inc. (2026, July 9). Micron Accelerates U.S. Investments, Pours First Concrete at New York Fab [Press release]. GlobeNewswire. https://www.globenewswire.com/news-release/2026/07/09/3324807/14450/en/Micron-Accelerates-U-S-Investments-Pours-First-Concrete-at-New-York-Fab.html* Morgan Stanley Adjusts Price Target on Comcast to $30 From $33. (2026, July 7). MarketScreener. https://www.marketscreener.com/news/morgan-stanley-adjusts-price-target-on-comcast-to-30-from-33-ce7f5edbd08cf624* NextEra Energy, Inc. (2026, July 9). NextEra Energy and Dominion Energy to merge [Form S-4]. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/0000753308/000110465926082301/tm2614888-13_s4.htm* NextEra Energy, Inc. (2026, July 10). NextEra Energy announces date for release of second-quarter 2026 financial results [Press release]. PR Newswire via TradingView News. https://www.tradingview.com/news/prnewswire:3f783c3848b02:0-nextera-energy-announces-date-for-release-of-second-quarter-2026-financial-results/* Semiconductor Selloff Deepens As AI Spending Fears Hit Intel. (2026, July 8). Forbes. https://www.forbes.com/sites/petercohan/2026/07/08/intel-stock-down-21-inside-the-july-2026-semiconductor-selloff/* T-Mobile Down for Thousands of Users, Downdetector Shows. (2026, July 7). GV Wire. https://www.gvwire.com/2026/07/07/t-mobile-down-for-thousands-of-users-downdetector-shows/* T-Mobile US, Inc. (2026, July 7). T-Mobile Appoints Chris Sambar Chief Enterprise Officer and Evolves Leadership Team to Advance its Next Era of Strategic Growth and Innovation [Press release]. T-Mobile Newsroom. https://www.t-mobile.com/news/business/t-mobile-appoints-chris-sambar-chief-enterprise-officer* T-Mobile stock gains as BofA upgrades to Buy, says satellite fears overblown. (2026, July 6). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/t-mobile-stock-gains-bofa-121406811.html* Wells Fargo cautious on AT&T, Verizon and T-Mobile as Starlink looms. (2026, July 8). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/wells-fargo-cautious-t-verizon-123610956.html* Wells Fargo initiates T-Mobile stock coverage with Equal Weight rating. (2026, July 8). Investing.com. https://www.investing.com/news/analyst-ratings/wells-fargo-initiates-tmobile-stock-coverage-with-equal-weight-rating-93CH-4781310* Wells Fargo Maintains Underweight on Charter Communications, Lowers Price Target to $160. (2026, July 7). Sahm Capital. https://www.sahmcapital.com/news/content/wells-fargo-maintains-underweight-on-charter-communications-lowers-price-target-to-160-2026-07-07Earnings slate referencesEarnings dates sourced from the W2628 earnings slate (04. Publishing/shows/weekend-update/W2628/dryrun/earnings_slate.md), pulled 2026-07-10.* JPMorgan Chase (JPM) — 2026-07-14 (Tuesday), consensus EPS $5.52, consensus revenue $51.06B* Goldman Sachs (GS) — 2026-07-14 (Tuesday), consensus EPS $14.47, consensus revenue $16.22B* ASML (ASML) — 2026-07-15 (Wednesday), consensus EPS $7.98, consensus revenue $10.26B* Morgan Stanley (MS) — 2026-07-15 (Wednesday), consensus EPS $2.89, consensus revenue $19.65B* Taiwan Semiconductor (TSM) — 2026-07-16 (Thursday), consensus EPS $3.80, consensus revenue $39.97B* Netflix (NFLX) — 2026-07-16 (Thursday), consensus EPS $0.79, consensus revenue $12.58B* UnitedHealth (UNH) — 2026-07-16 (Thursday), consensus EPS $4.84, consensus revenue $110.76BInternal dataInternal data is provided on a best efforts basis. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Oil holds steady despite Hormuz drone strikes, SK Hynix tests a $25B US listing, and the team runs its mid-year predictions scorecard across energy, tech, and healthcare — including Vertex’s $10B endocrine bet and Palantir’s Karp taking on Anthropic and OpenAI.The Cashflow MemoThe Prediction Scorecardhttps://telltales.topmarkcapital.com/predictions/Key Takeaways* Despite Hormuz drone strikes on three ships, Hunt sees no material oil supply disruption — crude drifts to the high-$70s (vs. high-$60s) while natural gas holds flat near $3.50 through 2027, and Medicare/Medicaid (~$2T of $7T federal spending) remains the only credible deficit lever.* SK Hynix is raising $25B in the US equity market ahead of a July 10 listing, reviving Hunt’s overbuild concerns for memory (Samsung/Hynix/Micron); IBM’s 7-angstrom (0.7nm) research chip claims a density lead over TSMC’s current 2nm node (1.6nm planned for next year).* The Nvidia-Palantir open-source JV (government first, banks next) reflects Jason’s models are commodity thesis; Alex Karp’s CNBC appearance pressed Anthropic and OpenAI on enterprise data trust, positioning Palantir’s context-graph as the model-agnostic integration layer.* Predictions scorecard: 2026 pharma M&A tracks to a record pace (~$150B in H1, ahead of 2019, driven by deal volume not mega-deals — largest single transaction only $13B); Tesla Robotaxi needs a serious hockey stick to catch Waymo given still-thin Austin/Miami fleets; xAI’s Grok 4.5 (claimed near-Opus-4.7 quality, cheaper/faster, but only 500K context) keeps the xAI leads call alive.* Vertex is paying ~$10B for Kynetix (San Diego endocrine-disorder pipeline, one drug already FDA-approved) on a bet that microplastic-driven endocrine disease is a growing secular market; CMS now projects US healthcare spend hits $9T (21% of GDP) by 2034.Show Notes[00:00:00] Intro & Welcome Mike opens the show; download this week’s Cash Flow Memo at telltales.us.[00:00:26] Exhibit C: Oil, Gas & Hormuz Risk Hunt argues the Hormuz drone strikes won’t meaningfully dent oil supply; he sees prices drifting into the high-$70s while natural gas holds flat near $3.50 through 2027.[00:04:23] Exhibit A: The Deficit, Defense Spending & Medicare Defense spending rises in FY27, interest costs hold near 3.5%, and Hunt makes the case for a bipartisan Medicare-for-All push to rationalize the ~$2 trillion Medicare/Medicaid budget.[00:06:18] Tech News: SK Hynix’s $25B Listing & IBM’s 7-Angstrom Chip SK Hynix raises $25B in the US ahead of a July 10 listing, raising overbuild concerns in memory; IBM claims a density lead over TSMC with a 7-angstrom (0.7nm) research chip.[00:09:23] Palantir, Karp’s CNBC Meltdown & the AI Trust War Alex Karp challenges Anthropic and OpenAI on enterprise data trust; Mike breaks down Palantir’s context-graph pitch as the model-agnostic integration layer for the enterprise, alongside its custom-model partnership with Nvidia.[00:13:17] Predictions Review: Energy & Nuclear US gas supply prediction hits 108 bcf/d; TerraPower’s Wyoming construction permit keeps the Gen IV nuclear call on track, while $4.50-5 natural gas and China oil demand growth both stall out.[00:16:21] Predictions Review: Tech, Robotaxis & Quantum Risk to Bitcoin Tesla Robotaxi needs a serious hockey stick to catch Waymo’s ride volume; new Google research shrinks the qubit count needed to crack Bitcoin encryption, pulling forward the threat timeline.[00:21:43] Predictions Review: Healthcare, Pharma M&A & GLP-1s 2026 pharma M&A tracks to a record ~$150B first half; Vertex pays ~$10B for endocrine-disorder specialist Kynetix, and a new Medicare GLP-1 bridge program offers $50/month prescriptions through year-end.[00:30:06] Wrap-Up Hunt and the team close out the predictions review largely unscathed.Get the full Cash Flow Memo with updated financials on ~80 companies at telltales.us — new episodes every week. Track how our calls are actually playing out at our predictions scorecard.Cashtags$AAPL $AMZN $GOOGL $LLY $MSFT $MU $NVDA $PLTR $TSLA $TSM $VRTX This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →Microsoft Is Funding the Next AI Layer With the Last OneEnterprise AI stopped being a story about models this week and became a story about invoices. On July second, Microsoft — page one of the Cash Flow Memo — stood up a unit called Frontier Co.: two and a half billion dollars, six thousand people, one job, which is to take AI products the last mile into enterprise deployment.¹ Two days later it moved to cut up to five thousand roles from sales, consulting, and Xbox.² The new layer is being paid for with the headcount of the old one. That is not a hiring plan. It is a company rebuilding itself around the part of AI that actually sends a bill.The model layer got three years of narrative. The deployment layer — the boring work of installing the thing, retraining the seat, wiring it into the workflow — is where the money changes hands, and the market has not repriced for that yet. Microsoft just showed you how the transition lands in a real profit-and-loss statement before it lands in a revenue line: deployment headcount up, legacy headcount down, net headcount roughly flat, and the revenue you are supposedly buying still not visible. The screens know how to price a growth story. They do not know how to price a margin-mix reallocation that hasn’t reached the top line.We have watched Microsoft run this exact play once before. The last decade’s version was the move from packaged software to subscription — the company retooled its sales motion and its cost base around the cloud years ahead of the recurring revenue, wore an ex-growth multiple through the gap, and re-rated hard only once the ARR became legible. Frontier Co. is the same bet, one rung up the stack. The reorg comes first. The revenue is the lagging indicator. The interval between them is exactly where a name gets mispriced.The pricing tells landed the same week, on both ends of the stack. Microsoft made the Copilot Business seat a permanent product at twenty-one dollars a month³ — the output price, now fixed. And AWS, per a Yahoo Finance report, raised GPU instance prices about twenty percent on July first⁴ — the input price, moving up. Read those two together and you are watching enterprise-AI unit economics get discovered in real time: the cost of compute rising, the price of the seat set. The names that compound from here are the ones that can lift the output price faster than the input cost climbs. Microsoft, sitting on the seat, can. Most of the memo, buying the compute, cannot.One honest caveat on the input side, because it is doing a lot of work: the AWS move is one vendor’s list price on specific instances. Azure and Google have not publicly matched, and a list price is not what a committed customer actually pays. Whether it holds through the next wave of capacity — the sixty-five-to-seventy-five-billion-dollars-per-gigawatt data-center builds Hunt, Jason, and Mike walked through on Wednesday⁵ — is the tell for whether this is structural scarcity or a headline. Don’t let one instance-price line stand in for the whole compute market.The cashflow read is in Marcus’s column below — short version, Microsoft is paying about thirty-eight times trailing free cash flow⁶ for a deployment curve that isn’t in the numbers yet, on capex already running close to a hundred billion a year.⁷ Palantir, the pure-play version of the same government-and-enterprise bet, asks a hundred and eight.⁸What changes the read is retention, not growth. The test on the next print, due late this month, is whether Copilot seat retention and attach start to show up inside Microsoft Cloud growth before the capex compounds past them. If deployment headcount grows and the seats don’t stick, that is the tell that enterprises are buying the org, not the outcome — and the whole bet inverts. Watch the AWS price too: if Azure and Google haven’t matched within a quarter, the twenty-percent move was a one-vendor list-price event, not the scarcity signal it read as. Mark the calendar for both.Wall Street’s consensus on enterprise AI: show us the revenue, then we’ll pay for it. But the org charts and the price tags moved this week, and the revenue line always arrives last. The last time Microsoft reorganized ahead of its own revenue, the people who waited for the number paid up for the wait.The Tape — W2627Universe of 94 cashflow-memo names, snap dates 2026-07-02 → 2026-07-03. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamThe enterprise-AI trade got expensive this week, and the cheapest way to own it is sitting at number four on the board. Salesforce already licenses a seat inside nearly every enterprise now buying AI deployment — and the memo has it at 10.5x trailing free cash flow, a 9.5% FCF yield, against single-digit NTM growth. Palantir asks ~108x for a version of the same government-and-enterprise AI story. That gap is either the market correctly pricing Salesforce as ex-growth, or an unpriced option on Agentforce turning installed seats into AI attach. The table can’t tell you which. The test on the next print is whether agent adoption shows up in current RPO and net seat expansion — or whether single-digit growth is the new ceiling.Telltales Yield — Bottom 10This Week’s ReportersNo universe names reporting in the coming 7 days.Sector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps91 of 91 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-07-03.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoW2627 — Tesla Blew Past Delivery Estimates, Comcast Split Itself into Cash, and Enterprise AI Started Setting PricesTesla blew past delivery estimates, Comcast split itself into cash, and enterprise AI started setting prices.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the companies in the Cash Flow Memo. About 14 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2628.Chapter markers* Time | Segment* 0:00 | Opening disclaimer* 0:15 | Cold open — throughline + prior-Wed callback* 0:45 | Theme — AI Goes to Work (Microsoft, Palantir)* 4:45 | Deep dive — Two Multiples (Tesla, Comcast)* 8:45 | Rapid-fire (Walmart, Harrow, Eli Lilly)* 11:45 | Close — Consensus Watch + earnings season preview* 12:30 | Closing disclaimerFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.Ava: Enterprise AI went from story to price action this week. Microsoft committed $2.5 billion and 6,000 employees to a dedicated AI implementation unit — and simultaneously flagged cuts to up to 5,000 more in legacy functions. Palantir won the U.S. Army’s data backbone contract for its highest-priority modernization program. And AWS quietly raised GPU instance prices 20% on July 1[^amzn-gpu-pricing-20260701] — the first open, on-record pricing signal that compute scarcity is structural, not cyclic. Meanwhile, two companies at opposite ends of the Cash Flow Memo’s valuation spectrum each delivered exactly what they promised. And the market’s reaction told you what it’s currently willing to pay for.Ava: On Wednesday, Hunt, Jason, and Mike worked through the cost of building the AI infrastructure itself — data center builds now running $65–75 billion per gigawatt, memory running at 30–40% of the total buildout cost[^ep-e2627]. This weekend, we pick up on the demand side: who is deploying that infrastructure, at what scale, and what the cash flow math says about what the market believes will pay for it.Theme — AI Goes to WorkAva: On page one of the Cash Flow Memo this week — Microsoft moved. Not in the abstract direction of AI, but in the direction of paying for it organizationally. On July 2, Microsoft committed $2.5 billion and is deploying 6,000 employees into a new entity called Frontier Co. — a dedicated AI implementation unit built specifically to take AI products from development into enterprise deployment[^msft-frontier-ai-20260702]. On July 1, Microsoft also made Copilot Business a permanent SKU at $21 per user per month[^msft-copilot-sku-20260701], the pricing structure that the deployment unit is built around. And on July 3, the company announced it is cutting up to 5,000 employees from sales, consulting, and Xbox[^msft-layoffs-20260703]. Microsoft is funding the AI deployment bet with the headcount from the pre-AI org. That is a choice. Marcus — the cashflow frame.Marcus: Microsoft just put a price tag on the deployment layer — and it’s the capex number that makes this interesting. The memo had Microsoft at about 38 times trailing free cash flow on roughly $76 billion of trailing FCF going into this[^memo-msft-evfcf-20260331][^memo-msft-fcf-20260331]. Capex is running close to $100 billion trailing twelve[^memo-msft-capex-20260331]. That’s not a rounding error — that’s a declared bet on infrastructure before the Copilot revenue compounding is visible in the numbers. The test on the next print: whether Copilot dollar retention starts to justify the capex ahead of it. 38 times is what you pay when you believe the deployment curve is real. This week Microsoft told you it believes.Ava: On the government side of the same argument: Palantir. The U.S. Army this month selected Palantir Foundry as the cloud data layer for NGC2 — Next Generation Command and Control — described by the Army as its highest-priority modernization effort[^pltr-army-ngc2-20260622]. On June 29, Palantir and Nvidia launched an engine for deploying Nvidia’s Nemotron open models in sovereign, air-gapped government environments[^pltr-nvidia-sovereign-ai-20260629]. The market digested all of it on July 1: Palantir up 7.8%, adding about $22 billion to its market value in a single session[^pltr-stock-rally-20260701]. DA Davidson followed on July 2 with a Buy upgrade and a $175 target[^pltr-da-davidson-upgrade-20260702]. Marcus — at 108 times free cash flow, what exactly is the market paying for?Marcus: Palantir is the closest thing the memo has to a pure-play on government AI becoming mandatory infrastructure rather than optional tooling. The memo has Palantir at about 108 times trailing free cash flow on roughly $2.7 billion of trailing FCF[^memo-pltr-evfcf-20260331][^memo-pltr-fcf-20260331]. Revenue ran about 85% growth year over year[^memo-pltr-rev-20260331]. That growth rate is real — but at this multiple, you are paying for every NATO-adjacent government following the Army’s architecture choice. NGC2 makes that thesis credibly possible. It doesn’t make it certain. The difference between possible and certain is where the risk lives.Ava: That’s the theme this week. AI isn’t just being built anymore — it’s going to work. AWS pricing compute as a scarce resource. Microsoft organizing its headcount around deployment. Palantir wiring the Army’s command layer into Foundry. The abstract investment argument just became a series of operating decisions with dollar amounts attached.Deep dive — Two Multiples, One WeekAva: The deep dive this week is a comparison. Two companies moved on the same week for completely different reasons — and they sit at opposite ends of what the market is currently willing to pay for. Tesla — also on page one of the memo this week — at just under 200 times trailing free cash flow. Comcast at 6.5 times trailing free cash flow. One company delivered a delivery beat. One delivered a restructuring announcement. The market applauded both. But the questions each answer are completely different.Ava: Tesla reported Q2 deliveries of 480,000 vehicles — up 25% year over year and marking the company’s first year-over-year delivery growth since 2023[^tsla-q2-deliveries-20260702]. That beat sell-side consensus by 74,000 units, or about 18% above where even the most bullish estimates were sitting[^tsla-deliveries-beat-20260702]. Comcast on June 29 announced it would spin off NBCUniversal and Sky into a new, separate publicly traded entity via a tax-free split expected to complete in approximately one year[^cmcsa-nbcu-spinoff-20260629]. Comcast is retaining a 19.9% stake in NBCUniversal for up to a year before monetizing[^cmcsa-ownership-20260629]. Comcast shares surged 21% in premarket on the announcement[^cmcsa-stock-surge-20260629]. Two very different proofs of value. Marcus — start with Tesla.Marcus: Tesla just proved the car business still works. Going into the Q2 financial print — which lands July 22[^tsla-earnings-schedule-20260702] — the memo had Tesla at just under 200 times trailing free cash flow on about $7 billion of trailing FCF, up more than double from the prior 12 months[^memo-tsla-evfcf-20260331][^memo-tsla-fcf-20260331]. The delivery beat answers one question: the demand is real, the business isn’t broken. The multiple asks a second question the delivery print does not answer: whether the autonomy layer scales into a standalone revenue stream. Those are different theses. One was validated this week. The other is what you are paying 200 times cash flow to believe.Ava: 200 times. Take a moment with that number.Marcus: On Comcast — the spinoff unlocks something the combined company had been hiding for years. The memo had Comcast at 6.5 times trailing free cash flow at about a 15% yield, on roughly $25 billion of trailing FCF going into the announcement[^memo-cmcsa-evfcf-20260331][^memo-cmcsa-fcf-20260331]. The broadband and cable infrastructure stays at Comcast — that’s the cash machine. The content SpinCo gets the narrative and the hype. How the debt distributes between the two entities during separation determines which stub actually screens cheaper at the stub level — that’s the number to watch during the 12 months of separation. The swing factor is whether broadband subscribers hold through the streaming transition once the content discount is removed.Ava: Goldman Sachs cut their price target to $26 this week[^cmcsa-gs-downgrade-20260702]. The broadband company was always 6.5 times — the content assets were the noise that obscured it.Marcus: That’s the argument. And it’s the cleanest sum-of-the-parts unlock in the memo universe right now. A 15% free cash flow yield on a broadband business with over 60 million subscribers is a different conversation once you don’t have to price it alongside Peacock.Ava: One name at nearly 200 times trailing free cash flow. One at 6.5 times. Both moved meaningfully on the same week. What the comparison says is something about where narrative premium lives right now versus where current cash generation prices. Tesla delivery beats don’t price autonomy — they confirm the baseline. Comcast restructurings don’t create cash — they reveal it. The market decided this week exactly how it wants to pay for each kind of proof.Rapid-fireAva: Rapid-fire. Three names, no deep analytical beat — just the week’s signal.Ava: Walmart. Cleveland Research flagged slowing U.S. comparable store sales and raised questions about whether Walmart is lowering prices aggressively to clear excess inventory, raising doubts on near-term sales guidance and merchandise margins[^wmt-comps-slowdown-20260701]. The stock dropped 8.5% on the note[^wmt-margin-strategy-20260701]. Then June non-farm payrolls came in significantly below economist projections on July 2 — eased rate concerns, institutional buyers stepped in, and Walmart bounced 3%[^wmt-rebound-payrolls-20260702]. The memo has Walmart at 62 times trailing free cash flow at a 1.5% yield. At 62 times, you are priced for flawless execution at 4% revenue growth. A Cleveland Research comp note is not a blip. It’s a thesis stress test. The bounce doesn’t resolve the question; it just means the question waits for next quarter.Ava: Harrow. The BYOOVIZ commercial launch happened July 1 — an FDA-approved interchangeable biosimilar referencing Lucentis, commercialized through Harrow’s exclusive agreement with Samsung Bioepis[^hrow-byooviz-launch-20260701]. BYOOVIZ is Harrow’s entry into the anti-VEGF market, which runs roughly $9 billion annually. Harrow’s full-year revenue guidance is $350–$365 million — the BYOOVIZ ramp is load-bearing for that number. At 48 times trailing free cash flow on a smaller-cap name, the launch velocity matters. The first signal on the ramp arrives with the Q2 print.Ava: Eli Lilly. The Medicare GLP-1 Bridge Program launched July 1, giving eligible Medicare Part D patients access to Foundayo — that’s orforglipron — and Zepbound at a $50 monthly copay[^lly-medicare-glp1-20260701]. The same week, the FDA selected Lilly for its PreCheck manufacturing fast-lane pilot, with Lilly’s active pharmaceutical ingredient plant in Indiana now in the program[^lly-fda-precheck-20260629]. Lilly’s full-year revenue guide is $82–$85 billion[^lly-q1-2026-20260430]. The memo has it at 81 times trailing free cash flow. The access expansion thesis just got two pieces of infrastructure in one week. The ramp is what the multiple is betting on — and a House investigation into China clinical trials with a July 17 deadline is the counter-catalyst to watch.CloseAva: That’s the show. Wall Street’s consensus on Tesla: the delivery beat validates the autonomy thesis. It validates the car thesis. But those are different theses at very different prices. A delivery beat confirms the baseline business isn’t broken. It doesn’t price the autonomy layer — that’s a separate bet, and it’s still a bet.Ava: Earnings season opens this coming week. JPMorgan and Goldman Sachs both report Tuesday[^earn-jpm][^earn-gs]. ASML drops Wednesday — which means the export control story and the Netherlands joining the Pax Silica alliance get a revenue number attached to them, with China at roughly 20% of projected 2026 systems revenue[^asml-decline-20260701]. Morgan Stanley also Wednesday[^earn-ms]. Thursday is stacked: Netflix, TSM, and UnitedHealth all in one session[^earn-nflx][^earn-tsm][^earn-unh]. Seven reports in four days. The opening bell of Q2 earnings season. Hunt, Jason, and Mike promised the mid-year predictions scorecard on Wednesday — and Hunt’s exact words were, next week we’ll all be kind of embarrassed by how poorly our predictions went[^ep-e2627]. Looking forward to it. They’re back Wednesday on episode E2628. Download the Cash Flow Memo at telltales.us.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* AWS raising GPU instance prices 20% on July 1. (2026, July 1). Yahoo Finance. https://finance.yahoo.com/technology/ai/articles/aws-raising-gpu-instance-prices-134420295.html* ASML Holding NV Stock (ASML) Moved Down by 6.02% on Jul 1: What Investors Need To Know. (2026, July 1). TradingKey. https://www.tradingkey.com/news/market-movers/262004606-market-movers-asml-20260701* Comcast announces it will spin off NBCUniversal and Sky from cable business. (2026, June 29). CNBC. https://www.cnbc.com/2026/06/29/comcast-announces-it-will-spin-off-media-and-tech-wings-into-separate-public-companies.html* Comcast (NASDAQ:CMCSA) Given New $26.00 Price Target at The Goldman Sachs Group. (2026, July 2). Markets Daily. https://www.themarketsdaily.com/2026/07/02/comcast-nasdaqcmcsa-given-new-26-00-price-target-at-the-goldman-sachs-group.html* Comcast NBCUniversal Spinoff Splits 65 Million Subscribers Across Two New Companies. (2026, June 29). Tech Times. https://www.techtimes.com/articles/319337/20260629/comcast-nbcuniversal-spinoff-splits-65-million-subscribers-across-two-new-companies.htm* Comcast stock surges as cable giant announces company split. (2026, June 29). Yahoo Finance. https://finance.yahoo.com/markets/article/comcast-stock-surges-as-cable-giant-announces-company-split-123931766.html* Eli Lilly and Company. (2026, April 30). Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines [Press release]. Eli Lilly Investor Relations. https://investor.lilly.com/news-releases/news-release-details/lilly-reports-first-quarter-2026-financial-results-raises-full* GlobeNewswire. (2026, July 1). Harrow Announces Commercial Launch of BYOOVIZ® in the United States [Press release]. https://www.globenewswire.com/news-release/2026/07/01/3320502/0/en/Harrow-Announces-Commercial-Launch-of-BYOOVIZ-in-the-United-States.html* Microsoft 365 Business Plans With Copilot Go Permanent for SMBs (July 2026). (2026, July 1). Windows Forum. https://windowsforum.com/threads/microsoft-365-business-plans-with-copilot-go-permanent-for-smbs-july-2026.425116/* Microsoft commits $2.5 billion and 6,000 employees to new AI implementation unit. (2026, July 2). CNBC. https://www.cnbc.com/2026/07/02/microsoft-commits-2point5-billion-6000-employees-ai-implementation-unit.html* Microsoft eyes another wave of layoffs that could hit 5,000 workers next week. (2026, July 3). Fox Business. https://www.foxbusiness.com/economy/microsoft-eyes-another-wave-layoffs-hit-5000-workers-next-week* Palantir Technologies. (2026, June 22). Palantir Secures Foundational Role in NGC2 Data Layer [Press release]. Palantir Investor Relations. https://investors.palantir.com/news-details/2026/Palantir-Secures-Foundational-Role-in-NGC2-Data-Layer/* Palantir Technologies. (2026, June 29). Palantir Launches Engine for Deploying NVIDIA Nemotron Open Models in Sovereign Environments [Press release]. Palantir Investor Relations. https://investors.palantir.com/news-details/2026/Palantir-Launches-Engine-for-Deploying-NVIDIA-Nemotron-Open-Models-in-Sovereign-Environments/* Palantir shares have struggled this year. D.A. Davidson says buy the dip. (2026, July 2). CNBC. https://www.cnbc.com/2026/07/02/palantir-shares-have-struggled-this-year-da-davidson-says-buy-the-dip.html* Palantir (NASDAQ: PLTR) Wins Role As Data Architecture Backbone For US Army’s NGC2 Command Program. (2026, June 27). Foreign Policy Journal. https://www.foreignpolicyjournal.com/2026/06/27/palantir-nasdaq-pltr-wins-role-as-data-architecture-backbone-for-us-armys-ngc2-command-program/* PR Newswire. (2026, July 1). What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management [Press release]. https://www.prnewswire.com/news-releases/what-medicare-part-d-patients-need-to-know-about-accessing-foundayo-orforglipron-and-zepbound-tirzepatide-for-weight-management-302810143.html* Tesla, Inc. (2026, July 2). Tesla Second Quarter 2026 Production, Deliveries and Deployments [Press release]. Tesla Investor Relations. https://ir.tesla.com/press-release/tesla-second-quarter-2026-production-deliveries-and-deployments* U.S. Food and Drug Administration. (2026, June 29). FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing. https://www.fda.gov/news-events/press-announcements/fda-selects-seven-participants-precheck-pilot-program-advance-us-drug-manufacturing* Walmart (WMT) Is Down 8.6% After Slowing U.S. Comps Raise Questions On Margin Strategy. (2026, July 1). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/walmart-wmt-down-8-6-051142700.html* Walmart Inc Stock (WMT) Moved Up by 3.15% on Jul 2: What Investors Need To Know. (2026, July 2). TradingKey. https://www.tradingkey.com/news/market-movers/262007772-market-movers-wmt-20260702* Why Walmart Plunged Today. (2026, July 1). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/why-walmart-plunged-today-185051907.htmlEarnings slate referencesEarnings dates sourced from the W2627 earnings slate (04. Publishing/shows/weekend-update/W2627/dryrun/earnings_slate.md), pulled 2026-07-04.* JPMorgan Chase (JPM) — 2026-07-14 (Tuesday), consensus EPS $5.61, consensus revenue $49.82B* Goldman Sachs (GS) — 2026-07-14 (Tuesday), consensus EPS $14.01, consensus revenue $16.02B* ASML (ASML) — 2026-07-15 (Wednesday), consensus EPS $7.98, consensus revenue $10.37B* Morgan Stanley (MS) — 2026-07-15 (Wednesday), consensus EPS $2.83, consensus revenue $19.29B* Netflix (NFLX) — 2026-07-16 (Thursday), consensus EPS $0.79, consensus revenue $12.58B* Taiwan Semiconductor (TSM) — 2026-07-16 (Thursday), consensus EPS $3.77, consensus revenue $40.02B* UnitedHealth (UNH) — 2026-07-16 (Thursday), consensus EPS $4.84, consensus revenue $110.76BInternal dataInternal data is provided on a best efforts basis. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Mike, Hunt, and Jason run the exhibits fast, then dig into the AI buildout math that keeps getting worse, Oracle’s brutal week, and a healthcare block anchored by Lilly’s 340B fight. As always, download the Cashflow Memo at telltales.us.The Cashflow MemoKey Takeaways* Oil has settled into a ~$70 floor with backwardation nearly gone (~$3 now vs. the $90 near-month / $75 twelve-month spread at the Iran peak), and Hunt reads the Strait of Hormuz drone tit-for-tat as an indefinite status quo gated by cargo insurance, not Iranian intent, while Northeast heat firms nat gas as power prices spike toward 15c/kWh.* The White House is clearing Anthropic’s Fable-05 (announced today) while still restricting OpenAI’s latest, a few-weeks delay the hosts dismiss as trivial and as the regulatory capture the labs originally lobbied for, with no real risk of Chinese models leapfrogging on the pause.* AI data center cost has jumped to $65–75B per gigawatt (up from $30–50B earlier this year) with memory alone now 30–40% of the build per Gavin Baker, and a structural memory shortage (Micron plus the two Koreans running low capex) plus rumored TSMC price hikes leave no one immune and make the space-based data center thesis incrementally more compelling.* Oracle logged its worst week since 2001 on a bloated risk section and dependence on OpenAI’s questionable funding, but the bull case is replacement cost: contracted capacity is worth more than Oracle spent, so the levered buildout bet holds as long as a customer exists, not necessarily OpenAI.* Eli Lilly is pressing the 340B program (now 16% of US drug sales) by demanding hospitals prove need, with Bill Cassidy legislation this week codifying the fight, while Lantheus’s FDA setback was manufacturer-controls-only (not efficacy) and dovetails with the FDA’s new PreCheck pre-clearance pilot, and Vertex’s non-opioid painkiller is climbing a flatter S-curve than hoped.Show Notes[00:00] Welcome & The Cashflow Memo Mike opens with the week’s format across energy, technology, and healthcare.[00:25] Oil at $70: Hormuz & Collapsed Backwardation Hunt on the Strait of Hormuz status quo, backwardation collapsing to ~$3, and why cargo insurance sets the real ceiling on tanker traffic.[02:26] Gas, Heat & Power Prices The Northeast heat wave firming nat gas as stressed power markets spike toward 15c/kWh.[07:23] Russia-Ukraine Stalemate & Venezuela Refinery drone strikes and fuel shortages with muted oil impact, plus Venezuela’s earthquake and the Gulf Coast’s fit for heavy crude.[11:56] Washington Clears Anthropic’s Fable-05 The White House allows Fable-05 while restricting OpenAI; regulatory capture and why the delay barely matters.[14:22] Chinese Models, Sonnet 5 & Tiered Pricing Distillation, token efficiency, and Sonnet 5 as a two-generation-old model upgraded — tiered effort as a pricing strategy.[16:04] The $75B Gigawatt & the Memory Shortage Data center cost doubling to $65–75B/GW, memory at 30–40% of the build, and a shortage that capex can’t quickly fix.[16:50] Oracle’s Worst Week Since 2001 The oversized risk section, OpenAI dependence, and the replacement-cost bull case.[18:18] Data Centers in Space Why orbit starts to pencil out when labor and time are the only knobs left to turn.[21:15] Healthcare: Pfizer, Lantheus & FDA PreCheck Pfizer’s patent-cliff cheapness, Lantheus’s manufacturer-only FDA rejection, and the FDA’s new pre-clearance pilot.[23:53] BioNTech, Moderna & Vertex’s Slow S-Curve Cash positions, pipeline burn, and a flatter-than-hoped non-opioid painkiller adoption curve.[25:07] Eli Lilly and the 340B Fight 16% of US drug sales flow through 340B; Lilly demands proof of need as Cassidy legislation codifies the battle.[27:37] Harrow Litigation & Mid-Year Predictions Preview A December 7th jury trial over a compounded product, and a predictions scorecard coming next week.Subscribe for weekly cashflow-driven investing across energy, technology, and healthcare, and grab the memo at telltales.us.Cashtags$AMZN $BNTX $GOOGL $LLY $LNTH $MRNA $MU $ORCL $PFE $TSM $VRTX This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →The Week Memory Stopped Being a CommodityFor forty years, memory was the worst business in technology. Brutally cyclical, structurally commoditized, a graveyard of balance sheets that overbuilt into every upcycle and got buried in the glut that followed. You did not own memory. You rented it, for one cycle, and you got out before the supply caught up. This week Micron told you that business is over — and the people still pricing it as a cycle are fighting the last war.Start with the number that actually matters, and it is not the print. Yes, Micron guided next quarter to fifty billion dollars against a Street modeling forty-three, and yes, the market cap crossed a trillion.¹ Spikes like that are exactly what the cyclical bears are built to fade. The thing that should stop you is buried below the headline: sixteen legally binding take-or-pay contracts, locking in roughly a fifth of Micron’s DRAM capacity through the end of the decade.² Take-or-pay is the language of pipelines and LNG terminals, not chips. It is what a supplier signs when the buyer is more afraid of not having the product than of overpaying for it. That sentence has never been true about memory before.This is a capital-cycle story, and the cleanest analog is crude. The oil majors spent decades destroying their own returns by spending every dollar of cash flow drilling into the next price spike. Then, somewhere after 2015, the survivors consolidated and discovered discipline — capex restraint, returns over volume, supply that no longer rushed to kill every upcycle. The multiples did not re-rate because demand exploded. They re-rated because the industry stopped overbuilding. Memory now has three players who matter, AI demand that arrives on multi-year contracts instead of a consumer whim, and customers signing away their option to walk. That is not a cycle turning. That is a commodity becoming a toll road.And you can read the toll on everyone downstream. Apple raised prices on fourteen products this week and took its worst single day in over a year, with Tim Cook calling the memory spike a hundred-year flood unlike anything in his forty years.³ A company that prints a hundred-thirty billion in trailing free cash flow does not pass costs to the customer over a blip — it eats them. It passes them when the input is structural, and the same week it is quietly lobbying Washington to buy from a blacklisted Chinese supplier just to get the parts.⁴ Oracle is funding its AI cloud with a twenty-four-billion-dollar free-cash-flow deficit and forty billion more in planned debt, the whole build premised on memory it has to secure years out.⁵ Broadcom and OpenAI unveiled a chip designed to cut inference cost in half — which is what you do when the underlying components got expensive enough to engineer around. Every one of those moves is a payment, in a different currency, to the same toll booth.The cashflow read is in Marcus’s column below — short version: the Cash Flow Memo had Micron going into the print at a hundred-plus times trailing free cash flow, and it was the wrong frame, because the contracts changed what the denominator will look like.What changes the read is the supply side, and the calendar is short. The test is whether Samsung and SK Hynix hold the same discipline or break ranks and flood capacity into these prices — the move that has ended every prior memory upcycle. Watch the fiscal-2027 capex commitments from all three, and watch whether more take-or-pay contracts get signed or this stays a sixteen-deal anomaly. The thesis breaks the moment one of the three decides that share matters more than price. It always has before.Wall Street’s consensus on memory: enjoy the spike, the cycle always rolls over, it always has. Sixteen take-or-pay contracts running to 2030 say the cartel finally learned what the oil majors learned — that the most valuable thing you can do with a commodity is refuse to make too much of it.The Tape — W2626Universe of 94 cashflow-memo names, snap dates 2026-06-19 → 2026-06-27. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamMicron isn’t in this table, and that’s the point — the print is too fresh and the fiscal-year filing hasn’t landed, so the memo number is already stale. Going into the quarter the memo had it at 102x trailing FCF, which was the wrong frame even then. The reframe is the contract book: 16 take-or-pay deals locking roughly a fifth of DRAM capacity through 2030. Take-or-pay converts a commodity denominator into something closer to contracted revenue, and the screens won’t reprice that until the filings show it. The test is the next fiscal-year filing — and whether Samsung and SK Hynix sign the same paper or break ranks on price.Telltales Yield — Bottom 10This Week’s ReportersSector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps90 of 90 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-06-27.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoMemory Hits Escape VelocityThe week the memory shortage stopped looking like a cycle, and everything downstream paid the bill.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 90-plus companies in the Cash Flow Memo. About 13 minutes. No filler. Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2627.Chapter markers* Time | Segment* 0:15 | Cold open — memory’s escape velocity* 0:45 | Theme — memory’s downstream: Apple and Oracle* 4:45 | Deep dive — Micron and Broadcom* 9:00 | Rapid-fire — Nike, pharma, Meta, Tesla* 12:15 | Close — Consensus Watch + forward weekFull transcriptCold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. We’re still in pilot, so tell us what’s working and what isn’t.Ava: Here’s the one thing to take from this week. Memory hit escape velocity. And everything downstream — Apple’s price tags, Oracle’s balance sheet, the chips hyperscalers are now designing just to get out from under the cost — is a consequence of that one fact. On Wednesday’s show, episode 2626, Hunt, Jason, and Mike flagged the memory squeeze forcing Apple to raise prices.[^ep-e2626] Then Micron reported. And the squeeze stopped looking like a cycle and started looking like a supercycle.Theme — memory’s downstreamAva: Start where it hits you at the checkout. Apple just told you the memory shortage has reached the price tag. The company raised prices on 14 products this week — MacBooks up $200, the iPad up to $449, Vision Pro now $3,699.[^aapl-price-hikes-20260625] The stock had its worst day in over a year, down about 6%, roughly $265 billion of market value gone in a session.[^aapl-stock-decline-20260625] And Tim Cook didn’t hedge it. He told the Wall Street Journal memory and storage prices have quadrupled in three quarters, and called it, quote, a hundred-year flood, unlike anything he’s seen in over 40 years.[^aapl-cook-quote-20260625]Ava: And then the quiet part. The same week Apple raised your prices, it was lobbying the Trump administration for permission to buy memory from ChangXin — a Chinese maker that sits on the Pentagon’s blacklist.[^aapl-cxmt-lobby-20260627] That’s how short memory is. And the talent is chasing the same scarcity — Apple’s head of Vision Pro and smart-glasses engineering left this week for OpenAI’s hardware unit, after seven years on the project.[^aapl-meade-openai-20260626] Marcus — Apple can afford to eat this. Why is it passing it on?Marcus: Because the flood is real and Apple is telling you it can’t source its way around it. This is a company that prints cash — the memo had Apple at 35 times trailing free cash flow at a roughly 3% yield going in, on about $130 billion of trailing free cash flow.[^memo-aapl-evfcf-20260627][^memo-aapl-fcf-20260627] A company with that cash machine raises prices on the customer only when the input cost is structural, not a blip. The price hikes aren’t the story. The lobbying to buy from a blacklisted supplier is the story. That’s a hardware company admitting the supply chain it actually wants is the one it’s not allowed to use.Ava: From the checkout to the data center. Oracle is building the AI cloud with borrowed money and a shrinking payroll. The company cut 21,000 jobs over the past year, about 13% of the workforce, while it pours money into infrastructure.[^orcl-layoffs-20260627] Free cash flow for fiscal 2026 swung to a deficit of nearly $24 billion, driven by $55.7 billion in capital spending.[^orcl-fcf-20260627] And it’s guiding next year to $90 billion in revenue while planning to raise another $40 billion in debt.[^orcl-guidance-20260627][^orcl-financing-20260627] Marcus, what does that infrastructure actually cost?Marcus: It costs the balance sheet, and Oracle’s making that bet out loud. There’s no multiple to anchor here — when you spend $55.7 billion on capex and free cash flow runs a $24 billion deficit, the price-to-cash-flow frame just doesn’t apply.[^memo-orcl-fcf-20260627] So don’t pretend it does. What you’re actually underwriting is whether $40 billion in fresh debt turns into $90 billion of durable cloud revenue, or into stranded capacity.Ava: A bet, not a business yet.Marcus: Not yet. And the tell will be the financing. Oracle already raised $43 billion in debt this past year, and it’s planning $40 billion more.[^orcl-financing-20260627] When a company funds the build with the bond market instead of its own cash flow, the bond market gets a vote on the strategy. On page 2 of the memo, Oracle sits right next to Broadcom — the two sides of the same AI infrastructure trade. One is borrowing to build it. The other is selling the shovels at a profit. Hold that thought.Deep dive — Micron and BroadcomAva: Here’s the deep dive, and it’s really one argument. Same week, same end-market, two completely different stories. Micron printed the memory supercycle in raw numbers. Broadcom showed you exactly what the hyperscalers will pay to escape its downstream cost. Two sides of one trade.Ava: The headlines, side by side. Micron reported fiscal Q3 revenue of $41.5 billion — against prior guidance of around $24 billion — and then guided next quarter to $50 billion, when Wall Street was modeling $43 billion.[^mu-q3-revenue-20260627][^mu-q4-guidance-20260627] The stock jumped 16% and the market cap crossed $1 trillion.[^mu-stock-surge-20260627][^mu-market-cap-20260627] Meanwhile Broadcom and OpenAI unveiled a custom inference chip called Jalapeño, built to cut AI inference cost by about half versus a standard GPU.[^avgo-jalapeno-chip-20260627][^avgo-jalapeno-cost-20260627] Marcus — which one is the bigger surprise?Marcus: Micron, and it’s not close. Going into this print the memo had Micron at 102 times trailing free cash flow — and I want to be clear, those numbers are now ancient history; we re-anchor when the fiscal-year filing lands.[^memo-mu-evfcf-20260627] Forget the multiple. The thing that matters is buried in the release: 16 legally binding take-or-pay contracts that lock in roughly 20% of Micron’s DRAM capacity through the end of 2030.[^mu-customer-agreements-20260627] That’s not a cycle. A cycle is when prices spike and supply floods in to kill them. This is customers signing five-year contracts to guarantee they get product at all. The cycle didn’t turn. The structure changed.Ava: But every memory bull has been burned by the next air pocket. What stops this from rolling over the way it always has?Marcus: The mix. Micron’s data center revenue went up more than sevenfold year over year, to about $11.5 billion in the quarter.[^mu-datacenter-20260627] The old memory cycle ran on phones and PCs — discretionary demand that turns on a dime. This run is driven by AI training and inference clusters, where the buyer is a hyperscaler signing multi-year capacity. Contracted demand doesn’t air-pocket the way discretionary demand does. The real risk isn’t a sudden glut — it’s that the build pauses. And the take-or-pay contracts are written so that even if a customer pauses, Micron still gets paid. That’s the difference between this and 2018.Ava: So why is Broadcom the other half of this?Marcus: Because Jalapeño is what you do when the input you depend on just got that expensive. Broadcom’s memo profile is the mirror image of Micron’s — about 68 times trailing free cash flow at a 1.5% yield, a real cash generator priced like one.[^memo-avgo-evfcf-20260627][^memo-avgo-fcfyield-20260627] And its AI semiconductor revenue is already running over $10 billion a quarter, guided toward more than $100 billion in fiscal 2027.[^avgo-fy2027-guidance-20260627] The Jalapeño chip — 50% cheaper inference, co-designed with OpenAI — is the hyperscalers saying out loud that GPU economics hurt enough to design around. Nvidia is the chip everyone’s now trying to engineer their way past. That’s not a knock on Nvidia. That’s a tell on how expensive the whole stack got.Ava: And does Jalapeño actually dent Nvidia, or is it a negotiating chip?Marcus: Both, and that’s the point. One custom processor doesn’t break a software moat that took 15 years to build. But it changes every procurement meeting — now the hyperscaler has a credible second source to wave around. The forward test for Broadcom is just as simple: does that $100 billion fiscal-2027 AI number actually show up, or does it stay a slide in a deck? If it shows up, 68 times trailing was cheap. If it slips, it was the top. Either way, Broadcom gets paid to build the escape hatch.Marcus: Here’s the line that ties it together. Memory is the new crude oil. And like crude, the people who locked in supply before the price doubled look smarter every single quarter. Micron just signed the people who locked in.Ava: Memory is the new crude oil. Sit with that one.Rapid-fireAva: Rapid fire. Step away from memory for a minute.Ava: Nike is the turnaround that keeps not arriving, and Tuesday it gets graded. The company reports Q4 results Tuesday afternoon, with the stock sitting at a 52-week low of $40, down about 35% on the year.[^nke-q4-earnings-20260627][^nke-52wk-low-20260627] KeyBanc downgraded it this week on slow turnaround progress and headwinds in China and Europe.[^nke-keybanc-downgrade-20260627] And here’s the crossover detail — Nike’s new finance chief is David Denton, hired straight out of the Pfizer CFO seat.[^nke-denton-cfo-20260627]Ava: Which brings us to pharma, where the week was busy. On page 15 of the memo — Pfizer and Moderna. Pfizer got an FDA approval expanding its IBRANCE breast-cancer regimen, and it’s pushing 10 Phase 3 studies this year on its monthly GLP-1, berobenatide — the obesity option the market isn’t really pricing.[^pfe-ibrance-approval-20260627][^pfe-berobenatide-phase3-20260627] Pfizer trades around 16 times free cash flow at a 6% yield, so you’re paid to wait.[^memo-pfe-evfcf-20260627] And Moderna got a unanimous, 9-0 FDA advisory vote backing its mRNA flu vaccine, with a decision due August 5 — which would be the first mRNA flu shot licensed in the US.[^mrna-flu-vac-20260627] The stock jumped about 12% on the news.[^mrna-stock-jump-20260627] Two names, one page, two very different clocks — Pfizer’s a yield-and-optionality story you can hold, Moderna’s a binary that resolves August 5.Ava: Meta showed you the memory supercycle hitting the biggest ad budget in tech. It raised its 2026 capital spending guide to between $125 and $145 billion, blaming higher component pricing and data-center costs.[^meta-capex-20260627] Same flood, different shore. It also unveiled in-house AI smart glasses at $299 and a prediction-market app called Arena.[^meta-glasses-20260627][^meta-prediction-market-20260627]Ava: And Tesla — the number to watch lands Thursday. Tesla reports Q2 deliveries July 2, with consensus around 406,000 vehicles and Goldman up at 420,000 on a European recovery.[^tsla-q2-schedule-20260627][^tsla-gs-forecast-20260627] One analyst cut the stock to Sell this week, citing energy storage revenue down 12% and robotaxi delays.[^tsla-downgrade-20260627] The delivery print is the first real read on whether Europe offsets China.CloseAva: That’s the show. Wall Street’s consensus on Micron: the memory cycle always rolls over, it always has. 16 take-or-pay contracts running through 2030 say maybe not this time. Keep score with me on that one.Ava: Forward week: Nike reports Tuesday, Tesla deliveries Thursday, and Moderna’s FDA clock runs toward August 5. Everything you heard today traces back to one chart — the price of memory — and the Cash Flow Memo is where we watch it propagate through all 90-plus names. Download it at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2627.Ava: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* Apple posts worst day in over a year after MacBook and iPad price hikes. (2026, June 25). CNBC. https://www.cnbc.com/2026/06/25/apple-macbook-ipad-price-hike-memory.html* Apple seeks US approval to buy chips from blacklisted CXMT: FT. (2026, June 27). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-27/apple-seeks-us-approval-to-buy-chips-from-blacklisted-cxmt-ft* Apple shares sink after price hikes hit iPads and Macs. (2026, June 25). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-25/apple-raises-mac-and-ipad-prices-to-counter-memory-shortages* Apple’s Vision Pro and smart glasses chief Paul Meade is leaving for OpenAI. (2026, June 26). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-26/apple-s-vision-pro-and-smart-glasses-chief-paul-meade-is-leaving-for-openai* Broadcom (AVGO) earnings report Q2 2026. (2026, June 3). CNBC. https://www.cnbc.com/2026/06/03/broadcom-avgo-earnings-report-q2-2026.html* FDA advisory panel votes 9-0 in favor of Moderna’s mRNA flu vaccine, setting stage for August decision. (2026, June 18). BioPharm International. https://www.biopharminternational.com/view/fda-advisory-panel-votes-9-0-in-favor-of-moderna-s-mrna-flu-vaccine-setting-stage-for-august-decision* FDA approves Pfizer’s IBRANCE regimen for HR+, HER2+ metastatic breast cancer frontline maintenance. (2026, June 24). BusinessWire. https://www.businesswire.com/news/home/20260617408304/en/FDA-Approves-Pfizers-IBRANCE-Regimen-for-HR-HER2-Metastatic-Breast-Cancer-Frontline-Maintenance* Goldman Sachs raises Tesla Q2 2026 delivery forecast to 420K. (2026, June 26). Basenor. https://www.basenor.com/blogs/news/goldman-sachs-raises-tesla-q2-2026-delivery-forecast-to-420k* KeyBanc lowers Nike rating to Sector Weight on near-term uncertainty. (2026, June 26). Investing.com. https://www.investing.com/news/stock-market-news/keybanc-lowers-nike-rating-to-sector-weight-on-nearterm-uncertainty-4762387* Meta plans to release AI-powered prediction market app, documents show. (2026, June 24). NPR. https://www.npr.org/2026/06/24/nx-s1-5869486/meta-prediction-market-app-ai* Meta Platforms, Inc. (2026). Form 8-K, FY2026 [Q1 results / 2026 capex guidance]. SEC EDGAR. https://www.sec.gov/Archives/edgar/data/0001326801/000162828026003832/meta-12312025xexhibit991.htm* Micron posts $41.5B Q3 revenue, guides Q4 to $50B. (2026, June 24). StockTitan. https://www.stocktitan.net/news/MU/micron-technology-inc-reports-record-results-for-the-third-quarter-6f50161e5zxh.html* Micron sales forecast tops estimates on memory-chip demand. (2026, June 24). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-24/micron-sales-forecast-tops-estimates-on-insatiable-memory-demand* Micron stock hits record high after Q3 earnings. (2026, June 24). TradingKey. https://www.tradingkey.com/analysis/stocks/us-stocks/261995206-micron-mu-q3-memory-shortage-cycle-ai-2027-samsung-skhynix-capex-tradingkey* Micron Technology stock could go parabolic after June 24. Here’s why. (2026, June 24). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/prediction-micron-technology-stock-could-110200571.html* MRNA stock surges as flu win and pipeline shift grab attention. (2026, June 26). Timothy Sykes News. https://www.timothysykes.com/news/moderna-inc-mrna-news-2026_06_26-2/* Nike names Pfizer CFO David Denton as next finance chief. (2026, June 23). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-23/nike-hires-pfizer-cfo-denton-to-take-over-for-departing-friend* NIKE, Inc. (2026, June). NIKE, Inc. announces fourth quarter fiscal 2026 earnings and conference call [Press release]. Nike Investor Relations. https://investors.nike.com/investors/news-events-and-reports/investor-news/investor-news-details/2026/NIKE-Inc–Announces-Fourth-Quarter-Fiscal-2026-Earnings-and-Conference-Call/default.aspx* Nike stock hits 52-week low. (2026, June 26). Investing.com. https://www.investing.com/news/company-news/nike-stock-hits-52week-low-at-4132-usd-93CH-4758516* Broadcom Inc. (2026, June 24). OpenAI and Broadcom unveil LLM-optimized intelligence processor [Press release]. Broadcom Investor Relations. https://investors.broadcom.com/news-releases/news-release-details/openai-and-broadcom-unveil-llm-optimized-intelligence-processor* OpenAI launches custom AI chip Jalapeño with Broadcom (AVGO). (2026, June 24). GuruFocus. https://www.gurufocus.com/news/8930240/openai-launches-custom-ai-chip-jalapeno-with-broadcom-avgo* Oracle Corporation. (2026, June 10). Oracle announces record Q4 and FY 2026 results driven by Cloud Infrastructure & Cloud Applications [Press release]. Oracle Investor Relations. https://investor.oracle.com/investor-news/news-details/2026/Oracle-Announces-Record-Q4-and-FY-2026-Results-Driven-by-Cloud-Infrastructure–Cloud-Applications/default.aspx* Oracle lays off 21,000 employees in just 12 months due to AI adoption and costly AI infrastructure ambitions. (2026, June 23). Tom’s Hardware. https://www.tomshardware.com/tech-industry/artificial-intelligence/oracle-lays-off-21-000-employees-in-just-12-months-due-to-ai-adoption-and-costly-ai-infrastructure-ambitions-says-layoffs-will-continue-as-internal-ai-deployment-grows* Oracle Q4 earnings and revenue top estimates; hyperscaler plans more debt issuance to support massive capex push. (2026, June 11). Sherwood News. https://sherwood.news/tech/oracle-q4-earnings-and-revenue-top-estimates/* Oracle shares slide as hefty AI spending, debt plans spook investors. (2026, June 11). The Spokesman-Review. https://www.spokesman.com/stories/2026/jun/11/oracle-shares-slide-as-hefty-ai-spending-debt-plan/* Robust Phase 2b efficacy and favorable tolerability support monthly dosing for Pfizer’s GLP-1 RA berobenatide. (2026, June 5). BioSpace. https://www.biospace.com/press-releases/robust-phase-2b-efficacy-and-favorable-tolerability-support-monthly-dosing-for-pfizers-glp-1-ra-berobenatide* Tesla downgraded to Sell, citing energy storage and robotaxi delays. (2026). Yahoo Finance. https://finance.yahoo.com/news/tesla-stock-drops-as-new-morgan-stanley-analyst-downgrades-shares-citing-valuation-164741776.html* Tesla Q2 2026 analyst delivery consensus. (2026, June 26). Electrek. https://electrek.co/2026/06/26/tesla-q2-2026-delivery-consensus-406000/Internal dataInternal data is provided on a best efforts basis. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Mike Nicoletti, Hunt Lawrence, and Jason Wallace dig into the looming Treasury market stress, proprietary-data risk in the age of frontier AI models, and a Medicare for All blueprint that could reshape healthcare investing. A 30-minute tour across energy, technology, and healthcare, anchored by this week’s Cash Flow Memo.The Cashflow MemoKey Takeaways* Hunt puts better-than-even odds on a 2008-style Treasury market dislocation within 12-24 months as ~$2.5T of new government paper collides with the incoming Fed chair’s plan to run the balance sheet from ~$7T down to ~$1.5T, plus the financing wave funding AI data centers (SpaceX alone just did $25B of public debt after its equity raise).* The only fiscal lever large enough to bend the deficit is healthcare, and Hunt floats Medicare for All run by an independent, Fed-style administrator (he names Dr. Oz) that ends the ~$600B/year Medicaid transfer to states; investment read is to avoid new healthcare positions broadly but identify the specific winners of a restructured system.* Apple is running Apple Intelligence inference on Nvidia Blackwell inside Google Cloud (not TPUs) specifically because Nvidia uniquely offers encrypted-data-in-memory, making proprietary-data protection the new competitive axis for frontier-model compute.* On a forced 5-year choice between Nvidia and Alphabet, the hosts lean Nvidia on relative value: ~$160B free cash flow trending toward ~$200B with minimal CapEx (vs. Apple’s $120B and Alphabet’s heavy capital program compressing its FCF), framed as the picks-and-shovels seller in the AI buildout.* The memory-supply shortage is forcing Apple to raise device prices (an estimated +$275 on the iPhone Pro just to hold gross margin); Micron reports tonight, and the squeeze is driving a stack-wide efficiency push (Nvidia cites ~2.5x inference efficiency gains since OpenAI’s 5.5 models).Show Notes[00:26] Oil Holds in the 70s, and a Treasury Warning Hunt sees no change in the oil supply/demand picture, WTI holding around $71, and lower oil prices paradoxically supporting natural gas via reduced Permian growth. He lays out a better-than-50% case for a 2008-style Treasury dislocation in the next 12-24 months, with healthcare as the only spending lever big enough to matter.[05:23] Medicare for All and Fixing Sick Care The hosts debate whether the U.S. can shift from triaging illness to keeping people healthy, why insurers’ one-year underwriting horizon works against long-term health, and how government’s interest in Medicare aligns with prevention.[08:07] Proprietary Data in the Age of Frontier Models How do Lilly, Citadel, or a startup protect proprietary information when agents can analyze anything on the open internet? Apple’s choice to run inference on Nvidia Blackwell for encrypted-in-memory data, cloud providers’ security track record, and the new attack surface agents introduce.[17:42] Nvidia vs. Alphabet for Five Years A forced one-stock choice: Alphabet as the chicken bet spanning search, cloud, Gemini, and DeepMind, versus Nvidia’s ~$160B-trending-$200B free cash flow on minimal CapEx. Plus the memory shortage forcing a ~$275 iPhone price hike and a stack-wide efficiency race.[23:44] Healthcare Science: CRISPR, the FDA, and China A generalizable CRISPR approach that shreds cancerous tumor DNA, an FDA program to cut 6-12 months off Phase 1 trials by partnering biotechs with academic centers, and the competitive threat from faster-moving Chinese biotech.[29:49] Closing: Medicare for All, the Fed, and the Financing Wave Dr. Oz as a Fed-style independent Medicare administrator, identifying the healthcare winners of a restructured system, and the collision of Treasury issuance with massive data-center financing (SpaceX’s $25B debt raise).Download this week’s Cash Flow Memo at telltales.us, and subscribe for energy, tech, and healthcare insights every Wednesday.Cashtags$AAPL $AMZN $CHTR $CMCSA $GOOGL $LLY $MSFT $MU $NVDA $TGT $UPS $XOM This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →Three Bottlenecks, One Multiple, and Only One MonopolyThe AI argument flipped sides this week. For two years the only question that mattered was whether anyone would actually buy all this compute, and Wednesday’s show put that one to bed. The question left standing is whether the supply chain can physically build it — the lithography, the power, the memory. And in the rush to own the chokepoints, the market did something lazy. It paid all three the same monopoly multiple. Only one of them is a monopoly.Start with the one that is. ASML makes the machine that etches the most advanced chips on earth, and it makes it alone — no second source, no roadmap to one, no credible challenger inside a decade. The Cash Flow Memo has it trading around sixty times free cash flow, on roughly eleven billion dollars of trailing free cash flow translated from euros.¹² That is a monopoly multiple, and for once it is bolted to an actual monopoly. The thing that can dent it is not a competitor — it is a government. Commerce Secretary Howard Lutnick told ASML, per Bloomberg, that he is concerned a top-tier extreme-ultraviolet machine may have reached China in violation of export controls; the company denied it has ever shipped one there.³ Notice what the risk actually is. Not the machine. The map of who is allowed to buy it. ASML’s customer list is the only variable that has ever moved this stock, and it is the one variable ASML does not control.Now the two the market is paying as if they were ASML. GE Vernova booked more data-center power orders last quarter than it did in all of the prior year, and its turbine backlog now stretches past a hundred-ten gigawatts into 2029.⁴⁵ Free cash flow grew almost four hundred percent.⁶ Real demand, real scarcity — for now. But a gas turbine is not an EUV machine. Siemens Energy and Mitsubishi build them too, and slot scarcity is the kind of bottleneck competition fills in three or four years, not three or four decades. GE Vernova is renting its scarcity. The order book is genuine; the durability is the open question, and a thirty-times multiple is pricing the scarcity as if it were permanent.Then memory — the bottleneck with the longest rap sheet. Micron reports Wednesday with its entire 2026 high-bandwidth-memory output already sold under contract and DRAM pricing set to jump fifty percent this quarter.⁷⁸ The cashflow read is in Marcus’s column below — short version, the trailing multiple is the cheap number, not the scary one. But here is the part the show had no room for: memory is the one bottleneck on this list that has detonated itself before. Every prior cycle ended the same way. All three makers see the shortage, all three turn the capex spigot at once, supply overshoots demand, and the pricing that looked structural turns out to have been a moment. Micron is committing roughly two hundred billion dollars to new capacity, and its two competitors are spending into the same shortage.⁹ That is either supply discipline or the seed of the next glut, and you cannot tell which from inside the shortage. You never can. That is what makes memory memory.So three bottlenecks, three very different half-lives, and a tape paying all three the monopoly rate. The durable one — the cornered machine — arguably earns it. The other two are borrowing the multiple from the durable one, and the loan comes due the day a competitor adds a turbine line or a third memory maker blinks first on capex.What changes the read is Wednesday, and the tell is Micron’s gross-margin guide. Guide above where consensus already sits and the cycle is still accelerating into the glut question, not away from it.¹⁰ Merely meet it, and a sold-out company that only meets gets sold on the news. The trade across the whole supply chain breaks the moment any one of the three memory makers signals it is racing the other two to fill capacity rather than pacing itself.Wall Street’s consensus on the supply chain: own the bottleneck, any bottleneck, at any multiple. The math says own the one nobody else can build — and rent the other two only as long as the scarcity lasts.The Tape — W2625Universe of 94 cashflow-memo names, snap dates 2026-06-15 → 2026-06-19. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamMicron reports Wednesday, and the reporters table holds the whole argument in two cells that read like a contradiction: a 1.0% trailing FCF yield sitting right beside 64% forward revenue growth. Trailing, Micron screens at 102x free cash flow — and that is a cyclical at the bottom of its cash cycle, where the trailing multiple measures the past and tells you nothing about the print. The 1.0% yield is the trough. The 64% is the market pricing what sold-out capacity earns once contract prices reset higher. The cheap-looking cell is the lie; the expensive-looking one is the tell. The test Wednesday is the gross-margin guide — clear where consensus already sits with the cycle still accelerating, or a sold-out name that merely meets gets sold on the news.Telltales Yield — Bottom 10This Week’s ReportersSector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps90 of 90 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-06-19.csv. NTM growth from analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoThe Week AI Became a Supply StoryThe bottleneck moved from demand to supply this week. Micron’s Wednesday print is the first real test.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 13 minutes. No filler. Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2626.Chapter markers* Time | Segment* 0:15 | Cold open — the supply side of AI* 0:45 | Theme — the two hardest things to build (ASML, GE Vernova)* 4:45 | Deep dive — Micron, the print that sets the cycle* 8:45 | Rapid-fire — Moderna, FedEx, Nike, Cheniere, Intel* 11:45 | Close — Consensus Watch + the week aheadFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. This is still a pilot, so tell us what’s working and what isn’t.Ava: And one more thing before we start — this one lands on Father’s Day. So happy Father’s Day to all the dads listening. We’re glad you’re spending part of the morning with us.Ava: Here’s the week in one sentence. The argument about whether anyone will actually buy all this AI compute? That got settled on Wednesday’s show. This week the question flipped to the other side of the ledger — can we build the supply. The machines that print the chips, the power that runs them, and the memory that feeds them. All three flashed at once. Three different stories, one spine — the build is now gated by what can physically be manufactured, not by whether the demand shows up. On this week’s Telltales, episode 2625, Hunt, Jason, and Mike spent the hour on the demand side — NVIDIA at $5 trillion, the end of the subsidized-token era, who actually pays for the compute.[^ep-e2625b] We’re taking the other half. The supply chain that has to deliver before any of that demand means a thing.Theme — The two hardest things to buildAva: Two things in this build are genuinely hard to make. One is the machine that etches the chip. The other is the electricity that runs it. Both made news this week, and both made it for the same reason — the demand has gotten ahead of the supply. Start with the machine almost nobody owns. This week the US government told the company that makes it that one of those machines may have ended up somewhere it isn’t allowed to go. US Commerce Secretary Howard Lutnick told ASML’s leadership he’s concerned one of its top-tier extreme-ultraviolet lithography machines may have reached China, in violation of export controls.[^asml-us-export-concern-20260619] ASML denied it flatly — says it has never shipped an EUV machine to China.[^asml-us-export-concern-20260619] This on the same company that just raised its full-year guide to €36–40 billion on AI demand.[^asml-q1-earnings-20260619] Marcus — what does a monopoly on the most important machine in the world actually cost?Marcus: ASML is the only company on earth that can make this machine, and the market has always paid it like one. The memo has ASML at about 62 times free cash flow,[^memo-asml-evfcf-20260619] on roughly $11 billion of trailing free cash flow, translated from euros.[^memo-asml-fcf-20260619] That’s a monopoly multiple for a monopoly. The export-control story doesn’t touch the cash — it touches who’s allowed to be a customer. And for this name, the customer list is the only variable that has ever mattered. A monopoly is worth 62 times right up until a government starts deciding who it can sell to.Ava: So the risk isn’t the machine. It’s the map of where it’s allowed to ship. And if Lutnick’s concern turns out to be real — if a top-tier machine genuinely reached China — the read-through isn’t just one company’s quarter. It’s that the export-control wall the entire AI-chip supply chain is built on has a crack in it.[^asml-us-export-concern-20260619] That’s the bigger story, and it’s why a denial isn’t the end of this one. Now the other hard thing — and it’s the boring one, right up until it’s the bottleneck. Electricity. GE Vernova booked more data-center power orders in a single quarter than it did in all of last year. $2.4 billion of electrification equipment orders for data centers in the first quarter alone.[^gev-data-center-orders-20260619] Its gas-turbine backlog now stretches past 110 gigawatts into 2029,[^gev-turbine-backlog-20260619] and Bernstein just opened coverage with an Outperform, calling it a play on the AI power boom.[^gev-bernstein-20260619] Marcus — second one. What’s the cash say?Marcus: The power names spent a decade as widow-and-orphan utilities. GE Vernova just stopped being one. The memo has it at about 33 times free cash flow,[^memo-gev-evfcf-20260619] and free cash flow grew almost 400% year over year.[^memo-gev-fcf-20260619] That’s not a utility growth rate — that’s an order book repricing to AI in real time. $2.4 billion of data-center orders in one quarter[^gev-data-center-orders-20260619] is the tell. The thing I’d watch is conversion: that backlog only matters if the turbine slots actually deliver on schedule and don’t slip. The orders are real. The execution is the open question.Deep dive — MicronAva: Now the print that sets the whole cycle. Micron — page 5 of the memo, sharing it with GE Vernova, power and memory side by side — reports Wednesday after the close,[^earn-mu] and the question isn’t whether they beat. The question is whether there’s any memory left to sell. Because Micron’s entire 2026 high-bandwidth-memory production is already sold out — every chip, under binding contract, before the year is even half over.[^mu-hbm-sold-out-20260619] And DRAM contract pricing is set to jump 50–55% this quarter alone versus the end of last year.[^mu-dram-pricing-cycle-20260619] Marcus — when the product’s sold out a year ahead, what are we actually pricing?Marcus: Here’s the trap on this one. Trailing, Micron screens at 102 times free cash flow.[^memo-mu-evfcf-20260619] Ignore that number. It’s a cyclical at the bottom of its cash-flow cycle, and a trailing multiple on a cyclical at the trough is noise — it tells you about the past, not the print. Free cash flow already grew more than 500% off the bottom,[^memo-mu-fcf-20260619] and the forward revenue line is up about 64%.[^memo-mu-ntmrev-20260619] You don’t value this on what it earned. You value it on what sold-out capacity earns at much higher pricing. And against that, 102 times trailing is the cheap number, not the scary one.Ava: So the terrifying multiple is the cheap one. Marcus’s favorite kind of sentence.Marcus: It is. And the supply side is the part the bears can’t model. Micron is committing roughly $200 billion to new capacity.[^mu-capex-expansion-20260619] You do not put $200 billion against a cycle you think is about to roll over. That’s management telling you the shortage is structural, not a head-fake. It’s the same story Nvidia’s Rubin platform is telling from the other side of the table — Micron is the qualified high-bandwidth-memory supplier into it, shipping in volume.[^mu-rubin-hbm4-20260619]Ava: And the hiring backs it up.Marcus: It does. Per the Talnexis hiring tracker, Micron is the #3 hiring floor on the entire board — 3,000 open roles, 181 of them added just this week.[^tlnx-mu-hiringfloor-20260619] You don’t staff like that into a cycle you expect to break. The one thing I’d actually watch Wednesday is the gross-margin guide — guide above where consensus already sits[^mu-margin-guidance-20260619] and the cycle’s still accelerating. Merely meet it and the stock’s already there, and a sold-out company that only meets is a sell-the-news.Ava: So what actually breaks this?Marcus: Two things, and I’d weight them. The real risk was never demand — it’s supply discipline. If all three memory makers turn the capex spigot at once, you get a glut, and the cycle ends the way every memory cycle has ended. I’d put that around 30%. The nearer risk is mix — if high-bandwidth memory crowds out standard DRAM capacity, the blended margin doesn’t reach what the Street’s penciling in. Call that another 10%. Which leaves the base case at 60% — and it’s the boring one: sold out, pricing up 50%, the capacity already committed. The cash shows up whether the multiple believes it or not.Ava: So 30% it ends in tears, 10% it just muddles through on margin, 60% it prints money — and Marcus will at least give you the whole distribution instead of selling you a price target. 81% gross margin on what used to be a commodity.[^mu-margin-guidance-20260619] Read that twice. Broadcom and Oracle spent Wednesday’s show proving the demand is real.[^ep-e2625b] Micron on Wednesday tells you whether the supply can keep up. Same trade, opposite end of the table.Rapid-fireAva: Rapid-fire. Five names, and markets open Monday.Ava: Moderna had its best week in four years, and for once it had nothing to do with COVID. An FDA advisory panel voted 9-0 to endorse its mRNA flu vaccine for adults 50 and older,[^mrna-flu-vaccine-approval-20260619] with a final FDA decision expected by August 5. The stock jumped 28%.[^mrna-stock-jump-20260619] Free cash flow is still negative here — this is an optionality name, not a cash machine — but it’s the first real commercial catalyst since the COVID franchise rolled over.Ava: Two reporters sit together on page 17 of the memo, and they’re back to back next week. FedEx is first, Tuesday after the close.[^earn-fdx] The number that matters isn’t the quarter — it’s the breakup. The Freight spinoff is on track: 80.1% of the shares distributed to FedEx holders, and Freight pays a $4.1 billion special dividend back to the parent on the way out.[^fdx-freight-spinoff-taxfree-20260619] Add $1 billion of cost cuts this year from the DRIVE program,[^fdx-drive-program-20260619] and a forward guide that just got raised.[^fdx-guidance-raise-20260619] A cleaner, lighter FedEx is the entire thesis.Ava: Nike reports the following Tuesday, June 30.[^earn-nke] This is the clearest test yet of whether Elliott Hill’s turnaround is real. The headwinds are brutal — a $1.5 billion annual tariff hit that took gross margin down 300 basis points,[^nke-tariff-cost-20260619] China down 16%,[^nke-china-decline-20260619] digital down 14%.[^nke-digital-decline-20260619] Win Now has to show up in a number Tuesday, not a slogan. First place it can.Ava: Cheniere keeps building while everyone else watches the oil price. It signed a $4.69 billion engineering contract with Bechtel for the Sabine Pass expansion,[^lng-sabine-pass-epc-20260619] with a final investment decision targeted for early 2027, and it just finished Corpus Christi Trains 5 and 6.[^lng-corpus-christi-progress-20260619] And it throws off nearly an 8% free-cash-flow yield while it does it.[^memo-lng-fcfyield-20260619] The cash machine of the energy names.Ava: And Intel had a genuinely good week on the factory floor — which is the only place that matters for this story. Its 18A-P process entered risk production: 9% more performance at the same power.[^intc-18ap-20260619] And NVIDIA is evaluating that node for a future design.[^intc-nvidia-18a-20260619] No order yet. But the whole Intel thesis comes down to whether anyone outside Intel will manufacture on its leading node — and NVIDIA kicking the tires is the first real evidence in years.Ava: And one to file away for the fall. Vertex got its kidney-disease drug, povetacicept, accepted for FDA review this week — its first real move into a major indication beyond cystic fibrosis, with a decision due November 30.[^vrtx-povetacicept-20260619] Not a Monday catalyst. But a real one on the calendar.CloseAva: That’s the show. Wall Street’s consensus on Micron heading into Wednesday: 30 analysts, unanimous Buy, an average target around $1,015 on a stock that’s already there.[^mu-analyst-target-revisions-20260619] Consensus says the supercycle is priced in. Consensus has been wrong about memory at every single turn of this cycle. Hiring data this week from Talnexis — talnexis.com. The throughline one more time: the AI demand debate is over. Whether the supply chain can deliver — the lithography, the power, the memory — is the only question left, and Wednesday’s Micron print is the first real answer. Hunt, Jason, and Mike are back Wednesday on episode 2626, picking up whether proprietary data can actually be protected.[^ep-e2625b] Download the Cash Flow Memo at telltales.us. I’m Ava Cabot. Thanks for listening.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* ASML Holding. (2026). Q1 2026 financial results [Press release]. https://www.asml.com/en/news/press-releases/2026/q1-2026-financial-results* Barchart. (2026). FedEx’s Q4 2026 earnings: What to expect. https://www.barchart.com/story/news/1533352/fedex-s-q4-2026-earnings-what-to-expect* Bernstein / CNBC. (2026, June 16). GE Vernova (GEV) quote and analyst coverage. CNBC. https://www.cnbc.com/quotes/GEV* Cheniere Energy. (2026). Corpus Christi liquefaction project. https://www.cheniere.com/about/where-we-work/ccl* FDA panel recommends Moderna’s mRNA flu shot for older adults. (2026). NBC News. https://www.nbcnews.com/health/health-news/fda-panel-recommends-modernas-mrna-flu-shot-older-adults-rcna350699* FedEx. (2026). FedEx Board of Directors approves spin-off of FedEx Freight [Investor news]. https://investors.fedex.com/news-and-events/investor-news/investor-news-details/2026/FedEx-Board-of-Directors-Approves-Spin-off-of-FedEx-Freight/default.aspx* FXLeaders. (2026, June 19). Micron earnings preview: MU stock faces key test as earnings approach. https://www.fxleaders.com/news/2026/06/19/micron-earnings-preview-mu-stock-faces-key-test-as-earnings-approach-after-strong-rally/* Micron sold out of 2026 HBM. (2026, June 19). Yahoo Finance. https://finance.yahoo.com/news/micron-sold-2026-hbm-us-231248051.html* Micron Technology (MU) price target. (2026, June 19). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/micron-technology-mu-price-target-011038074.html* Micron Technology (MU) wins HBM4 for Nvidia Vera Rubin. (2026, June 19). Yahoo Finance. https://finance.yahoo.com/technology/ai/articles/micron-technology-mu-wins-hbm4-211205119.html* Micron Technology: HBM sold out for 2026 — Wall Street is still underpricing. (2026, June 19). Seeking Alpha. https://seekingalpha.com/article/4881338-micron-technology-hbm-sold-out-for-2026-wall-street-is-still-underpricing* Nike China guidance reset. (2026). AInvest. https://www.ainvest.com/news/nike-china-guidance-reset-term-pain-confirms-deep-rooted-inventory-demand-headwinds-2604/* Nike stock 2026: NKE turnaround analysis. (2026). Top1Markets. https://www.top1markets.com/news/nike-stock-2026-nke-turnaround-analysis-elliott-hill* Sabine Pass LNG expansion contract. (2026). Simply Wall St. https://simplywall.st/stocks/us/energy/nyse-lng/cheniere-energy/news/sabine-pass-lng-expansion-contract-might-change-the-case-for* STAT Times. (2026). FedEx to reduce cost by $1bn in FY2026; net income drops 5% in FY2025. https://www.stattimes.com/air-cargo/fedex-to-reduce-cost-by-1bn-in-fy2026-net-income-drops-5-in-fy2025-1355655* Supply Chain Dive. (2026). Nike’s $1.5B tariff hit and sourcing shift. https://www.supplychaindive.com/news/nike-1b-tariff-sourcing-price-hikes/752159/* The end of cheap memory: Why 2026 marks a structural shift in tech economics. (2026, June 19). Investing.com. https://www.investing.com/analysis/the-end-of-cheap-memory-why-2026-marks-a-structural-shift-in-tech-economics-200675634* The Register. (2026, June 17). Intel starts cooking up enhanced 18A-P silicon for would-be foundry customers. https://www.theregister.com/systems/2026/06/17/intel-starts-cooking-up-enhanced-18a-p-silicon-for-would-be-foundry-customers/5257487* Timothy Sykes. (2026, June 17). Moderna Inc. (MRNA) news. https://www.timothysykes.com/news/moderna-inc-mrna-news-2026_06_17/* US tells ASML it is concerned China may have top chip tool. (2026, June 19). Bloomberg. https://www.bloomberg.com/news/articles/2026-06-19/us-tells-asml-it-s-concerned-china-may-have-top-chip-tool* Utility Dive. (2026). GE Vernova bullish on electrical infrastructure as turbine backlog grows. https://www.utilitydive.com/news/ge-vernova-bullish-on-electrical-infrastructure-as-turbine-backlog-grows/803631/* Utility Dive. (2026). GE Vernova expects to end 2025 with an 80 GW gas turbine backlog that stretches into 2029. https://www.utilitydive.com/news/ge-vernova-expects-to-end-2025-with-an-80-gw-gas-turbine-backlog-that-stretches-into-2029/807662/* Vertex Pharmaceuticals. (2026). Vertex announces US FDA acceptance of biologics license application for povetacicept [Press release]. https://news.vrtx.com/news-releases/news-release-details/vertex-announces-us-fda-acceptance-biologics-license-application* Yahoo Finance. (2026). Intel bets on 18A, Xeon 6. https://finance.yahoo.com/sectors/technology/articles/intel-bets-18a-xeon-6-070403655.htmlInternal dataInternal data is provided on a best efforts basis.Forward earnings* FDX — FedEx, 2026-06-23 (Tuesday) AMC, fiscal Q4 2026. Consensus EPS 5.91 / revenue $24.04B. Earnings calendar.* MU — Micron, 2026-06-24 (Wednesday) AMC, fiscal Q3 2026. (Consensus columns unreliable this week; report date verified.) Earnings calendar.* NKE — Nike, 2026-06-30 (Tuesday) AMC, fiscal Q4 2026. Consensus EPS 0.11 / revenue $10.85B. Earnings calendar.Hiring intelligence (Talnexis)* MU — Micron #3 hiring floor (3,061 open roles, +181 in the 7-day window), detected 2026-06-19. Source: Talnexis hiring intelligence, https://www.talnexis.com/ This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

All three hosts in one room: a macro tour through oil, gas and a new Fed chair, then a deep dive on NVIDIA at $5 trillion, the software stack’s capex problem, and the Anthropic export-control fight that turns proprietary data into the next moat.The Cashflow MemoKey Takeaways* Macro (Hunt’s exhibits): Oil sits ~$80 heading toward $70 (vs $60 on its way to $50 when the Iran event started), with backwardation compressing to under $10; natural gas averages ~$3.50 across both ’26 and ’27. New Fed chair Kevin Warsh signaled aggressive balance-sheet runoff (~$750B/yr toward a target near $1.5T) and a possible bias to hike — a lot of paper for the market to absorb against a ~$1.5T deficit.* NVIDIA at ~$5T is turning into a value stock: free cash flow on a $200-250B run-rate by year-end (vs a record ~$160B). The bull case has shifted from the chip cycle to TAM expansion — server → rack → row → full reference data-center design, an x86-killer CPU, and direct buildouts for cash-rich non-hyperscalers like Eli Lilly (~$20B FCF), Exxon/Chevron, and Citadel — though AI capex at ~3% of GDP raises a law-of-large-numbers ceiling on incremental budget growth.* Software dispersion is about capex risk: Salesforce screens cheap at ~18x FCF because it owns its own data centers and will likely have to deploy GPUs (capex rising from ~zero), while ServiceNow trades >50x renting AWS; Snowflake stays cash-light on heavy SBC but saw NRR re-accelerate on ~30% revenue growth as its AI product (chat over enterprise data) ramps.* The Anthropic throughline: a cyber-capable model released to ~40 entities (JPMorgan et al.), Amazon/Jassy lobbying Washington for export controls, the guardrailed Fable version jailbroken within two days, and distillation risk from Tencent/Alibaba (~1 year behind). The hosts read Jassy’s move as AWS self-protection, not public spirit — AWS was almost certainly one of the 40.* AI economics as a J-curve, proprietary data as the new moat: OpenAI/Anthropic head public with no profits against massive compute rent; the tell to watch is the end of the subsidized-token era (Uber/Lyft tripled fares post-IPO once VC subsidies ended). Microsoft blocked Anthropic’s models internally after a ToS change let Anthropic capture and train on user prompts (i.e., customer code) — a breach of trust that makes walled-off hosting (Citadel on Google) the real battleground.Show Notes[00:00] Intro & this week’s Cash Flow Memo Mike sets up the episode and points listeners to the memo at telltales.us.[00:26] Exhibits A/B/C — Oil, Gas & the Fed Hunt’s five minutes: oil $80 toward $70 with backwardation under $10, nat gas ~$3.50 across ’26-’27, and new Fed chair Kevin Warsh signaling balance-sheet runoff and a possible hike bias.[04:37] Apple & Snap — foldables, camera AirPods, AR glasses Apple’s underwhelming conference (a 2028 foldable, AirPods with cameras) versus Snap’s see-through AR glasses and why Meta’s audio-only glasses are the best product today.[07:30] Why Amazon called Washington on Anthropic Anthropic’s cyber-capable model, the limited release to ~40 entities, and the hosts’ read that Jassy’s export-control push is AWS self-protection.[10:53] Jailbreaking the guardrails & the China distillation risk The Fable guardrailed version cracked in two days, and why Tencent/Alibaba stay roughly a year behind.[13:46] What is SpaceX worth? — AI’s J-curve to profits SpaceX public and +30%, OpenAI/Anthropic going public with no profits, and how to think about revenue growth that costs enormous compute.[15:44] The end of the subsidized-token era Jason’s Uber/Lyft analogy: cheap VC-funded tokens today, tripled rates after the IPO.[16:11] Microsoft’s per-seat agent bet Why fixed price-per-seat plus usage upside is the right model for a slow-moving enterprise base, and the job-displacement question.[18:54] Software dispersion — Salesforce, ServiceNow & Snowflake Salesforce at 18x FCF and a coming GPU capex bill, ServiceNow renting AWS, and Snowflake’s NRR re-acceleration.[21:34] Oracle, Broadcom & NVIDIA at $5 trillion Oracle and Broadcom’s pivots, then NVIDIA as a record-FCF value stock.[24:45] NVIDIA’s next TAM — racks, rows, x86 & selling direct From server to full reference data-center design, going after the x86 CPU market, and building private clouds for enterprises.[25:53] Healthcare & the cash-flow hunt — Lilly, Exxon/Chevron, Citadel NVIDIA chasing free-cash-flow-rich customers: Lilly’s walled-off AI buildout, oil majors, and Citadel’s Google deal.[29:48] Proprietary data as the new moat Microsoft blocks Anthropic’s models after a ToS change to capture and train on customer prompts — a breach of trust.[32:31] Next week & sign-off A teed-up deep dive on protecting proprietary data: defense versus offense, and whether anything can truly be walled off.If these conversations have earned a place in your week, send the show to one person who’d genuinely enjoy it. Download the Cash Flow Memo at telltales.us.Cashtags$AAPL $AMZN $AVGO $BABA $CRM $CVX $GOOGL $JPM $LLY $LYFT $META $MSFT $NOW $NVDA $ORCL $SNAP $SNOW $TSM $UBER $XOM This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

For the first time in four years, there’s no new Telltales episode this week.The one week all three of us were finally in the same city — Hunt, Jason, and Mike, in one room in New York instead of scattered across two coasts — the recording gremlins picked their moment. The primary recording failed partway through. There’s a backup, and we’re actively working to recover it.So here’s the plan: if we recover the audio, this week’s episode lands in your feed the moment it’s clean. If we don’t, no harm done — Hunt, Jason, and Mike are back in the chair next Wednesday, and Ava is back with the Weekend Update on Saturday.While you wait, this week’s Cash Flow Memo is below. And if these conversations have earned a place in your week, send the show to one person who’d genuinely enjoy it. Almost all of our growth has come from listeners doing exactly that — and we don’t take a single recommendation for granted.This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.The Cashflow Memo This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →Good News, Sold: The AI Buildout’s First Bill Came DueEvery capital cycle has the same tell. It is not the day the spending stops. It is the day the market stops clapping for it — when a company does exactly what it promised and the stock falls anyway. This week the most expensive trade on earth hit that day three times.Oracle delivered the backlog it told everyone it would deliver. A six-hundred-thirty-eight-billion-dollar pile of contracted future revenue, up more than three-and-a-half times in a year.¹ Cloud infrastructure revenue up ninety-three percent.² It did the thing. The stock fell ten percent.³For two years the AI trade was a referendum on demand: is it real, how big, how fast. The bull won that argument. So the market moved the goalposts, the way it always does at this point in a buildout — from is the demand there to who pays to meet it, and what does the bill do to the balance sheet carrying it. Bill Maris said the quiet part on All-In this week: a trillion dollars of spend commitments sitting on sixty billion of revenue, and now you go to the public markets and hope retail picks up the difference.⁴ That is the bear case in one sentence. Three names walked straight into it this week, and the interesting part is that each of them is paying the bill a different way.Oracle is borrowing it. Trailing free cash flow is already negative — they spent the better part of fifty billion dollars on capex to build the capacity behind that backlog, and the money to fund the next leg is coming out of the debt market into a tape that has stopped rewarding capital plans.⁵ NextEra is diluting for it. The biggest bet in the history of regulated utilities — a sixty-seven-billion-dollar, all-stock takeover of Dominion, built explicitly to wire thirty gigawatts of data-center power by twenty-thirty-five, Google and Meta already signed.⁶ All-stock is the tell. A utility already carrying sixteen times debt to free cash flow cannot borrow its way to the biggest deal in its sector’s history, so it is paying with equity and handing the cost to the shareholder it already has.⁷ The stock fell nine percent.⁸ Micron is the one name pre-selling it: its entire next fiscal year of high-bandwidth memory is already spoken for, certified into Nvidia’s roadmap, the demand contracted before the capacity ships.⁹Three funding strategies — debt, equity, pre-sold demand — and one underlying wager: that AI demand is durable enough to convert all of it to cash before the interest comes due. The cashflow read is in Marcus’s column below; short version, two of these three have no multiple to quote because the denominator is still negative. Page one of the Cash Flow Memo this week is a capex ledger, not an earnings sheet.This is what the back half of a capital cycle looks like, and it rhymes. The railroads, the fiber glut, the shale decade — the capital cycle never turns when the building stops. It turns when the market stops paying for the announcement and starts pricing the lag between the spend and the cash. The demand did not get worse this week. The accounting for it did.The next data point is dated. Micron reports Wednesday the twenty-fourth.¹⁰ On the screen it trades at a hundred times trailing free cash flow, which sounds insane and tells you nothing — that is trough cash flow at the bottom of a memory cycle. Price it forward and consensus has it at a single-digit multiple of next year’s earnings,¹¹ with trailing cash flow already up more than five-fold off the low.¹² The test is not the headline print. It is whether the forward demand the whole buildout is leaning on shows up in one company’s order book. If Micron’s guide confirms, the bill looks affordable. If it wobbles, the cycle just got more expensive for all three.Wall Street’s consensus on the AI buildout: too crowded, too expensive, too late. The stocks fell this week not because the demand soured — because the market finally started counting the cost. That is not the top. That is the capital cycle clearing its throat.The Tape — W2624Universe of 94 cashflow-memo names, snap dates 2026-06-05 → 2026-06-15. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamHealthcare spent the week getting repriced by Washington, and the screens are tarring the whole sector with one brush. Regeneron is the name that brush gets wrong. It sits near the top of the board at 11.3x EV/FCF on an 8.8% free cash flow yield — cheaper than UnitedHealth, with no federal prosecutor auditing the numerator. That is the distinction the table cannot draw: UNH’s cash engine is the thing the DOJ is investigating; Regeneron’s is a drug franchise nobody has subpoenaed. Same sector, same de-rate, two completely different reasons for the cheap — one is cheap because the cash might be fiction, the other because it shares a GICS code with the one that might be. The test on the next print is whether biosimilar pressure on the franchise shows up in the cash line, or the de-rate was just guilt by association.Telltales Yield — Bottom 10This Week’s ReportersSector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps90 of 90 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-06-15.csv. NTM growth from FMP analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoWhen Cheap Stopped Being SafeThe week being cheap stopped being safe, and the AI buildout kept spending anyway.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the universe of the Cash Flow Memo. About 13 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2625.Chapter markers* Time | Segment* 0:15 | Cold open* 0:55 | Theme — the AI buildout’s bill: Oracle, NextEra, Micron* 5:10 | Deep dive — UnitedHealth vs CarMax* 9:25 | Rapid-fire — Moderna, Intel* 11:30 | Close + Consensus WatchFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. We’re still early — this is a pilot, and we want to hear what’s working.Ava: Here’s the week. Being cheap stopped being safe. The cheapest large-cap in healthcare spent the week with a federal prosecutor at the door. The retail name everyone screens as cheap is being handed customers by a tariff. And while the market was busy repricing the cheap stuff, the most expensive trade on earth — the AI buildout — just kept writing bigger and bigger checks, and got punished for it anyway. On Wednesday’s main show, episode 2624, Hunt, Jason, and Mike worked through the economics of that buildout — the data centers, and the sheer physics of powering them.[^ep-e2624] We’re going to put the cashflow lens on the bill. Because this was the week the bill started showing up in three different places at once.Theme — the AI buildout’s billAva: Start with the most expensive trade in the market, because this week it got complicated. For two years the AI story was demand — is it real, how big, how fast. This week the question flipped to cost. Who delivers it, who powers it, and whose balance sheet carries it. And here’s the contrarian note hanging over the whole thing: as Bill Maris put it on All-In this week, quote, a trillion in spend commitments on $60 billion of revenue, and now you’re going to go to the public and hope that retail is going to pick that up.[^tp-maris-allin-20260609] Hold that thought. Because three companies just tested it.Ava: Start with Oracle, because it did exactly what it promised and got punished for it. It delivered the backlog it said it would — and the stock fell 10% anyway.[^orcl-stock-20260610] Page 2 of the memo: remaining performance obligations hit a record $638 billion, up 363% year over year.[^orcl-rpo-20260610] Cloud infrastructure revenue up 93%.[^orcl-oci-growth-20260610] They did the thing. Marcus — why did doing the thing get them sold?Marcus: Because the market stopped grading the backlog and started grading the bill. Oracle’s trailing free cash flow is negative — minus $21 billion[^memo-orcl-fcf-20260615] — because they spent $48 billion on capex over the last year to build the capacity behind that backlog.[^memo-orcl-capex-20260615] So there’s no multiple to quote. Don’t reach for one; it’s a negative number. What prices Oracle now is one question: does $638 billion of contracted intent convert to cash before the interest on the build eats them. They raised the capital plan into a tape that no longer claps for capital plans. Maris’s line is the bear case in one sentence — and Oracle just walked straight into it.Ava: So next door, the power bill. NextEra just made the biggest bet in the history of regulated utilities — and got the same treatment Oracle did. A $67 billion, all-stock takeover of Dominion Energy, the largest regulated-utility deal ever, built explicitly to power AI data centers — 30 GW of it by 2035, with Google and Meta already signed on.[^nee-dominion-acquisition-20260610][^nee-datacenters-expansion-20260615] The stock fell 9%.[^nee-stock-decline-20260610] Marcus, what does the grid cost?Marcus: It costs more than NextEra has. This is a utility that already carries 16x debt to free cash flow[^memo-nee-debtfcf-20260615] — and it’s buying the biggest deal in the sector’s history. They’re paying in stock, not debt, which is the tell: they’re funding the buildout by diluting, because the balance sheet can’t borrow its way there at 41x free cash flow.[^memo-nee-evfcf-20260615] The 9% drop isn’t the market rejecting data-center power. It’s the market asking who eats the cost of building it — and deciding, this week, that the answer is the existing shareholder.Ava: And the third bill is memory, where Wall Street has completely lost its composure. Micron, page 5, reports a week from Wednesday — and ahead of it, price targets went from $550 to $1,750 in a matter of days.[^mu-pt-raise-20260608][^mu-analyst-targets-20260610] Micron got certified for Nvidia’s next-generation HBM4 memory, and its entire fiscal-year production is already spoken for.[^mu-hbm4-cert-20260610] One more tell you won’t see in the price: the Talnexis hiring tracker shows Micron added 200 roles last week, hiring at full-cycle pace.[^tlnx-mu-hiring-20260615] Marcus, the stock screens at 100x cash flow — is that insane?Marcus: It looks insane and it isn’t, and that’s the whole trick with memory. The 100x figure is trailing free cash flow at the bottom of the cycle[^memo-mu-evfcf-20260615] — it tells you nothing. Price it forward: consensus earnings put Micron at about 7x next fiscal year.[^mu-fwd-pe-20260615] Trailing cash flow is already up more than 5x off the trough, and revenue is guided to grow 60%+.[^memo-mu-fcf-20260615] You don’t value a cyclical on a trough multiple; you value it on where the cash is going — and forward, this is a single-digit multiple. The risk isn’t the price. The risk is that the whole supercycle thesis — Oracle’s backlog, NextEra’s gigawatts, Micron’s HBM — is one connected bet that the AI demand is durable. Three names, one wager. The print on the 24th is the next data point on whether it holds.Deep dive — UnitedHealth vs CarMaxAva: Now the other half of the market — the cheap half. Two companies, both trading at single-digit-ish multiples, both cheap for a reason, and the reasons could not be more opposite. One is being investigated by the government for charging too much. The other is being handed customers by the government’s tariffs. Same week, two service businesses, two completely different verdicts on what cheap means.Ava: Here are the headlines, side by side. UnitedHealth, all the way back on page 19 of the memo: the CEO, Andrew Witty, resigned; the company pulled its full-year guidance; and the Justice Department opened a criminal and civil probe into whether it inflated Medicare diagnoses to juice reimbursements.[^unh-ceo-resignation-20260615][^unh-guidance-pull-20260615][^unh-doj-probe-20260615] The stock is down about a third from its high.[^unh-stock-recovery-20260615] And CarMax, page 8, reports Wednesday — first print under a new CEO, with an activist on the register, into a tariff backdrop that’s pushing buyers out of new cars and straight onto its lots.[^kmx-cfo-transition-20260615][^kmx-activist-20260615][^kmx-tariffs-20260615] Marcus — which kind of cheap actually pays you?Marcus: Take the scary one first. UnitedHealth trades at 14x trailing free cash flow, a 7% yield.[^memo-unh-evfcf-20260615] On the screen that’s the cheapest quality compounder in the market. Here’s the problem: the thing generating the cash is exactly what the DOJ is investigating. The free cash flow comes from Medicare Advantage billing, and a federal prosecutor is now asking whether that billing was fraudulent.[^unh-doj-probe-20260615] So you’re not buying 14x earnings. You’re buying 14x a number that’s under subpoena. Cheap doesn’t help you when the regulator is auditing the numerator.Ava: And yet the stock just rebounded almost back to its high. Make that make sense.Marcus: It doesn’t, and that’s the tell. In the same two weeks the probe widened, six different shops raised their price targets — and Bank of America went the other way and cut it to neutral.[^unh-analyst-upgrade-20260615][^unh-bofa-downgrade-20260615] So the sell-side is openly split on the same name in the same fortnight. That’s not a market pricing a verdict. It’s a market pricing a coin flip on whether a federal probe breaks the cash engine or just dents it. When the analysts can’t agree which, the multiple isn’t cheap — it’s unresolved.Ava: So UnitedHealth’s cheap is a question mark. What’s CarMax’s cheap?Marcus: Cheaper on the screen than in the business. Price CarMax on earnings and it’s a mid-teens multiple — about 15x forward,[^kmx-fwd-pe-20260615] a normal retailer, not a coiled spring. So the bet was never the multiple. It’s the setup: tariffs added thousands of dollars to new-car prices, used demand is the spillover, and there’s an activist pushing the new CEO to convert it.[^kmx-tariffs-20260615] The test on Wednesday is one number — used unit volume. If that’s accelerating, the multiple re-rates. If it’s flat, it’s just a tired retailer at 15x.Ava: So one cheap stock where the earnings might be fiction, and one that’s barely cheap once you do the math. Marcus, ever the optimist.Marcus: I deal in denominators. But the asymmetry is real: UnitedHealth’s downside is a business model the government breaks; CarMax’s downside is a soft quarter. One is binary. The other is just cyclical. Same word — cheap — two completely different bets.Ava: Mark the calendar. Wednesday tells us which one.Rapid-fireAva: Two more to close, both moving fast.Ava: Moderna got a different kind of government attention — the bad kind. Health and Human Services terminated a $590 million contract for Moderna’s bird-flu vaccine, and cancelled 22 more mRNA research contracts across the board, under the new RFK Jr. vaccine policy.[^mrna-barda-birdfly-20260610][^mrna-barda-platform-shift-20260610] There’s an FDA advisory meeting Wednesday on an mRNA flu shot.[^mrna-fda-advisory-20260618] This is the same theme as UnitedHealth from the other direction — Washington isn’t just regulating healthcare this year, it’s picking which platforms live. mRNA just got told it’s on the wrong list.Ava: And Intel — remember Intel? Up 250% this year, and almost nobody noticed.[^intc-ytdperformance-20260615] The catalyst this week: Google committed more than 3 million of its TPU chips to Intel’s foundry for 2028, pulling that order away from Taiwan Semi.[^intc-google-tpu-20260608] Bank of America double-upgraded the stock straight from sell to buy.[^intc-bofaupgrade-20260611] After a decade of being the company the buildout left behind, Intel spent this week being the company the buildout came back to.CloseAva: That’s the show. Wall Street’s consensus this week: UnitedHealth is a falling knife, and the AI infrastructure names are crowded. One of those is wrong, and it’s the one nobody wants to touch. Here’s the throughline into Monday: being cheap stopped being safe this week, because the thing setting the price wasn’t the business — it was the government on one side and the buildout’s bill on the other. UnitedHealth at 14x with a prosecutor. CarMax at mid-teens with a tariff at its back. Oracle, NextEra, and Micron spending into the doubt. Cheap got cheaper, expensive kept spending, and the market spent the week deciding it doesn’t trust either one. The hiring data we cited on Micron is from Talnexis — talnexis.com. You can pull up the Cash Flow Memo yourself at telltales.us. The forward week is loaded: CarMax reports Wednesday, FedEx the following Tuesday in its first quarter as a pure-play after spinning off freight,[^earn-fdx] and Micron Wednesday the 24th.[^earn-mu] And Hunt, Jason, and Mike are back Wednesday on episode 2625. We’ll see you next Saturday.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* Applied Clinical Trials Online. (2026, June). HHS cancellation of BARDA mRNA vaccine trial. https://www.appliedclinicaltrialsonline.com/view/hhs-cancellation-barda-mrna-vaccine-trial-design-oversight-funding* Bank of America via TipRanks. (2026, June). UnitedHealth downgraded to Neutral at BofA amid Medicare Advantage uncertainty. https://www.tipranks.com/news/the-fly/unitedhealth-downgraded-to-neutral-at-bofa-amid-ma-uncertainty* Converge Digest. (2026, June 10). Oracle’s AI infrastructure business drives 93% IaaS growth. https://convergedigest.com/oracles-ai-infrastructure-business-drives-93-iaas-growth/* Cryptonomist. (2026, June 4). UnitedHealth stock stalls near $377 as lawsuit risk returns. https://en.cryptonomist.ch/2026/06/04/unitedhealth-stock-stalls-near-377-as-lawsuit-risk-returns/* eciks.org. (2026, June 10). NextEra Energy to acquire Dominion Energy in $67 billion all-stock transaction. https://eciks.org/8282-85162-dominion-energy-nextera-67-billion-merger* eMarketer. (2026, June). Auto tariffs are an opportunity for used car dealers. https://www.emarketer.com/content/auto-tariffs-opportunity-used-car-dealers* Fierce Healthcare. (2026, June). DOJ’s criminal probe into UnitedHealth extends to Optum Rx. https://www.fiercehealthcare.com/payers/wsj-report-doj-interviewing-former-employees-about-medicare-billing-practices-unitedhealth* GuruFocus. (2026, June 10). NextEra Energy (NEE) shares decline amid Dominion Energy acquisition. https://www.gurufocus.com/news/8910473/nextera-energy-nee-shares-decline-amid-dominion-energy-acquisition* HeyGo Trade. (2026, June). Intel up 250% in 2026: Is the AI comeback real or a short squeeze? https://www.heygotrade.com/en/blog/intel-stock-2026-ai-comeback/* IndMoney. (2026, June 10). Oracle Q4 FY2026 earnings: Why ORCL stock fell 10% despite a strong beat. https://www.indmoney.com/blog/us-stocks/oracle-q4-fy-2026-earnings-orcl-stock-drop* Interactive Crypto. (2026, June 9). Micron jumps as HBM4 certification and a Wells Fargo $1,220 target reset the narrative. https://www.interactivecrypto.com/micron-jumps-9-9-as-hbm4-certification-and-a-wells-fargo-1-220-target-reset-the-narrative-jun-20* Maris, B. (2026, June 9). Bill Maris: How Google could crush AI competitors, why small funds win, and AI’s Atari stage [Video]. All-In Podcast, YouTube. https://www.youtube.com/watch?v=0umrMuUClC4* MEXC Learn. (2026, May 27–June 8). Wall Street upgraded UNH six times in two weeks (JPMorgan $466, Bernstein $492). https://www.mexc.com/learn/article/wall-street-upgraded-unh-six-times-in-two-weeks-can-unitedhealth-stock-hit-492-unh-price-target-2026-2030/1* The Motley Fool. (2026, June 10). Oracle just revealed a massive $638 billion backlog. Here’s why the stock fell anyway. https://www.fool.com/investing/2026/06/10/oracle-just-revealed-a-massive-638-billion-backlog/* PharmAphorum. (2026, June). UnitedHealth CEO Andrew Witty steps down. https://pharmaphorum.com/news/unitedhealth-ceo-andrew-witty-steps-down* Simply Wall St News. (2026, June). Why CarMax (KMX) is up 8.1% after rising optimism around its 2026 earnings report. https://simplywall.st/stocks/us/retail/nyse-kmx/carmax/news/why-carmax-kmx-is-up-81-after-rising-optimism-around-its-202* TheStreet. (2026, June). Intel stock: BofA raises price target to $135 | INTC. https://www.thestreet.com/investing/stocks/intc-intel-stock-price-target-bank-of-america-june-2026* Timothy Sykes News. (2026, June). CarMax (KMX) draws activist interest as traders eye earnings. https://www.timothysykes.com/news/carmax-inc-kmx-news-2026_06_03/* U.S. Food and Drug Administration. (2026, June 18). Vaccines and Related Biological Products Advisory Committee June 18, 2026 meeting announcement. https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-june-18-2026-meeting-announcement* U.S. Securities and Exchange Commission. (2026). UnitedHealth Group, Form 8-K, Q1 2026. https://www.sec.gov/* Vantage Markets. (2026, June 9). Intel stock up 11%: INTC jumps on Google’s 3M AI chip deal. https://www.vantagemarkets.com/market-analysis/intel-stock-price-analysis-june-9-2026/* Yahoo Finance. (2026, June). NextEra (NEE) anticipates adding up to 30 gigawatts of power for data centers by 2035. https://finance.yahoo.com/news/nextera-nee-anticipates-adding-30-104711159.htmlHiring intelligence* Talnexis. (2026, June 15). Hiring intelligence — Micron (200 new roles in 7 days, #9 hiring-velocity mover). https://www.talnexis.com/Internal dataInternal data is provided on a best efforts basis.Forward earnings (FMP)* KMX — 2026-06-17 (Wednesday), Q1 FY27. FMP /stable/earnings?symbol=KMX, pulled 2026-06-15.* FDX — 2026-06-23 (Tuesday), Q4 FY26 (first pure-play print post freight spin-off). FMP /stable/earnings?symbol=FDX, pulled 2026-06-15.* MU — 2026-06-24 (Wednesday), Q3 FY26, consensus EPS $19.96 / revenue $34.72B. FMP /stable/earnings?symbol=MU, pulled 2026-06-15.* MU forward P/E ≈6.9x — FY ending 2027-08-28 consensus EPS $108.83 (21 analysts) vs price $746.79. FMP analyst estimates (annual), pulled 2026-06-15.* KMX forward P/E ≈15x — FY ending 2027-02-28 EPS $2.35 (17.2x) / FY 2028-02-28 EPS $2.85 (14.2x) vs price $40.34. FMP analyst estimates (annual), pulled 2026-06-15. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt, Jason, and Mike work through an oil market frozen by the US-Iran standoff, then spend the back half stress-testing SpaceX’s ~$2 trillion valuation against Tesla’s — landing on data centers in orbit and a chronic compute shortage as the load-bearing assumptions. Plus Apple’s WWDC miss, the software disruption map, and a strong week of healthcare data.The Cashflow MemoKey Takeaways* Hunt’s working case: if the US-Iran standoff just persists, oil sits near $90 twelve months out despite deep backwardation (mid-$90s spot vs mid-$70s forward); the casualty is natural gas, because roughly two-thirds of dry-gas supply growth is Permian associated gas, so a higher oil price pumps more gas and keeps gas pricing weak.* Exhibit A is the macro tail risk: holding public-debt-to-GNP under 100% requires keeping the deficit flat-to-declining near $1.5T even with higher defense spend — a developed-world problem (Japan is ~180%), not just a US one, and the thing that most threatens the credit markets.* SpaceX’s ~$2T valuation only pencils on space-based data centers: 150kW micro-satellites (one NVL72-rack equivalent, Nvidia silicon, in-sourced solar), a ~1 GW launch cadence targeted by year-end, ~170 Starship launches per gigawatt (a launch every other day) off a 20-30 ship fleet. At ~$20B FCF per deployed gigawatt, ~$100B FCF — a 5% cash yield — looks more reachable for SpaceX than for Tesla at $1.4T, which needs robotaxi plus humanoids to get there.* Compute scarcity is the load-bearing assumption under both bets: xAI’s ~$20B Colossus buildout in Memphis is already leasing capacity to Anthropic and Google at ~$25B of revenue — a near one-year payback that shows how acute the shortage is. The safer, cheaper derivative on chronic compute shortage remains Nvidia.* AI has collapsed the cost to write software but not to support or design it: as the agent becomes the hub, Apple looks exposed (a second straight underwhelming Siri at WWDC, starting to look like IBM or Intel), while horizontal incumbents like Salesforce and ServiceNow can expand share and consumption-priced models gain over seat-based ones. In healthcare, Lilly’s triple-agonist retatrutide showed dramatic weight loss with less muscle loss, plus a gene-therapy LDL result, and Revolution Medicines tripled survival duration in pancreatic cancer by hitting targets long thought undruggable.Show Notes[00:00] Intro: The Cash Flow Memo Mike opens the weekly walk through energy, technology, and healthcare. Download the memo at telltales.us.[00:52] Oil, Iran, and Why Gas Stays Weak With supply off ~2.5-3M bbl/d and the Iran embargo likely to persist, Hunt sees oil near $90 a year out despite heavy backwardation — and natural gas as the casualty, since Permian associated gas grows with oil.[04:24] Exhibit A: The Deficit and the Credit Markets Keeping public-debt-to-GNP under 100% means holding the deficit near $1.5T even with higher defense spend. A developed-world problem, not just a US one.[05:32] SpaceX vs Tesla: Which $2T Bet? Google’s ~$80B equity raise and the SpaceX, OpenAI, and Anthropic financings frame the question: is SpaceX at $2T or Tesla at $1.4T the more defensible valuation?[06:57] Data Centers in Space: The Economics 150kW micro-satellites the size of an Nvidia NVL72 rack, in-sourced solar, ~1 GW launch cadence by year-end — and a deployed cost on par with land, minus the 3-7 year build cycle.[12:30] 170 Launches a Gigawatt: The Physics The hard part is mass to orbit: ~170 Starship launches per gigawatt, a launch every other day, on an 18-hour turnaround across a 20-30 ship fleet. At ~$20B FCF per GW, $100B FCF becomes conceivable by ~2028.[15:43] Colossus, Compute Scarcity, and Nvidia xAI’s ~$20B Memphis buildout now leases to Anthropic and Google at ~$25B revenue — a one-year payback that proves how short compute is. The cheaper, safer derivative is Nvidia.[17:22] Apple’s WWDC Miss and the Agent-as-Hub Threat A second straight underwhelming Siri. If the agent becomes the hub for your data, the device is just a screen — and Apple, staked on privacy, is letting the opportunity pass. Starting to look like IBM or Intel.[20:32] Enterprise Software: Horizontal Wins, Vertical Fragile AI made writing software trivial, not supporting it. Token budgets fold into the software budget; horizontal incumbents (Salesforce, ServiceNow) expand, vertical and seat-based models get fragile, and consumption pricing wins.[23:47] Healthcare: Lilly, Gene Therapy, and Pancreatic Cancer Lilly’s triple-agonist retatrutide (less muscle loss) and a gene-therapy LDL result, Mayo’s AI-assisted earlier pancreatic-cancer detection, and Revolution Medicines tripling survival on previously undruggable targets.[26:03] Wrap-Up Possibly back next week on how SpaceX trades in the aftermarket. Get the Cash Flow Memo at telltales.us.Cashtags$AAPL $CRM $GOOGL $INTC $LLY $MSFT $NOW $NVDA $RVMD $TSLA This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

▶ Explore this week’s Tape — live, sortable, drill-down →Even the Cash Machines Are Borrowing NowThe story this week was not that the AI build is expensive. Everyone knew that. The story was that the companies best equipped to pay for it out of their own pockets stopped doing so — three of them, in the same five trading days.Alphabet, which had not sold a share of stock since its IPO, raised about eighty-five billion dollars in equity to fund its data-center build, with Berkshire Hathaway taking ten billion of it directly (per CNBC).¹ Meta, which did not need a dime, was reported to be lining up a raise of its own — and shed almost seven percent on Friday on the rumor alone (per Bloomberg).² Apple, on page one of the same Cash Flow Memo, did the one thing nobody else in the arms race is doing: it rented.Take the first one, because it is the one with thirty years of history behind it.A company funds its capital spending out of its own cash flow right up until the build outgrows the cash flow. The day it reaches for outside money is the day the build stopped paying for itself. Alphabet’s trailing free cash flow fell about forty-four percent year over year — the capex ate it — so they sold stock.³ The company that described itself as the asset-light, capital-light compounder for two decades just issued eighty-five billion dollars of equity to buy data centers. Asset-light.The cashflow read is in Marcus’s column below — short version: at roughly seventy times trailing free cash flow, this is now a capital-intensive company that happens to own a search engine.⁴But the tell this week was not Alphabet alone. It was the synchronization. Meta still throws off about fifty billion dollars of trailing free cash flow, still growing north of twenty percent, and trades at thirty-two times — the cheapest large-cap cash machine on the board.⁵⁶ When the best-capitalized company in a sector decides it wants a financing cushion anyway, that is not a statement about that company. It is a statement about the size of the build.We have watched real demand get financed externally before. The late-nineties fiber boom funded a build the internet genuinely needed — and the companies laying the cable raised equity and debt into the same thesis at the same moment. The capacity got used. A decade later. The financing peak and the equity peak landed in the same window, and the build being right did not save the multiple. The lesson was never that the demand was fake. It was that synchronized external financing is what a capital cycle looks like at its most expensive, not its cheapest.Which is what makes Apple the sharpest line on the page. Apple pays Google roughly a billion dollars a year to run the next Siri on Gemini rather than train a frontier model itself — less than one percent of the hundred-twenty-nine billion dollars in free cash flow it generates annually.⁷⁸ Everyone else is spending a hundred times that and selling stock to do it. Dilute, borrow, or rent: only one of the three costs the shareholder nothing.So the demand side is now financed. What gets tested next is absorption — whether the capacity fills before the financing cycle turns. The first data point lands Wednesday after the close, when Oracle reports against a backlog north of five hundred fifty billion dollars and trailing free cash flow that is already negative.⁹¹⁰ Broadcom just showed everyone the grading curve: a record AI-chip quarter, up more than a hundred-forty percent (per Broadcom’s fiscal-Q2 release), and the stock fell fifteen percent anyway because Hock Tan declined to raise the story he had already sold.¹¹¹² At these multiples, delivering is not enough; you have to deliver and beat the build you already financed. Mark the calendar for Wednesday. The thesis breaks if the backlog keeps growing and the cash behind it never shows up.Wall Street’s consensus on the AI build: the balance sheets are fortresses and the capex funds itself. Three of the richest companies on earth sold or floated stock this week to tell you it doesn’t.The Tape — W2623Universe of 94 cashflow-memo names, snap dates 2026-06-02 → 2026-06-05. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.Telltales Yield — Top 10From the Cashflow Desk — Marcus GrahamThe name sitting at the top of our own board is the one that does not have to finance anything. Uber leads the composite this week on a 7.5% free-cash-flow yield, growing the forward top line about fifteen percent, at thirteen times EV to free cash flow. It converts cash and grows without selling a data center or a share to do it — the asset-light, self-funding profile Alphabet used to own before it raised eighty-five billion dollars of equity this week to pay for the build. The screens still file Uber under gig economy and the hyperscalers under quality compounders. The cash flow says the labels are backwards. What changes the read is the day Uber has to raise outside capital the way the hyperscalers now are; until then, the top of the board is the part of the market still paying for itself.Telltales Yield — Bottom 10This Week’s ReportersNote: Oracle’s 46.3% NTM revenue-growth figure is the raw FMP analyst-estimates consensus and looks anomalous against Oracle’s own ~15% forward guide; we read Oracle through its RPO backlog and trailing free cash flow (negative this quarter on the capex cycle), as in The Take above, not this estimate.Sector MediansDebt / FCF Watch (highest leverage on TTM FCF)Weekly Price MovementTop 5 (week-over-week price) Bottom 5 (week-over-week price) Banks (shown separately — FCF metric not meaningful)Finance-book — FCF not comparableCustomer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild. Data Gaps90 of 90 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).Source: cashflow-memo master_2026-06-05.csv. NTM growth from FMP analyst-estimates consensus. Composite is a percentile rank, not a recommendation.The Issue — This Week's BriefThe Cashflow MemoWho Pays for the AI Build?The week the AI trade stopped being about the chips and became a question about who pays for them.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the universe of companies in the Cash Flow Memo. About 13 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2624.Chapter markers* Time | Segment* 0:00 | Disclaimer* 0:15 | Cold open* 0:45 | Theme — Who pays for the AI build* 4:45 | Deep dive — AI infrastructure’s two-act week* 8:45 | Rapid-fire + the forward week* 11:45 | Close + Consensus WatchFull transcriptDisclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. We’re still in pilot, so tell us what’s working and what isn’t.Ava: Here’s the week. For two years, the AI trade was a story about chips — who makes the fastest one, who gets the allocation. This week it turned into a different question, and it’s a harder one. Who actually pays for the build? Broadcom printed a record and got punished for it. Oracle’s about to walk into the same exam on Wednesday. And three of the biggest companies on earth spent the week showing you three completely different ways to fund the thing — dilute, borrow, or rent. On Wednesday’s main show, episode 2623, Hunt, Jason, and Mike framed the AI capex boom as the macro tailwind holding up a $31 trillion economy.[^ep-e2623] We’re going to put the cashflow lens on it. Because the tailwind has an invoice attached, and this week the invoice started coming due.Theme — Who pays for the AI buildAva: Start on page one of the memo, because Apple and Alphabet are sitting right next to each other this week giving opposite answers to the same question. Alphabet chose dilution. The asset-light beautiful business, the company that hadn’t sold a share of stock since its IPO, just raised about $85 billion in an equity offering to fund its AI build — with Berkshire Hathaway taking $10 billion of it in a private placement.[^googl-capital-raise-20260601] That’s to cover a capital-expenditure budget of $180–190 billion this year alone.[^googl-capex-2026-20260601] Marcus — what does that raise tell you that the press release won’t?Marcus: It tells you the cash machine stopped covering its own build. Going into this, the memo had Alphabet’s trailing free cash flow falling 44% year over year — capex is eating it alive.[^memo-googl-fcf-20260605] You don’t raise $85 billion in equity when your own cash flow funds the plan. You raise it when it doesn’t. 69 times trailing free cash flow for a company now diluting shareholders to keep up.[^memo-googl-evfcf-20260605] The beautiful business framing is over. This is a capital-intensive company that happens to own a search engine.Ava: Meta took door number two. Mark Zuckerberg spent the week reportedly floating an equity raise of his own to fund $125–145 billion of capex — and the stock fell almost 7% on Friday just on the report that it might.[^meta-capital-raise-20260605] Same week, he’s hinting Meta might enter cloud computing to find an offset.[^meta-cloud-computing-20260603] Marcus, Meta’s the one name here that doesn’t actually need the money.Marcus: Right, and that’s what makes it interesting. Meta still generates $50 billion of trailing free cash flow, and unlike Alphabet, it’s still growing — up about 22%.[^memo-meta-fcf-20260605] At 32 times free cash flow it’s the cheapest name in this whole group.[^memo-meta-evfcf-20260605] So when the best cash machine in the bunch is reportedly willing to dilute anyway, that’s the tell. It’s not that Meta can’t fund the build. It’s that the build is now big enough that even the best balance sheet here wants a cushion. The market saw the same thing. That’s the selloff.Ava: And then there’s Apple, on the same page, doing the thing nobody else in the arms race is doing. It’s not building an AI brain. It’s renting one. WWDC opens Monday, and the centerpiece reveal is Siri 2.0 — powered by Google’s Gemini.[^aapl-wwdc-20260601] Apple is paying Google roughly $1 billion a year for access to a 1.2-trillion-parameter model rather than train its own.[^aapl-google-deal-20260602] Marcus, a billion a year. Everyone else is spending a hundred times that.Marcus: And it might be the smartest line item in the whole sector. Apple throws off $129 billion of free cash flow a year, and it’s still growing.[^memo-aapl-fcf-20260605] A billion to rent the frontier is a rounding error against that — less than 1% of the cash Apple generates. At 35 times trailing free cash flow, Apple’s letting everyone else spend hundreds of billions to build the capability, then buying the output wholesale.[^memo-aapl-evfcf-20260605] Dilute, borrow, or rent. This week you got to watch all three, side by side. Only one of them doesn’t cost the shareholder a thing.Ava: Three doors. One invoice. Hold that thought, because the companies actually selling the shovels had their own reckoning this week.Deep dive — AI infrastructure’s two-act weekAva: Page two of the memo, Broadcom and Oracle, back to back — and between them they tell you everything about how the market is grading AI infrastructure right now. Same business, same end-market, one week apart. One company just delivered the print. The other has to deliver it on Wednesday. Here’s the contrast on the table. Broadcom reported Wednesday: AI semiconductor revenue up 143% year over year, to nearly $11 billion in a single quarter.[^avgo-ai-revenue-20260603] A record. CEO Hock Tan stood up and said he has, quote, line of sight to $100 billion in AI chip revenue in 2027.[^avgo-2027-target-20260603] And the stock fell 15%.[^avgo-stock-reaction-20260603] On a record. Marcus — explain that one.Marcus: The market didn’t sell the print. It sold the discipline. Going into this, the memo had Broadcom at 68 times trailing free cash flow with 57% forward revenue growth baked in.[^memo-avgo-evfcf-20260605] At 68 times, you are not paying for what the company delivered. You’re paying for the raise — for Tan to put a bigger number on the board. He didn’t. He kept the 2027 target flat and refused to bump it. So the stock gave back the premium that was sitting there waiting for the bump. The business is flawless. The expectations were priced one notch higher than flawless. That’s the whole 15%, right there.Ava: A record print — and the stock still falls. That’s what a 68 multiple does to you.Ava: So that’s the company that already reported. Now flip to Oracle, which walks into the exact same test Wednesday after the close. The setup: a backlog — remaining performance obligations — of $553 billion, up 325% year over year.[^orcl-rpo-backlog-20260604] Cloud infrastructure revenue up 84%.[^orcl-rpo-backlog-20260604] The stock fell 8% Friday before it even reported, when a strong jobs number pushed rate-cut hopes out.[^orcl-stock-decline-20260605] Marcus, Oracle’s the one name on this page where you can’t even use a multiple.Marcus: Right, and that’s the most important thing to understand before Wednesday. Oracle’s trailing free cash flow is negative — minus $21 billion.[^memo-orcl-fcf-20260605] There is no enterprise-value-to-free-cash-flow number, because there’s no free cash flow. They’re spending it all on the build. So don’t reach for a multiple — it’ll just be a negative number that means nothing. What prices Oracle is one question: does the backlog convert? $553 billion of contracted intent, growing 46% on the forward top line.[^memo-orcl-ntm-20260605] If that’s real revenue, the negative cash flow today is the cost of the build, exactly like Hunt said Wednesday. If it’s optimistic paper, this is the most expensive backlog in software. Wednesday is the first data point on which one it is.Ava: So connect the two. Broadcom got marked down for not raising the story. What does that do to Oracle’s setup on Wednesday?Marcus: It raises the bar. Broadcom just taught the market that delivering isn’t enough at these multiples — you have to deliver and beat the story you already sold. Oracle reports right into that mood. The $553 billion backlog is the story.[^orcl-rpo-backlog-20260604] If the cash behind it doesn’t start showing up Wednesday, Oracle gets the Broadcom treatment — except Oracle doesn’t have positive free cash flow to cushion the fall. Same exam, one week later, harder grader.Ava: And the one name standing behind both of them — selling the silicon into that whole build — had its own week. Marcus, Nvidia.Marcus: Nvidia is the supply that proves the demand both of these companies are selling. At the Taipei keynote this week, Jensen Huang said it flat: quote, Vera Rubin is in full production.[^tp-jensen-production-20260601] That’s the next-generation architecture confirmed off the roadmap and into the fab. And he made the claim that, if it holds, is the entire moat: quote, Today, Nvidia’s token cost is the lowest in the world.[^tp-jensen-tokencost-20260601] His framing — not by a little, by orders of magnitude. Against 41 times trailing free cash flow, that pricing-power claim is the whole argument.[^memo-nvda-evfcf-20260605] And here’s the tell the market usually waits for the print to see — per Talnexis hiring data, Nvidia’s AI engineering roles have been accelerating for weeks, and its customer-deployment postings just spiked.[^tlnx-nvda-hiring-20260605] That’s not a chip-research pattern. That’s staffing to go deploy an installed base. Demand you can see in the job board before you see it in the revenue.Ava: So the scoreboard for the week. Broadcom delivered and still got marked down. Oracle has to prove the backlog is real. And Nvidia is hiring like the demand is already in the building. Imagine that.Rapid-fire + the forward weekAva: Three quick ones, and then the forward week. First, Celsius. The energy-drink story just picked up a regulator. Texas Attorney General Ken Paxton opened a formal investigation into Celsius and Alani Nu over alleged deceptive marketing to minors[^celh-txag-20260605] — and that’s a fresh overhang on top of margin pressure the company’s already flagged as it digests the Alani Nu and Rockstar acquisitions.[^celh-margin-pressure-20260604] The stock’s been telling you about the margin worry. Now there’s a legal one too.Ava: Second, Five Below, and this one’s just a clean beat. Comparable sales up almost 23%. Adjusted earnings beat the Street by more than 30%. And management raised the full-year guide.[^five-q1-eps-20260603] In a week when half of retail is talking about a cautious consumer, Five Below printed the quarter the rest of the sector wishes it had.Ava: Third, Vertex. A pipeline name doing pipeline things. The FDA accepted Vertex’s application for povetacicept in IgA nephropathy — a kidney disease — with a decision date set for November 30.[^vrtx-povetacicept-20260601] That stacks on top of the cystic-fibrosis franchise and the new non-opioid painkiller. Vertex isn’t a one-drug company anymore, and the back half of this year is a string of catalysts.Ava: And the forward week. Oracle is the marquee print — Wednesday after the close, and you just heard why it matters. Lennar reports Thursday, and watch the gross margin: it collapsed to about 15% last quarter on the heaviest incentives since 2010, and the question is whether that was the floor.[^len-earnings-20260528] Then, looking out: CarMax reports the following Wednesday, June 17;[^earn-kmx] FedEx reports June 23, its first quarter as a pure-play express network after spinning off its freight business and pulling out about $4 billion in cash.[^fdx-q4-earnings-20260602] And keep an eye on Lantheus — there’s a reported $7 billion takeover interest and an FDA decision both landing this month.[^lnth-pdufa-20260605] Cheapest name in our biotech set, two binary events, one window.Close + Consensus WatchAva: That’s the show. Wall Street’s consensus on the AI-infrastructure week: Broadcom stumbled, Oracle’s the safe re-rate, and the hyperscalers can fund this forever. I’d put all three on the watch list, because all three are about to be tested. Here’s the throughline to take into Monday: this was the week the AI trade stopped being about the chips and became a question about who pays for them. Dilute, borrow, or rent on the demand side. Deliver the backlog or don’t on the supply side. The capex is real, the tailwind is real — and now, finally, so is the bill. One more thing: the hiring data we cited this week is from Talnexis — talnexis.com. You can pull up the Cash Flow Memo yourself at telltales.us. And Hunt, Jason, and Mike are back Wednesday on episode 2624, continuing the healthcare-and-deficit thread. We’ll see you next Saturday.DisclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* Bloomberg. (2026, June 5). Meta shares fall up to 7% on report of potential stock sale for AI funding. https://www.bloomberg.com/news/articles/2026-06-05/meta-considers-raising-billions-in-share-sale-ft-reports* BusinessWire. (2026, June 1). Vertex announces U.S. FDA acceptance of Biologics License Application for accelerated approval of povetacicept in IgA nephropathy [Press release]. https://www.businesswire.com/news/home/20260601424914/en/Vertex-Announces-US-FDA-Acceptance-of-Biologics-License-Application-for-Accelerated-Approval-of-Povetacicept-in-IgA-Nephropathy* CNBC. (2026, June 1). Alphabet plans to raise $80 billion from stock sales to fund AI build-out. https://www.cnbc.com/2026/06/01/alphabet-to-raise-80-billion-from-stock-sales-to-fund-ai-buildout.html* FedEx Investor Relations. (2026, June 2). FedEx board of directors approves spin-off of FedEx Freight [Press release]. https://investors.fedex.com/news-and-events/investor-news/investor-news-details/2026/FedEx-Board-of-Directors-Approves-Spin-off-of-FedEx-Freight/default.aspx* FinancialContent. (2026, June 5). Why Oracle (ORCL) shares are sliding today. https://markets.financialcontent.com/stocks/article/stockstory-2026-6-5-why-oracle-orcl-shares-are-sliding-today* FX Leaders. (2026, June 4). Oracle (ORCL) stock analysis: $553B backlog, AI revenue surge, and a $700B bet on cloud infrastructure. https://www.fxleaders.com/news/2026/06/04/oracle-orcl-stock-analysis-553b-backlog-ai-revenue-surge-and-a-700b-bet-on-cloud-infrastructure/* GlobeNewswire. (2026, May 7). Lantheus reports first quarter 2026 financial results and provides business update [Press release]. https://www.globenewswire.com/news-release/2026/05/07/3289785/0/en/Lantheus-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html* HeyGoTrade. (2026, June 3). Broadcom (AVGO) after the earnings drop: Buy the dip or stay cautious? https://www.heygotrade.com/en/blog/broadcom-avgo-stock-2026/* Huang, J. (2026, June 1). NVIDIA GTC Taipei 2026 keynote [Keynote address]. NVIDIA. YouTube. https://www.youtube.com/watch?v=wSp6AiNIrsY* Lennar Corporation. (2026, May 28). Lennar Corporation to broadcast its second quarter 2026 earnings call on June 12, 2026 [Press release]. https://newsroom.lennar.com/2026-05-28-Lennar-Corporation-to-Broadcast-Its-Second-Quarter-2026-Earnings-Call-on-June-12,-2026* Money Morning. (2026, June 5). Alphabet just sold $84.75 billion in stock. Here’s why that might be the smartest move of 2026. https://moneymorning.com/2026/06/05/alphabet-googl-84-billion-equity-raise-ai-infrastructure-2026* Office of the Texas Attorney General. (2026). Attorney General Ken Paxton announces investigation of Celsius Energy Drink Company to protect Texas. https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-announces-investigation-celsius-energy-drink-company-protect-texas* QuiverQuant. (2026, June 4). Celsius Holdings (CELH) slides as investors digest conference materials highlighting margin pressure and integration execution risk. https://www.quiverquant.com/news/Celsius+Holdings+(CELH)+slides+as+investors+digest+conference+materials+highlighting+margin+pressure+and+integration+execution+risk* Stock Titan. (2026, June 3). Broadcom Q2 2026 revenue up 48%, guides to $29.4B. https://www.stocktitan.net/news/AVGO/broadcom-inc-announces-second-quarter-fiscal-year-2026-financial-if4yrbje8hq6.html* Tech Insider. (2026, June 3). Broadcom AI revenue surges: Custom chip strategy 2026. https://tech-insider.org/broadcom-ai-revenue-custom-chips-2026/* The Motley Fool. (2026, June 1). Apple’s WWDC is June 8. Here’s the 1 announcement that could move the stock. https://www.fool.com/investing/2026/06/01/apples-wwdc-is-june-8-heres-the-1-announcement-tha/* The Motley Fool. (2026, June 2). Apple’s biggest AI test arrives June 8. Here’s what’s really at stake at WWDC. https://www.fool.com/investing/2026/06/02/apple-biggest-ai-test-june-8-whats-stake-wwdc/* The Motley Fool. (2026, June 3). Meta Platforms just hinted at a new business unit that could generate billions. https://www.fool.com/investing/2026/06/03/meta-platforms-just-hinted-at-a-new-business-unit/* Yahoo Finance. (2026, June 3). Five Below (FIVE) Q1 earnings and revenues surpass estimates. https://finance.yahoo.com/markets/stocks/articles/five-below-five-q1-earnings-211002302.htmlHiring intelligenceHiring-velocity claims for Nvidia are sourced from Talnexis, a hiring-intelligence platform that tracks public job-board postings across tracked tech companies, refreshed daily. Source: Talnexis (https://www.talnexis.com/). Signals cited: HIRING_VELOCITY on AI/ML (12→14→20, three-week trend) and CATEGORY_SPIKE on Solution Engineering (4→14, 3.5x in 7 days), both detected 2026-06-05. See 04. Publishing/shows/weekend-update/W2623/dryrun/talnexis_signals.md.Forward earnings (FMP)CarMax (KMX) earnings date — 2026-06-17 (Wednesday) before market open, consensus EPS $0.94, revenue $7.39B. Source: FMP /stable/earnings?symbol=KMX, pulled 2026-06-05. See 04. Publishing/shows/weekend-update/W2623/dryrun/earnings_slate.md.Internal dataInternal data is provided on a best efforts basis.Tracked-people quotesJensen Huang quotes are drawn verbatim (with keynote timestamps) from the Telltales tracked-people signal corpus:* Vera Rubin is in full production. — Jensen Huang @ 00:40:39* Today, Nvidia’s token cost is the lowest in the world. Not by 10%, by X factors, orders of magnitude. — Jensen Huang @ 00:48:44Source: NVIDIA GTC Taipei 2026 keynote, 2026-06-01 (https://www.youtube.com/watch?v=wSp6AiNIrsY). Memo: 01. Raw/secondary/people/Jensen Huang/2026-06-01 - NVIDIA - NVIDIA-GTC-Taipei-2026-Keynote-Full-Replay - signal.md. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

A wide-angle look at the three forces colliding in the market: oil supply through a contested Strait of Hormuz, the AI capex boom propping up the economy, and a US healthcare system whose broken incentives now intersect with an unsustainable federal deficit. Pull up the Cash Flow Memo at telltales.us and follow along with Exhibits A (US government finances), B (natural gas), and C (oil).The Cashflow MemoKey Takeaways* Hunt models a ~2M bbl/day inventory draw from the Iran disruption but expects no price spike: near-month crude rising to ~$95, 2026 average ~$84, with the $120–140 bear case unlikely because Straits of Hormuz volumes (~20% of global supply) are being rerouted via the Red Sea, Turkey, and Fujairah. He puts ~50% odds on the US–Iran impasse persisting indefinitely, with the Revolutionary Guards now the real arbiters in Tehran.* AI capex is the macro tailwind holding up the economy: hyperscaler spending (Amazon, Microsoft, Google, Meta) is approaching ~$1T in a ~$31T economy, and Google issued equity for the first time since its IPO to fund it. Q1 earnings were strong and Hunt sees no recession despite $90 oil.* The ACA created a zero-risk insurer model where a guaranteed 15–20% margin on cost actively incentivizes payers to pay more, not less (15% of $200 beats 15% of $100). Section 6001’s ban on new physician-owned hospitals (no new entrants since 2010) plus certificate-of-need laws structurally foreclose competition — McAllen vs. El Paso showed 2x cost for worse outcomes years before the ACA.* Cost-conscious payers can break the cartel: Montana’s reference-based pricing at 2x Medicare cut costs with no benefit reductions before lobbying reversed it. Mike’s fix needs all three legs at once — enforced price transparency (the unenforced 2021 rule), expanded low-cost supply (repeal 6001), and a cost-conscious payer. Surgery Center of Oklahoma and ICHRA show market mechanics already working at the margin.* The real forcing function is the deficit: new Fed chair Warsh wants to shrink the Fed’s ~$7T balance sheet toward ~$1–1.5T, which on top of a ~$1.5T deficit means finding buyers for ~$2.5T/year of Treasurys against uncertain demand. With US healthcare at ~18% of GDP vs. Show Notes[00:00:30] Oil, Iran & the Inventory Draw (Exhibit C) Hunt sizes a ~2M bbl/day inventory draw and explains how Straits of Hormuz volumes are being rerouted through the Red Sea, Turkey, and Fujairah.[00:04:15] Crude Price Outlook (Exhibit B) Near-month moving toward ~$95, 2026 average ~$84, future strip ~$76 — and why the $120–140 spike scenario is unlikely.[00:06:03] Who Actually Runs Iran The Revolutionary Guards as the real arbiters, and why Hunt puts ~50% odds on an indefinite US–Iran impasse.[00:08:14] No Recession, and the AI Capex Engine Strong Q1 earnings, ~$1T of hyperscaler capital spending in a ~$31T economy, and Google’s first equity issuance since its IPO.[00:09:22] The Deficit Problem (Exhibit A) Why holding Medicare and Medicaid spending flat is the non-negotiable lever for the FY27 budget math.[00:11:00] Healthcare’s Broken Incentives: McAllen vs. El Paso Two Texas border towns, 2x the Medicare spend, worse outcomes — and why this predates the ACA.[00:13:17] The Zero-Risk Insurer How a guaranteed 15–20% margin on cost incentivizes payers to pay more, not less.[00:14:20] Foreclosing Competition: Section 6001 & Certificate of Need No new physician-owned hospitals since 2010, and why you have to ask your competitor for permission to compete.[00:15:30] Montana’s Reference-Pricing Experiment A $23k vs. $103k knee replacement, pricing set at 2x Medicare, and how lobbying unwound the savings.[00:17:43] Price Transparency That Nobody Enforces The 2021 rule, two administrations that ignored it, and why you still can’t get a quote.[00:19:55] Opting Out: Surgery Center of Oklahoma A cash-only, menu-priced model — and why it can’t legally undercut Medicare.[00:21:00] Hunt’s Solution: Medicare for All A bipartisan Trump–Bernie path to anyone entering Medicare at any age.[00:22:58] Mike’s Three Fixes & Jason’s ICHRA Transparency, low-cost supply, and a cost-conscious payer — plus the employer-budget model that puts patients back in the driver’s seat.[00:26:02] Vertical Integration & UnitedHealthcare The monopoly that sets the price, accepts the payment, and provides the care.[00:27:43] AI in Healthcare: Upcoding vs. Real-Time Auditing From gaming medical codes to the Johns Hopkins finding that 21% of care is unnecessary and 60% is shoppable.[00:28:54] The Debt Crisis Endgame: Warsh & the Fed Shrinking a ~$7T balance sheet, ~$2.5T of annual Treasury supply, and why post-’08 was deflation, not inflation.[00:33:17] Closing: Don’t Sell Quality Cash Flow Why Microsoft, Amazon, Exxon, and Chevron are better credits than the US government right now.Get the Cash Flow Memo at telltales.us, and subscribe for next week’s continuation on healthcare reform and the deficit.Cashtags$AMZN $MSFT $GOOGL $META $CVX $XOM $UNH This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

The Trillion-Dollar Bet That the Cycle Is DeadThe market just handed a memory company a trillion-dollar valuation at roughly a hundred times trailing free cash flow, on a yield under one percent.¹² Strip the letters AI off that sentence and it is a bet that the most violently cyclical business in technology has quietly stopped being cyclical.On Wednesday’s main show, Hunt, Jason, and Mike spent an hour on the opposite problem — how you get to a two-trillion-dollar valuation on a company with almost no free cash flow at all. That was the SpaceX S-1.³ This week the market answered the mirror image for Micron. It looked at the cash that actually exists, and it priced that cash as if it can never fall again.Here is the part the screens are not showing you. As recently as fiscal 2023, Micron lost almost six billion dollars in a single year — and its gross margin went negative, which is the polite way of saying it sold memory for less than it cost to make.⁴ That was not 1998. That was two years ago. The cycle before it: fourteen billion in net income in 2018, gone to a fraction of that by 2020.⁵ Boom, glut, collapse, repeat. The most reliable pattern in semiconductors, and Micron has run it twice in the last eight years.The mechanism is not mysterious. High memory prices pull in capacity. Capacity becomes supply. Supply kills the price. A hundred times trailing free cash flow is the market betting that mechanism has been switched off — that high-bandwidth memory, the stuff that feeds the AI accelerators, is different enough to outrun the cycle for years instead of quarters. The bull case is real, and worth stating fairly: Micron’s entire 2026 HBM output is already sold out,⁶ management says it can fill only half to two-thirds of what its largest customers are asking for,⁷ and trailing free cash flow has grown more than fivefold off the 2023 trough.⁸ The stock rose nineteen percent the day it crossed a trillion, and nearly ninety percent in a month.⁹¹⁰ None of that is fake. The only question is whether it is permanent.Now put Broadcom next to it, because it reports Wednesday and the contrast is the whole point.¹¹ Broadcom is guiding AI-chip revenue up a hundred and forty percent, to roughly eleven billion dollars in a single quarter¹² — and it goes into that print at about seventy times trailing free cash flow, on more than thirty billion dollars of cash it has already banked.¹³¹⁴ The cashflow read is in Marcus’s column below; short version, one of these names is a bet on a shortage and the other is a bet on a standard. Micron needs the cycle to stay broken. Broadcom gets paid whether the buyer is Google, Meta, or Anthropic, and it needs nothing about memory pricing to be true. Page one of the Cash Flow Memo has both names. The market is paying the fatter multiple for the one carrying all the cycle risk.What changes the read is not a hiring chart or a single beat. It is the first crack in sold out. Broadcom’s print on Wednesday, June third, is the near-term referee — if a hundred-and-forty-percent AI guide actually holds, the standard is winning and the shortage trade has competition. The Micron test runs longer: watch HBM contract pricing into 2026 and the first time a competitor qualifies into the big accelerator sockets. The thesis breaks the day sold out quietly becomes renegotiated. That is always how a memory cycle turns. Not with a warning. With a renegotiation.For a long-cycle owner the discipline is simple and unpopular. You are not paid to decide whether AI memory demand is real this year. It is. You are paid to ask what Micron earns across the whole cycle, trough included, and whether a trillion-dollar tag survives the year the glut comes back. In 2023 the answer to that question was a six-billion-dollar loss. The market has decided that year was the last of its kind. The market has decided that before.Wall Street’s consensus on Micron’s trillion-dollar tag: AI broke the memory cycle. The memory cycle has broken that consensus before — twice since 2018, and the second time the gross margin went negative.The Tape — W2622Universe of 94 cashflow-memo names, snap dates 2026-05-26 → 2026-05-30. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Financials shown separately.Telltales Yield — Top 10* # | Ticker | Sector | Composite | FCF Yld | NTM Growth | EV/FCF | 1-wk Px* 1 | UBER | Technology | 80 | 7.5% | 15.2% | 13.2 | -2.0%* 2 | FCX | Basic Materials | 78 | 6.3% | 19.8% | 16.0 | 6.0%* 3 | REGN | Healthcare | 77 | 8.8% | 10.6% | 11.3 | -3.8%* 4 | LNTH | Healthcare | 73 | 6.6% | 13.2% | 15.1 | -3.6%* 5 | CRM | Technology | 72 | 8.5% | 9.6% | 11.8 | 6.1%* 6 | NOW | Technology | 68 | 3.8% | 18.5% | 26.1 | 21.8%* 7 | ABNB | Consumer Cyclical | 67 | 6.5% | 10.6% | 15.3 | 0.7%* 8 | PYPL | Financial Services | 67 | 16.5% | 4.1% | 6.1 | 1.2%* 9 | AM | Energy | 67 | 8.5% | 6.0% | 11.8 | -5.5%* 10 | LNG | Energy | 66 | 7.9% | 6.7% | 12.6 | -6.6%From the Cashflow Desk — Marcus GrahamMicron’s trillion-dollar tag and Broadcom’s get talked about as the same AI trade. They are not. Micron sits at 102x trailing FCF — a multiple that only pays off if the memory cycle is dead, in a business that lost $5.8B two fiscal years ago when the last glut hit. Broadcom goes into Wednesday’s print near 68x and needs nothing about memory pricing to cooperate; it gets paid on the custom-silicon standard whether the buyer is Google, Meta, or Anthropic. One name is a bet on a shortage. The other is a bet on a standard, and the standard is the cheaper multiple. The test is Wednesday, June 3: if Broadcom’s AI guide holds, the cycle-proof story suddenly has a cheaper rival. We re-anchor Micron when the next HBM contract-pricing print lands.Telltales Yield — Bottom 10* # | Ticker | Sector | Composite | FCF Yld | NTM Growth | EV/FCF | 1-wk Px* 1 | VG | Energy | 2 | -8.2% | -9.2% | — | -12.9%* 2 | LEN | Consumer Cyclical | 18 | 0.1% | 3.4% | 1589.4 | 1.0%* 3 | NKE | Consumer Cyclical | 19 | 1.8% | 0.6% | 56.0 | 3.5%* 4 | FANG | Energy | 20 | 2.8% | -6.6% | 36.4 | -4.6%* 5 | XOM | Energy | 22 | 3.3% | -9.0% | 30.6 | -6.2%* 6 | SBUX | Consumer Cyclical | 25 | 2.4% | 2.3% | 40.8 | -3.8%* 7 | CVX | Energy | 29 | 4.1% | -13.0% | 24.5 | -4.7%* 8 | WMT | Consumer Defensive | 29 | 1.6% | 4.7% | 64.0 | -3.8%* 9 | INTC | Technology | 35 | -0.4% | 10.7% | — | -4.3%* 10 | COST | Consumer Defensive | 36 | 2.2% | 7.9% | 45.8 | -7.0%This Week’s Reporters* Ticker | Sector | Reports | FCF Yld | NTM Growth | Composite* AVGO | Technology | 2026-06-03 | 1.5% | 57.1% | 58* FIVE | Consumer Defensive | 2026-06-03 | 3.0% | 9.9% | 48Sector Medians* Sector | N | Median Composite | Median FCF Yld | Median NTM Growth* Financial Services | 4 | 61 | 3.8% | 11.6%* Healthcare | 10 | 56 | 6.4% | 10.0%* Technology | 15 | 54 | 1.6% | 25.1%* Communication Services | 11 | 54 | 4.1% | 4.5%* Basic Materials | 3 | 50 | 6.3% | 6.5%* Industrials | 8 | 49 | 3.3% | 9.0%* Consumer Defensive | 5 | 48 | 3.0% | 7.9%* Consumer Cyclical | 12 | 45 | 3.3% | 4.8%* Energy | 21 | 44 | 5.9% | 0.7%* Utilities | 1 | 42 | 2.4% | 9.5%Debt / FCF Watch (highest leverage on TTM FCF)* Ticker | Sector | Net Debt / FCF | FCF Yld | Composite* TRGP | Energy | 20.8 | 1.2% | 44* NEE | Utilities | 16.2 | 2.4% | 42* MTDR | Energy | 12.8 | 2.7% | 51* CHTR | Communication Services | 10.6 | 8.0% | 50* ET | Energy | 10.0 | 5.4% | 44* DE | Industrials | 9.4 | 4.4% | 56* EPD | Energy | 9.4 | 3.3% | 43* FDX | Industrials | 8.8 | 3.6% | 46Weekly Price MovementTop 5 (week-over-week price) | Ticker | Sector | Price | 1-wk % | |——–|——–|——:|——-:| | SNOW | Technology | $255.55 | 48.4% | | MU | Technology | $971.00 | 29.3% | | NOW | Technology | $124.37 | 21.8% | | ORCL | Technology | $225.78 | 17.5% | | PLTR | Technology | $156.54 | 14.4% |Bottom 5 (week-over-week price) | Ticker | Sector | Price | 1-wk % | |——–|——–|——:|——-:| | VG | Energy | $12.04 | -12.9% | | OKE | Energy | $83.94 | -10.7% | | KMI | Energy | $31.08 | -8.0% | | TRGP | Energy | $255.07 | -7.8% | | CF | Basic Materials | $112.35 | -7.7% |Financials (shown separately — FCF metric not meaningful)* Ticker | Price | 52-wk Position | Div Yld* JPM | $299.31 | 51% | 2.1%* MS | $208.00 | 100% | 2.0%* GS | $1025.56 | 100% | 1.9%* IBKR | $86.97 | 96% | 0.1%Data Gaps90 of 90 non-Financial names ranked. 0 dropped for missing FCF yield or NTM revenue growth.Source: cashflow-memo master_2026-05-30.csv. NTM growth from FMP analyst-estimates consensus. Composite is a percentile rank, not a recommendation.▶ Explore the interactive Tape →The Cashflow MemoFive Prices, One QuestionThe week the market argued what AI revenue is worth, and gave five different answers.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the companies in the Cash Flow Memo. About 14 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2623.Chapter markers* Time | Segment* 0:00 | Disclaimer* 0:15 | Cold open* 0:45 | Theme — What is AI worth? (Snowflake, Salesforce, Palantir)* 4:45 | Deep dive — Micron & Broadcom* 8:45 | Rapid-fire — Lilly, Kratos, and the forward week* 11:45 | Close & Consensus Watch* 12:45 | DisclaimerFull transcriptDisclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. On Wednesday’s main show, Hunt, Jason, and Mike spent an hour on one question — how do you get to a $2 trillion valuation on a company with almost no free cash flow? That was the SpaceX S-1.[^ep-e2622] This week the market asked the opposite question, and asked it five times. Not how you justify a valuation with no cash — but what the AI cash flow that actually exists is worth. And across five names, it came back with five completely different answers. That’s the show.Theme — What is AI worth?Ava: On page 2 of the memo this week, the whole enterprise-software book tells one story — and then contradicts itself. This is the cleanest version of the only fight that mattered all week: AI revenue is real, it’s growing, and the market cannot agree what it’s worth. Watch it price three layers of the same stack three completely different ways.Ava: Start with the data layer. Snowflake had the best trading day in its history this week — up 36% in a single session[^news-snow-surge] — on a Q1 beat[^news-snow-q1] and a $6 billion, five-year commitment from AWS.[^news-snow-aws] Now the application layer. Salesforce beat the same week, and told you Agentforce is already a $1.2 billion business growing more than 200%[^news-crm-arr] — and the stock is down 33% on the year.[^news-crm-stock] Same enterprise-AI dollar. One name up a third in a session, the other down a third on the year. Marcus — one of those prices is wrong.Marcus: The market is buying the picks-and-shovels and pricing the application like it’s already roadkill. Going into this print the memo had Salesforce at 12 times trailing free cash flow on an 8% free-cash yield, Q4 10-K confirmed[^memo-crm-evfcf][^memo-crm-yield] — we re-anchor when the Q1 10-Q files. 12 times, on a company that’s still growing and already running a real AI-agent business. That’s the price of a melting ice cube. Snowflake went into its own print at 45 times[^memo-snow-evfcf], and the market just paid up for more. The whole spread is one bet — agents eat the workflow vendor and feed the data platform — and you’re paying the fattest multiple for the side that might lose.Ava: A melting ice cube growing 200%. Sure. And here’s the tell the stock price is ignoring — per Talnexis hiring data, Salesforce’s AI and machine-learning job postings jumped more than five-fold in a single week.[^tlnx-crm-aiml] Companies that believe they’re being disrupted don’t staff the disruption. And then there’s the third layer — over on page 5, with the chips and the defense names.Ava: Palantir is being priced as something you simply can’t avoid buying. The stock jumped 9% this week[^news-pltr-surge] — not on earnings, on procurement. The Pentagon made its Maven system a formal program of record[^news-pltr-maven], and the Army folded 75 separate contracts into a single $10 billion enterprise agreement.[^news-pltr-army] When the buyer standardizes on you, you stop being a vendor. You become infrastructure. Marcus — what does infrastructure cost?Marcus: It’s the most expensive name in the entire memo, and it’s expensive on purpose. 130 times trailing free cash flow[^memo-pltr-evfcf] — but a program of record isn’t a contract, it’s a multi-year funding line, and free cash flow already grew almost 200% over the last year.[^memo-pltr-fcf] That multiple isn’t pricing today’s cash. It’s pricing a decade of government AI spend compounding. The test is whether commercial growth holds up next to the government book. If it stalls, 130 times is a long way down.Ava: So: rewarded, buried, and untouchable. Three layers, three verdicts, one week.Deep dive — Micron & BroadcomAva: Here’s the same fight, one layer down, in its purest form. Micron and Broadcom are the two ways to own the silicon underneath the entire AI build — the memory, and the custom chips. Same supercycle. The market just priced them like they live in different decades.Ava: Micron crossed $1 trillion in market value this week for the first time ever[^news-mu-trillion] — up 19% the day it happened, 88% in a month[^news-mu-momentum] — because its entire 2026 high-bandwidth-memory output is already sold out[^news-mu-hbm], and management says it can fill maybe half to two-thirds of what its biggest customers are asking for.[^news-mu-demand] Broadcom reports Wednesday[^earn-avgo], guiding AI-chip revenue up 140% year-over-year — to almost $11 billion in a single quarter.[^news-avgo-ai] Two anchors of the same build. Marcus — which one is mispriced?Marcus: The surprising one is Micron, because a memory company is not supposed to trade like this. Memory is the most violently cyclical business in technology — boom, glut, collapse, repeat. And the memo has it at 102 times trailing free cash flow[^memo-mu-evfcf] at a yield under 1%.[^memo-mu-yield] On paper, that’s absurd. Except free cash flow grew more than fivefold off the last trough[^memo-mu-fcf], and the bull thesis is that this time the cycle doesn’t come back — that AI memory demand outruns supply for years, not quarters. 102 times is the market betting the cycle is dead. If memory is still cyclical, this is the top.Marcus: Broadcom is the opposite trade — same supercycle, half the multiple. Going into Wednesday the memo has it at 68 times trailing free cash flow[^memo-avgo-evfcf], on $32 billion of cash it’s already banked[^memo-avgo-fcf] — not a memory company’s hope, actual trailing cash. And Broadcom doesn’t need the cycle to break. It designs the custom chips and the networking that wire a million accelerators into one machine[^news-avgo-network], and it gets paid whether the buyer is Google, Meta, or Anthropic.[^news-avgo-anthropic] Micron is a bet on a shortage. Broadcom is a bet on a standard.Marcus: So here’s what the comparison actually says. One supercycle, and the market trusts one of these names with twice the multiple of the other. Wednesday’s print is the first real referee — if Broadcom’s AI guide holds, the safer way to own this build is the custom-silicon standard, and Micron’s trillion-dollar tag is the one carrying all the cycle risk.Ava: Two ways to own the same boom, priced like a coin flip. Wednesday we find out which side the house is on.Rapid-fire — Lilly, Kratos, and the forward weekAva: Away from the AI-pricing fight, two catalysts moved real money this week — and a few names report before you’re back here next Saturday.Ava: Eli Lilly had the kind of week that resets a franchise — twice. Phase 3 data on retatrutide, its triple-hormone obesity drug, came in at 28% average weight loss over 80 weeks[^news-lly-reta] — that’s bariatric-surgery territory, from an injection. And separately, the one-time gene-editing therapy it picked up in the Verve deal cut bad cholesterol by up to 62% with a single infusion.[^news-lly-verve] Two franchises, two different decades of revenue, one week. Lilly presents the full data at the diabetes meeting in New Orleans, June 5-8[^news-lly-ada] — and that’s a clean segue, because Wednesday’s main show is the healthcare deep dive Hunt, Jason, and Mike have been promising.Ava: Kratos jumped almost 14% in a day[^news-ktos-surge] on a report the Trump administration may take direct financial stakes in U.S. drone manufacturers — the government as an equity investor in its own supply chain. Same week, Kratos and GE Aerospace won a joint Air Force contract to develop the engine for collaborative combat aircraft.[^news-ktos-ge] It’s the Palantir thread again: the Pentagon isn’t just buying defense technology, it’s trying to own the means of producing it.Ava: A few more before Monday. Meta started charging for the thing it always gave away — paid Instagram, Facebook, and WhatsApp tiers went live this week at $3-4 a month.[^news-meta-subs] The company that built an empire on free is now testing whether its users will pay for it. In energy, Hunt made the oil call on Wednesday, so I’ll leave the Strait of Hormuz to him — the company news this week was a handoff at the top of Occidental, where Vicki Hollub steps down and Richard Jackson takes over June 1.[^news-oxy-ceo] And the forward calendar: Broadcom and Five Below both report Wednesday[^earn-five] — Five Below the cleaner tariff read, sourcing well over half its goods from China[^news-five-china] — with Oracle the Wednesday after.[^earn-orcl]Close & Consensus WatchAva: That’s the Weekend Update. Five names, five different prices on the same idea — that AI revenue is real, and growing. Snowflake priced for acceleration. Salesforce priced for death. Palantir priced as a utility. Micron priced like the cycle is finally over. Broadcom priced like the only grown-up in the room. They cannot all be right. Wall Street’s consensus on enterprise AI this week: Snowflake’s the winner, Salesforce is roadkill. Same quarter, both beat — and one of those calls is wrong. Broadcom’s print Wednesday is the first real referee. Hiring data this week from Talnexis — talnexis.com. All of it runs off the Cash Flow Memo, the universe we track every week. Grab it at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2623 — the healthcare deep dive they’ve been teasing for two weeks. We’ll see you Saturday.DisclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* A single dose of Lilly’s PCSK9 base editor VERVE-102 reduced PCSK9 by up to 88% and LDL-C by up to 62% with durable effects. (2026, May 27). PR Newswire. https://www.prnewswire.com/news-releases/a-single-dose-of-lillys-pcsk9-base-editor-verve-102-reduced-pcsk9-by-up-to-88-and-ldl-c-by-up-to-62-with-durable-effects-supporting-its-potential-as-a-one-time-treatment-for-hypercholesterolemia-302780172.html (Peer-reviewed: New England Journal of Medicine, https://www.nejm.org/doi/full/10.1056/NEJMoa2601283)* Broadcom (AVGO) set for strong Q2 earnings driven by AI growth. (2026, May 29). GuruFocus. https://www.gurufocus.com/news/8891842/broadcom-avgo-set-for-strong-q2-earnings-driven-by-ai-growth* CRM drops 33% in 2026 despite earnings beat as AI fears overshadow $1.2B Agentforce growth. (2026, May 28). FX Leaders. https://www.fxleaders.com/news/2026/05/28/crm-drops-33-in-2026-despite-earnings-beat-as-ai-fears-overshadow-1-2b-agentforce-growth/* The custom AI ASIC state of play (May 2026): Broadcom deals, Google TPUs, Meta MTIA & beyond. (2026, May). Tom’s Hardware. https://www.tomshardware.com/tech-industry/semiconductors/custom-ai-asics-examined-from-broadcom-to-mtia* Debt financing deal for Anthropic PBC involves Broadcom and Alphabet. (2026, May 28). GuruFocus. https://www.gurufocus.com/news/8890022/debt-financing-deal-for-anthropic-pbc-involves-broadcom-and-alphabet* Does Five Below’s tariff response strategy strengthen its value brand or signal margin strain? (2025, December 25). Sahm Capital. https://www.sahmcapital.com/news/content/does-five-below-fives-tariff-response-strategy-strengthen-its-value-brand-or-signal-margin-strain-2025-12-25* Eli Lilly (LLY) showcases new findings at ADA’s 86th Scientific Sessions. (2026, May 28). GuruFocus. https://www.gurufocus.com/news/8889220/eli-lilly-lly-showcases-new-findings-at-adas-86th-scientific-sessions* Kratos contract wins deepen role in hypersonics propulsion and space systems. (2026, May 29). Yahoo Finance. https://finance.yahoo.com/news/kratos-contract-wins-deepen-role-120929437.html* Lilly’s triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial. (2026, May 21). PR Newswire. https://www.prnewswire.com/news-releases/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss-in-pivotal-phase-3-obesity-trial-302778859.html* Meta officially launches Instagram, Facebook, and WhatsApp subscriptions, with more to come — including AI plans. (2026, May 27). TechCrunch. https://techcrunch.com/2026/05/27/meta-officially-launches-instagram-facebook-and-whatsapp-subscriptions-with-more-to-come-including-ai-plans/* Micron hits $1 trillion market cap for the first time as stock surges 19%. (2026, May 26). CNBC. https://www.cnbc.com/2026/05/26/micron-stock-trillion-market-cap.html* Micron technology: AI-powered semiconductor demand and the capital expenditure question (management can fulfill 50% to two-thirds of customer demand). (2026, May). MarketMinute / FinancialContent. https://markets.financialcontent.com/stocks/article/marketminute-2026-3-20-micron-technology-guidance-miss-ai-powered-semiconductor-demand-and-the-capital-expenditure-crisis* Micron’s entire 2026 HBM output sold out. (2026, May). HeyGoTrade. https://www.heygotrade.com/en/blog/mu-stock-analysis/* MU stock outlook May 30 2026: Micron at $1 trillion — AI demand & next-week preview (shares +88% over the past month). (2026, May 30). FX Leaders. https://www.fxleaders.com/news/2026/05/30/mu-stock-outlook-may-30-2026-micron-at-1-trillion-ai-demand-next-week-preview/* Occidental Petroleum. (2026, May 5). Occidental announces CEO succession [Press release]. https://www.oxy.com/news/news-releases/occidental-announces-ceo-succession/* Snowflake. (2026, May 27). Snowflake expands AWS collaboration with $6B commitment to accelerate enterprise agentic AI adoption [Press release]. https://www.snowflake.com/en/news/press-releases/snowflake-expands-aws-collaboration-with-6b-commitment-to-accelerate-enterprise-agentic-ai-adoption/* Snowflake Q1 fiscal 2027 earnings beat, $6 billion AWS deal (product revenue $1.33B, up 34% YoY; EPS $0.39 vs. $0.32 consensus). (2026, May 27). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/snowflake-q1-fiscal-2027-earnings-120043255.html* Snowflake surges 36% for best day ever on AI frenzy, fueling software rally. (2026, May 28). CNBC. https://www.cnbc.com/2026/05/28/snowflake-snow-software-stock-rally.html* Talnexis. (2026, May 24). Salesforce — AI/ML hiring category spike (28 roles in 7 days vs. 5 prior, 5.6x) [Hiring intelligence]. https://www.talnexis.com/* United States Army. (2025, July 31). U.S. Army awards enterprise service agreement to enhance military readiness and drive operational efficiency (75 contracts consolidated; $10B cap over up to 10 years) [Press release]. https://www.army.mil/article/287506/u_s_army_awards_enterprise_service_agreement_to_enhance_military_readiness-and-drive-operational-efficiency* Why Kratos Defense stock popped today (up 13.8% on May 28 following WSJ report the Trump administration may invest directly in U.S. drone manufacturers). (2026, May 28). The Motley Fool. https://www.fool.com/investing/2026/05/28/why-kratos-defense-stock-popped-today/* Why Palantir stock is soaring today (up ~9% on potential U.S. drone-manufacturer funding and software-sector momentum). (2026, May 28). The Motley Fool. https://www.fool.com/investing/2026/05/28/why-palantir-stock-is-soaring-today/* Why Palantir’s new program of record with the Pentagon could be a game changer (Maven Smart System designated a formal program of record, March 2026). (2026, March 31). The Motley Fool. https://www.fool.com/investing/2026/03/31/why-palantir-s-new-program-of-record-with-the-penta/Internal dataInternal data is provided on a best efforts basis.Forward earnings (FMP)* AVGO — Broadcom, 2026-06-03 (Wednesday). Consensus EPS $2.40, revenue ~$22.12B. FMP /stable/earnings?symbol=AVGO, pulled 2026-05-30.* FIVE — Five Below, 2026-06-03 (Wednesday). Consensus EPS $1.76, revenue ~$1.23B. FMP /stable/earnings?symbol=FIVE, pulled 2026-05-30.* ORCL — Oracle, 2026-06-10 (Wednesday). Consensus EPS $1.96, revenue ~$19.10B. FMP /stable/earnings?symbol=ORCL, pulled 2026-05-30. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt, Jason, and Mike break down the freshly filed SpaceX S-1 and ask the only question that matters: how do you justify a $2 trillion valuation on a company with almost no free cash flow? They work through the AI stack, the Starlink connectivity business, and the launch economics that quietly underwrite all of it.The Cashflow MemoKey Takeaways* SpaceX filed its S-1 targeting a ~$2T valuation against negligible free cash flow; Hunt frames it next to Tesla (~$1.5T on ~$6B FCF) as proof you can pile on valuation with no EBITDA or FCF, set against NVIDIA’s new record ~$163B FCF run-rate and Apple’s ~$120B.* The promotional $22T TAM rests mostly on the least-proven leg — AI (Macrohard agentic workloads, applications not yet invented), a Tesla/SpaceX JV pairing Tesla’s world model with xAI’s language models, plus a ~$55B Terafab chip-production plan.* The Anthropic lease puts a mark on the data centers: xAI leasing Colossus-1 to Anthropic at ~$1.5B/month against a * Launch is the real crown jewel, not Starlink: 122 SpaceX launches vs. 43 customer launches in 2025; re-pricing Starlink at market rate lifts space revenue from $4.1B to ~$11B straight to cash. Customer-launch gross margin is 65-75% and rising as cost/kg falls from Falcon’s ~$850 toward Starship’s ~$100 (NASA: ~$19,000); Starship R&D is $4B this year, up from $3B.* Space-based data centers are an extension of Starlink, not a monolith: each Starlink sat is ~25kW of servers, AI racks run ~125kW in sun-synchronous orbit, launched at daily cadence — a distributed inference network. The choke-point thesis: frontier labs (Anthropic/OpenAI/Gemini) may route inference through Starlink for performance, handing SpaceX negotiating leverage. Starlink itself did $11.4B revenue in 2025 at 39% operating / 63% EBITDA margin across 10.3M subs.Show Notes[00:02] Open & Disclaimer Welcome and the standard informational disclaimer.[00:30] Exhibits A, B & C: Energy and the Government’s Books Hunt on oil and gas pricing through the Iran disruption, weak Waha gas curtailing Permian supply, and a fiscal ’27 federal deficit that stays stuck near $1.5T.[05:51] Macro Grab Bag: Grid Curtailment, Taiwan, and Reshoring DOE clears PJM to curtail data-center power in a grid stress event; the hosts reject Chamath’s nobody cares about Taiwan in 18 months call; Gavin Baker’s point that the Iran war helps US reshoring by raising energy costs more abroad than at home.[09:55] NVIDIA & Apple: Free Cash Flow Records NVIDIA at a ~$163B FCF run-rate (new all-time record, eclipsing old Exxon peak), Apple at ~$120B, against $5.6T and ~$4.5T market caps.[11:34] The SpaceX Question: $2T With No Cash Flow Framing the S-1 alongside Tesla — huge valuations attached to businesses not yet generating EBITDA, income, or free cash flow.[12:51] The AI Stack: xAI, Colossus, the Anthropic Lease, Cursor & Macrohard The $22T TAM and its least-proven leg; xAI’s record build speed; Anthropic leasing Colossus-1 at ~$1.5B/month; the Cursor acqui-hire; Macrohard agentic workloads as a Tesla/SpaceX JV; the $55B Terafab plan.[19:05] Starlink: The Supposed Crown Jewel $11.4B 2025 revenue, 39% operating / 63% EBITDA margin, 10.3M subscribers — and why the hosts think the conventional crown jewel label is misplaced.[19:43] Launch Economics: The Real Crown Jewel 122 SpaceX vs. 43 customer launches; backing Starlink out at market rate to reveal true space economics; 65-75% and rising customer-launch margins; cost/kg from Falcon ~$850 toward Starship ~$100 vs. NASA’s ~$19,000.[22:52] Data Centers in Orbit Why a space data center is a distributed network of ~125kW AI racks in sun-synchronous orbit, not a monolith; the physics of power and heat; latency math vs. terrestrial fiber.[25:54] Q&A: Would You Switch? The Choke-Point Thesis, T-Mobile & Space Junk Whether you’d prefer Starlink inference in 24 months; routing frontier-model inference through Starlink as a negotiating choke point; Starlink V3 + T-Mobile direct-to-cell; Kessler-cascade space-junk risk.[32:18] Next Week Healthcare deep dive, then a future episode on Musk’s TSMC-replacement / Terafab vision and space junk.Subscribe and grab the Cashflow Memo at telltales.us.Cashtags$$SPCX $NVDA $AAPL $GOOGL $TSLA $XOM $MSFT $AMZN $TMUS $TSM This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

The Cashflow MemoCapital Structure WeekNvidia confirmed the demand picture. Three companies restructured this week to monetize it.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 94 companies in the Cash Flow Memo. About 13 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2622.Chapter markers* 0:00 | Opening disclaimer* 0:15 | Cold open + the week’s throughline* 0:45 | Theme — Capital structure week (NextEra, Lantheus, FedEx)* 4:45 | Deep dive — Nvidia Q1 FY27* 8:45 | Rapid-fire — CRM/SNOW pre-prints, Deere, BioNTech, Target/Walmart, Verizon/T-Mobile, Regeneron* 11:45 | Close + Consensus Watch + forward week* 12:30 | Closing disclaimerFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. And this is still a pilot — tell us what’s landing and what isn’t.Ava: Here’s the week. Nvidia confirmed the AI demand picture on Tuesday. And three companies in the memo restructured this week to monetize it. NextEra is buying a $67 billion utility for the power. Lantheus is in sale talks at roughly $7 billion for the radiopharma platform. And FedEx is spinning Freight on June 1. On Wednesday’s show, Hunt, Jason, and Mike walked through Google’s real AI risk — not ChatGPT, but agentic search and Gemini Spark[^ep-e2621]. Today’s show is what the rest of the universe did about it.Theme — Capital structure weekAva: Three restructurings in five days, three different time horizons, one read. Page 18, page 15, page 17 of the memo — all printing the same idea. The AI demand picture is now confirmed enough that companies are willing to redraw their balance sheets around it.Ava: NextEra. $67 billion all-stock bid for Dominion Energy[^news-nee-dominion-20260523]. Combined entity becomes the world’s largest regulated utility, and management is explicit about what it’s for — they’re contracted to build 30+ data center campuses, with 15 to 30 gigawatts of generation by 2035[^news-nee-data-center-campuses-20260523]. Meta already has a 2.5 gigawatt solar-and-storage deal signed[^news-nee-meta-partnership-20260523]. Dominion stock up 9% on the announcement. NextEra down 4%[^news-nee-dominion-20260523].Ava: Lantheus. In talks to sell to Curium at roughly $7 billion — broke Thursday[^news-lnth-curium-20260523]. This is the radiopharma roll-up everyone in oncology imaging has been waiting for. Q1 beat, PYLARIFY TruVu cleared FDA in March with a 50% batch-size lift, and the LNTH-2501 PDUFA lands June 29[^news-lnth-q1-20260523][^news-lnth-pylarify-20260523][^news-lnth-pdufa-20260523].Ava: FedEx. Freight spins June 1 as FDXF[^news-fdx-spinoff-20260523]. Dual-market trading starts Tuesday. FedEx retains a 19.9% stake; the rest goes to holders, tax-free for U.S. federal purposes[^news-fdx-dual-market-20260523][^news-fdx-tax-20260523]. CEO Raj Subramaniam separately dismissed the Amazon-logistics-threat narrative this week[^news-fdx-amazon-20260523]. Marcus — the cashflow take. Start with the one that’s actually changing right now.Marcus: NextEra is the one that matters this week. The memo had them at 28x trailing free cash flow at a 5% yield going in, Q1 10-Q confirmed[^memo-nee-evfcf-20260522]. That’s a clean number for a regulated utility. But the load-bearing line was already debt-to-FCF at 11x trailing[^memo-nee-debtfcf-20260522]. Now they’re eating Dominion’s leverage in an all-stock deal. The trade is: investors get the regulated-utility tail on AI infrastructure that hyperscaler multiples don’t price, and in exchange they take on a balance sheet that will look heavier before it earns through. What to watch on the next print is whether the contracted gigawatt backlog converts fast enough to absorb the debt the deal piles on.Ava: Translation: you bought the utility because the data centers needed the power, not the chips. Lantheus?Marcus: Lantheus is the cleanest balance sheet of the three. The memo had them at 35x trailing free cash flow at a roughly 3% yield, debt-to-FCF basically zero[^memo-lnth-evfcf-20260522][^memo-lnth-debtfcf-20260522]. $7 billion is a reasonable mark on a company with a Q1 beat, a fresh FDA approval, and a PDUFA five weeks out. The radiopharma platform is what Curium is buying — the imaging stack plus the therapeutic pipeline. Not financial engineering. Strategic consolidation in a category where the FDA pipeline is the asset.Ava: And FedEx is the third one — different structure entirely.Marcus: FedEx is the most interesting capital structure of the three. The memo had FDX at 22x trailing free cash flow at a roughly 6% yield, debt-to-FCF at 7.5x[^memo-fdx-evfcf-20260522][^memo-fdx-debtfcf-20260522]. The Freight spin lets the parent re-rate around the express business; the retained stake gives the holdco a forward monetization option. That’s not a tax dodge — that’s management taking the discount the market puts on the bundle and letting it trade separately.Ava: Three balance-sheet decisions, made the same week Nvidia gave you the demand picture they’re all pricing against. Mark that.Deep dive — NvidiaAva: Nvidia’s Q1 fiscal 2027 print, after the close Tuesday. The bull case got everything it asked for. The bear case got nothing it asked for.Ava: Revenue $82 billion, up 85% year-over-year and 20% sequentially[^news-nvda-q1-rev-20260523]. Data Center alone was $75 billion — nearly double the prior-year quarter[^news-nvda-data-center-20260523]. Gross margin held at 75%, essentially flat to Q4[^news-nvda-gm-20260523]. Diluted GAAP EPS $1.87, up 140%[^news-nvda-eps-20260523].Ava: Then they guided. Q2 revenue $91 billion, plus-or-minus 2%[^news-nvda-q2-guide-20260523]. Margin guide held at 75%[^news-nvda-margin-guide-20260523]. Blackwell 300 and the B200 line sold out through mid-2026 per management[^news-nvda-blackwell-demand-20260523]. Rubin platform confirmed for Q3 launch this year, Rubin Ultra in H2 2027[^news-nvda-rubin-20260523].Ava: And then the capital return. They raised the dividend 25-fold — from $0.01 to $0.25 per share — and authorized an additional $80 billion of buybacks[^news-nvda-capital-allocation-20260523]. Marcus, the cashflow take.Marcus: Nvidia just gave you the next twelve months of justification in one forward number. The memo had them at 50x trailing free cash flow at about a 2% yield going in, Q4 FY26 10-K confirmed[^memo-nvda-evfcf-20260522]. We re-anchor when the Q1 10-Q files. The $91 billion Q2 guide is what changes the read[^news-nvda-q2-guide-20260523] — that’s a single quarter of revenue close to the company’s entire trailing-twelve free cash flow base[^memo-nvda-fcf-20260522]. The multiple was never the problem here. The problem was always whether the Q2 guide would hold the rate of change. It did.Ava: One sentence on why the dividend matters.Marcus: It signals that Jensen Huang now believes the cash generation is structural, not cyclical. You don’t 25x the dividend on a company you think is at the top. The $80 billion buyback authorization is the second signal — they’re going to be in the open market accumulating their own equity while the next product cycle ramps. The question for the next print isn’t whether the demand is real. The question is whether anything in the Blackwell-to-Rubin transition slips, because at this multiple, any timing miss is the entire risk.Ava: And the consensus narrative on the print?Marcus: Wall Street had a version of the law of large numbers eats Nvidia by 2027. The Q2 $91 billion guide just told you the law of large numbers gets eaten first. Bear modelers said this rate of change couldn’t continue at this base. They were wrong, and they’re going to be wrong again next quarter unless something physical breaks in the supply chain.Ava: So the bear case now has to argue physics, not math. Two prints from now, mark the calendar.Rapid-fireAva: Five forward-week catalysts and one governance shock to close. Buckle up.Ava: Page 2 of the memo — Salesforce and Snowflake both report after the close Tuesday[^earn-crm][^earn-snow]. Consensus on Salesforce: $3.12 EPS, $11 billion revenue[^earn-crm]. Consensus on Snowflake: $0.32, $1.3 billion[^earn-snow]. The Salesforce setup has CEO Marc Benioff committing $300 million of Anthropic token spend for the year, with AI coding agents delivering 30% engineering productivity gains and no incremental engineering hires[^news-crm-benioff-anthropic-20260523]. And per Talnexis hiring data, Salesforce’s AI/ML postings spiked 5.6x in the last 7 days — 28 new roles versus 5 the week prior — heading straight into the print[^tlnx-crm-aiml-20260523]. Memo had Salesforce at 28x trailing free cash flow going in, Q4 10-K confirmed[^memo-crm-evfcf-20260522]. Re-anchor Wednesday morning.Ava: Snowflake is the harder one. Memo can’t anchor on a multiple — trailing free cash flow runs negative, capex still scaling against the AI workload ramp[^memo-snow-fcf-20260522]. What prices Snowflake right now is Cortex AI adoption — 9,100 customer accounts, 200%+ YoY AI-workload growth, NRR holding at 125%, RPO accelerating 42% year-over-year[^news-snow-cortex-20260523][^news-snow-nrr-20260523]. And the Talnexis hiring tracker shows Snowflake’s Partnerships postings up 5.5x in 7 days — 11 new partnerships roles versus 2 the week prior[^tlnx-snow-partnerships-20260523]. The pre-print read: the ecosystem-monetization push is hiring like it’s a real business.Ava: Deere reported Wednesday. EPS $6.55 against $5.74 consensus, a 14% beat[^news-de-q2-earnings-20260521]. But the composition is the story. Construction and Forestry revenue up 29%, op profit up 48%[^news-de-construction-20260521]. Production and Precision Ag revenue down 14%, op profit down 39%[^news-de-ag-decline-20260521]. And $272 million of the beat came from a Supreme Court IEEPA tariff recovery[^news-de-tariff-20260521]. Strip that out, the print is in-line at best. Construction is booming, farmers are buying nothing, and the tariff lawyers paid the difference.Ava: BioNTech. Q1 loss of €531.9 million — and the company is buying back €1 billion of stock into it[^news-bntx-q1-loss-20260523]. What they’re spending on is BNT327, their lead bispecific antibody. Phase 2 small-cell lung cancer just printed 16.8 months median overall survival[^news-bntx-bnt327-survival-20260523]. Phase 3 push is on, with combination trials running across non-small-cell lung, triple-negative breast, and pancreatic[^news-bntx-bnt327-combos-20260523]. The loss is real. The platform bet is what’s getting funded.Ava: Page 8 — Target and Walmart, same week, opposite reads. Target beat on Q1 comps up 5.6% — their first positive comp in five quarters — and raised the full-year guide[^news-tgt-q1-20260523][^news-tgt-guidance-20260523]. Walmart printed strong e-commerce growth — 26% globally, marketplace up nearly 50% — and the stock fell 7% on a cautious full-year guide[^news-wmt-ecom-20260523][^news-wmt-earnings-20260523]. Same consumer. Same week. Two different reads on what Walmart’s franchise actually sees ahead of it.Ava: Page 6 — both wireless carrier CEO chairs moved this week. Dan Schulman in at Verizon, Hans Vestberg to Special Advisor through October[^news-vz-ceo-20260523]. Srini Gopalan in at T-Mobile in six weeks, Mike Sievert to vice chairman[^news-tmus-ceo-20260523]. And the same week — Verizon, AT&T, and T-Mobile announced a three-way joint venture on direct-to-device satellite to compete with Starlink, while T-Mobile separately launched SuperBroadband with Starlink at $250 a month[^news-tmus-jv-20260523][^news-tmus-starlink-20260523]. Read into the timing what you will.Ava: And Regeneron — fianlimab-plus-Libtayo missed primary endpoint in the 1,546-patient melanoma Phase 3, lost head-to-head to Keytruda, stock down 10.5% on the news[^news-regn-melanoma-20260523]. The Eylea HD extended-dosing approval and Dupixent’s 33% Q1 growth are still there[^news-regn-eylea-20260523][^news-regn-dupixent-20260523]. But the oncology pipeline just took a real hit.CloseAva: That’s the show. Wall Street’s consensus on the week: Nvidia was priced for perfection going in, and the print was the test. They were half right. It was priced for perfection. It also delivered perfection. The next test is whether Salesforce and Snowflake confirm the Agentforce and Cortex traction Tuesday afternoon.Ava: Hiring data this week from Talnexis — talnexis.com.Ava: Forward week — Salesforce and Snowflake Tuesday after the close, Costco Wednesday, Broadcom and Five Below on June 3. Hunt, Jason, and Mike are back Wednesday on episode 2622 — Hunt teased a surprise topic in place of the usual healthcare slot[^ep-e2621]. Get the Cash Flow Memo at telltales.us.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* BioNTech Investor Relations. (2026, May). BioNTech clinical data at ELCC 2026 highlight potential of differentiated late-stage portfolio in lung cancer [Press release]. https://investors.biontech.de/news-releases/news-release-details/biontech-clinical-data-elcc-2026-highlight-potential* Fierce Biotech. (2026, May). BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific. https://www.fiercebiotech.com/biotech/biontech-shows-lung-cancer-survival-data-behind-phase-3-push-red-hot-bispecific* Canary Media. (2026, May 18). NextEra Energy wants to buy its way into Data Center Alley. https://www.canarymedia.com/articles/utilities/nextera-energy-wants-to-buy-its-way-into-data-center-alley* Carbon Credits. (2026, May). Meta and NextEra partner for a big solar and storage energy deal. https://carboncredits.com/meta-and-nextera-partner-for-a-big-solar-and-storage-energy-deal/* CNBC. (2026, May 12). FedEx CEO brushes off Amazon’s new logistics service that recently sent shares tumbling. https://www.cnbc.com/2026/05/12/fed-ex-ceo-jim-cramer-amazon-logistics.html* CNBC. (2026, May 18). NextEra Energy (NEE) to buy Dominion Energy (D). https://www.cnbc.com/2026/05/18/nextera-nee-dominion-energy-d-data-center-ai.html* CNBC. (2026, May 18). Regeneron drops after skin cancer treatment misses late-stage trial goal. https://www.cnbc.com/2026/05/18/regeneron-drops-after-skin-cancer-treatment-misses-late-stage-trial-goal.html* CNBC. (2026, May 20). Nvidia (NVDA) earnings report Q1 2027. https://www.cnbc.com/2026/05/20/nvidia-nvda-earnings-report-q1-2027.html* CNBC. (2026, May 21). Walmart issues worse-than-expected outlook as high gas prices hit shoppers, shares drop 7%. https://www.cnbc.com/2026/05/21/walmart-wmt-earnings-q1-2027.html* Eyewire+. (2026). Regeneron secures FDA approval to extend Eylea HD dosing intervals to up to 20 weeks. https://eyewire.news/news/regeneron-secures-fda-approval-to-extend-eylea-hd-dosing-intervals-to-up-to-20-weeks* FedEx Investor News. (2026, May 13). FedEx board of directors approves spin-off of FedEx Freight [Press release]. https://investors.fedex.com/news-and-events/investor-news/investor-news-details/2026/FedEx-Board-of-Directors-Approves-Spin-off-of-FedEx-Freight/default.aspx* Financial Content. (2025, December 29). Nvidia’s Blackwell dynasty: B200 and GB200 sold out through mid-2026 as backlog hits 3.6 million units. https://markets.financialcontent.com/wral/article/tokenring-2025-12-29-nvidias-blackwell-dynasty-b200-and-gb200-sold-out-through-mid-2026-as-backlog-hits-3-6-million-units* GeekWire. (2026, May 23). T-Mobile enlists Starlink satellites for new SuperBroadband business internet service. https://www.geekwire.com/2026/t-mobile-enlists-starlink-satellites-for-new-superbroadband-business-internet-service/* Investing.com. (2026, April 29). Regeneron beats first quarter estimates on Dupixent strength. https://www.investing.com/news/earnings/regeneron-beats-first-quarter-estimates-on-dupixent-strength-4644258* Lantheus Holdings. (2026, March 6). Lantheus announces FDA approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection [Press release]. https://investor.lantheus.com/news-releases/news-release-details/lantheus-announces-fda-approval-pylarify-truvutm-piflufolastat-f* Lantheus Holdings. (2026, May 7). Form 10-Q FY2026 [SEC filing]. https://www.sec.gov/Archives/edgar/data/0001521036/000119312526210373/lnth-20260331.htm* Lopez, M. (2026, May 22). Lantheus (LNTH) weighs potential $7 billion sale following offer from Curium. Bloomberg. https://www.bloomberg.com/news/articles/2026-05-22/lantheus-is-said-to-weigh-sale-following-offer-from-curium* MarketBeat. (2026, May 20). NVIDIA Corp. Q1 FY2027 earnings report. https://www.marketbeat.com/earnings/reports/2026-5-20-nvidia-co-stock/* MarketBeat. (2026, May 21). Deere & Company Q2 2026 earnings report. https://www.marketbeat.com/earnings/reports/2026-5-21-deere-company-stock/* Morningstar. (2026, May 12). FedEx board of directors approves spin-off of FedEx Freight. https://www.morningstar.com/news/business-wire/20260512056825/fedex-board-of-directors-approves-spin-off-of-fedex-freight* NVIDIA Newsroom. (n.d.). Rubin platform AI supercomputer [Press release]. https://nvidianews.nvidia.com/news/rubin-platform-ai-supercomputer* Quartz. (2026, May 20). Target Q1 2026 earnings beat: Sales surge, outlook raised. https://qz.com/target-earnings-sales-growth-full-year-outlook-052026* Quiver Quantitative. (2026, May 7). Lantheus Holdings ($LNTH) releases Q1 2026 earnings. https://www.quiverquant.com/news/LANTHEUS+HOLDINGS+%28%24LNTH%29+Releases+Q1+2026+Earnings* Salesforce. (n.d.). Marc Benioff says Salesforce will spend $300M on Anthropic in 2026. Yahoo Finance. https://finance.yahoo.com/sectors/technology/articles/marc-benioff-says-salesforce-spend-133651072.html* Simply Wall St. (2026, May 23). Assessing BioNTech (BNTX) valuation after prolonged share price weakness and loss-making results. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bntx/biontech/news/assessing-biontech-bntx-valuation-after-prolonged-share-pric* Snowflake. (n.d.). Snowflake Inc. Q4 FY2026 earnings 8-K [SEC filing]. https://www.sec.gov/Archives/edgar/data/0001640147/000162828026011631/fy2026q4earnings.htm* StockInvest.us. (n.d.). Snowflake earnings report: Key numbers & transcript summary. https://stockinvest.us/earnings-report/SNOW* Target Corporate. (2026, May 20). Target Q1 2026 earnings highlights [Press release]. https://corporate.target.com/news-features/article/2026/05/q1-2026-earnings* Telecoms.com. (2026, May 23). Gopalan to replace Sievert as T-Mobile US CEO in six weeks. https://www.telecoms.com/operator-ecosystem/gopalan-to-replace-sievert-as-t-mobile-us-ceo-in-six-weeks/* Teslarati. (2026, May 23). SpaceX just forced Verizon, AT&T and T-Mobile to team up for the first time in history. https://www.teslarati.com/spacex-starlink-vs-verizon-att-tmobile-d2d-direct-device/* Verizon. (n.d.). Verizon announces CEO transition [Press release]. https://www.verizon.com/about/news/verizon-announces-ceo-transition* Walmart Inc. (2026, May 21). Form 8-K — earnings release FY27 Q1 [SEC filing]. https://www.sec.gov/Archives/edgar/data/0000104169/000010416926000095/earningspresentationfy27.htm* Yahoo Finance. (2026, May 21). Deere & Co (DE) Q2 2026 earnings call highlights: Strong sales growth amidst challenges. https://finance.yahoo.com/markets/stocks/articles/deere-co-q2-2026-earnings-230050659.html* 24/7 Wall St. (2026, May 21). Deere (DE) Q2 2026 earnings call transcript. https://247wallst.com/companies/de/earnings/Internal dataInternal data is provided on a best efforts basis.Hiring intelligence dataHiring data this week from Talnexis — talnexis.com. Talnexis tracks 98 top tech companies and refreshes hiring intelligence daily from public job boards.* CRM — Salesforce: AI_HIRING_SURGE on AI/ML postings (28 roles in 7d vs 5 prior, 5.6x). Detected 2026-05-23. Source: https://www.talnexis.com/* SNOW — Snowflake: CATEGORY_SPIKE on Partnerships postings (11 roles in 7d vs 2 prior, 5.5x). Detected 2026-05-23. Source: https://www.talnexis.com/Earnings calendarSource: FMP /api/v3/earning_calendar, pulled 2026-05-23. Filtered to the 94-ticker Cashflow Memo universe.* CRM — Salesforce: 2026-05-27 AMC. Consensus EPS $3.12, revenue $11.05B* SNOW — Snowflake: 2026-05-27 AMC. Consensus EPS $0.32, revenue $1.32B* COST — Costco: 2026-05-28. Consensus EPS $4.98, revenue $69.61B* AVGO — Broadcom: 2026-06-03. Consensus EPS $2.40, revenue $22.04B* FIVE — Five Below: 2026-06-03. Consensus EPS $1.71, revenue $1.21B This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Hunt Lawrence, Mike Nicoletti, and Jason Wallace unpack why the Hormuz panic doesn’t hold, where Google’s real AI risk actually lives, and how the PBM business model is unwinding in real time. Get the Cash Flow Memo at telltales.us.The Cashflow MemoKey Takeaways* Hunt’s oil base case holds at $90 (Brent $108 / WTI $104 today) against consensus $150 calls: Saudi Aramco already posted higher March cash flow routing crude to the Red Sea, ADNOC is twinning the Oman→Fujairah line, Iraq/Kuwait are moving barrels by truck-and-pipe through Syria, and Iran loses leverage over time even without a nuclear deal.* Exhibit A is straining on interest expense (10Y at 4.5% vs. the 3.5% baseline assumption); Mike’s debt/GDP-stabilization-near-100% bet leans on Claude-class AI compressing Medicare/Medicaid spend into flat-to-declining, with defense and interest as the other binding lines.* Google ran from $162 to $400 in 52 weeks: AI Overviews defused the visible ChatGPT threat, but the real risk is agentic search rewiring monetization (Exa just raised $225M at $2B+ from a16z), and Jason posits a chunk of Google’s incremental search revenue is OpenAI paying for web-index grounding.* Gemini Spark (I/O) is Google playing innovator’s-dilemma offense, a 24/7 personal agent running across Gmail/Calendar/Drive that no entrant can replicate without Google’s existing data perimeter; the Google + Meta + Amazon ad-network moat remains durable enough that OpenAI is retreating to Anthropic-style subscription revenue.* PBM pricing power is unwinding in real time: Trump Rx relaunched with Cost Plus Drug + Amazon Fulfillment backends (drugs at ~25% of copay), UNH/OptumRx moving to a transparent flat-fee model and dropping prior auth on 30% of minor procedures, CVS adding biosimilars, and Lilly’s DTC channel proving out, all setting up a healthcare-investment deep dive in two weeks.Show Notes[00:00] Welcome to Telltales Mike opens the show and points listeners to this week’s Cash Flow Memo at telltales.us.[00:18] Disclaimer Standard disclosure.[00:31] Exhibits A, B, C — Oil, Hormuz, and the Federal Deficit Hunt walks through how Saudi Aramco, ADNOC, Iraq, and Kuwait are routing barrels around Hormuz via Red Sea ports, the Fujairah pipeline, and Syrian truck-and-pipe corridors. Why consensus $150 oil is wrong and Hunt’s $90 base case holds. Closes on interest expense and Medicare/Medicaid as the binding lines on Exhibit A.[06:52] More than Moats: Google Hunt frames Alphabet as the latest More than Moats target after Lilly, Nvidia, Goldman, and Microsoft. Mike and Jason work through the antitrust outcome (Chrome retained, web-index data opened to competitors), AI Overviews defending low-intent queries, and the real risk: agentic search and Exa’s $225M raise.[13:04] Google I/O and Gemini Spark Jason walks through I/O announcements including the new content-credentialing system and Gemini Spark, Google’s always-on personal agent running across Gmail, Calendar, and Drive. Why no entrant can replicate this without Google’s existing data perimeter.[15:34] The Advertising Moat Hunt frames Google + Meta + Amazon as a durable ad-network oligopoly. Why OpenAI’s billion-user advertising thesis is failing and the pivot back to Anthropic-style subscription revenue.[19:53] Healthcare: PBMs, Trump Rx, and Lilly DTC Jason walks through Bill Cassidy’s primary loss, Trump Rx’s relaunch on Cost Plus Drug and Amazon Fulfillment rails, CVS adding biosimilars, OptumRx moving to a transparent flat-fee PBM model, UnitedHealth dropping prior auth on 30% of minor procedures, and Eli Lilly’s working DTC channel.[23:50] Fixing the Premium Side Hunt asks how to bring the same rationalization to monthly health insurance premiums. Mike on diagnostic-monitoring opt-in plans with discounted premiums; Hunt on quarterly rebate structures that reward healthier behavior. Why emergency care is the structural hard problem.[29:33] Healthcare Investment Ideas — Two-Week Prep Hunt commits the team to identifying three or four entities running rational healthcare models that could be good investments. Surprise topic next Wednesday; healthcare deep dive in two weeks.[30:38] Sign-Off Stay healthy, back next Wednesday.Subscribe wherever you listen, and grab the Cash Flow Memo at telltales.us.Cashtags$GOOGL $AMZN $AAPL $MSFT $NVDA $META $CVS $LLY $UNH $GS This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

The Cashflow MemoEarnings Week Is a Split Screen — Nvidia, the Big-Box Gauntlet, and the Retail Read-AcrossThe AI trade and the tariff trade get tested on the same three days. By Friday, the market knows which side delivered.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 13 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode E2621.Chapter markers* Time | Segment* 0:00 | Opening disclaimer* 0:15 | Cold open & this week’s split screen* 0:45 | Theme — The Big-Box Gauntlet (HD, LOW, TGT, WMT)* 4:45 | Deep dive — Nvidia going into Q1 FY27* 8:45 | Rapid-fire — EQT, UnitedHealth, Microsoft* 11:45 | Close & Consensus Watch* 12:30 | Closing disclaimerFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. We’re still in the early run of the show — listener feedback is shaping what we do.Ava: This week is a split screen. Nvidia prints Wednesday after the close. The big-box retailers print Tuesday through Thursday — Home Depot, Lowe’s, Target, Walmart. The AI trade and the tariff trade get tested on the same three days. By Friday, the market knows which side delivered.Ava: On Wednesday’s main show, Hunt, Jason, and Mike walked through Meta as the most profitable AI application ever built — the answer to whether AI capex actually compounds back into the income statement[^ep-e2620]. This week the test moves to the picks-and-shovels side. Nvidia. And the read-across to whether the tariff regime is showing up at the cash register.Theme — The Big-Box GauntletAva: On page 8 of the memo this week — Home Depot Tuesday morning[^earn-hd], Lowe’s and Target Wednesday before the open[^earn-low][^earn-tgt], Walmart Thursday[^earn-wmt]. Four big-box prints, three days, one customer.Ava: The customer is the same — middle America, mortgage-burdened, tariff-exposed. The wound isn’t.Ava: Home Depot is the only one of the four where the stock has already done the work. 25% off the 52-week high going into the print[^hd-performance-20260513]. Reports Tuesday at 9:00 AM ET, $3.42 consensus on $41.6B[^hd-earnings-20260505]. Truist cut its price target from $424 to $394 three days ago[^hd-truist-20260512]. And management already told everyone they will source no more than 10% of products from any single foreign country — that’s the tariff hedge, on the record, before the print[^hd-tariffs-20260512].Ava: Lowe’s is the rare print where two top-tier analysts disagree on the same number. Reports Wednesday before the open. $2.96 EPS on $23B[^earn-low]. Citi upgraded to Buy on May 12, $285 target — they cited four straight quarters of positive comps[^low-citi-upgrade-20260512]. BofA downgraded to Neutral on May 5, $260 target — they cited housing turnover at multi-decade lows[^low-bofa-downgrade-20260505]. Same company. Same week. Two completely different setups.Ava: Target is the only one of the four printing into a customer base that left. Reports Wednesday before the open — same morning as Lowe’s. Consensus $1.41 on $24.5B[^tgt-earnings-20260515]. Foot traffic at Target stores is down year-over-year for 25 of the last 27 weeks since the January DEI announcement[^tgt-dei-20260515]. The boycott officially ended in March — with no new diversity commitments. And Ulta Beauty is walking out of the partnership in August after five years[^tgt-ulta-20260515].Ava: Walmart is the only one of the four restructuring while expanding. New CEO John Furner cut 1,000 corporate roles this week[^wmt-restructuring-20260513]. Prints Thursday. $0.65 on $175B. The ad business is up 50% year-over-year and the U.S. e-commerce business posted its first profitable quarter globally[^wmt-ad-growth-20260323][^wmt-ecom-profit-20260215]. The memo can’t anchor Walmart — trailing-twelve free cash flow is negative because of capex[^memo-wmt-fcf-20260515]. Marcus stays off the name.Ava: Marcus, two of these are pricing differently than they look. The cashflow take.Marcus: Target is the wounded one in the gauntlet, and the memo isn’t pricing it as wounded yet. 24x trailing free cash flow on $3B of TTM FCF, 10-K confirmed[^memo-tgt-evfcf-20260515][^memo-tgt-fcf-20260515]. The market is pricing Target like the foot-traffic hole closes on its own — 25 of the last 27 weeks say it doesn’t[^tgt-dei-20260515]. The gross-margin guide Wednesday morning is what tells you which side is closer to right.Marcus: Home Depot is the cleanest test of the four. 24x trailing free cash flow on $16B of TTM FCF, 10-K confirmed[^memo-hd-evfcf-20260515][^memo-hd-fcf-20260515]. That’s not punitive for the share-leader of home improvement. The stock is 25% off the high — most of that move is housing turnover, not Home Depot losing share[^hd-performance-20260513]. The test Tuesday morning is whether the pro-contractor segment is actually offsetting DIY weakness[^hd-contractor-20260224], or whether management has been packaging hope as a thesis.Ava: Two prints, two questions. Whether the foot traffic comes back at Target. Whether the pro contractor is real at Home Depot. Lowe’s settles a disagreement between two analysts. And Walmart has to convince anyone watching that cutting jobs is part of the growth story, not in spite of it.Deep dive — NvidiaAva: Nvidia. Wednesday after the close. This is the most consequential print of the year.Ava: Consensus is $1.74 EPS on $78B in revenue, plus or minus 2%[^nvda-fy27-guidance-202605][^nvda-earnings-consensus-202605][^earn-nvda]. Blackwell B200 and GB200 are sold out through mid-2026 on a backlog described as, quote, insane — 3.6 million units[^nvda-blackwell-backlog-202605]. Hyperscaler capex for 2026 is guided at $725B, up 77% year over year[^nvda-hyperscaler-capex-202605]. Nvidia takes roughly 90% of the AI accelerator dollar inside that.Ava: Now the China complication. On March 5, Nvidia halted all H200 production for China — about 400,000 units of orders that don’t get filled, roughly $30B of walked-away revenue[^nvda-h200-halt-202605]. Then this week, Jensen Huang rode Air Force One to Beijing. For context — Trump brought 17 CEOs to China; only two got Air Force One seats. Musk and Huang[^nvda-huang-trump-202605]. Huang secured U.S. export approval for H200 sales to 10 Chinese firms — Alibaba, Tencent, ByteDance, JD.com — opening an estimated $50B annual market[^nvda-china-h200-202605]. And then Beijing told its tech companies to pause orders while the government decides on import approval[^nvda-china-h200-pause-202605].Ava: And one more. The Rubin platform was announced at CES — 5x Blackwell on inference, 3.5x Blackwell on training, 10x reduction in inference token cost[^nvda-rubin-202605][^nvda-rubin-economics-202605]. Production ramps the back half of this year. AWS, Google Cloud, Microsoft, and Oracle are first in line.Ava: Marcus, the cashflow take.Marcus: Nvidia going into Wednesday night is the only mega-cap in the AI stack where the multiple looks reasonable against the cash. 50x trailing free cash flow on $103B of TTM FCF, fiscal year 2026 10-K confirmed[^memo-nvda-evfcf-20260515][^memo-nvda-fcf-20260515]. Free cash flow grew about 80% year over year[^memo-nvda-fcfgrowth-20260515]. That’s the reasonable end of expensive in the AI stack — and reasonable means the math has to keep compounding. The test Wednesday isn’t the print. It’s whether the Q2 guide carries Rubin pricing.Ava: The China story — net positive or net negative for the next twelve months?Marcus: Net positive. And that’s the contrarian read. The H200 halt walked away from roughly $30B in China revenue, which everyone scored as a loss. But Nvidia carries a $95B supply commitment with TSMC[^nvda-tsmc-supply-202605]. That capacity doesn’t sit idle — it reallocates to Vera Rubin. So the trade is: walk away from H200 China at H200 margins, redirect TSMC capacity to the highest-priced product in the lineup. That’s the better margin trade. The export approval and the China pause net to noise — Nvidia keeps the option, the 10 Chinese firms stay in the queue. The downside case is the policy whiplash recurs and the option goes to zero. Probability-weighted, I take the trade.Ava: And what changes the read after Wednesday?Marcus: The demand side is set. Hyperscaler capex guided up 77% this year[^nvda-hyperscaler-capex-202605], Nvidia at the center of the dollar. The variable is Rubin pricing on the Q2 call. The new platform is 5x Blackwell on inference[^nvda-rubin-202605]. If management talks Rubin pricing on Wednesday, the multiple has room. If they don’t, this is as good as the cycle gets — and the next derate comes in the back half. The print is consensus minus surprise. The guide is the trade.Ava: So the question Wednesday night isn’t whether Nvidia beats. It’s whether Rubin shows up in the language.Rapid-fireAva: Three quick ones, a forward week sweep, and we’re out.Ava: EQT just printed the best quarter in its history. Q1 free cash flow of $1.8B exceeded the company’s full-year 2022 free cash flow[^eqt-fcf-20260513]. Net debt fell below $5.7B[^eqt-debt-20260513]. Fitch upgraded EQT to investment grade BBB and Citi upgraded to Buy on May 13[^eqt-earnings-20260513][^eqt-citi-20260513]. The company is openly marketing itself as the preferred power partner for Appalachian AI data centers through the 2030s[^eqt-datacenters-202604]. The memo has EQT at 14x trailing free cash flow at an 8% yield[^memo-eqt-evfcf-20260515][^memo-eqt-fcfyield-20260515]. Natural gas isn’t a commodity story this year. It’s an AI infrastructure story. EQT is the cleanest expression of it.Ava: UnitedHealth is the year’s biggest comeback so far. Stock hit a 52-week high of $404 on Tuesday. 47% off the March lows[^unh-stock-recovery-20260513]. Q1 EPS of $7.23 beat consensus by $0.47[^unh-q1-earnings-20260421]. The CFO committed $1.5B to AI this year and claimed 2:1 returns inside 12 months[^unh-ai-investment-20260512]. The memo has UnitedHealth at 5x trailing free cash flow at an 18.5% yield[^memo-unh-evfcf-20260515][^memo-unh-fcfyield-20260515]. That yield is what’s pricing the DOJ Medicare billing investigation that’s still open[^unh-doj-investigation-20260512]. The recovery is real. The shadow is also real.Ava: Microsoft just got a new bull. Bill Ackman’s Pershing Square disclosed a $2.1B position this week — accumulated since February — calling Microsoft, quote, a highly compelling valuation[^msft-ackman-disclosure-20260515]. The memo has Microsoft at 135x trailing free cash flow[^memo-msft-evfcf-20260515]. Marcus has been calling that not compelling. One of them is wrong — it’s a fair fight. The pressure point is free cash flow margin, which compressed from 29% to 19% year over year because of AI capex[^msft-fcf-margin-20260414]. Either Azure scales the dollar back into the margin, or Ackman is buying the most expensive software stock of the cycle.Ava: Forward week. Costco prints May 28[^earn-cost], Salesforce May 27[^earn-crm], Deere Thursday alongside Walmart[^earn-de]. We pick those up next Saturday.CloseAva: That’s the show. The split-screen week starts Tuesday morning. By the time Marcus and I are back next Saturday, the market will have decided which side delivered.Ava: Wall Street’s consensus on the week — Nvidia beats and retail misses. The risk is that one of those is fully in the tape.Ava: Hunt, Jason, and Mike are back Wednesday on episode 2621 with the Nvidia post-mortem, the retail read-across, and a deep dive on Google.Ava: Subscribe and download this week’s Cash Flow Memo at telltales.us. 86 companies across 20 pages. The same memo we anchor every beat on. See you next Saturday.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* Ad-Hoc News. (2026, May 13). EQT Corp stock (US26884L1098): Citi upgrades to Buy after strong Q1. https://www.ad-hoc-news.de/boerse/news/ueberblick/eqt-corp-stock-us26884l1098-citi-upgrades-to-buy-after-strong-q1/69322288* Alphastreet. (2026, May 15). Target Q1 2026 earnings preview — May 20, Street expects $1.41 EPS. https://news.alphastreet.com/target-q1-2026-earnings-preview-may-20-street-expects-1-41-eps/* CFO Dive. (2026, May 12). Home Depot warns of tariff impact, modest price hikes. https://www.cfodive.com/news/home-depot-warns-tariff-impact-modest-price-hikes/758202/* CNBC. (2026, May 13). HD: Home Depot Inc — stock price, quote and news. https://www.cnbc.com/quotes/HD* CNBC. (2026, May 13). Walmart cuts 1,000 roles to simplify operations, Reuters reports. https://www.cnbc.com/2026/05/13/walmart-cuts-1000-roles-to-simplify-operations-reports.html* CNBC. (2026, April 21). UnitedHealth Group reports Q1 2026 earnings. https://www.cnbc.com/2026/04/21/unitedhealth-group-unh-earnings-q1-2026.html* Financial Content Markets. (2026, May). Nvidia’s Blackwell dynasty: B200 and GB200 sold out through mid-2026 as backlog hits 3.6 million units. https://markets.financialcontent.com/wral/article/tokenring-2025-12-29-nvidias-blackwell-dynasty-b200-and-gb200-sold-out-through-mid-2026-as-backlog-hits-3-6-million-units* Fortune. (2026, May 15). Bill Ackman’s Pershing Square takes Microsoft stake on OpenAI, Azure spending. https://fortune.com/2026/05/15/bill-ackman-microsoft-stock-openai-azure-spending/* GuruFocus. (2026, May 13). UnitedHealth Group (UNH) hits new high as strong earnings propel stock surge. https://www.gurufocus.com/news/8856079/unitedhealth-group-unh-hits-new-high-as-strong-earnings-propel-stock-surge* Insider Monkey. (2026, May 12). Citi recommends buying Lowe’s (LOW) as a cyclical share gainer. https://www.insidermonkey.com/blog/citi-recommends-buying-lowes-low-as-a-cyclical-share-gainer-1760400/* Investing.com. (2026, May 13). Earnings call transcript: EQT Corporation Q1 2026 delivers strong results, stock rises. https://www.investing.com/news/transcripts/earnings-call-transcript-eqt-corporation-q1-2026-delivers-strong-results-stock-rises-93CH-4629992* Marcellus Drilling News. (2026, April). EQT targets AI data center power demand in Southwest PA. https://marcellusdrilling.com/2026/04/eqt-targets-ai-data-center-power-demand-in-southwest-pa/* MarketScreener. (2026, May 12). Bank of America Securities 2026 Global Healthcare Conference — UnitedHealth presentation. https://www.marketscreener.com/news/bank-of-america-securities-2026-global-healthcare-conference-a-presentation-05-12-2026-00-00-00-ce7f5bdfda88f525* Medical Economics. (2026, May 12). UnitedHealth Group under DOJ investigation over Medicare billing practices. https://www.medicaleconomics.com/view/unitedhealth-group-under-doj-investigation-over-medicare-billing-practices* Morningstar. (2026, May). Ahead of earnings, is Nvidia stock a Buy, a Sell, or Fairly Valued?. https://www.morningstar.com/stocks/ahead-earnings-is-nvidia-stock-buy-sell-or-fairly-valued-3* NVIDIA Newsroom. (2026, May 14). NVIDIA launches next-generation Rubin AI compute platform at CES 2026 [Press release]. https://nvidianews.nvidia.com/news/rubin-platform-ai-supercomputer* NVIDIA Newsroom. (2026, May). NVIDIA unveils Rubin CPX: A new class of GPU designed for massive-context inference [Press release]. https://nvidianews.nvidia.com/news/nvidia-unveils-rubin-cpx-a-new-class-of-gpu-designed-for-massive-context-inference* Quartz. (2026, May). China reportedly moves to pause Nvidia H200 orders. https://qz.com/nvidia-china-h200-chip-sales-us-trump-policy* 24/7 Wall St. (2026, May 5). Lowe’s just got yanked from the BofA Buy List: Is the home improvement trade stalling?. https://247wallst.com/investing/2026/05/05/lowes-just-got-yanked-from-the-bofa-buy-list-is-the-home-improvement-trade-stalling/* 24/7 Wall St. (2026, May 14). Did Nvidia CEO Jensen Huang just unlock the $50 billion China market?. https://247wallst.com/investing/2026/05/14/did-nvidia-ceo-jensen-huang-just-unlock-the-50-billion-china-market/* 24/7 Wall St. (2026, May 14). Trump brought 17 CEOs to China. Only two got seats on Air Force One: Elon Musk and Jensen Huang. https://247wallst.com/investing/2026/05/14/trump-brought-17-ceos-to-china-only-two-got-seats-on-air-force-one-elon-musk-and-jensen-huang/* The Home Depot Investor Relations. (2026, May 5). The Home Depot to host first quarter earnings conference call on May 19 [Press release]. https://ir.homedepot.com/news-releases/2026/05-05-2026-130040601* TipRanks. (2026, May). Nvidia stock forecast 2026 — what top financial analysts expect ahead of Q1 earnings. https://www.tipranks.com/news/nvidia-stock-hits-all-time-highs-ahead-of-q1-earnings-what-top-financial-analysts-expect-from-here* Tom’s Hardware. (2026, May 14). Google, Microsoft, Meta, and Amazon capex spending to hit $725 billion in 2026, up 77% from last year. https://www.tomshardware.com/tech-industry/big-tech/big-techs-ai-spending-plans-reach-725-billion* Trading Key. (2026, May 13). HD: Home Depot Inc stock moved down by 3.20% on May 13 — key drivers unveiled. https://www.tradingkey.com/news/market-movers/261890878-market-movers-hd-20260513* U.S. News & World Report. (2026, February 24). Home Depot’s contractor bet pays off in soft US housing market. https://money.usnews.com/investing/news/articles/2026-02-24/home-improvement-retailer-home-depot-edges-past-quarterly-sales-estimates* Ulta Beauty Investor Relations. (2026, May 15). Ulta Beauty and Target announce plans to conclude partnership in 2026 [Press release]. https://www.ulta.com/investor/news-events/press-releases/detail/209/ulta-beauty-and-target-announce-plans-to-conclude* Walmart Corporate. (2026, March 23). Walmart and VIZIO scale content to commerce at NewFronts. https://corporate.walmart.com/news/2026/03/23/walmart-and-vizio-scale-content-to-commerce-at-newfronts* Walmart Corporate. (2026, February 19). Walmart releases Q4 FY26 earnings [Press release]. https://corporate.walmart.com/news/2026/02/19/walmart-releases-q4-fy26-earnings* What The Chip Happened. (2026, May). The $600+ billion demand wall: Why Nvidia remains the most mispriced mega-cap in tech. https://news.whatthechippened.com/p/the-600-billion-demand-wall-why-nvidia* Yahoo Finance. (2026, May 9). Microsoft free cash flow margin compression signals AI spending pressure. https://finance.yahoo.com/quote/MSFT/news/* Yahoo Finance. (2026, May 13). EQT (EQT) releases financial and operational results for Q1 2026. https://finance.yahoo.com/markets/stocks/articles/eqt-eqt-releases-financial-operational-113332756.html* Yahoo Finance. (2026, May 13). EQT Corp Q1 2026 earnings call highlights: Record cash flow and strategic growth plans. https://finance.yahoo.com/sectors/energy/articles/eqt-corp-eqt-q1-2026-070435529.html* Yahoo Finance. (2026, May 15). DEI boycott played a role in Target’s Q1 sales slump as foot traffic declined. https://finance.yahoo.com/news/dei-boycott-played-a-role-in-targets-q1-sales-slump-as-foot-traffic-declined-183135827.htmlInternal dataInternal data is provided on a best efforts basis.Forward earnings dates (FMP)* HD — 2026-05-19 (9:00 AM ET). Consensus EPS $3.42, revenue $41.61B. Source: FMP /stable/earnings?symbol=HD.* LOW — 2026-05-20 BMO. Consensus EPS $2.96, revenue $22.98B. Source: FMP /stable/earnings?symbol=LOW.* TGT — 2026-05-20 BMO. Consensus EPS $1.41, revenue $24.66B. Source: FMP /stable/earnings?symbol=TGT.* NVDA — 2026-05-20 AMC. Consensus EPS $1.76, revenue $78.42B. Source: FMP /stable/earnings?symbol=NVDA.* WMT — 2026-05-21. Consensus EPS $0.65, revenue $174.72B. Source: FMP /stable/earnings?symbol=WMT.* DE — 2026-05-21. Consensus EPS $5.70, revenue $11.55B. Source: FMP /stable/earnings?symbol=DE.* CRM — 2026-05-27. Consensus EPS $3.12, revenue $11.05B. Source: FMP /stable/earnings?symbol=CRM.* COST — 2026-05-28. Consensus EPS $4.91, revenue $69.58B. Source: FMP /stable/earnings?symbol=COST.All dates pulled 2026-05-15 from the FMP earnings calendar; see earnings_slate.md. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

This week on Telltales: Hunt, Jason, and Mike pressure-test Meta’s position as an AI cash machine, walk through the Iran-driven oil setup, and unpack the FDA shake-up and a second consecutive Harrow miss.The Cashflow MemoKey Takeaways* Meta is the most profitable AI application ever built: revenue doubled from ~$110B in 2021 to a $220B run rate today, with current growth still ~30% YoY on a $200B base — AI rebuilt the attribution layer Apple’s ATT broke in 2021.* Meta’s capex bet is uniquely uncomfortable: on the last call management told analysts they have no idea what ROIC will be on AI infrastructure spend because, unlike Amazon, Microsoft, Google, and Oracle, Meta isn’t renting the servers — it’s defensive spend against what Zuckerberg called an existential paradigm shift.* Oil setup remains manageable despite the Iran standoff and Strait of Hormuz closure: near-month crude is in the $90s, full-year 2026 futures price in at ~$79, 2027 at ~$73, against a ~2M bbl/day inventory draw absorbable by ~1B bbls of US crude inventory plus China’s reserve.* Trump administration’s $1.5T defense ask for fiscal 2027 won’t fully land, but the equipment refresh is happening — bigger concern is US public debt >100% of GNP with no clear capital-markets trigger date, only inevitability.* Harrow/Vevye second consecutive miss: CVS formulary win pulled high-deductible Q1 patients into the $59 Access-for-All program, forcing rebate outflows of $200–$300 per patient back to the PBM — thesis intact but a 5-year payout, not 2–3 years.Show Notes[00:18] Iran Standoff & Crude Inventory Math Hunt frames the Strait of Hormuz closure and the inventory math: a 2M bbl/day draw is absorbable against ~1B bbls of US crude inventory plus China’s reserve.[04:00] Oil Futures Curve & Gasoline Politics Near-month crude in the $90s, 2026 futures price in at ~$79, 2027 at ~$73 — manageable prices, with a path to ~$3.50 gasoline rather than $4.50.[05:36] Defense Budget & US Deficit Trump’s $1.5T fiscal 2027 ask won’t fully land, but the equipment refresh is happening. The real concern is public debt >100% of GNP and an uncertain capital-markets trigger.[07:12] Meta Deep Dive: The Attention Machine Why Meta is unlike other Mag-7 stories — Facebook and Instagram as discovery-to-purchase advertising machines, not search-intent platforms.[13:04] Meta as the Most Profitable AI Application Ever Built ML in ad ranking since 2007, PyTorch’s origin story, and why Meta has been quietly compounding AI dollars longer than any of the LLM darlings.[16:56] Apple ATT, Revenue Doubling, and the CapEx Question The 2021–2022 flat-revenue year that forced Meta to rebuild attribution with AI — and the open question of ROIC on today’s infrastructure spend.[23:29] News: Amazon Supply Chain Services, OpenAI Ads, Nvidia, Tesla, TSMC Amazon stands up a UPS/FedEx competitor, OpenAI launches a self-service ad platform aimed at Google, Nvidia’s earnings cadence, and Musk’s Terra Fab ambitions.[25:49] FDA Shake-Up: Makary Out, Real-Time Reviews In Marty Makary resigns under pressure after the Replimune denial — but the real story is two new real-time review studies with Amgen and AstraZeneca that could compress drug-approval timelines.[30:26] Harrow Earnings: The PBM Rebate Trap on CVS Formulary Second consecutive miss. Winning CVS formulary placement pulled high-deductible patients into the $59 Access-for-All program, forcing rebate outflows that wiped out Q1 economics. Thesis intact, payout extended.Subscribe and get the Cash Flow Memo at telltales.us — financials on ~80 companies plus the oil, natural gas, and US deficit exhibits referenced in every episode.Cashtags$META $AAPL $AMZN $GOOGL $MSFT $ORCL $NVDA $TSLA $TSM $CVS $LLY $REPL $AMGN $AZN This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

The Cashflow MemoAI Is Finally Paying. The Question This Week Was How The Suppliers Got Paid.Micron’s 2026 memory is sold out, with customers writing prepayment checks for chips that don’t exist. AMD’s Q1 data center revenue was up 57% — but the strength was EPYC CPUs, not the OpenAI GPU deal, which contributed zero dollars to the quarter. Palantir printed an 85% revenue quarter at a Rule of 40 score of 145. And Disney’s first full quarter under D’Amaro printed streaming income up 88%.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 13 minutes. No filler.Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2620.Chapter markers* Time | Segment* 0:00 | Opening disclaimer* 0:15 | Cold open — throughline + E2619 callback + Mother’s Day* 1:30 | Theme — How the suppliers got paid (MU vs AMD compare/contrast)* 5:30 | Deep dive — Palantir* 9:30 | Rapid-fire — CRCL / DIS / UBER / ABNB + forward-week earnings* 13:00 | Close — Consensus Watch + Wednesday tease* 13:30 | Closing disclaimerFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham — the cashflow desk.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack.Ava: And before we get into it, happy Mother’s Day to all the moms in the audience. Thank you for spending part of today with us.Ava: Here’s the throughline for this week. AI is finally paying — but the unit economics of how suppliers capture that demand vary wildly. On Wednesday’s show, Hunt, Jason, and Mike walked the hyperscaler stack from the bottom up — Hunt made the case that Amazon’s networking edge may matter more than Nvidia’s chips[^ep-e2619]. That was the architecture conversation. Today is the unit-economics conversation, supplier side. Micron printed the cleanest version. Customers writing prepayment checks for memory that doesn’t exist yet[^news-mu-hbm-booked-20260507] — pricing power so strong it’s hitting cash this quarter. AMD printed the messier version. Data center revenue up 57%[^news-amd-datacenter-20260505], but the strength was in EPYC server CPUs and existing Instinct GPU shipments[^news-amd-10q-q1-20260505], not the OpenAI deal everyone is anchoring on. That deal — signed last October[^news-amd-openai-20251006], OpenAI got warrants for up to 10% of AMD[^news-amd-openai-warrant-20251006] — contributed zero dollars to Q1[^news-amd-10q-q1-20260505]. Shipments don’t start until the second half of this year[^news-amd-openai-20251006]. The CPU side of AMD’s print connects back to Intel two weeks ago — same demand signal, different name on the box[^news-intc-q1-20260423][^news-intc-cpu-ai-20260423]. That’s the show.Theme — How the suppliers got paidAva: Two supplier prints this week, both validating AI demand, very different evidence about pricing power. Micron is charging customers in advance. AMD’s strength came from CPUs, not GPUs — same story Intel told the market two weeks ago[^news-intc-q1-20260423].Ava: Page 8 — Micron. Micron’s 2026 high-bandwidth memory is fully booked, with customers signing multi-year prepayment agreements for supply that doesn’t exist yet[^news-mu-hbm-booked-20260507]. CEO Sanjay Mehrotra said Micron can only meet between 50 and 67% of demand from key customers[^news-mu-demand-constrained-20260507]. The four largest spenders on AI — Meta, Microsoft, Amazon, and Apple — all publicly cited memory cost and availability constraints. Stock hit an all-time high of $683 on May 7[^news-mu-ath-20260507]. Mizuho took the price target from $545 to $740[^news-mu-mizuho-20260509]. And Micron raised fiscal 2026 capex to $25B from $20B, a 25% step up[^news-mu-capex-raise-20260507].Ava: And AMD. After the close on May 5 — Q1 revenue $10.3B, data center revenue up 57% to $5.8B[^news-amd-q1-20260505][^news-amd-datacenter-20260505], Q2 guidance $11.2B[^news-amd-q2-guidance-20260505], stock up 16% the next day[^news-amd-stock-20260505]. Important read on that data center number. The growth came from EPYC server CPUs and the existing Instinct GPU ramp[^news-amd-10q-q1-20260505], not from the OpenAI deal. Per the 10-Q, the OpenAI warrants haven’t vested[^news-amd-10q-q1-20260505]. Shipments don’t start until the second half of this year[^news-amd-openai-20251006]. The deal contributed zero dollars to Q1[^news-amd-10q-q1-20260505]. Which connects directly to Intel two weeks ago. Intel printed Q1 revenue up 7% YoY to $13.6B[^news-intc-q1-20260423], with management telling the Street that the CPU-to-GPU ratio in AI deployments is shifting from 1:8 toward 1:4, and trending toward parity as multi-agent workloads scale[^news-intc-cpu-ai-20260423]. That’s the read across both prints. AI demand isn’t just GPUs. Hyperscalers are buying head-node CPUs alongside their accelerator clusters. CPU demand is having a renaissance after two flat years, and AMD just confirmed what Intel told the market. Marcus, the cashflow take.Marcus: The Q1 print is good news about the business AMD already has — EPYC share, current Instinct shipments — not about the business AMD bought with equity last October. The OpenAI warrant is a future customer-acquisition cost that doesn’t hit the P&L until the second half of this year[^news-amd-openai-20251006]. When it does, it shows up in two places. As data center revenue ramping into 2027. And as up to 160 million shares of dilution if MI450 hits its deployment milestones[^news-amd-openai-warrant-20251006]. The memo had AMD at 167× trailing free cash flow on $4.4B of TTM FCF[^memo-amd-evfcf-20260328][^memo-amd-fcf-20260328] — that multiple is being defended by the forward book, not by what just printed. Q1 didn’t move the actual question. The actual question is whether the OpenAI relationship — paid for in October at a penny a share — produces enough revenue to justify the dilution. We don’t get a read on that until late 2026 at the earliest.Marcus: The compare to Micron sharpens the point. Both names trade at multiples that need a story. Micron at 209× free cash flow has the leverage of a structural shortage[^memo-mu-evfcf-20260226][^memo-mu-fcf-20260226] — they’re charging in advance because they can, and the cash is hitting the bank this quarter. AMD at 167× paid customers in equity last October to lock in revenue that hasn’t started yet, while the current quarter prints fine on CPU demand and legacy GPU shipments. Both stocks are pricing forward stories. Only one of those stories has cash hitting the bank right now.Ava: Two suppliers, two prints. Same end-market. Pick your fighter.Deep dive — PalantirAva: Page 17 — Palantir. The cleanest AI is actually paying print of the cycle so far. After the close on May 4. Q1 revenue $1.63B, up 85% year-over-year — the fastest growth rate since the company went public in 2020[^news-pltr-q1-20260504]. Beat consensus by $90M. U.S. revenue alone hit $1.28B, up 104% — the first time U.S. growth has crossed 100%[^news-pltr-us-growth-20260504]. U.S. commercial revenue up 133%. Net income quadrupled to $870M, EPS $0.34[^news-pltr-netincome-20260504]. Adjusted free cash flow $925M on a 57% margin[^news-pltr-fcf-20260504]. Rule of 40 score: 145[^news-pltr-rule40-20260504]. Quick aside for readers who don’t follow software — Rule of 40 is the standard efficiency benchmark in SaaS. You add a company’s revenue growth and its profit margin. 40 is the bar for a healthy software company. Palantir is at 145. Roughly four times the bar. Back to the print — full-year guidance raised from $7.2B to $7.65B[^news-pltr-fy-guidance-20260504]. Marcus, the cashflow take.Marcus: Palantir is the proof point that the rest of enterprise software has been promising and not delivering. The memo has Palantir at 160× trailing free cash flow on $1.9B of TTM FCF[^memo-pltr-evfcf-20260331][^memo-pltr-fcf-20260331]. We re-anchor when the Q1 10-Q files. The number that actually matters from this print is the U.S. commercial line — that’s a customer set that didn’t exist 18 months ago paying real money for AI deployment, not pilots.Ava: 160× free cash flow. Rule of 40 at 145.Marcus: 160× is not defensible on a static comp. It’s defensible only if you believe the U.S. commercial growth rate doesn’t normalize for another four to six quarters. So weight the outcomes. Bull case at 30% — government and commercial both compound from here. Base case at 50% — commercial decelerates and the multiple compresses by half on a stock that still works. Bear case at 20% — the multiple does what 160× multiples always do.Ava: So the question is whether the customer set that just appeared keeps appearing.Marcus: That’s the entire question. Argus upgraded to Buy on May 7, Citi took the target to $225[^news-pltr-argus-20260507][^news-pltr-citi-20260507]. The Street is pricing the bull. Watch the Q2 print for whether U.S. commercial holds north of 100% year-over-year, or steps down to 70. 70 is still a great number. It is also a different multiple.Ava: 145 Rule of 40. That number alone is the whole story.Rapid-fireAva: Five to close out — one pre-print catalyst, three prints already on the tape, and the forward week.Ava: First — Circle. Reports Monday morning[^earn-crcl]. Wall Street consensus $717M revenue, $0.18 EPS[^news-crcl-q1-20260510]. The setup matters more than the number. The CLARITY Act compromise cleared Congress, banning passive deposit-style yield on stablecoins while explicitly preserving rewards tied to user activity. The stock jumped 20% on May 4[^news-crcl-clarity-20260504]. USDC circulation hit $78B[^news-crcl-usdc-20260506]. Visa is rolling out USDC settlement to U.S. banks including Cross River and Lead, and signed on as lead design partner for Circle’s Arc blockchain[^news-crcl-visa-20260510]. Mastercard expanded USDC settlement across Eastern Europe, Middle East, and Africa[^news-crcl-mastercard-20260510]. Wall Street’s consensus on Circle: a crypto play with regulatory tail risk. After this week, that’s not what Circle is anymore. Stablecoins just became payments infrastructure. Watch the reserve income line on Monday.Ava: Second — Disney. D’Amaro’s first full quarter as CEO and the integration thesis printed. Reported Tuesday, May 6[^news-dis-earnings-20260506]. Q2 fiscal 2026 revenue $25.2B, up 7% year-over-year, beat consensus. Streaming income up 88% to $582M[^news-dis-streaming-20260506]. Parks operating income at a fiscal Q2 record of $2.6B despite domestic attendance down 1% — per-capita spending up 5%[^news-dis-parks-20260506]. ESPN direct-to-consumer launched at $29.99 a month for Unlimited[^news-dis-espn-20260506]. And Disney raised the fiscal 2026 buyback from $7B to at least $8B[^news-dis-buyback-20260506]. Memo had Disney at 21× trailing free cash flow on $10.5B of TTM FCF, a 5.6% yield[^memo-dis-evfcf-20260328][^memo-dis-fcf-20260328]. Streaming is a profit line now, not a loss line.Ava: Third — Uber. Reported May 6[^news-uber-q1-20260506]. Q1 EPS $0.72, beating consensus of $0.70. Revenue $13.2B, slight miss. The numbers that mattered weren’t in the headline — Uber One membership crossed 50 million, and members now drive 50% of gross bookings across Mobility and Delivery[^news-uber-one-20260506]. Adjusted EBITDA grew 33% year-over-year to $2.5B[^news-uber-ebitda-20260506]. CEO Khosrowshahi said Uber will reach Waymo services in 15 cities by year-end, with autonomous mobility trips growing more than tenfold year-over-year[^news-uber-av-20260506]. Buyback authorization raised by $20B, last-12-months free cash flow at an all-time high of $8.5B[^news-uber-buyback-20260506]. The Cash Flow Memo had Uber at 11× trailing free cash flow on $13B of TTM FCF — the cheapest AI-distribution play in the universe[^memo-uber-evfcf-20260331][^memo-uber-fcf-20260331]. The autonomous threat became the autonomous distribution contract.Ava: Fourth — Airbnb. Reported May 7[^news-abnb-earnings-20260507]. Q1 revenue $2.68B, beat. EPS $0.26, missed by $0.03. Gross booking value up 19% year-over-year to $29B. Adjusted EBITDA up 24%. The numbers from the call that matter for the throughline — nearly 60% of Airbnb engineering code in Q1 was coauthored with AI, roughly double the industry average. Their AI customer support agent now resolves 40% of issues without human escalation, up from 33% earlier in the year[^news-abnb-chesky-ai-20260507]. CEO Brian Chesky said AI-enabled engineers can now do work that previously required teams of 20. Memo had Airbnb at 23× trailing free cash flow on $3.2B of TTM FCF[^memo-abnb-evfcf-20260331][^memo-abnb-fcf-20260331]. Summer Release lands May 20[^news-abnb-summer-release-20260520]. Chesky is running the most visible AI-native operations reorg in consumer tech.Ava: And fifth — the forward earnings sweep next week. Venture Global reports Tuesday[^earn-vg]. Home Depot Tuesday[^earn-hd]. Walmart, Target, Lowe’s, Deere, and — the one to watch — Nvidia, all in 72 hours Tuesday through Thursday[^earn-wmt][^earn-tgt][^earn-low][^earn-de][^earn-nvda]. We’ll cover Nvidia properly next Saturday — the weekend before the print, with the options-implied move and the H200 China question front and center.CloseAva: That’s the show. Wall Street’s consensus this week: AMD is the cheap Nvidia alternative, Micron is priced for perfection, and Palantir is hype. Zero out of three. AMD paid OpenAI 10% of itself last October to lock in a customer that contributed zero dollars to Q1 — the cash flow from that bet doesn’t start for another two quarters. The Q1 strength was CPU demand, same story Intel told the market two weeks ago. Micron getting prepayments for chips that don’t exist is not perfection — it’s a structural shortage. And Palantir’s Rule of 40 at 145 is not hype — it’s the cleanest cash conversion of any software name in the cycle.Ava: Hunt, Jason, and Mike are back Wednesday on episode 2620. Download the memo at telltales.us. Happy Mother’s Day. We’ll see you next Saturday.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* AMD. (2025, October 6). AMD and OpenAI announce strategic partnership to deploy 6 gigawatts of AMD GPUs [Press release]. Advanced Micro Devices, Inc. https://ir.amd.com/news-events/press-releases/detail/1260/amd-and-openai-announce-strategic-partnership-to-deploy-6-gigawatts-of-amd-gpus* AMD. (2026, May 5). AMD reports first quarter 2026 financial results [Press release]. Advanced Micro Devices, Inc. https://ir.amd.com/news-events/press-releases/detail/1284/amd-reports-first-quarter-2026-financial-results2a. AMD. (2026, May 5). Form 10-Q for the quarterly period ended March 28, 2026 [SEC filing]. Advanced Micro Devices, Inc. https://ir.amd.com/sec-filings2b. Intel Corporation. (2026, April 23). Intel reports first-quarter 2026 financial results [Press release]. Intel Investor Relations. https://www.intc.com/news-events/press-releases/detail/1767/intel-reports-first-quarter-2026-financial-results* Airbnb. (2026, May 7). Airbnb announces first quarter 2026 results [Press release]. PR Newswire. https://www.prnewswire.com/news-releases/airbnb-announces-first-quarter-2026-results-302759162.html* CFO Dive. (2026, May 6). Uber CFO: Stock undervalued; $20B buyback authorization announced. CFO Dive. https://www.cfodive.com/news/uber-cfo-stock-undervalued-buyback-program-driverlessvehicles-ridesharing/736583/* CNBC. (2026, May 4). Circle jumps nearly 20% on CLARITY Act compromise that preserves stablecoin rewards. CNBC. https://www.cnbc.com/2026/05/04/circle-jumps-16percent-on-clarity-act-compromise-that-preserves-stablecoin-rewards.html* CNBC. (2026, May 4). Palantir (PLTR) Q1 earnings report 2026. CNBC. https://www.cnbc.com/2026/05/04/palantir-pltr-q1-earnings-report-2026.html* CNBC. (2026, May 6). Disney (DIS) Q2 2026 earnings. CNBC. https://www.cnbc.com/2026/05/06/disney-dis-earnings-q2-2026.html* CNBC. (2026, May 6). Uber (UBER) Q1 2026 earnings — Uber One reaches 50M members; Khosrowshahi targets Waymo in 15 cities. CNBC. https://www.cnbc.com/2026/05/06/uber-uber-2026-q1-earnings.html* CoinDesk. (2026, May 10). Visa brings USDC settlement to U.S. banks after $3.5 billion stablecoin pilot. CoinDesk. https://www.coindesk.com/business/2025/12/16/visa-brings-circle-s-usdc-settlement-to-u-s-banks-following-usd3-5-billion-stablecoin-pilot* DigiTimes. (2026, May 7). Micron hikes FY26 capex above $25B from $20B. DigiTimes. https://www.digitimes.com/news/a20251218VL201/micron-2026-fab-capex-expansion.html* Deadline. (2026, May 6). Josh D’Amaro says Disney+ will be the centerpiece of an immersive, interactive digital future. Deadline. https://deadline.com/2026/05/josh-damaro-disney-plus-centerpiece-digital-future-1236882741/* Fortune. (2026, May 7). Airbnb CEO Brian Chesky on AI-coauthored code (60%) and AI support resolving 40% of issues. Fortune. https://fortune.com/2026/05/07/airbnb-ceo-brian-chesky-two-people-wont-survive-ai-era-pure-people-managers-workers-resist-change/* Fox Business. (2026, May 6). Disney unveils new direct-to-consumer ESPN streaming service with $29.99 price tag. Fox Business. https://www.foxbusiness.com/media/disney-unveils-new-direct-consumer-espn-streaming-service-price-tag* Investing.com. (2026, May 4). Palantir Q1 2026 slides: U.S. revenue tops 100% growth, Rule of 40 hits 145. Investing.com. https://www.investing.com/news/company-news/palantir-q1-2026-slides-us-revenue-tops-100-growth-rule-of-40-hits-145-93CH-4657648* Investing.com. (2026, May 6). Uber Q1 2026 slides: profitability surges 44% amid revenue headwinds. Investing.com. https://www.investing.com/news/company-news/uber-q1-2026-slides-profitability-surges-44-amid-revenue-headwinds-93CH-4663758* Mastercard. (2026, May 10). Mastercard expands partnership with Circle. Mastercard. https://www.mastercard.com/global/en/news-and-trends/stories/2026/circle_kash_razzaghi.html* Mizuho Securities. (2026, May 9). Micron Technology price target raise from $545 to $740 [Analyst note]. Cited in multiple outlets.* MooMoo. (2026, May 6). Circle (CRCL) Q1 2026 earnings preview: Can the stablecoin giant sustain its growth momentum. MooMoo. https://www.moomoo.com/community/feed/circle-crcl-q1-2026-earnings-preview-can-the-stablecoin-giant-sustain-its-growth-momentum-116526937407494* Rental Scale-Up. (2026, May 10). Airbnb May 20 2026 Summer Release: What to expect, and why this update matters more than ever. Rental Scale-Up by PriceLabs. https://www.rentalscaleup.com/airbnb-may-20-2026-summer-release-what-to-expect-and-why-this-update-matters-more-than-ever/* Seeking Alpha. (2026, May 7). HBM sold out for 2026: Wall Street is still underpricing. Seeking Alpha. https://seekingalpha.com/article/4881338-micron-technology-hbm-sold-out-for-2026-wall-street-is-still-underpricing* Seeking Alpha. (2026, May 10). Circle Internet Group earnings dates & report. Seeking Alpha. https://seekingalpha.com/symbol/CRCL/earnings* The Ad-Hoc News / Bloomberg. (2026, May 7). The memory giant that can’t make chips fast enough. Ad-Hoc News. https://www.ad-hoc-news.de/boerse/news/ueberblick/the-memory-giant-that-can-t-make-chips-fast-enough/69278905* The Main Street Mouse. (2026, May 6). Disney beats expectations as streaming and U.S. parks drive strong Q2 results. The Main Street Mouse. https://www.themainstreetmouse.com/2026/05/06/disney-beats-expectations-as-streaming-and-u-s-parks-drive-strong-q2-results/* The Motley Fool. (2026, May 4). Palantir stock investors just got incredible news. The Motley Fool. https://www.fool.com/investing/2026/05/04/palantir-stock-investors-just-got-incredible-news/* The Motley Fool. (2026, May 9). Why is AMD stock soaring? The Motley Fool. https://www.fool.com/investing/2026/05/09/why-is-amd-stock-soaring/* TheWrap. (2026, May 6). Disney revenue climbs 7% to $25.2 billion in Q2, boosted by streaming, theme parks. TheWrap. https://www.thewrap.com/industry-news/business/disney-earnings-q2-2026/* Variety. (2026, May 6). Disney Q2 2026 revenue rises 7% in earnings beat, streaming income up 88% to $582 million. Variety. https://variety.com/2026/tv/news/disney-q2-2026-earnings-josh-damaro-streaming-income-1236738974/* Uber Investor Relations. (2026, May 6). Uber announces results for first quarter 2026 [Press release]. https://investor.uber.com/news-events/news/press-release-details/2026/Uber-Announces-Results-for-First-Quarter-2026/default.aspx* ARTVOICE. (2026, May 8). MU stock price just hit an all-time high and here’s the reason why. ARTVOICE. https://artvoice.com/2026/05/08/mu-stock-price-just-hit-an-all-time-high-and-heres-the-reason-why/* Argus Research. (2026, May 7). Palantir Technologies upgrade to Buy with $190 price target [Analyst note].* Citi Research. (2026, May 7). Palantir Technologies price target raised to $225 from $210 [Analyst note].Internal dataInternal data is provided on a best efforts basis.Forward earnings calendar (FMP)Forward earnings dates pulled from FMP /stable/earnings, source 2026-05-10. See 04. Publishing/shows/weekend-update/W2619/dryrun/earnings_slate.md for the full week.* CRCL — 2026-05-11* VG — 2026-05-12* HD — 2026-05-19* LOW — 2026-05-20* NVDA — 2026-05-20* TGT — 2026-05-20* DE — 2026-05-21* WMT — 2026-05-21 This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

This week we walk through the post-Hormuz oil setup, the Intel stake math, and a layer-by-layer review of the hyperscalers — Amazon, Microsoft, Google, Oracle, and Meta — as they navigate the AI buildout.The Cashflow MemoKey Takeaways* Iran ceasefire path holds — Project Freedom (defended Hormuz corridor) is suspended in favor of a one-page 14-point memo brokered via Pakistan; Hunt models ’26 oil at ~$80 and ’27 at ~$72-73, with the $25B war cost absorbable inside the existing $900B defense budget.* Intel stake now worth ~$56B against a $9B cost basis — Mike argues the administration should sell to fund war spending; UAE exiting OPEC+ adds another structural shift but limited ’27 price impact.* Hyperscaler stack defined as five layers (infrastructure → platform → model → harness → application); Amazon leads on platform breadth and faces fewer internal-vs-customer capacity conflicts than Microsoft or Google because AWS scale dwarfs internal compute needs.* Networking has become the strategic differentiator — post-Mellanox, Nvidia prioritizes customers buying bundled compute and networking, which de-prioritized Amazon and forced Trainium; Anthropic running on Trainium signals inference workloads splitting from Nvidia-dominated training.* Meta got beat up unfairly on CapEx ROIC questions — the same AI infrastructure that rebuilt ad attribution post-Apple ATT is what analysts criticize; Zuckerberg pushed back that ROIC isn’t the right lens for application-layer businesses where you build user experience first and monetize later.Show Notes[00:00] Cold Open & Disclaimer Mike opens the show. Standard disclaimer.[00:26] Iran, Hormuz, and Project Freedom Hunt’s six minutes on Iran. Project Freedom (defended-corridor through the strait) is suspended for a one-page memo brokered via Pakistan. Modeling ’26 oil at ~$80 and ’27 at ~$72-73.[06:56] The $56 Billion Intel Stake The Trump administration’s 10% Intel position bought for $9B is now worth ~$56B. Mike’s view: sell it. Plus JP Morgan’s bearish 50s oil call and UAE leaving OPEC+.[09:27] Hyperscaling: Who’s In and How They Got Here Setting up the hyperscaler review. Hunt on Amazon’s accidental cloud head start and the AWS vs. Azure share question.[11:45] The Five Layers of the Stack Mike defines the stack: infrastructure → platform → model → harness → application. Where CoreWeave fits, where Bedrock fits, why platform-as-a-service is the moat.[16:06] Amazon, Trainium, and the Nvidia Networking Story Why Amazon was slow on Nvidia, what changed after Mellanox, and how Anthropic running on Trainium signals the training-vs-inference split.[18:26] Google and Microsoft’s Capacity Conflict Both face the same problem: allocate compute to customers or to internal AI products. Google opening up TPUs. Microsoft’s Copilot and GitHub agent-driven usage explosion.[21:52] Meta’s Already-Built AI Infrastructure Meta rebuilt ad attribution after Apple’s ATT changes by pouring CapEx into AI infra — the spending analysts now punish them for is what powers the ad-business growth.[23:10] Earnings Calls and the ROIC Debate Every analyst question this earnings season was about return on invested capital. Zuckerberg’s pushback: that’s not how application-layer businesses are built.[24:45] The Five-Year CapEx Amortization Question Hunt presses on whether $700M-per-build economics actually pencil with five-year chip obsolescence. Jason on AI displacing labor, Mike on Rentahuman.ai.[27:28] Healthcare Cost Disruption Off-patent generics, GP-as-AI-agent, Amazon One Medical, and the Obamacare 15% profit cap that incentivizes insurers to grow costs.[32:09] Closing & Next Week Next episode: Meta and its digital advertising competitors, plus more on flatlining federal healthcare spending.Subscribe and download this week’s Cash Flow Memo at telltales.us.Cashtags$AMZN $MSFT $GOOG $GOOGL $META $NVDA $ORCL $CRWV $INTC $AAPL $JPM This post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

The Cashflow MemoApple, Meta, Microsoft, Alphabet, and Amazon all printed in 48 hours. Same capex cycle, three different cloud margin stories — and Apple and Meta both quietly repositioned the balance sheet.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 13 minutes. No filler.Download the memo at telltales.us. Mike, Jason, and Hunt are back Wednesday on episode 2619.Chapter markers* Time | Segment* 0:00 | Opening disclaimer* 0:15 | Cold open* 0:45 | Theme — capital cycle resets (AAPL, META)* 4:45 | Deep dive — hyperscaler cloud face-off (AMZN, MSFT, GOOGL)* 8:45 | Rapid-fire (OXY, DIS, PLTR, CVS, MCD)* 11:45 | Close* 12:30 | Closing disclaimerFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham, the analyst on the show. Every beat you hear from me is anchored in a number from the Cash Flow Memo. If the multiple doesn’t make sense against the cash the company actually generates, I’ll say so.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. We’re still in the pilot window, so feedback is welcome through the Substack at telltales.us.Ava: This was the heaviest hyperscaler print week of the year. Microsoft, Alphabet, and Amazon all reported within a 36-hour window. Apple printed Thursday after the close. Meta printed Wednesday. Roughly $9 trillion of market cap reset its capex framing in the same 48 hours. On Wednesday’s episode 2618, Mike, Jason, and Hunt walked through the big-retail valuation convergence and Hunt’s revised oil thesis, and they teed up a dedicated hyperscaler episode for this week.[^ep-e2618] We did the work for them. The theme first.Theme — capital cycle resetsAva: Two prints this week did something the headline numbers don’t capture. Apple and Meta sit on opposite ends of the universe — different businesses, different buyers, different growth profiles. Both used this print to reposition the balance sheet for an AI capex cycle bigger than what’s been committed to publicly. That’s the theme.Ava: Apple, page 1 of the memo, after the close Thursday. Q2 revenue ~$111B, up 17% YoY, beating consensus.[^news-aapl-q2-print-20260430] Gross margin 49.3% — an all-time record.[^news-aapl-margin-record-20260430] iPhone up 22%. Greater China up 28% on top of December’s 38%.[^news-aapl-china-beat-20260430] Apple authorized an additional $100B in buybacks and raised the dividend 4%.[^news-aapl-buyback-dividend-20260501] Incoming CEO John Ternus made his first public appearance on the call, taking the chair September 1.[^news-aapl-ternus-debut-20260430] But three structural changes hit at once. Apple guided June gross margin to 47.5–48.5% — the first explicit step-down in 8 quarters.[^news-aapl-guidance-strong-20260501] CFO Parekh said Apple is no longer providing net cash neutral as a formal target.[^news-aapl-cash-framework-20260430] And the buyback was halved during the transition window — 93M shares in Q1 to 42M in Q2.[^news-aapl-buyback-halved-20260430] Marcus, the cashflow read.Marcus: Going into this print, the memo had Apple at 37x trailing free cash flow at a 2.6% yield, on ~$106B of trailing free cash flow.[^memo-aapl-priorqtr-20260424] Buyback over that window, ~$92B.[^memo-aapl-buyback-priorqtr-20260424] Those are Q1 10-Q confirmed; we re-anchor when the Q2 10-Q files later this month. The operating print is the best in Apple’s history — that’s not the question. The capital structure read is what matters here. Net cash went from $54B to $62B despite $15B of returns this quarter. The most plausible read on retiring the net-cash-neutral framework is Apple is creating room to issue debt against an AI capex step-up without an offsetting drawdown obligation. Halving the buyback during the transition window gives Ternus operating room to redirect capital differently than Cook. The 37x multiple is being asked to hold at peak gross margin right before a confirmed step-down. The memory cost language has now escalated three calls running — minimal, then a bit more, now significantly higher in June with an increasing impact beyond June. Action: hold; do not add at this price.Ava: Meta, page 1. Q1 revenue ~$56B, up 33% YoY, beating consensus.[^news-meta-q1-earnings-20260429] Meta raised 2026 capex guidance to $125–145B, $10B higher at both ends of the range.[^news-meta-capex-raise-20260429] JPMorgan downgraded the stock to neutral from overweight; the stock fell about 9% after-hours.[^news-meta-jpmorgan-downgrade-20260430] Mark Zuckerberg announced 8,000 layoffs effective immediately, citing AI infrastructure costs.[^news-meta-layoffs-20260501] Marcus.Marcus: Meta is mid-AI-capex cycle. Capex was running ~$70B trailing twelve going into this print, and the company just guided this year up to $125–145B.[^memo-meta-capex-priorqtr-20260424] When you spend that much faster than you generate operating cash, free cash flow goes negative — that’s the cost of the build, not a flag. So the multiple isn’t the right frame on this name. What actually prices Meta right now is the revenue acceleration. Price-per-ad doubled growth rate Q-over-Q from +6% to +12% — single most important number on the print.[^news-meta-price-per-ad-20260429] The bigger number behind the capex raise is what Susan flagged separately on the call — Meta booked $107B of new contractual commitments in this quarter alone. A single-quarter increment larger than Meta’s entire 2026 capex range.[^news-meta-contractual-commitments-20260429] Off-balance-sheet commitment is now the figure to track. Same pattern as Apple — the headline is operating, the actionable is capital structure.Deep dive — hyperscaler cloud face-offAva: All three hyperscalers reported within 36 hours. All three guided capex up. All three said AI demand exceeds supply. The margin print is wildly different — and the divergence tells you where each cloud sits on the AI maturity curve.Ava: Amazon, page 1. AWS revenue ~$38B, up 28% YoY — the fastest AWS growth in 15 quarters.[^news-amzn-aws-q1-20260429] Total Q1 revenue beat at ~$182B against consensus of ~$177B.[^news-amzn-q1-earnings-20260429] AWS operating margin stepped from 35.0% in Q4 to 37.8% in Q1 — +280bp sequentially, on $14B of segment operating income.[^news-amzn-aws-margin-20260429] Custom silicon run rate $20B; Trainium-specific revenue commitments now $225B, the first ever disclosure.[^news-amzn-trainium-20260429] Andy Jassy said selling Trainium racks externally is a good chance over the next couple of years.[^news-amzn-trainium-20260429] Q2 revenue guide $194–199B, well above estimates.[^news-amzn-q2-guidance-20260429] Marcus.Marcus: AWS is the cleanest single-number story of the week. The +280bp sequential step-up in segment margin lands directly inside Andy Jassy’s several hundred basis points claim from the shareholder letter. Management did not attribute the lift explicitly to Trainium — leaving headroom on later calls. Going into the print, the memo had Amazon at ~63x trailing free cash flow at a ~1.5% yield, on ~$43B of trailing free cash flow. That’s Q4 10-K confirmed.[^memo-amzn-priorqtr-20260424] The Q1 print just absorbed even more operating cash into capex — Amazon’s free cash flow collapsed ~95% on a TTM basis.[^news-amzn-fcf-20260429] So the consolidated multiple is even less informative; we re-anchor when the Q1 10-Q files. The anchor is the segment margin, not the consolidated multiple. Action: the obvious sub-$200 entry window has closed; hold or add modestly into the Q2 print, where the test is whether 37.8% holds or compounds.Ava: Microsoft, page 1. Q3 revenue ~$83B, up 18% YoY. Azure growth +40% cc.[^news-msft-q3-earnings-20260429] Microsoft guided 2026 capital spending to $190B, well above Wall Street estimates.[^news-msft-capex-190b-20260429] Microsoft 365 Copilot crossed 20M paid enterprise users — up 250% YoY, with Accenture taking 740K seats in the largest-ever single deal.[^news-msft-copilot-20m-users-20260430] And the OpenAI partnership was restructured. The exclusive Azure arrangement ended; OpenAI can now deploy on competing clouds. Microsoft retains royalty-free IP through 2032 and a capped revenue share through 2030.[^news-msft-openai-nonexclusive-20260427][^news-msft-openai-revised-terms-20260427] Stock fell ~6% post-earnings.[^news-msft-stock-decline-earnings-20260430] Marcus.Marcus: Going into this print, the memo had Microsoft at ~97x trailing free cash flow at a 1% yield, on ~$32B of trailing-twelve free cash flow. That’s Q2 10-Q confirmed.[^memo-msft-priorqtr-20260424] Q3 pushes the multiple higher and the yield lower — peak multiple on peak narrative. We re-anchor when the Q3 10-Q files. The Copilot inflection at 20M seats with Outlook-level usage intensity is the single most important data point on the print. The buried quality concern — all-in commercial bookings −6% cc, +7% ex-OpenAI.[^news-msft-bookings-20260429] Mostly comp lap and OpenAI restructure timing, not core enterprise weakness, but the kind of number that would headline a different stock. The OpenAI restructure is the swap of exclusivity premium for predictability — Microsoft now collects a capped annuity through 2030 off a counterparty that just recapped. Lower upside, higher floor. Action: hold; do not add unless Maia and Cobalt margin compounds faster than guided.Ava: Alphabet, page 1. Q1 revenue ~$110B, up 22% YoY.[^news-googl-q1-earnings-20260429] Google Cloud revenue $20B, up 63% — the first time crossing the $20B threshold and the strongest cloud growth rate since the unit began breaking out revenue in 2020.[^news-googl-cloud-acceleration-20260429] Cloud backlog nearly doubled QoQ to $460B.[^news-googl-cloud-backlog-20260429] Sundar Pichai said cloud revenue would have been higher if Google had been able to meet the demand.[^news-googl-cloud-supply-20260429] Capex guidance raised to $180–190B, with FY27 flagged for further increases.[^news-googl-capex-raise-20260429] And for the first time, Alphabet disclosed it is selling TPU chips off-cloud to capital markets firms and frontier AI labs.[^news-googl-tpu-sales-20260429] Marcus.Marcus: Going into this print, the memo already had Alphabet’s multiple unusable as a clean anchor — ~365x trailing free cash flow at a ~0.25% yield, on $11B of trailing free cash flow against $91B of capex. Q4 10-K confirmed.[^memo-googl-priorqtr-20260424] The print this week makes the multiple even less informative. The lever is the cloud op margin print — ~33% in Q1 vs ~18% a year ago. Roughly +1,500bp of YoY cloud margin expansion, even with Wiz dragging the segment.[^news-googl-cloud-margin-20260429] The AI revenue is low margin thesis dies here. Mix shift to GenAI products with SaaS economics is what bear modelers said couldn’t happen at this stage of the cycle. GenAI-built product revenue +800% YoY against +400% in Q4 — the second derivative is going positive.[^news-googl-genai-revenue-20260429] Selling TPU off-cloud is a structural pivot. Alphabet is now willing to sell training compute to OpenAI-class competitors. Action: thesis got materially stronger. This is the underappreciated print of the three.Ava: One frame on the three. Same TAM. Same capex envelope going up. Three different margin stories. Marcus, the editorial line.Marcus: AWS resolved Mike’s pre-print test on Trainium — segment margin stepped up exactly where Jassy said it would. The bull case got the data point it was watching for. Microsoft thesis improved at the platform layer, but the bookings number is the buried quality concern. Alphabet is the most underappreciated of the three because the AI-margin bear thesis just died on a +1,500bp cloud margin expansion. Three completely different reads inside 36 hours of the same end-market.Rapid-fireAva: Five forward-week catalysts to close.Ava: Occidental Petroleum, OXY, page 9, reports Tuesday with the call Wednesday morning.[^earn-oxy] CEO succession announced this week — Vicki Hollub retires June 1 after a decade running the company; Richard Jackson takes the chair, an insider since 2003 with a background in Permian operations and cost efficiency.[^news-oxy-ceo-succession-20260501] OxyChem sale to Berkshire Hathaway closed January at ~$10B and funded ~$6B in principal debt reduction toward the $15B target.[^news-oxy-oxychem-sale-20260102] Stock up 37% YTD through April 25.[^news-oxy-analyst-targets-20260426] On the memo, OXY runs a slightly negative free cash flow yield on ~−$700M of TTM free cash flow.[^memo-oxy-fcfyield-20260502] The print needs to validate the WTI-above-$100 backdrop Hunt walked through on Wednesday’s show or expose hedge positioning into the run.Ava: Disney, DIS, page 4, reports before the open Tuesday.[^earn-dis] New CEO Josh D’Amaro made two strategic decisions this week. ESPN stays — no spin-off; ESPN gets deepened into the streaming ecosystem.[^news-dis-espn-20260428] And D’Amaro is exploring a paid membership tier internally called Disney Prime, modeled on Amazon Prime, combining parks, streaming, cruise, and merchandise into a single super-app.[^news-dis-superapp-20260501][^news-dis-prime-20260502] On the memo, Disney is page 4 at 19x free cash flow at ~6% yield — the cleanest media valuation in the universe.[^memo-dis-evfcf-20260502] The print question is whether super-app and ESPN integration give Disney a new monetization surface, or just organizational complexity.Ava: Palantir, PLTR, page 20, reports Monday after the close.[^earn-pltr] Options market is pricing ~10.5% move on the print.[^news-pltr-options-20260501] Wall Street expects revenue ~$1.5B, up 74% YoY, with consensus EPS $0.28 — about 115% earnings growth.[^news-pltr-q1-forecast-20260501] Palantir signed a $300M USDA contract for farmland management and is one of three finalists for a ~$32B FAA air traffic control modernization contract.[^news-pltr-usda-20260422][^news-pltr-faa-contract-20260425] On the memo, Palantir is at ~240x trailing free cash flow at well below 1% yield.[^memo-pltr-evfcf-20260502] The question every print: can the government contract pipeline grow fast enough to justify the multiple, or is every beat already priced in.Ava: CVS Health, CVS, page 19, reports before the open Wednesday.[^earn-cvs] CEO transition — David Joyner replaces Karen Lynch, effective this week.[^news-cvs-ceo-joyner-20260427] Aetna will exit the ACA individual exchange marketplace effective 2026, leaving roughly 1M members without coverage.[^news-cvs-aca-exit-20260501] Medicare Advantage rate increases provide an offset; CVS reiterated full-year guidance, and the stock closed up ~4% April 28.[^news-cvs-earnings-guidance-20260428] On the memo, CVS sits at 3x free cash flow at ~53% yield — by some distance the most extreme yield in the universe.[^memo-cvs-evfcf-20260502] The Lynch exit and ACA retreat are the execution flags against that multiple.Ava: McDonald’s, MCD, page 16, reports Thursday before the open.[^earn-mcd] The simultaneous catalyst is Tuesday’s nationwide rollout of six specialty drinks — boba refreshers, a Dirty Dr Pepper — with 14,000 new beverage specialist roles and dedicated drink-counter spaces.[^news-mcd-drinks-launch-20260428] McDonald’s is targeting the $100B global beverage category at higher margins than standard sodas.[^news-mcd-beverages-margins-20260428] On the memo, MCD trades at 38x free cash flow at ~3% yield.[^memo-mcd-evfcf-20260502] The cautionary tale is CosMc’s — McDonald’s closed eight pilot locations in spring 2025 after drinks proved too complex for standard restaurant operations.[^news-mcd-cosmcs-closure-20260428] The question on the print is whether the in-store rollout is that mistake at scale, or whether a simpler execution model changes the answer.CloseAva: That’s the show. The hyperscaler week resolved Mike, Jason, and Hunt’s pre-print test on AWS margin and broke the AI-margin bear thesis at Alphabet. Microsoft’s print is the one with the buried quality concern. Apple and Meta both used this week to reset capital structure for a capex cycle bigger than what’s been committed to publicly. Next week is a forward-print sweep — Diamondback, Palantir, and Vertex on Monday; Occidental and TransDigm on Tuesday; Disney and CVS Wednesday; McDonald’s and Targa Thursday. Mike, Jason, and Hunt are back Wednesday on episode 2619. Download the Cash Flow Memo at telltales.us. I’m Ava Cabot. See you next Saturday.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* AJMC. (2026, May 1). Aetna members with ACA plans will need new coverage in 2026; CVS to exit ACA marketplace. AJMC. https://www.ajmc.com/view/aetna-members-with-aca-plans-will-need-new-coverage-in-2026-cvs-to-exit-aca-marketplace* AP News. (2026, April 28). McDonald’s bets on boba refreshers and a dirty Dr Pepper to drive its next growth. AP News. https://apnews.com/article/mcdonalds-taco-bell-kfc-drinks-beverages-coffee-334a949beb01c8e9c270094fb64420ed* Bloomberg. (2026, April 29). Amazon’s free cash flow sinks 95% as AI capex soars. Bloomberg. https://www.bloomberg.com/news/articles/2026-04-29/amazon-reports-biggest-cloud-sales-jump-since-2022-on-ai-demand* Business Insider. (2026, April 28). Disney has decided to hang onto ESPN. Business Insider. https://www.businessinsider.com/espn-disney-spin-sell-decision-josh-damaro-2026-4* Business Insider. (2026, April 29). Amazon Q1 2026 earnings report — AWS, AI, capex. Business Insider. https://www.businessinsider.com/amazon-q1-earnings-amzn-stock-price-aws-ai-capex-2026-4* CNBC. (2026, April 22). Palantir inks $300 million deal with USDA to safeguard food supply. CNBC. https://www.cnbc.com/2026/04/22/palantir-inks-300-million-deal-with-usda-to-safeguard-food-supply.html* CNBC. (2026, April 29). Alphabet (GOOGL) Q1 2026 earnings. CNBC. https://www.cnbc.com/2026/04/29/alphabet-googl-q1-2026-earnings.html* CNBC. (2026, April 29). Amazon Q1 2026 earnings report. CNBC. https://www.cnbc.com/2026/04/29/amazon-amzn-q1-earnings-report-2026.html* CNBC. (2026, April 29). Meta Q1 2026 earnings report. CNBC. https://www.cnbc.com/2026/04/29/meta-q1-earnings-report-2026.html* CNBC. (2026, April 29). Microsoft Q3 FY2026 earnings report — capex $190B. CNBC. https://www.cnbc.com/2026/04/29/microsoft-msft-q3-earnings-report-2026.html* CNBC. (2026, April 30). Apple (AAPL) Q2 2026 earnings report. CNBC. https://www.cnbc.com/2026/04/30/apple-aapl-q2-2026-earnings-report.html* CNBC. (2026, May 1). Apple stock rallies on Q2 earnings and Q3 guidance. CNBC. https://www.cnbc.com/2026/05/01/apple-stock-rallies-on-q2-earnings-and-q3-guidance.html* CNBC. (2026, May 1). Occidental names veteran Richard Jackson as CEO; Vicki Hollub to retire. CNBC. https://www.cnbc.com/2026/05/01/occidental-names-veteran-richard-jackson-as-ceo-vicki-hollub-to-retire.html* CoinCentral. (2026, April 25). Palantir (PLTR) stock climbs on new government contracts and analyst confidence. CoinCentral. https://coincentral.com/palantir-pltr-stock-climbs-on-new-government-contracts-and-analyst-confidence/* eTeknix. (2026, April 30). Microsoft passes 20 million paid Copilot users and says usage is now similar to Outlook. eTeknix. https://eteknix.com/microsoft-passes-20-million-paid-copilot-users-and-says-usage-is-now-similar-to-outlook* Forbes. (2026, April 27). OpenAI and Microsoft end exclusive partnership and revenue sharing. Forbes. https://www.forbes.com/sites/aliciapark/2026/04/27/openai-and-microsoft-end-exclusive-partnership-and-revenue-sharing/* Inside the Magic. (2026, May 2). The Disney Prime revolution: CEO Josh D’Amaro’s bold plan to put the magic behind a new monthly fee. Inside the Magic. https://insidethemagic.net/2026/05/disney-ceo-josh-damaro-considering-creating-disney-super-app-that-combines-all-platforms-with-paid-subscription-rl1* Investing.com. (2026, April 30). Apple stock gains after remarkable margin guidance — Apple tops quarterly estimates, approves additional $100 billion buyback. Investing.com. https://www.investing.com/news/earnings/apple-tops-quarterly-estimates-approves-additional-100-billion-buyback-4651105* Laughing Place. (2026, May 1). One Disney, one app: Executives reportedly discussing single Super App in Disney+. Laughing Place. https://laughingplace.com/disney-business/disney-super-app* MarketBeat. (2026, April 30). Alphabet’s earnings didn’t just beat — they changed the story. MarketBeat. https://www.marketbeat.com/originals/alphabets-earnings-didnt-just-beatthey-changed-the-story/* Managed Healthcare Executive. (2026, April 27). Karen Lynch steps down as CEO of CVS Health. Managed Healthcare Executive. https://www.managedhealthcareexecutive.com/view/karen-lynch-steps-down-as-ceo-of-cvs-health* Primary Ignition. (2026, April 26). Oxy share price surges 37% — Why Wall Street suddenly cares again. Primary Ignition. https://primaryignition.com/2026/04/26/oxy-share-price-surges-37-why-wall-street-suddenly-cares-again/* Quiver Quantitative. (2026, April 28). CVS rises as investors focus on earnings outlook and Medicare Advantage tailwinds. Quiver Quantitative. https://www.quiverquant.com/news/CVS+rises+as+investors+focus+on+earnings+outlook+and+Medicare+Advantage+tailwinds* Reuters. (2026, April 27). Microsoft, OpenAI change terms of deal so startup can court Amazon and others. Reuters. https://www.reuters.com/legal/litigation/microsoft-end-exclusive-license-openais-technology-2026-04-27/* Reuters. (2026, April 29). Alphabet revenue tops expectations on record quarter for cloud unit. Reuters. https://www.reuters.com/business/alphabets-cloud-unit-beats-quarterly-revenue-estimates-strong-ai-demand-2026-04-29/* Reuters. (2026, April 30). Apple shares rise as iPhone 17 and MacBook Neo drive forecast. Reuters. https://www.reuters.com/business/apple-sales-beat-expectations-powered-by-mac-iphone-hits-supply-constraints-2026-04-30/* Stockmktnewz [@stockmktnewz]. (2026, April 30). JPMorgan downgrades Meta to Neutral, lowers PT from $825 to $725 [Post]. Threads. https://www.threads.com/@stockmktnewz/post/DXwdecOCXPG/jp-morgan-today-downgraded-meta-platforms-meta-to-neutral-down-from-overweight* TIKR. (2026, April). Occidental completes sale of OxyChem. TIKR. https://www.tikr.com/blog/occidental-petroleum-stock-has-pulled-back-10-from-its-2026-high* TipRanks. (2026, May 1). Palantir Q1 earnings on May 4. Options market braces for a 10.55% swing. TipRanks. https://www.tipranks.com/news/palantir-pltr-q1-earnings-on-may-4-options-market-braces-for-a-10-55-swing* TipRanks. (2026, May 1). Palantir (PLTR) Q1 earnings on May 4. Wall Street analysts eye 115% earnings jump. TipRanks. https://www.tipranks.com/news/palantir-pltr-will-report-q1-earnings-on-may-4-wall-street-analysts-eye-115-earnings-jump* Tom’s Hardware. (2026, May 1). Mark Zuckerberg says Meta is cutting 8,000 jobs to pay for AI infrastructure. Tom’s Hardware. https://www.tomshardware.com/tech-industry/big-tech/mark-zuckerberg-says-meta-is-cutting-8000-jobs-to-pay-for-ai-infrastructure* 24/7 Wall St. (2026, April 30). Opinion: Microsoft probably should have rallied after those solid earnings. 24/7 Wall St. https://247wallst.com/investing/2026/04/30/opinion-microsoft-probably-should-have-rallied-after-those-solid-earnings/* 9to5Mac. (2026, April 30). John Ternus joins Apple’s Q2 2026 earnings call, touts incredible roadmap ahead. 9to5Mac. https://9to5mac.com/2026/04/30/john-ternus-joins-apples-q2-2026-earnings-call-touts-incredible-roadmap-ahead/* Yahoo Finance. (2026, April 29). Microsoft Q3 2026 earnings beat on cloud and AI growth. Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/microsoft-q3-2026-earnings-beat-205308206.html* Yahoo Finance. (2026, April 30). Meta stock sinks after Q1 earnings as company raises 2026 AI spending forecast to $125 billion–$145 billion. Yahoo Finance. https://finance.yahoo.com/sectors/technology/article/meta-stock-sinks-after-q1-earnings-as-company-raises-2026-ai-spending-forecast-to-125-billion-145-billion-160136308.htmlInternal dataInternal data is provided on a best efforts basis.Forward earnings (FMP)Source: FMP /stable/earnings?symbol=X, pulled 2026-05-02. See [[Weekend Update Dryruns/W2618/earnings_slate]].* OXY — 2026-05-05, conference call 2026-05-06. Consensus EPS $0.62, revenue $5.42B.* DIS — 2026-05-06 BMO. Consensus EPS $1.49, revenue $24.84B.* PLTR — 2026-05-04 AMC. Consensus EPS $0.29, revenue $1.54B.* CVS — 2026-05-06 BMO. Consensus EPS $2.21, revenue $94.97B.* MCD — 2026-05-07 BMO. Consensus EPS $2.75, revenue $6.47B. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Mike, Hunt, and Jason work through a revised oil thesis, the converging big-retail battle between Amazon, Walmart, and Costco, a hyperscaler preview, and the most-favored-nations finish line in pharma.The Cashflow MemoKey Takeaways* Hunt revised his oil thesis: the Strait of Hormuz impasse with Iran now looks structural after the US rejected Iran’s offer of a 5-year enrichment pause, pushing near-month oil from a ~$90 anchor toward a $110–$120 range with downstream pressure on natural gas as Permian associated gas keeps Waha hub pricing in negative territory.* Big retail is converging on the same customer: Walmart’s PE ran from low-20s to mid-40s, Costco trades at 47x with a $440B market cap and no debt, and Amazon’s 12-month PE has fallen below Walmart’s for the first time despite running zero-margin retail monetized through advertising and a logistics network now larger than UPS.* The hosts singled out Costco as the most challenged of the three on valuation alone — 47x for a retailer with an unclear growth runway leaves no margin of safety, while Amazon retail looks structurally underpriced if AWS is roughly two-thirds of the $2.8T EV (implying ~$1.2T for everything else, vs. Walmart’s $1T enterprise value).* Defense tech is the next disruption beat: $30,000 drones have effectively kept US destroyers offshore in the Gulf, F-35-style cost-plus contracting is broken, and Palantir-style product-first defense companies (Palantir was added this week to the Netflix page in the memo) are the model — Hunt is hunting for a drone-company addition next.* Healthcare update: the White House finalized Most Favored Nations contracts with all 17 top pharma companies (Regeneron last), Lilly is on an acquisition spree, and Teva bought a biotech with no approved drugs in market — Jason stays constructive on generics manufacturers as the structural winners of the looming patent-cliff wave.Show Notes[00:00:18] Disclaimer Standard informational disclaimer.[00:00:27] Exhibit C: Oil and the Hormuz Impasse Hunt walks through a meaningful change in his oil supply/demand view — the US-Iran embargo now looks structural after Iran’s enrichment offer was rejected. Near-month oil targets shift toward $110–$120.[00:05:38] Exhibit B: Gas and the Permian Problem Stronger oil pulls more associated gas out of the Permian, pushing Waha hub pricing into negative territory and supporting a bearish gas outlook into 2027.[00:09:00] Exhibit A: Federal Cashflow and Defense Spending Healthcare cost flattening, Doge aftereffects, and why the real defense fight is about efficiency, not topline.[00:11:58] Defense Tech Disruption Jason and Mike on Palantir’s product-first model, the F-35 lesson, and why the prime-contractor lobby is the main obstacle to better procurement.[00:14:14] New Memo Additions: Palantir and Micron Hunt adds Palantir to the Netflix page and Micron to the telecom page in this weekend’s 4/27 draft.[00:15:35] Big Retail: Amazon vs Walmart vs Costco Walmart and Costco trade at mid-40s PE; Amazon’s PE has slipped below Walmart’s for the first time despite hidden value in retail and logistics.[00:23:04] Why Costco Looks Most Challenged At 47x with no obvious growth runway, Costco has the thinnest margin of safety of the three.[00:25:43] Hyperscaler Preview AWS is roughly 50% larger than Azure, implying AWS is ~two-thirds of Amazon’s EV and leaving the retail + logistics piece around $1.2T — vs. Walmart’s $1T.[00:28:33] OpenAI, SoftBank, Oracle WSJ flags OpenAI missing 2025 budget targets, with knock-on effects to SoftBank, Oracle, and AMD — Jason notes the spending plan hasn’t actually changed.[00:29:33] Pharma: Most Favored Nations Complete White House finalized MFN contracts with all 17 top pharma companies, Regeneron last. FDA is exploring real-time trial-data review.[00:31:03] M&A: Lilly Spree, Teva Strategy Shift Lilly keeps acquiring; Teva buys a biotech with no approved drugs — a possible drift away from generics at the worst time, given the patent-cliff tailwind ahead.[00:32:30] Coming Attractions Hyperscaler deep dive, Anthropic, a drone-company memo addition, and Circle on the Mastercard page.Get the Cashflow Memo at telltales.us and subscribe for new episodes every Wednesday.Cashtags$AMZN $WMT $COST $PLTR $MU $MSFT $GOOG $ORCL $AAPL $NVDA $LLY $REGN $TEVA $SPOT $TMUS $VZ $T $UPS $MA $AMDThis post and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

The Cashflow MemoQ1 prints divide — Intel’s best day since 1987, Charter’s worstTesla, ServiceNow, Apple, Intel, Charter, UnitedHealth, Kinder Morgan all printed. Five megacaps and Regeneron up next week.The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the 86 companies in the Cash Flow Memo. About 13 minutes. No filler.Download the memo at telltales.us. Mike, Jason, and Hunt are back Wednesday on episode 2618.Chapter markers* Time | Segment* 0:00 | Opening disclaimer* 0:15 | Cold open* 0:45 | Theme — Q1 prints divide (TSLA, NOW, AAPL)* 4:45 | Deep dive — INTC + CHTR* 8:45 | Rapid-fire (UNH, KMI, AMZN, MSFT)* 11:45 | Close* 12:30 | Closing disclaimerFull transcriptOpening disclaimerAva: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.Cold openAva: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.Marcus: And I’m Marcus Graham, the analyst on the show. Every beat you hear from me is anchored in a number from the Cash Flow Memo. If the multiple doesn’t make sense against the cash the company actually generates, I’ll say so.Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. We’re still in the pilot window, so feedback is welcome through the Substack at telltales.us.Ava: This was the heaviest single earnings week of the cycle for the Cash Flow Memo universe. Tesla, ServiceNow, Intel, Charter, UnitedHealth, and Kinder Morgan all reported. Apple, Amazon, Microsoft, Meta, Alphabet, and Regeneron all report next week. On Wednesday’s episode 2617, Mike, Jason, and Hunt opened on Tim Cook stepping down at Apple and pressed the question of whether a hardware-led AI bet was Apple’s edge or its Intel-style blind spot.[^ep-e2617] By Friday afternoon, the cautionary tale was out-printing the cautionary subject. Intel had its best single session since 1987. We get there. The theme first.Theme — Q1 prints divideAva: This was the first week the market told you what kind of Q1 print it was going to reward. The answer: very few of them. Three names on page 1 and page 2 of the memo printed this week. Two beat. One beat and got punished. All three are stories the market spent the week re-pricing.Ava: Tesla, page 1 of the memo, after the close Tuesday. Revenue $22.39B, a slight beat against consensus.[^news-tsla-q1-print-20260422] Q1 deliveries 358,023 units, missing consensus by about 7,600.[^news-tsla-q1-deliveries-20260422] Auto gross margin excluding credits 19.2%, the highest of any quarter in 2025.[^news-tsla-q1-margin-20260422] On the call, Musk pushed unsupervised consumer Full Self-Driving to Q4 of this year at the earliest[^news-tsla-fsd-delay-20260422] and announced full-year capex would rise to $25B from prior guidance of $20B.[^news-tsla-capex-20260422] Marcus, the cashflow read.Marcus: Tesla generated $1.4B of free cash flow in Q1, sequentially.[^news-tsla-capex-20260422] On the memo, the trailing-twelve-months free cash flow yield is still negative — -0.3%.[^memo-tsla-fcfyield-20260424] So the print resolves a little of the cash question and re-opens it at the same time. $25B of capex against an Optimus factory build and a Cybercab line that’s already started production[^news-tsla-optimus-20260422][^news-tsla-cybercab-production-20260423] is what $1.4B of quarterly cash buys you. And note the working-capital signal: Tesla maxed out a $5.8B Chinese bank facility this quarter while sitting on $44.7B of US cash on the balance sheet.[^news-tsla-china-debt-20260423] That’s a market-specific liquidity problem inside a balance sheet that does not need help in aggregate.Ava: ServiceNow, page 2 of the memo, after the close Tuesday. Subscription revenue $3.67B, up 22% YoY, beating guidance.[^news-now-q1-earnings-20260422] AI revenue guidance raised to $1.5B for 2026 from $1.0B. Customers spending more than $1M in Now Assist annual contract value grew 130% YoY.[^news-now-ai-traction-20260422] Stock dropped 18%. Middle East deal slippage, a 75 bps margin headwind from the Armis acquisition, and a guide reset that pushed normalized expansion out to 2027.[^news-now-earnings-selloff-20260422] Marcus, what does the memo say.Marcus: ServiceNow trades at 213x trailing free cash flow on the memo.[^memo-now-evfcf-20260424] At that multiple, a beat plus a guide raise on AI bookings is what’s expected. It’s not what gets you paid. What gets you paid at 213x is acceleration. The market saw deal slippage, margin compression, and a reset on the timing of the AI revenue conversion, and concluded the gap between bookings and revenue recognition is bigger than the multiple was pricing. Trailing-twelve free cash flow grew 55% YoY.[^memo-now-fcf-20260424] That’s still a beat. It’s just not a 213x beat.Ava: Apple, also page 1. Earnings April 30, consensus $1.92 on $109.35B in revenue.[^earn-aapl] But the news this week was the succession. Tim Cook steps down September 1. John Ternus, head of hardware engineering, takes the chair.[^news-aapl-cook-ternus-20260421] iPhone shipments in China up 20% YoY in Q1, strongest growth among major vendors against an overall market that was down 4%.[^news-aapl-china-iphone-20260417] India’s Competition Commission has set a final hearing for May 21 on a $38B antitrust case Apple is contesting.[^news-aapl-india-fine-20260420] Marcus, into the print, what does the memo carry.Marcus: Apple is on page 1 at 37x trailing free cash flow with a free cash flow yield of 2.6%.[^memo-aapl-evfcf-20260424] Trailing twelve months, Apple generated $105.6B of free cash flow, up about 18% from the prior trailing twelve.[^memo-aapl-fcf-20260424] Buyback was $91.8B over that same window.[^memo-aapl-buyback-20260424] That’s what Cook is handing Ternus. Whatever the AI strategy looks like under the new chair, the cash engine doesn’t need to be repaired. It needs to be redirected.Deep dive — Intel and CharterAva: Two earnings prints sat at opposite ends of the week. Both are deep dives because each one moved its stock more than 20% — one up, one down — and each one reset the conversation around the company.Ava: Intel, page 3 of the memo. Q1 revenue $13.6B against consensus of $12.6B, a $943M beat.[^news-intc-q1-beat-20260423] Non-GAAP earnings per share $0.29 against a $0.01 estimate.[^news-intc-eps-beat-20260424] Data Center and AI revenue up 22% YoY to $5.1B, and CEO Lip-Bu Tan called the demand for server CPUs huge on the call.[^news-intc-dcai-22pct-20260424] Q2 guide $13.8B–$14.8B, above consensus. EPS guide $0.20.[^news-intc-q2-guidance-20260423] The number behind the number — Intel announced Tuesday that Tesla had been signed as the first major customer for the 14A process node, for TeraFab AI chip production. Tan said on the call there was no better partner.[^news-intc-tesla-14a-20260422] On Friday, the stock closed up 24% at an all-time high above $82, the best single session since 1987.[^news-intc-stock-24pct-20260424] Marcus, the cashflow read.Marcus: This is where the memo asks a different question than the tape. Intel’s trailing-twelve free cash flow is -$16.2B and the free cash flow yield is -4.8%.[^memo-intc-fcf-20260424][^memo-intc-fcfyield-20260424] The memo can’t carry an EV/FCF multiple on Intel because the denominator is negative. The Q1 print does not change that. What the print changes is the slope. Revenue beat by $943M on a base where management has been guiding flat. The Q2 guide steps revenue up another 2-3% sequentially. 18A is hitting yield milestones, and 14A just landed Tesla.[^news-intc-18a-14a-20260424] If you believe the slope, the question is when free cash flow inflects positive. If you don’t, the multiple still doesn’t exist.Ava: One more piece of context. The US government’s 9.9% stake in Intel, acquired through CHIPS Act conversion for $8.9B, is now worth approximately $36B at Friday’s close.[^news-intc-govt-stake-20260424] Marcus, that math.Marcus: That’s a 4x return for Treasury inside roughly a year, which is the cleanest mark to date on the CHIPS Act capital structure. It doesn’t change Intel’s free cash flow. It does change the political price of letting the company run an aggressive foundry capex plan. Washington is now long the foundry build, marked to market.Ava: Charter Communications, page 5 of the memo, before the open Thursday. Earnings per share $9.17 against consensus of $10.01, an $0.84 miss.[^news-chtr-eps-miss-20260424] Stock fell 24%. The cleanest single-day decline in our universe this week. Inside the print: Spectrum Internet customers declined by 120,000 subscribers in Q1, against improvement in mobile and video.[^news-chtr-internet-loss-20260424] Capex guidance is the second beat. 2026 capex peaks at $11.4B before tracking down to under $8B by 2028.[^news-chtr-capex-guidance-20260424] And the Cox Communications acquisition, $34.5B and $800M in identified synergies, has cleared the FCC and DOJ but is still waiting on California CPUC approval.[^news-chtr-cox-status-20260424][^news-chtr-cox-synergies-20260424] Marcus, the memo number.Marcus: Charter trades at 69.7x free cash flow on the memo.[^memo-chtr-evfcf-20260424] Trailing twelve months Charter generated $1.8B of free cash flow.[^memo-chtr-fcf-20260424] The free cash flow yield looks attractive at 6%.[^memo-chtr-fcfyield-20260424] But debt to free cash flow is 53x.[^memo-chtr-debtfcf-20260424] That’s the number the multiple is pricing. At 53x debt to free cash flow, you do not have permission to lose broadband subscribers in your peak capex year while the merger you’re counting on for synergies is still sitting at one state regulator. The selloff is a re-pricing of the Cox close from a near-certainty into a timing risk.Ava: One forward question. Capex steps down by more than $3B between the 2026 peak and the 2028 run-rate. If the broadband line stops bleeding, the free cash flow profile changes meaningfully. Marcus, the read.Marcus: $3B of capex coming out is roughly equal to all of Charter’s current trailing free cash flow. So if the broadband line stabilizes and the Cox synergies actually print, you can re-rate this name in 2027. That’s the bull case. The bear case is the same one we just watched for 24%. Peak capex, broadband bleed, and a deal in regulatory limbo, all stacked.Rapid-fireAva: Four catalysts to close the show.Ava: UnitedHealth, UNH, page 19, Monday before open. Adjusted EPS $7.23 against consensus of $6.57, a $0.66 beat.[^news-unh-q1-earnings-20260421] Medical loss ratio improved to 83.9%, 90 bps better YoY and a clean beat against the 85.5% the Street was carrying.[^news-unh-mlr-20260421] Full-year guide raised to above $18.25 per share, and management called the medical cost trend acceleration peaked.[^news-unh-guidance-20260421] Separately, UnitedHealthcare announced it will eliminate most medical prior authorization requirements at 1,500 rural hospitals nationwide and accelerate payments to under 15 days.[^news-unh-rural-auth-20260420] On the memo, UNH trades at 3.7x free cash flow at a 26% free cash flow yield.[^memo-unh-evfcf-20260424][^memo-unh-fcfyield-20260424] The print is the inflection the cost-trend bears were asking for.Ava: Kinder Morgan, KMI, page 10, after the close Tuesday. EPS $0.48 against consensus $0.38, a 23% surprise.[^news-kmi-q1-eps-20260422] Adjusted EBITDA up 18% YoY to $2.54B.[^news-kmi-ebitda-growth-20260422] Moody’s upgraded Kinder Morgan to Baa1, putting all three rating agencies at BBB+ or equivalent.[^news-kmi-moodys-upgrade-20260422] Management projects US natural gas demand at 150 Bcf per day by 2031, a 27% step up from current levels.[^news-kmi-gas-demand-forecast-20260422] On the memo, 30x free cash flow at a 4.5% free cash flow yield.[^memo-kmi-evfcf-20260424][^memo-kmi-fcfyield-20260424] The midstream tape this week was the cleanest read on data center power demand in any sector, and KMI is pricing some of it.Ava: Amazon, AMZN, page 1, reports after the close Wednesday. Consensus $1.61 on $177.28B in revenue.[^earn-amzn] Two prints to flag going in. Amazon set its 2026 capex budget at $200B, the highest annual capex by any company in history.[^news-amzn-capex-200b-20260424] And Amazon committed an additional $25B to Anthropic, against Anthropic’s $100B AWS commitment over the next decade.[^news-amzn-anthropic-25b-20260420] Stock closed at an all-time high of $255.28 Wednesday.[^news-amzn-ath-255-20260423] On the memo, Amazon is 63x free cash flow at a 1.6% yield.[^memo-amzn-evfcf-20260424][^memo-amzn-fcfyield-20260424] What to watch on the call: AWS revenue growth, capex commentary, and any margin response to a $200B build.Ava: Microsoft, MSFT, page 1, also Wednesday after close. Consensus $4.07 on $81.37B.[^earn-msft] News this week — Microsoft offered first-ever voluntary retirement buyouts to approximately 8,750 US employees, 7% of the US workforce, at senior director level and below.[^news-msft-buyout-program-20260423] Stock fell 4% on the announcement.[^news-msft-stock-decline-20260423] UBS expects Azure growth around 38% on the call against a 9% consensus.[^news-msft-azure-forecast-20260424] On the memo, 97x free cash flow at a 1% yield.[^memo-msft-evfcf-20260424][^memo-msft-fcfyield-20260424] At that multiple, the buyout is the kind of cost discipline the market wanted before the AI capex print, not after.CloseAva: That’s the show. Roughly $5.5T of market cap reports in a 36-hour window next Wednesday and Thursday. Apple, Amazon, Microsoft, Meta, Alphabet, and Regeneron. The weekend after, we’ll have read all six. Mike, Jason, and Hunt are back Wednesday on episode 2618, picking up Amazon alongside Walmart per their carryover from this week.[^ep-e2617] Download the Cash Flow Memo at telltales.us. I’m Ava Cabot. See you next Saturday.Closing disclaimerAva: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.Sources* Amazon Hits Record Highs Before Q1 Earnings: Is AMZN Stock Still a Buy? (2026, April 24). Barchart. https://www.barchart.com/story/news/1504346/amazon-hits-record-highs-before-q1-earnings-is-amzn-stock-still-a-buy* Amazon (AMZN) Stock Closes at All-Time High of $255.28, Anthropic Partnership and AWS Momentum Reshape Growth. (2026, April 23). Foreign Policy Journal. https://www.foreignpolicyjournal.com/2026/04/23/amazon-amzn-stock-closes-at-all-time-high-of-255-28anthropic-partnership-and-aws-momentum-reshape-growth/* Amazon to invest up to another $25 billion in Anthropic as part of AI infrastructure deal. (2026, April 20). CNBC. https://www.cnbc.com/2026/04/20/amazon-invest-up-to-25-billion-in-anthropic-part-of-ai-infrastructure.html* Apple’s iPhone shipments in China surge 20% in first quarter, data shows. (2026, April 17). CNBC. https://www.cnbc.com/2026/04/17/apples-iphone-shipments-in-china-surge-20percent-in-first-quarter-data-shows.html* Apple withholds data in India antitrust case, watchdog sets final hearing. (2026, April 20). Reuters. https://www.reuters.com/sustainability/boards-policy-regulation/apple-withholds-data-india-antitrust-case-watchdog-sets-final-hearing-2026-04-20/* Charter Communications, Inc. Q1 2026 Earnings Call Summary. (2026, April 24). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/charter-communications-inc-q1-2026-164933509.html* Charter Communications Q1 2026 earnings: EPS of $9.17 misses consensus estimate of $10.01 by $0.84. (2026, April 24). Yahoo Finance. https://finance.yahoo.com/quote/CHTR/* Charter loses 120,000 broadband subs in Q1 2026. (2026, April 24). Fierce Network. https://www.fierce-network.com/broadband/charter-loses-120000-broadband-subs-q1-2026* Charter outlines $11.4B 2026 CapEx while expecting run-rate spending below $8B after evolution and expansion conclude. (2026, April 24). Seeking Alpha. https://seekingalpha.com/news/4579478-charter-outlines-11_4b-2026-capex-while-expecting-run-rate-spending-below-8b-after-evolution-and-expansion-conclude-nasdaq-chtr* Cox Acquisition and $3.7 Billion in CapEx Cuts: The Bull Case for Charter Communications Stock. (2026, April 24). TIKR. https://www.tikr.com/blog/cox-acquisition-and-3-7-billion-in-capex-cuts-the-bull-case-for-charter-communications-stock* Elon Musk pushes unsupervised FSD for consumer Teslas — again. (2026, April 22). Electrek. https://electrek.co/2026/04/22/tesla-elon-musk-unsupervised-fsd-consumer-cars-q4-delay-again* Intel Corporation. (2026, April 23). Intel reports first-quarter 2026 financial results [Press release]. BusinessWire. https://www.businesswire.com/news/home/20260423038467/en/Intel-Reports-First-Quarter-2026-Financial-Results* Intel Corp (INTC) Q1 2026 Earnings Call Highlights: Surpassing Expectations with Strong AI. (2026, April 24). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/intel-corp-intc-q1-2026-071441642.html* Intel forecasts second-quarter revenue above estimates, shares jump 19%. (2026, April 23). Reuters. https://reuters.com/legal/transactional/intel-forecasts-second-quarter-revenue-above-estimates-2026-04-23* Intel lands Tesla as first major customer for 14A chip technology. (2026, April 22). Reuters. https://www.reuters.com/business/autos-transportation/tesla-ceo-musk-says-company-plans-use-intels-14a-process-terafab-2026-04-22/* Intel says 18A yield improves as 14A advances to early customer engagement stage. (2026, April 24). DigiTimes. https://digitimes.com/news/a20260424VL204/intel-manufacturing-packaging-design-development.html* Intel’s revival is real: $13.6B in Q1. (2026, April 24). The Next Web. https://thenextweb.com/news/intel-q1-2026-earnings-ai-cpu* Intel’s stock has best day since 1987, soaring 24% as chipmaker shows signs of a turnaround. (2026, April 24). CNBC. https://www.cnbc.com/2026/04/24/intel-stock-soars-more-than-20percent-as-chipmaker-shows-signs-of-turnaround.html* Kinder Morgan (KMI) Q1 2026 Earnings Transcript. (2026, April 22). The Motley Fool. https://www.fool.com/earnings/call-transcripts/2026/04/22/kinder-morgan-kmi-q1-2026-earnings-transcript/* Kinder Morgan Q1 2026 earnings surge with major gas projects. (2026, April 22). StockTitan. https://www.stocktitan.net/sec-filings/EP/8-k-kinder-morgan-inc-reports-material-event-7ee87f94de39.html* Kinder Morgan Q1 Earnings and Revenues Top Estimates. (2026, April 22). Yahoo Finance. https://finance.yahoo.com/markets/stocks/articles/kinder-morgan-kmi-q1-earnings-214507014.html* Microsoft Falls 4% as $110 Billion AI Bet Forces Historic Employee Buyout: What Investors Need to Know. (2026, April 23). 24/7 Wall St. https://247wallst.com/investing/2026/04/23/microsoft-falls-4-as-110-billion-ai-bet-forces-historic-employee-buyout* Microsoft plans first-ever voluntary employee buyout for up to 7% of U.S. workforce. (2026, April 23). CNBC. https://www.cnbc.com/2026/04/23/microsoft-plans-first-voluntary-retirement-program-for-us-employees.html* Musk says spending plans will rise substantially as Tesla delivers cash surprise in Q1 earnings. (2026, April 22). Reuters. https://www.reuters.com/world/us/live-updates-tesla-report-2026-q1-earnings-after-markets-close-2026-04-22/* ServiceNow, Inc. (2026, April 22). ServiceNow reports first quarter 2026 financial results [Press release]. Business Wire. https://www.businesswire.com/news/home/20260422839830/en/ServiceNow-Reports-First-Quarter-2026-Financial-Results* ServiceNow (NOW) Q1 2026 Earnings Call Transcript. (2026, April 22). Seeking Alpha. https://seekingalpha.com/article/4893100-servicenow-inc-now-q1-2026-earnings-call-transcript* ServiceNow Q1 2026 earnings: stock drops 17% on margin fears. (2026, April 23). Quartz. https://qz.com/servicenow-stock-earnings-middle-east-margin-pressure-042326* Tesla confirms Cybercab production has started despite delays in unsupervised driving. (2026, April 23). Electrek. https://electrek.co/2026/04/23/tesla-cybercab-production-starts-no-nhtsa-2500-vehicle-cap/* Tesla Q1 2026 Earnings Report. (2026, April 22). CNBC. https://www.cnbc.com/2026/04/22/tesla-tsla-q1-2026-earnings-report.html* Tesla reports Q1 2026 earnings: Still profitable. (2026, April 22). Ars Technica. https://arstechnica.com/cars/2026/04/tesla-reports-q1-2026-earnings-still-profitable/* Tesla (TSLA) maxes out $5.8 billion Chinese bank debt facility as China sales crash. (2026, April 23). Electrek. https://electrek.co/2026/04/23/tesla-tsla-maxes-out-5-8-billion-chinese-bank-debt-facility-10q/* Tesla (TSLA) releases Q1 2026 financial results: slight beat on earnings. (2026, April 22). Electrek. https://electrek.co/2026/04/22/tesla-tsla-q1-2026-financial-results/* The US government’s Intel stake is now worth $36 billion. Nobody in Washington planned it that way. (2026, April 24). The Next Web. https://thenextweb.com/news/us-government-intel-stake-36-billion-chips-act* UBS has strong cloud growth expectations ahead of hyperscaler earnings. (2026, April 24). Proactive Investors. https://www.proactiveinvestors.com/companies/news/1091181/ubs-has-strong-cloud-growth-expectations-ahead-of-hyperscaler-earnings-1091181.html* UnitedHealth Group. (2026, April 20). UnitedHealthcare eliminates most medical prior authorizations, accelerates payments for key rural care hospitals and providers nationwide [Press release]. https://www.unitedhealthgroup.com/newsroom/2026/2026-04-20-uhc-eliminates-most-medical-prior-authorizations-accelerates-payments-for-key-rural-care-hospitals-providers.html* UnitedHealth Group. (2026, April 21). UnitedHealth Group reports first quarter 2026 results [Press release]. https://www.unitedhealthgroup.com/newsroom/2026/2026-04-21-uhg-reports-first-quarter-2026-results.html* UnitedHealth Group (UNH) earnings Q1 2026. (2026, April 21). CNBC. https://www.cnbc.com/2026/04/21/unitedhealth-group-unh-earnings-q1-2026.html* UnitedHealth posts quarterly profit above Wall Street estimates, on track for turnaround. (2026, April 21). Reuters. https://www.reuters.com/legal/litigation/unitedhealth-reports-2026-q1-profit-above-wall-street-estimates-vying-turnaround-2026-04-21/* Why the timing of Apple’s CEO change could mean a good earnings report is around the corner. (2026, April 21). CNBC. https://www.cnbc.com/2026/04/21/why-the-timing-of-apples-ceo-change-could-mean-a-good-earnings-report-is-around-the-corner.html* Transcript: Kinder Morgan Q1 2026 Earnings Conference Call. (2026, April 22). Benzinga. https://www.benzinga.com/insights/news/26/04/51987212/transcript-kinder-morgan-q1-2026-earnings-conference-callInternal dataInternal data is provided on a best efforts basis. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

SHOWNOTESTim Cook is out, John Turner is in, and Apple’s AI strategy just became the most important question on page one. This week we pressure-test Apple’s hardware-first bet against the Intel cautionary tale, run Hunt’s contrarian oil math on a closed Strait of Hormuz, and hit a packed healthcare slate from CDC leadership to an mRNA cancer vaccine breakthrough.[00:00] Welcome and Episode PreviewMike opens on Apple’s CEO succession, framing the episode around whether naming a hardware leader in the AI era is genius or miscalculation.[01:23] Iran, Hormuz, and the Oil MarketHunt walks through why oil prices have stayed rational despite a closed Strait of Hormuz, Saudi Aramco making more in March on lower volumes, and why the world can operate at 95-96M bbl/day without serious damage. Includes a read on the $1.5T defense budget ask and why it will not pass.[12:05] Apple: John Turner Named CEO and the AI BetPost-Jobs product history points to Apple Silicon as the one truly new program, which is exactly what Turner led. The debate: can Apple monetize AI via on-device inference and an app-store style tax on agent transactions, or is outsourcing AI to Google an Intel-style blind spot?[20:35] Tesla, SpaceX, and Valuation DisciplineHunt argues Apple sits cheap relative to the capex-heavy hyperscalers; Tesla remains expensive; SpaceX’s data-centers-in-space pitch embeds an even bigger premium. Mike’s framework: hold the rare windows when great companies trade at fair multiples, do not chase concept valuations.[25:39] Healthcare: CDC, Peptides, mRNA Cancer, Lilly M&A, UNHErika Schwartz nominated to lead CDC (uncontroversial, stability pick); FDA reclassifies 12 peptides; UCLA mRNA pancreatic cancer phase-1 results (90% five-year survival in immune responders); Lilly buys Lon Therapeutics for in vivo CAR-T; UnitedHealthcare earnings plus a prior-auth elimination pilot.[33:38] Wrap and Next WeekNext up: Amazon alongside Walmart, then Google the following week.Get the Cash Flow Memo at telltales.us and follow for weekly deep-dives on energy, technology, and healthcare.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

OPENING DISCLAIMER — 0:00AVA: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.COLD OPEN — 0:15AVA: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.MARCUS: And I’m Marcus Graham. Every Saturday we walk through what happened this week — and what’s coming next week — across the eighty-nine companies in the Cash Flow Memo. No filler. AVA: Quick note before we start. This is a pilot episode, so we want your feedback — what works, what doesn’t, what you want more of. The show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. We welcome your feedback.AVA: On Wednesday, Mike, Jason, and Hunt spent most of episode twenty-six-sixteen on Hormuz, the deficit math, and the dominant-company debate — Lilly, Nvidia, Microsoft. Today we pick up downstream of that conversation, with the first big week of earnings season behind us. The AI build kept accelerating. A streaming founder stepped off his own board. And one of the cheapest stocks in the healthcare book heads into a print that could re-rate the whole managed-care complex.THEME — AI CHIP CYCLE — 0:45AVA: Let’s start with chips. Three names on page three of the memo set the tone this week — Taiwan Semi and ASML reported, and Intel reports Thursday. Same cycle, three very different places on the cashflow map.AVA: Taiwan Semi first. The company reported Thursday morning. Revenue thirty-five-point-nine billion dollars, up forty-one percent year over year. Net profit up fifty-eight percent. Both records. High-performance compute — which is AI plus networking — was sixty-one percent of revenue. Three-nanometer was twenty-five percent of wafer revenue. The Q2 guide came in at thirty-nine to forty-point-two billion — ten percent sequential growth, unusual in that seat this time of year. And capex got pushed to the high end of the fifty-two to fifty-six billion range.AVA: AI demand is not slowing, and the purest shovel in the build is telling you the order book is still accelerating. That matters most for Nvidia, which reports May twentieth.AVA: On the same page — ASML. Revenue eight-point-eight billion euro, order book called “very strong,” and management raised the full-year guide to thirty-six to forty billion euro. Stock traded down three percent on the open anyway. Marcus — what does the memo say about where ASML trades?MARCUS: ASML is expensive. The stock sits at seventy-four times free cash flow, and a free cash flow yield of just over one percent. Trailing twelve months, the company generated seven-point-five billion dollars of free cash flow — up seventeen percent. That’s clean growth, but it’s growing into a price that already prices in three more years of raised guides. The stock sold off on a raised guide because that multiple leaves no room for a stumble. If the memo number is your anchor, ASML is the chip stock you own for the monopoly, not for the cash yield.AVA: Then Intel, same page. Stock is up seventy-six percent year-to-date. The rally is built on two narratives — the twenty-five-billion-dollar Terafab joint venture with Elon Musk and Intel’s plant, and a foundry deal with AWS. Thursday’s print has to validate both. Marcus, how does this one read on the memo?MARCUS: Free cash flow for the trailing twelve months is negative sixteen-point-two billion dollars. This is not a cashflow stock; it is a restructuring narrative riding on whether the Terafab commitment converts into revenue inside of two quarters. The debt sits at forty-six billion. If Thursday’s guide doesn’t move that story forward, the seventy-six percent rally is doing the work of a beat that hasn’t happened yet. That said, I’d expect Intel to talk up booming CPU demand on the call. TSMC’s leading-edge capacity is sold out, and hyperscalers need a second source. At the leading nodes, Intel and Samsung are the only options.AVA: Three stocks, same cycle. One with no cash flow. One expensive on cash flow. And Taiwan Semi sits in between — still cheap on the multiple, still growing into it. The memo is how you tell them apart. DEEP DIVE — NETFLIX — 4:45AVA: To the deep dive. Netflix, page four. Reported Thursday after the close. EPS beat handily. Revenue up sixteen percent. The ad business reiterated a three-billion-dollar revenue target for 2026, with over four thousand advertisers on the platform.AVA: The stock dropped the most in six months anyway. Two reasons. The Q2 revenue guide came in below consensus. And the bigger one: Reed Hastings is not seeking reelection to the Netflix board. Twenty-eight years after he founded the company. Marcus — the memo has Netflix at a price most listeners wouldn’t call cheap. How does the print change that?MARCUS: It doesn’t change it. Netflix trades at thirty-nine times free cash flow. That’s priced for a growth-and-moat story. But trailing twelve months, free cash flow came in at ten-and-a-half billion dollars — down fourteen percent year over year. Growth going negative at thirty-nine times is how multiples compress.AVA: Management has been giving cash back hard. Gross buybacks ran almost seven billion dollars in the last four quarters — roughly four-point-eight billion net of stock issuance. Does that cadence hold from here?MARCUS: Four-point-eight billion of net buybacks on ten-and-a-half billion of free cash flow — about forty-five percent going back to shareholders. It’s a real capital-return program, and it’s been the stabilizer for the share count and the multiple. The question is whether you keep running that cadence into a year where free cash flow is shrinking, there’s a content arms race pulling capital in, and the founder is stepping off the board. The easy answer is no. You’d expect a more conservative allocator — which Greg Peters and Ted Sarandos are — to slow buybacks, redirect to content, and let the multiple do what it’s going to do.AVA: Hastings built the model where cash return was the discipline that kept Netflix from re-running the content-spend cycle. That discipline is now leaving the room during a content arms race. Also earlier this month, Netflix lost the bidding war for Warner Brothers content to a competing streamer. Streaming consolidation is real. A beat quarter with a founder exit and a soft guide, at thirty-nine times cash flow, is not what you want going into that fight.RAPID-FIRE — 8:45AVA: Forward week. Big slate. Four names to watch.AVA: UnitedHealth — UNH, page nineteen — reports Tuesday morning. Consensus wants six-point-six-three in EPS on one-hundred-nine-point-four billion in revenue. The setup: on April seventh, CMS raised the 2027 Medicare Advantage rate by two-point-four-eight percent — the first favorable rate rule in three years. The memo has UNH at three-point-seven times free cash flow, with a twenty-six percent free cash flow yield. That’s not a normal number. The market is pricing in a permanent impairment, and the print is the first chance to push back on that. If UNH beats, managed care re-rates.AVA: Tesla, page one — reports Wednesday. Q1 deliveries already missed — three-hundred-fifty-eight thousand against the company’s own three-hundred-sixty-five. JPMorgan flagged one-hundred-sixty-four thousand unsold units in inventory and laid out a sixty percent downside scenario. The memo shows Tesla with negative free cash flow of five-point-one billion over the trailing twelve months. The earnings number is not what this print is about. It’s the physical-AI language on the call — whether Musk gives a Robotaxi date, an Optimus milestone, or a new revenue line that the market can attach to. That’s the whole bar.AVA: McDonald’s, page sixteen. Not reporting this week — the Q1 print is May seventh. But Tuesday is the launch of the new McValue menu: under-three-dollar items, four-dollar breakfast, five-dollar lunch. McDonald’s is a cash flow bellwether for the low-income consumer. Memo has McDonald’s at thirty-eight times free cash flow, with debt to free cash flow at seven-point-seven — rich on cash flow and highly levered. Watch the first two weeks of menu-launch traffic data as a read on whether the low-end consumer is responding. Real signal comes on the May print.AVA: Uber, page twenty. Not an earnings name this week, but the big catalyst. Uber committed ten billion dollars this week to build a Robotaxi platform by 2028. Twenty-eight cities, Lucid and Nuro as hardware partners, employee test rides launching now. This is a break from the asset-light model that Uber’s valuation rests on. The memo has Uber at eleven-point-seven times free cash flow — cheap by tech standards. That multiple was earned by being capital-light. Ten billion of robotaxi capex puts part of it on the table. Watch the reaction on the May sixth print when management quantifies the spend. CLOSE — 11:45AVA: Hunt, Jason, and Mike will pick up Intel and Tesla on Wednesday’s main Telltales episode. If you want to follow along, the Cash Flow Memo is at telltales-dot-us. CLOSING DISCLAIMER — 12:30AVA: The views expressed on this podcast are the host alone and do not constitute an offer to sell or a recommendation to purchase, or a solicitation of an offer to buy any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the host nor any of their employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness, or completeness of this information. The host and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future, and may or may not hold positions in the securities mentioned.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

This week on Telltales: we work through Hormuz's impact on oil and gas, the federal deficit's interest-rate squeeze, and then spend most of the hour on the dominant-company question — from Lilly and Nvidia to the real debate: is Microsoft a value trap or the operating system for the agent era?[00:00] Cold Open & Memo SetupMike opens the episode and points listeners to the Cash Flow Memo at telltales.us — 20 pages covering energy, technology, and healthcare.[00:22] Iran, Hormuz, and the Energy MapHunt walks through how a six-week Straits closure reshapes production — US and Russia up, Saudi and Gulf Arabs down — and why Asian demand is quietly rolling over as diesel and jet fuel run short.[01:48] Oil Strip at $80, Waha Gas at Minus SixPermian associated-gas economics force producers to shut in oil rather than pay to move gas; the 2026 strip sits near $80 vs. a pre-campaign path to $50.[03:17] The Deficit Math That Actually MattersInterest expense has gone from $400B to $1T; tariffs are doing the heavy lifting on the revenue side at ~$500B run-rate. Markets won't accept FY26 > FY25.[04:42] Healthcare Cost Discipline — Real or Temporary?Medicare/Medicaid at $1.8T out of $7T in projected spending; Mike and Jason weigh whether Trump-era savings survive past this administration or snap back to the 8% trajectory.[07:15] Global Recession Risk from HormuzJason flags that the US blocking the Straits is a rare posture; Hermes and Ferrari weakness show the luxury tape softening first.[08:52] Eli Lilly: Dominant, But Not AppleGLP-1 carries the story; oncology and the broader pipeline are strong but every drug is only as good as its next patent. In winner-take-all pharma, blockbusters go to zero overnight.[10:29] Nvidia: Cheaper Than the S&P$200B+ revenue, >$100B free cash flow at a $4.5T cap — trades below S&P average on cash flow. The circular-revenue concern vs. the structural hyperscaler demand story.[15:09] Microsoft: Value or Value TrapStock at $370 vs. $550 high. Azure capacity curtailed to prioritize internal Copilot workloads. Satya-era subscription pivot and the OpenAI bet in historical context.[20:59] The Agent-Era Workflow ShiftMike and Jason describe how Claude Code has replaced chat interfaces for research — the file system is becoming the agent's workspace, which either helps or hurts the Office franchise.[23:41] Anthropic as the Natural Enterprise PartnerWhy Anthropic's enterprise focus fits Microsoft's Fortune 500 book better than OpenAI's consumer pivot.[25:22] Teams, Windows, and the Agent OS ThesisThe long case for Microsoft: own the communication layer and build the operating system agents actually run on.[28:38] Healthcare M&A and the Anthropic–Novartis SignalBiotech deals running at a record pace but still sub-$10B. Anthropic acqui-hires a 10-person biotech for $400M and adds the Novartis CEO to its board — AI's oldest pitch, finally getting institutional weight.[31:19] What's NextApple next week, Amazon and Walmart the week after — continuing the dominant-company framework and the question of who becomes the next Intel.Subscribe for next week's Apple episode, and download this week's memo at telltales.us.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

NVIDIA has evolved from a near-bankrupt GPU maker into the most dominant force in computing infrastructure. This week we unpack the "process power" framework that explains why, and ask whether Eli Lilly can replicate the same playbook in pharma.[00:00] Exhibit C: Oil Markets & Iran CeasefireIf the ceasefire holds, global production declines ~1M bbl/day. Demand stays flat at 103M. Average oil price for the rest of 2026 likely lands around $80. Higher oil prices paradoxically push nat gas lower via increased Permian associated gas production.[03:00] Exhibit B: Natural Gas OutlookHenry Hub at $2.86 prompt with $3.70 for 2027. Permian associated gas growing from 23 to 25 Bcf/d this year. Waha hub negative since January. Hoping gas holds $3.50-$4.00 range but oversupply risk persists.[04:23] Exhibit A: Fiscal & Defense SpendingWar supplemental request dropped from $200B to $80B. Defense budget proposal at $1.5T vs. current ~$900B run rate. Tariff revenue only ~$300B of $5.5T total federal revenue. Deficit must decline as a percentage of GNP — no other path.[08:27] Modern Warfare & Cost ReductionAutonomous drone-based interceptors replacing $10M missiles. Future defense procurement shifts from stockpile building to productive capacity and supply chain resilience. Iran's drone supply to Russia now disrupted.[10:00] NVIDIA Deep Dive: Process PowerHamilton Helmer's "Seven Powers" framework applied to NVIDIA. The real moat isn't CUDA's network effect — it's the 9-month iteration cadence established in 1997 when Jensen acquired a hardware emulator on the brink of bankruptcy. That process advantage compounded over a decade when nobody was watching.[14:00] NVIDIA's Vertical IntegrationFrom DGX-1 with Intel Xeon CPUs to today's full-stack offering: NVIDIA GPUs, NVIDIA CPUs, Mellanox networking (acquired 2019), and Groq LPUs. They sell complete data center aisles, capturing margin that Intel shared with Dell and Broadcom.[16:00] Intel's Cautionary TaleIntel voluntarily gave up Moore's Law process leadership because next-gen economics didn't satisfy shareholders. Now at $50B revenue with zero free cash flow. NVIDIA's position is stronger than Intel's ever was.[19:00] NVIDIA's Next FrontiersJetsons robotics chips (a decade in development), CUDA Q2Q quantum computing simulators. NVIDIA has taken the CUDA playbook wide across verticals — payoffs expected over the next few decades.[20:00] Taiwan Semiconductor DependencyTSMC sales up 30% monthly. Samsung's operating profit tripled. Elon bringing Intel into Tesla's Terra Fab project with Samsung. TSMC in monopoly position, deliberately under-building capacity.[21:45] AI Compute Demand: Anthropic & xAIAnthropic's token production showing exponential growth since AI agents launched. New model cost ~$10B to train — likely first fully trained on Blackwells. xAI planning models up to 10 trillion parameters.[23:22] Pharma Tariffs: 100% on Active IngredientsTargets China supply chain dependence. Extensive exemptions for orphan drugs, cancer therapies. 16 pharma companies have MFN agreements. 20% reduced rate for onshoring. Market reaction muted — this is a carrot, not a stick.[25:21] Eli Lilly: Dominant but ExpensiveRevenue up 40% YoY, FCF up 80%. Trading at ~50x FCF — more expensive than NVIDIA's 40x. Oral GLP-1 pill is a competitive advantage, but barriers to entry are lower than semiconductors. Process power in biotech is rare and harder to sustain.Subscribe to the Cash Flow Memo at telltales.us and download this week's data package covering 80+ companies across energy, tech, and healthcare.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

This week’s Telltales Podcast moves from geopolitics to technology to healthcare, connecting the latest market headlines back to cash flow, capital allocation, and competitive advantage. Mike, Jason, and Hunt discuss how energy risk, AI spending, and pharma dealmaking could shape investors’ thinking in the months ahead.[00:00] Opening and memo overviewMike opens the episode by framing the discussion around energy, technology, and healthcare, with references to the Cash Flow Memo and the weekly exhibits on government finances, natural gas, and oil.[00:20] Iran, oil risk, and Exhibit CHunt lays out his current view on Iran, the Strait of Hormuz, and why geopolitical risk may keep oil prices supported rather than sending them back toward much lower levels.[03:58] Exhibit A and the macro backdropThe conversation shifts briefly to the dollar, defense spending, and how fiscal developments could affect the broader economic picture.[05:03] Ceasefire timing and what to watch nextMike and Jason discuss the significance of the April 6 date, the uncertainty around negotiations, and how public reporting can differ sharply from realities on the ground.[06:32] Helium shortages and second-order inflation effectsThe hosts revisit helium after recent supply disruptions, highlighting how conflict can ripple far beyond oil into industrial gases and other inflation-sensitive inputs.[10:13] Middle East realignment and the long-term oil outlookJason and Hunt explore the bigger strategic picture, including regional cooperation, Saudi-Israel normalization, and what a more stable or less stable Middle East could mean for energy markets.[18:38] Artemis II, NASA contractors, and the economics of launchThe episode turns to space, where the hosts compare legacy aerospace contractors with SpaceX and debate what the future of launch economics and government contracts might look like.[21:12] Apple at 50: low capex, AI, and the future of SiriApple’s anniversary sparks a deeper debate on whether the company is prudently waiting on AI or risking a slow erosion of its moat by underinvesting in next-generation infrastructure and products.[24:00] The Intel comparison and platform riskMike argues that Apple could face an Intel-like problem if financial discipline overtakes product ambition, especially as outside AI providers gain leverage over the user experience.[28:00] OpenAI, suppliers, and bargaining powerThe hosts examine how AI could reshape platform economics, with Apple potentially becoming more dependent on third-party model providers and losing some of its traditional control.[30:15] Healthcare M&A and Eli Lilly’s latest pushJason closes with healthcare news, including fresh pharma dealmaking and Eli Lilly’s move into an oral weight-loss treatment, with implications for manufacturing, pricing, and competition.[31:24] Why Lilly looks so strongThe team discusses why Lilly continues to stand out, from product execution to strategic positioning, and tees up a deeper dive for a future episode.Thanks for listening to Telltales. Subscribe for weekly discussions on investing, cash flow, and company analysis, and check out the Cash Flow Memo for the financial exhibits and company updates that accompany each episode.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

SHOWNOTESIn this episode of Telltales, Mike Nicoletti, Jason Wallace, and Hunt Lawrence unpack the latest Cash Flow Memo across energy, technology, and healthcare. The conversation ranges from Iran-driven oil risk and natural gas pricing to AI infrastructure demand, semiconductor inputs, and the long-term investment case for cancer therapies.[00:00] Energy outlook after the Iran conflict Hunt opens with Exhibit C, explaining why he now sees oil supply tightening slightly versus prior expectations and why a return to something closer to normal in the straits could still leave a durable geopolitical risk premium in crude.[03:24] Why oil may stay higher for longer The team discusses why WTI may average closer to $80 in 2026-2028 rather than revisiting $60, with uncertainty around Iran, damaged infrastructure, and future military escalation all influencing pricing.[05:21] Exhibit A and the US fiscal picture Hunt argues the US remains relatively insulated on national accounts because it produces as much oil as it uses and more gas than it consumes, while still expecting the federal deficit trend to improve gradually.[08:24] Energy equities and capital discipline The discussion turns to oil and gas names in the memo, with the view that upstream oil producers are still discounting a more conservative price deck and are unlikely to overspend even if oil averages above current expectations.[10:09] Natural gas headwinds and LNG timing Hunt explains why higher oil production in the Permian can pressure gas prices through associated gas output, and why new LNG capacity should help eventually but may take longer to meaningfully change the price outlook.[12:11] Helium, fertilizers, and second-order inflation effects Mike and Jason highlight other commodities affected by the conflict, including helium and fertilizers, and explain why higher input costs could ripple into semiconductors, MRI operations, and broader inflation-sensitive markets.[13:15] Big Tech resilience and AI inference demand The hosts shift to technology, arguing that the largest platform companies remain well positioned as inference demand accelerates and hyperscalers continue building the compute capacity needed to support AI applications.[15:10] The falling cost curve of AI Mike frames technology as fundamentally deflationary and points to the sharp drop in token costs as evidence that innovation is still rapidly compressing compute economics despite rising capital intensity.[16:02] Google’s Turbo Quant and edge AI potential Jason explains Google’s new model architecture and why a major reduction in memory requirements could make local AI more practical, expand context windows, and move models closer to persistent memory-like functionality.[18:15] Apple, CPUs, and the agent economy The conversation explores why Mac Mini demand may be stronger than expected and how AI agents are increasing the need for traditional CPU compute alongside GPUs.[19:52] ARM, Intel, AMD, and the data center transition Mike and Jason discuss the shift away from x86, rising custom silicon adoption by hyperscalers, and why ARM-based architectures appear to be gaining ground in modern AI infrastructure.[20:48] NVIDIA’s expanding role in the stack The team explains how NVIDIA has evolved from a GPU story into a full data center systems story, with process speed and integrated infrastructure now central to its ability to defend margins.[23:02] AI meets healthcare in personalized cancer treatment Jason shares a story about a custom mRNA cancer vaccine for a dog, using it as an early proof point for how AI-assisted analysis could accelerate more personalized approaches to oncology.[24:23] Vertex and Harrow updates The healthcare segment covers encouraging Vertex phase 3 kidney disease data and a revealing reimbursement gap at Harrow, where a low direct-to-patient price contrasts sharply with insurance billing levels.[26:11] BioNTech after its founders The hosts debate BioNTech’s future, concluding that the company has enough late-stage assets and commercialization work ahead of it to remain viable even as the founders step back from day-to-day operating focus.[29:50] Why cancer vaccines remain one of the biggest themes Moderna and BioNTech are highlighted as current leaders in cancer vaccines, while Jason argues the future of cancer care will likely be shaped by a combination of new therapies, better monitoring, and individualized immune-based treatment.[31:49] The search for the next major investing themes The episode closes with a broader challenge: if AI and cancer therapies are already on the list of transformational trends, what are the other breakthroughs investors should be watching over the next three to four years?If you enjoy this style of investing discussion, subscribe to Telltales and download the Cash Flow Memo at telltales.us. For more weekly analysis on energy, technology, healthcare, and cashflow-driven investing, stay tuned for the next episode.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

SHOWNOTESThis week on Telltales, Hunt, Mike, and Jason break down the most consequential disruption to global energy markets in decades — the effective closure of the Strait of Hormuz — and what it means for oil prices, capital markets, and portfolio positioning. The conversation then pivots to AI agents, harness engineering, and the structural shift in how companies will operate.[00:00] **Strait of Hormuz Closure and Oil Market Impact**Hunt walks through the mechanics of losing ~20 million barrels of daily transit through Hormuz, the Israeli strike on Iran’s Pars gas facility, and Iran’s threatened retaliation against Saudi, UAE, and Qatari infrastructure. Near-month crude has moved from $60 pre-conflict to $100, with October $120 calls trading at $2.[03:16] **Scenarios for Oil Price Resolution**Could a ceasefire or Iranian-controlled transit regime bring prices back toward $80? Hunt outlines the pipeline alternatives — Red Sea, Fujairah, Turkey — and what a partial normalization by Q4 might look like. The consensus: $60 oil is gone for the foreseeable future.[06:16] **Why This Wasn’t a War of Choice**Jason and Hunt argue the Iran conflict was inevitable given the nuclear trajectory, with Iran’s stated objectives making a deal structurally impossible. The military campaign has been more decisive than expected, but drone suppression remains the key challenge.[09:50] **Exhibit B: Natural Gas Supply Problem**Permian associated gas continues to flood the market at 24 Bcf/day, with hub prices negative. New pipeline capacity (up to 5 Bcf/day) is coming but won’t arrive until late 2026. Higher oil activity will only worsen the gas oversupply.[11:07] **Exhibit A: US Government Fiscal Outlook**Healthcare spending is the main lever. Medicare and Medicaid may flatten with Trump administration changes. The US is improving directionally versus China, Japan, and Europe. The Fed holds rates steady.[14:00] **Mag Seven Resilience and AI CapEx Justification**Despite geopolitical turmoil, the Mag Seven remain remarkably steady at 40% of the index. Hunt, Mike, and Jason argue the AI infrastructure buildout is justified — each new chip generation is ~10x more efficient, breaking the typical industrial capacity cycle.[17:01] **Capital Returns and Why This Cycle Is Different**Mike draws on Edward Chancellor’s Capital Returns framework: unlike concrete plants, new GPU capacity is 90% more efficient than what it replaces. Token consumption is scaling with problem complexity, and Jensen Huang’s GTC keynote framed token budgets as the new employee benefit.[19:42] **AI Impact on Healthcare and Pharma R&D**Jason sees pharma companies testing more molecules rather than cutting headcount. The biggest efficiency gain: regulatory filing assembly for FDA submissions. Net effect is more drugs in the pipeline, which is positive for patients.[23:09] **Agents: From Open Claw to 2 Billion Users**The team debates agent adoption. Jason predicts every iPhone becomes an agent within a year — the orchestration runs on-device while inference runs in the cloud. Apple’s Siri delays leave the door open for Anthropic, OpenAI, and Google.[25:24] **Harness Engineering: The Next Software Layer**Mike defines the emerging discipline: writing traditional software that feeds the right context to LLMs at the right time. From Cursor to Claude Code to Open Claw, the pattern is vertical tools designed for specific jobs. Companies will reorganize around people + AI with tools and skills.[29:39] **Diagnostics, GLP-1s, and Bending the Healthcare Cost Curve**The path to lower healthcare costs runs through cheaper diagnostics (blood draws, genomics, AI symptom analysis) gating access to specialists, plus long-term benefits from GLP-1 adoption reducing total system burden.Download the full Cash Flow Memo with updated financials for ~80 companies at telltales.us. New episodes every Wednesday.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

In this episode of Telltales, Mike Nicoletti, Jason Wallace, and Hunt Lawrence analyze global energy markets, the cash flow profiles of the world’s largest technology companies, and key developments in biotech and healthcare investing.[00:00] IntroductionMike introduces the episode and the Cash Flow Memo, which tracks financials across major companies and macro exhibits covering U.S. government finances, oil, and natural gas.[00:29] Oil Markets and Iran TensionsHunt explains how geopolitical tensions involving Iran and shipping through the Strait of Hormuz are affecting oil prices and global supply dynamics.[03:00] Natural Gas, LNG, and Permian SupplyThe hosts discuss LNG disruptions from Qatar, rising global gas prices, and the persistent oversupply of U.S. natural gas driven by Permian Basin associated gas.[05:41] U.S. Government FinancesA look at the U.S. fiscal picture, including deficit trends, tariff revenue, and the continued role of the dollar as a global reserve currency.[07:04] Mega-Cap Tech FinancialsApple, Amazon, Alphabet, Microsoft, and Tesla are compared through the lens of revenue, EBITDA, capital spending, and free cash flow.[11:44] Amazon vs WalmartThe panel breaks down Amazon as two businesses—retail and cloud—and compares its economics with Walmart’s massive retail operation.[16:21] Nvidia’s Cash Flow MachineNvidia’s extraordinary margins and free cash flow generation are highlighted, along with discussion of the sustainability of AI-driven demand.[18:00] Moats in the AI EraThe hosts debate competitive advantages among major tech companies, including risks facing Apple, Alphabet, Microsoft, and Nvidia as AI reshapes the industry.[20:33] Biotech Leadership ChangesDiscussion turns to BioNTech and Moderna, including founder departures and how early-stage research cultures influence biotech companies.[24:00] Pharma R&D and Capital AllocationThe hosts analyze R&D spending at companies like Pfizer and Vertex, focusing on how capital allocation affects long-term drug pipelines.[25:53] Harrow’s OutlookThe team reviews Harrow’s recent results and guidance, explaining why the long-term thesis remains intact despite short-term market reactions.[27:38] AI PredictionsEach host offers predictions about near-term developments in artificial intelligence, including the possibility of new model breakthroughs and Microsoft’s next Copilot evolution.[31:50] Closing RemarksThe episode concludes with final thoughts and a preview of next week’s discussion.If you enjoy deep dives into company cash flows and long-term investing, subscribe to Telltales and download the Cash Flow Memo at telltales.us.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

SHOWNOTESThis week on Telltales, the team moves from energy geopolitics to mega-cap tech cash flows and healthcare catalysts—through the lens of what actually endures: free cash flow, incentives, and execution.[00:00] Welcome to Telltales + Cash Flow Memo setupMike frames the episode’s focus across energy, technology, and healthcare—and points listeners to the memo and exhibits.[00:29] Exhibit C: Oil supply, Iran risk, and what changes (or doesn’t)Hunt walks through how recent Middle East tensions can shift the crude supply outlook, while noting limited physical damage so far.[02:49] Exhibit B: Natural gas, LNG dynamics, and the forward curveThe conversation pivots to natural gas fundamentals and how supply/demand expectations translate into pricing and planning.[05:33] US fiscal picture: deficits, the dollar, and gold signalsThe group discusses US Treasury math, what’s improving (and what isn’t), and how markets interpret the trajectory via gold and rates.[09:27] Index concentration and the “Magnificent Seven” stability debateHunt challenges the idea that concentration equals fragility, arguing the biggest names are proving steadier than expected.[11:49] Tesla: robotaxis, humanoid robots, and valuation as a long-dated optionThey debate whether autonomy and robotics justify Tesla’s premium—and how production choices signal a strategic pivot.[14:28] Enterprise software in an AI world: why Snowflake still mattersSnowflake’s role is framed as “memory” and infrastructure for AI systems, not just another software line item competing with new tools.[18:30] Nvidia vs the field: scale, cash flow, and the next bottleneckThe team breaks down Nvidia’s dominance versus challengers and explores where constraints may emerge—especially around data center buildout and permitting.[22:25] Harrow: guidance optics, management credibility, and Vivi/Vevye tailwindsA sharp selloff meets a fundamentals discussion: conservative guidance, product momentum, and a meaningful catalyst through CVS’s PBM channel.[25:18] FDA acceleration: priority review vouchers and faster approvalsJason covers a rapid approval example and what it implies about timelines, costs, and the evolving regulatory playbook.[26:16] Clinical trials shift: fewer Phase 3 requirements and higher ROI on R&DThey discuss how moving from “two Phase 3 trials” toward “one + longer follow-up” can change economics for smaller biotechs and drug development broadly.[28:16] Vertex as a healthcare execution benchmarkIn a “Nvidia of healthcare” style prompt, the group highlights Vertex as best-in-class at in-house R&D returns and sustained pipeline strength.[29:38] Closing thoughtsA wrap on how US capital markets absorb macro shocks—and why business quality ultimately anchors long-term outcomes.If you found this helpful, grab the Cash Flow Memo, drop a comment with the company you want covered next, and subscribe for weekly episodes on cash flow-first investing.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

Is genetic sequencing the future of healthcare? In this Top Mark Capital Fellow Webinar, Montana Joy breaks down how next-generation sequencing is transforming oncology, infectious disease, prenatal testing, and personalized medicine—and why now may be the inflection point.[00:00] Introduction: The Shift Toward Molecular MedicineMike Nicoletti introduces the webinar and frames the central theme: the move from symptom-based care to genetically informed, personalized treatment strategies.[02:00] The Top Mark Fellowship & Research ContextAn inside look at the fellowship program and how a year of structured research led to this deep dive into genetic sequencing and its healthcare implications.[04:38] What Is Genetic Sequencing?Montana explains DNA sequencing basics, genetic variants, and how changes at the molecular level can alter protein production and clinical outcomes.[06:41] Why Sequencing Matters: Cost, Survival, and Early DetectionHow falling sequencing costs and earlier diagnosis can improve survival rates, reduce long-term healthcare costs, and enable preventative medicine.[09:09] Prenatal Genetic Testing: The First Commercial BreakthroughHow non-invasive prenatal testing (NIPT) brought sequencing into mainstream clinical use and paved the way for broader adoption.[11:34] Minimal Residual Disease (MRD) Testing in OncologyHow cell-free tumor DNA enables continuous molecular monitoring, earlier relapse detection, and more precise post-treatment decisions.[15:22] RNA Vaccines and Precision ImmunotherapyFrom COVID-19 to personalized cancer vaccines, sequencing enables rapid vaccine design and adaptive immune targeting.[18:00] The Sequencing Landscape: Illumina, PacBio, Oxford Nanopore & MoreA breakdown of first-, second-, and third-generation sequencers, key competitive factors (accuracy, speed, cost, volume), and major industry players.[21:43] AI, Machine Learning & the Future of DiagnosticsHow genetic data combined with AI could accelerate diagnostic accuracy and expand personalized oncology and rare disease treatment.[24:00] Multi-Cancer Early Detection (MCED) and Market ExpansionDiscussion of emerging MCED tests, current clinical limitations, and the long-term potential for population-wide cancer screening.[28:36] Beyond Oncology: Infectious Disease & Sickle Cell ApplicationsSequencing applications in infectious disease, genetic disorders, and microbiome-driven treatments.[29:25] FDA Pathways & Personalized RNA TherapiesHow regulators are adapting approval frameworks for individualized, process-driven therapies like personalized cancer vaccines.[33:00] Pharmacogenomics & Universal Sequencing by 2050?A forward-looking discussion: Will everyone be sequenced once in their lifetime? What becomes actionable at $100–$300 per genome?[35:16] Who Wins? Installed Base, Software, and the “Picks & Shovels”Evaluating competitive moats in sequencing—hardware, reagents, installed systems, and the growing importance of software analytics.[40:09] Diagnostic-Driven Healthcare SystemsWhy rising healthcare costs and improving diagnostic accuracy may shift care from provider-driven to diagnostics-first models.Genetic sequencing is no longer just a research tool—it’s becoming foundational to modern healthcare. If you’re interested in the intersection of biotechnology, oncology, and long-term investing, this is a trend worth watching closely.Subscribe for more Top Mark Capital webinars and research discussions exploring the future of healthcare and investing.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

SHOWNOTESThis week on Telltales, the team digs into the cash flow realities behind energy markets, AI-driven software disruption, and fast-moving healthcare headlines. Plus, they connect the dots between government finances, rates, and the incentives shaping corporate behavior.[00:00] Welcome to Telltales + Cash Flow Memo The crew tees up a fast tour through energy, technology, and healthcare using this week’s memo and exhibits.[00:19] Disclaimer Investing discussion for informational purposes only—do your own work.[00:35] Oil demand growth slows, supply stays strong Why global demand growth looks softer (China maturity, EV adoption) and what that implies for WTI absent geopolitical risk.[02:40] Natural gas: “too much production” and power demand flat The group discusses why gas demand in power isn’t accelerating and how policy/regulatory dynamics may be affecting coal retirements.[03:39] Exhibit A: Tariffs, revenues, and the bond market A look at shifting U.S. revenue lines, tariff uncertainty/refunds, and why the 10-year yield matters for housing affordability.[07:06] SaaS disruption: opportunity or value trap? Salesforce, ServiceNow, and Snowflake sell off as investors debate “build vs buy” software in an AI world—and what that means for durable cash flow.[10:00] Switching costs, SLAs, and the real value of software vendors Why uptime, support, and accountability still matter—and why the endpoint may be “more software,” not less.[13:40] Meta’s AMD GPU deal and the Taiwan Semi choke point A breakdown of buyer power in AI chips, why capacity allocation matters, and how warrant structures reshape incentives.[17:16] Streaming and platforms: Disney, Netflix, Meta, Spotify Comparing balance sheets, valuation moves, and how AI could (or won’t) improve these business models.[21:18] Healthcare: GLP-1 price war dynamics What happens when insurance isn’t the payer, Novo vs Lilly pricing pressure, and why safety may be the more important “race” than speed of weight loss.[22:33] UnitedHealth, PBMs, and regulatory whack-a-mole The team discusses PBM vulnerability, potential margin shifts, and why fraud enforcement/data transparency could change incentives.[25:03] Longevity: Yamanaka factors and first-in-human study A look at Life Biosciences, organ “reprogramming” research, and how AI may accelerate earlier-stage discovery.[26:07] Hims & Hers vs Novo Nordisk: compounding, patents, and enforcement How shortages opened the door, where the envelope got pushed too far, and why IP protection underpins pharma innovation.[28:28] Cancer vaccines: additive, not replacing standard of care Why the highest-probability outcome is vaccines reducing recurrence post-treatment—and what that means for future cost and care intensity.[31:05] Grail’s early cancer detection study: promising theory, tough economics The study design trade-offs, funding constraints, and whether improved technology could revive the approach.[33:16] Wrap-up The crew signs off and previews next week—download the Cash Flow Memo and follow along with the exhibits for deeper context.If you found this helpful, like, subscribe, and share the episode—and grab the Cash Flow Memo so you can track the numbers alongside the discussion.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

SHOWNOTESThis week on Telltales, Mike, Jason, and Hunt move from energy market crosscurrents into an AI-driven “SaaSpocalypse,” then close with high-stakes healthcare updates—from Lilly’s trillion-dollar run to PBM reform and early cancer detection.[00:19] DisclaimerImportant investing and risk disclosure before the discussion begins.[00:29] Exhibit C: Oil, Iran, and Geopolitical RiskCrude holds in the mid-$60s as tensions around Iran and the Strait of Hormuz keep markets on edge. The team weighs U.S. posture, escalation scenarios, and what could force a near-term resolution.[03:00] Exhibit B: Natural Gas Backwardation and Permian PainNatural gas pricing looks oddly soft despite a strong winter for demand, while Waha trades negative through cold weather. The group discusses upcoming pipeline capacity and what it could mean for Henry Hub and Gulf Coast pricing.[04:36] Exhibit A: U.S. Finances, Defense Spending, and the FedA reality check on deficits, interest costs, and the limits of materially higher defense budgets. Hunt also discusses the Fed balance sheet, QT, and how lower short rates may not translate cleanly to long-bond relief.[08:35] SaaSpocalypse: How AI Disrupts Software and Who WinsThe cost of writing code collapses, UI becomes less central, and the market rethinks what a software company actually is. They debate moats, distribution, sales vs. engineering, and why “when AI works, we just call it software.”[12:21] Microsoft Office, File Formats, and Network EffectsIs the Office moat about features—or about interoperability and trust? Jason argues AI could dissolve file-format lock-in via on-the-fly conversion, while Mike counters that pros still need power tools and workflows.[17:11] Big Tech Capex and AI Inference DemandThey connect massive data center spend (Amazon, Alphabet, Microsoft, Meta, Oracle) to rising inference usage rather than just training. The team frames this as both opportunity and disruption risk for incumbent SaaS.[21:26] Is Tesla Overvalued? Robotaxis, Regulation, and RealityA hands-on Full Self-Driving trip shapes Jason’s view that the technology is “extremely close,” shifting the bottleneck to regulation. They discuss what has to happen for robotaxi economics to justify Tesla’s valuation.[24:18] Is Eli Lilly Overvalued? Weight Loss, Alzheimer’s, and Direct-to-ConsumerLilly’s trillion-dollar milestone meets a cash-flow and durability debate: long patent lives, strong execution, and a surprisingly large share of prescriptions flowing through a direct-pay platform.[26:00] PBMs in the CrosshairsA bipartisan proposal targets vertically integrated PBM structures, with the group arguing that PBMs’ share of drug economics is distorting incentives. They explain why breaking up the model could shift profit pools back toward drugmakers and patients.[27:29] Multi-Cancer Early Detection: Medicare Reimbursement PathA policy update on potential Medicare reimbursement starting in 2028 for blood-based early cancer detection tests. Jason explains the “needle in a haystack” science and why earlier detection could improve outcomes and lower total costs.[28:29] Vertex: Non-Opioid Pain and CF Competitive LandscapeThey review Vertex’s pain medicine data as a meaningful step toward reducing opioid use in acute settings. The conversation also touches CF innovation and why some competing mRNA approaches have recently stalled.[31:43] Harrow: CVS Formulary Coverage and Early SignalsHarrow lands CVS PBM formulary coverage and becomes the top prescribed dry-eye therapy within CVS workflows. Early prescription signals look promising, though the team notes data remains incomplete.[32:41] Lantheus: Management Reset and Thesis WatchA CEO change brings back leadership from the original investment era. They discuss pricing missteps, why the thesis may still hold, and what they’re watching next.[33:29] BioNTech vs Moderna: Cash Discipline and Vaccine EconomicsBioNTech’s cash preservation gets praise while Moderna navigates FDA review dynamics for its flu vaccine. A candid comment about U.S.-centric profitability highlights how much the U.S. subsidizes life-science innovation.Thanks for listening—download the latest Cash Flow Memo at telltales.us and subscribe for next week’s continued discussion on AI disruption, energy, and healthcare.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

SHOWNOTESThis week on Telltales, the team runs through the latest Cash Flow Memo and the three exhibits—U.S. government finances, natural gas, and oil—then closes with the massive Big Tech CapEx wave and what it means for chips, data centers, and geopolitics.[00:00] Welcome to Telltales + Cash Flow Memo overview Quick setup on the episode’s focus across energy, technology, and healthcare—and how to use the weekly memo alongside the exhibits.[00:19] Disclaimer Important investing and information-use disclaimer before the discussion begins.[00:35] Exhibit C: Oil supply/demand and the Iran “risk premium” Oil prices look meaningfully higher due to potential military action risk, with negotiations likely stretched out—keeping volatility elevated even if the base case is “status quo.”[02:00] Why WTI in the low-60s may persist The group discusses slower global demand growth (especially China) and how surplus capacity could take longer to work off, supporting a range-bound outlook despite the market’s inherent volatility.[03:08] Exhibit B: Natural gas—cold winter, but price disappointment Even with extreme weather, the gas strip remains below the hoped-for $4 level; the conversation centers on why demand isn’t the problem, and why supply growth keeps winning.[05:12] Gas-to-power, coal, and LNG policy shifts Coal plant dynamics, evolving renewable incentives, and LNG export growth (plus new authorizations) reshape the demand mix—while associated gas from the Permian continues to pressure the market.[08:31] Exhibit A: U.S. government cash flow and the rate/issuance puzzle The team discusses balance sheet drawdown ambitions, the risk of stressing long rates, and why Treasury might lean toward shorter maturities even as deficits remain large.[11:06] Page 17: FedEx, UPS, Nike, Costco, Lennar A quick pass on how China and global trade show up differently across logistics, sourcing-heavy consumer brands, retail supply chains, and homebuilding inputs.[12:52] Pages 5–6: Cable vs Telco competition heats up Charter/Comcast and AT&T/Verizon/T-Mobile are less China-exposed today, but face intensifying competition as cable pushes wireless and telcos push fiber and fixed wireless.[14:45] A wild card: SpaceX as a future “telco page” peer The team flags how Starlink could change the competitive landscape—especially for last-mile connectivity.[15:06] Page 16: Restaurants, beverages, and travel—how “international” matters McDonald’s, Starbucks, Chipotle, Celsius, and Hilton spark a discussion on global exposure, brand localization risk, and the long runway (or limits) for beverage expansion abroad.[16:56] Page 7: Payments—MasterCard, Visa, PayPal Why global card networks can be insulated from China in one sense (local payment ecosystems) while still benefiting from worldwide commerce growth.[17:36] Page 15: Pharma and biotech supply chains The group highlights China’s role in inputs and manufacturing, the incentives to reshore, and why smaller biotechs may keep outsourcing due to cost and cash constraints.[20:21] Page 8 + beyond: Retail sourcing and U.S. industrial “moats” Walmart/Target and home improvement retailers feel China most through goods sourcing, while industrial leaders (and aerospace suppliers) raise questions about competition, approvals, and future global demand.[22:51] Page 13: Banks and brokers—global exposure in context A quick look at JPMorgan, Morgan Stanley, Goldman Sachs, and Interactive Brokers—where international activity matters, but may not dominate cash flow.[24:27] Energy pages: why China isn’t the main factor here The group wraps the memo tour with a fast view of energy coverage and why China is less central for the companies highlighted.[25:48] Big Tech CapEx shock: $700B+ and what it implies Meta, Google, Amazon, Microsoft (and more) are spending at nation-GDP scale; the team debates what’s driving it, how it’s funded, and why “not spending it all” could even be market-positive.[26:41] Chips, capacity, and the TSMC bottleneck question If everyone depends on the same advanced manufacturing base, can supply keep up—and what does that mean for timelines, pricing power, and who benefits?[27:47] Data centers: land, regulation, and the real constraints Beyond chips, the discussion moves to land availability, state-level pushback, and how power procurement and cost allocation can shape where and how fast capacity gets built.[31:09] Cost anatomy of AI infrastructure and the “power isn’t the limiter” view A breakdown of what it takes to build data center capacity—power vs shells vs racks/chips—and why the group believes power can be built out if policy and incentives align.[33:26] Taiwan geopolitics and investing under uncertainty The team closes on Taiwan risk framing, long timelines, and why outcomes may be pursued only when “victory” is assured—military or political.If you’re using the Cash Flow Memo, drop a comment with the tickers you want covered next week—and subscribe so you don’t miss the next exhibit-driven deep dive.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

SHOWNOTESThis week on Telltales, the team connects the dots between macro headlines and the Cash Flow Memo—spanning energy markets, Fed policy, AI’s impact on software, and where China creates real business exposure across industries.[00:20] DisclaimerA quick reminder that the discussion is informational only and not investment advice.[00:45] Exhibit C: Oil Market SetupUS–Iran negotiations and potential sanctions relief could add supply, while shifting demand dynamics (including India) shape the medium-term oil price outlook.[05:06] Exhibit A: Deficits, the Fed, and a New Chair NarrativeA deep dive into the Federal Reserve balance sheet debate, quantitative tightening, and how policy credibility could ripple into rates, the dollar, and even gold/silver sentiment.[10:44] Space Update: Moon Mission + Space-Based Data CentersNASA’s upcoming moon mission sparks a broader conversation: could data centers move to space, and what are the real engineering constraints (heat, orbits, satellite scale)?[14:48] Software Selloff: Can AI Replace SaaS?The crew unpacks why big software names are under pressure—debating whether AI can truly “code on demand” and what moats still matter (support, mission-critical workflows, and systems of record).[18:11] China Impact (Page 20): Consumer Platforms + Supply Chain RealityA quick scan of consumer-facing businesses and where China matters more through sourcing, manufacturing, and supply chain fragility than direct revenue.[19:16] China Impact (Page 1): Apple and Tesla as the BookendsWhy Apple’s manufacturing footprint and China sales exposure remain central—and how Tesla’s China production influences the risk profile.[21:07] Healthcare Focus (Page 19): Big Pharma vs China’s Rising Biotech StackA practical look at how China is integrating across pharma supply chains (generics, CDMOs/CROs, biologics), and why that could evolve into true competitive pressure over time.[23:40] China Impact (Page 2): Cloud + Model Access StrategyOracle, OpenAI financing, and the logic behind AWS positioning as an aggregator of multiple models—versus single-model platform tie-ups.[26:15] China Impact (Page 18): Copper, Lithium, Solar, and the Energy TransitionHow China’s role in solar equipment, lithium refining, and battery production filters into commodities and utilities—and why lithium refining capacity is becoming strategically important.[31:11] Wrap + Next WeekClosing thoughts and a preview of next week’s episode—plus a note on upcoming additions to the pages as new public market names emerge.If you’re using the Cash Flow Memo alongside the episode, download it, follow along by page, and share the show with an investor friend who cares about fundamentals, cash flow, or sailing.SHOWNOTESThis week on Telltales, the team connects the dots between macro headlines and the Cash Flow Memo—spanning energy markets, Fed policy, AI’s impact on software, and where China creates real business exposure across industries.[00:20] DisclaimerA quick reminder that the discussion is informational only and not investment advice.[00:45] Exhibit C: Oil Market SetupUS–Iran negotiations and potential sanctions relief could add supply, while shifting demand dynamics (including India) shape the medium-term oil price outlook.[05:06] Exhibit A: Deficits, the Fed, and a New Chair NarrativeA deep dive into the Federal Reserve balance sheet debate, quantitative tightening, and how policy credibility could ripple into rates, the dollar, and even gold/silver sentiment.[10:44] Space Update: Moon Mission + Space-Based Data CentersNASA’s upcoming moon mission sparks a broader conversation: could data centers move to space, and what are the real engineering constraints (heat, orbits, satellite scale)?[14:48] Software Selloff: Can AI Replace SaaS?The crew unpacks why big software names are under pressure—debating whether AI can truly “code on demand” and what moats still matter (support, mission-critical workflows, and systems of record).[18:11] China Impact (Page 20): Consumer Platforms + Supply Chain RealityA quick scan of consumer-facing businesses and where China matters more through sourcing, manufacturing, and supply chain fragility than direct revenue.[19:16] China Impact (Page 1): Apple and Tesla as the BookendsWhy Apple’s manufacturing footprint and China sales exposure remain central—and how Tesla’s China production influences the risk profile.[21:07] Healthcare Focus (Page 19): Big Pharma vs China’s Rising Biotech StackA practical look at how China is integrating across pharma supply chains (generics, CDMOs/CROs, biologics), and why that could evolve into true competitive pressure over time.[23:40] China Impact (Page 2): Cloud + Model Access StrategyOracle, OpenAI financing, and the logic behind AWS positioning as an aggregator of multiple models—versus single-model platform tie-ups.[26:15] China Impact (Page 18): Copper, Lithium, Solar, and the Energy TransitionHow China’s role in solar equipment, lithium refining, and battery production filters into commodities and utilities—and why lithium refining capacity is becoming strategically important.[31:11] Wrap + Next WeekClosing thoughts and a preview of next week’s episode—plus a note on upcoming additions to the pages as new public market names emerge.If you’re using the Cash Flow Memo alongside the episode, download it, follow along by page, and share the show with an investor friend who cares about fundamentals, cash flow, or sailing.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com

SHOWNOTESIn this special “Cashflow Pick’em” edition, the team runs through the Cash Flow Memo and drafts the companies they think will grow free cash flow the most (percentage basis). Along the way, they hit the latest in oil and natural gas, then pivot into healthcare policy and the AI-driven semiconductor buildout.[00:32] Disclaimer Investment discussion for informational purposes only; do your own work before making any decisions.[00:42] Exhibits A–C: Oil, Gas, and U.S. Fiscal Process Oil firms up on geopolitical risk, natural gas rebounds sharply amid cold-weather pricing, and the team notes progress on U.S. spending bills and budgeting timelines.[05:26] Page 9: Energy Majors and LNG Hunt makes his pick among XOM, CVX, COP, OXY, and LNG—favoring LNG on capacity execution and positioning despite broader LNG supply concerns.[05:59] Page 10: Midstream Showdown On KMI, EPD, ET, WES, and ONEOK, Hunt leans toward EPD for integration and consistent operating performance.[06:19] Page 11: Upstream Discipline Test With oil down meaningfully, Hunt selects EOG as the most disciplined operator best suited to manage a tougher commodity tape.[06:45] Page 12: Natural Gas Producers and Midstream Weighing AR, EQT, CHK, and AM, Hunt calls it close but lands on AR, citing solid positioning and management.[08:01] Page 13: Banks and Brokers Jason and Mike both pick IBKR (and note broad AI agreement), while Hunt goes contrarian with GS; they discuss how buybacks vs. organic growth can drive FCF outcomes.[09:11] Page 14: Industrials and Aerospace Jason picks TDG on aircraft production recovery, Mike sticks with GNRC, and Hunt picks CAT—highlighting end-market sensitivity and where operating leverage may show up.[10:01] Healthcare: Big Pharma and Biotech Picks Jason picks LNTH (new prostate diagnostic and Alzheimer’s imaging growth), Mike picks VRTX, and they recap last year’s surprising winner and how baselines can distort growth rates.[11:34] Page 16: Consumer, Restaurants, and Beverage Jason and Mike align on CELH (including growth from Alani Nu), while Hunt goes with CMG and discusses leadership changes and brand durability.[13:28] Page 17: Logistics, Retail, and Housing Jason sticks with FDX (including a thesis around USPS services), while Mike and Hunt pick LEN—framing potential tailwinds for homebuilding and affordability dynamics.[15:01] Page 18: Materials, Fertilizer, and Utilities The team debates FCX vs. ALB vs. CF vs. NEE, focusing on lithium snapback potential, copper strength, and commodity-linked cashflow volatility.[17:05] Page 19: Managed Care and Pharma Giants With UNH, CVS, REGN, and LLY, the group converges on LLY again—weight-loss and Alzheimer’s themes dominate the discussion.[18:41] Page 20: Platforms, Delivery, Travel, and Small-Cap Healthcare Jason and Mike pick HROW again as commercialization scales, while Hunt chooses UBER, arguing the market may be underestimating Uber’s moat as autonomy ramps.[20:20] Scoreboard and Pick Recap They tally results (including AI agents) and reflect on where each host’s picks were strongest vs. weakest.[21:08] Healthcare Policy: PBM Reform and Incentives Jason breaks down PBM-related provisions affecting Medicare Part D incentives and rebates, plus how workarounds (e.g., GPO structures) can blunt intended reforms.[23:05] Administration, FDA Direction, and System-Level Change The team argues that structural regulatory changes to food/health oversight may be more durable than headline-grabbing controversies, emphasizing long-term consumer impact.[26:36] Semiconductors: ASML Bookings and the Capex Reality Check They interpret strong ASML bookings as evidence the AI infrastructure buildout remains real, then discuss TSM capacity constraints, Intel’s catch-up spend, and why partners seek second sources.[29:10] China, Taiwan Risk, and the Next Topic Arc A forward-looking setup for deeper China/Taiwan discussion across the memo universe, with a reading plug for Apple in China and how policy risk filters through real businesses.Thanks for listening. If you want the updated Cash Flow Memo and exhibits, download it at the podcast site—then drop a comment with your own “Pick’em” winners and what data you’re watching this year.This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com